{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Cerezyme in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cerezyme"]], "act": "question"}]}
{"index": 1, "text": "what version of Cerezyme is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Cerezyme", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Lisinopril", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lisinopril"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "storage instructions for drug Lisinopril", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does PROMETHEGAN cause anxiety?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PROMETHEGAN"], ["<symptom>", "anxiety"]], "act": "question"}]}
{"index": 1, "text": "anxiety is a dangerous side effect of PROMETHEGAN. Central Nervous System Drowsiness is the most prominent CNS effect of this drug. Sedation, somnolence, blurred vision, dizziness; confusion, disorientation, and extrapyramidal symptoms such as oculogyric crisis, torticollis, and tongue protrusion; lassitude, tinnitus, incoordination, fatigue, euphoria, nervousness, diplopia, insomnia, tremors, convulsive seizures, excitation, catatonic-like states, hysteria. Hallucinations have also been reported. Cardiovascular \u2013 Increased or decreased blood pressure, tachycardia, bradycardia, faintness. Dermatologic \u2013 Dermatitis, photosensitivity, urticaria. Hematologic \u2013 Leukopenia, thrombocytopenia, thrombocytopenic purpura, agranulocytosis. Gastrointest", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Prevalite", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Prevalite"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant depression", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "depression"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "depression is a mild side effect of Prevalite. The most common adverse reaction is constipation. When used as a cholesterol-lowering agent, predisposing factors for most complaints of constipation are high dose and increased age (more than 60 years old). Most instances of constipation are mild, transient and controlled with conventional therapy. Some patients require a temporary decrease in dosage or discontinuation of therapy. Less Frequent Adverse Reactions: Abdominal discomfort and/or pain, flatulence, nausea, vomiting, diarrhea, eructation, anorexia, steatorrhea, bleeding tendencies due to hypoprothrombinemia (Vitamin K deficiency) as well as Vitamin A (one case of night blindness reported) and D deficiencies, hyperchloremic acidosis", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "Should I take Amiodarone?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amiodarone"]], "act": "question"}]}
{"index": 0, "text": "Amiodarone may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "glaucoma", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "inform"}]}
{"index": 1, "text": "Adverse reactions have been very common in virtually all series of patients treated with amiodarone for ventricular arrhythmias with relatively large doses of drug (400 mg/day and above), occurring in about three-fourths of all patients and causing discontinuation in 7 to 18%. The most serious reactions are pulmonary toxicity, exacerbation of arrhythmia, and rare serious liver injury (see \" WARNINGS \" ), but other adverse effects constitute important problems. They are often reversible with dose reduction or cessation of amiodarone treatment. Most of the adverse effects appear to become more frequent with continued treatment beyond six months, although rates appear to remain relatively const", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Albumin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Albumin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take Loxapine?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Loxapine"]], "act": "question"}]}
{"index": 0, "text": "Loxapine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "anxiety", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "inform"}]}
{"index": 1, "text": "CNS Effects: Manifestations of adverse effects on the central nervous system, other than extrapyramidal effects, have been seen infrequently. Drowsiness, usually mild, may occur at the beginning of therapy or when dosage is increased. It usually subsides with continued loxapine therapy. The incidence of sedation has been less than that of certain aliphatic phenothiazines and slightly more than the piperazine phenothiazines. Dizziness, faintness, staggering gait, shuffling gait, muscle twitching, weakness, insomnia, agitation, tension, seizures, akinesia, slurred speech, numbness, and confusional states have been reported. Neuroleptic malignant syndrome (NMS) has been reported (see WARNINGS )", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant tourettes", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant AMIDATE\u2122", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "AMIDATE\u2122"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what are the ingredients of IMPOYZ?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "IMPOYZ"]], "act": "question"}]}
{"index": 0, "text": "what version of IMPOYZ is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Clobetasol Propionate,Butylated Hydroxytoluene,Cetostearyl Alcohol,Cyclomethicone,Diethylene Glycol Monoethyl Ether,Isopropyl Myristate,Methylparaben,Propylparaben,White Wax,Glyceryl Monostearate,PEG-100 Stearate,Water", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Carbidopa?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Carbidopa"]], "act": "question"}]}
{"index": 1, "text": "what version of Carbidopa is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Carbidopa and levodopa extended-release tablet contains carbidopa and levodopa in a 1:4 ratio as either the 50 mg/200 mg tablet or the 25 mg/100 mg tablet. The daily dosage of carbidopa and levodopa extended-release tablets must be determined by careful titration. Patients should be monitored closely during the dose adjustment period, particularly with regard to appearance or worsening of involuntary movements, dyskinesias or nausea. Carbidopa and levodopa extended-release tablets should not be chewed or crushed. Standard drugs for Parkinson's disease, other than levodopa without a decarboxylase inhibitor, may be used concomitantly while carbidopa and levodopa extended-release tablet is bein", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Ursodiol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ursodiol"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Indapamide in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Indapamide"]], "act": "question"}]}
{"index": 1, "text": "what version of Indapamide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Indapamide", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant Aktipak", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Aktipak"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Lorazepam?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lorazepam"]], "act": "question"}]}
{"index": 1, "text": "Lorazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The effectiveness of lorazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "does Erythromycin cause itchy_skin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Erythromycin"], ["<symptom>", "itchy_skin"]], "act": "question"}]}
{"index": 0, "text": "itchy_skin is a mild side effect of Erythromycin. The most frequent side effects of oral erythromycin preparations are gastrointestinal and are dose-related. They include nausea, vomiting, abdominal pain, diarrhea and anorexia. Symptoms of hepatitis, hepatic dysfunction and/or abnormal liver function test results may occur (see WARNINGS ). Onset of pseudomembranous colitis symptoms may occur during or after antibacterial treatment (see WARNINGS ). Erythromycin has been associated with QT prolongation and ventricular arrhythmias, including ventricular tachycardia and torsade de pointes (see WARNINGS ). Allergic reactions ranging from urticaria to anaphylaxis have occurred. Skin reactions ranging from mild eruptions to erythema multiforme, St", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "what is the dose for Midodrine?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Midodrine"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of Midodrine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Midodrine is 4 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant baby", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant Lac-Hydrin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lac-Hydrin"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what is in Gemfibrozil?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Gemfibrozil"]], "act": "question"}]}
{"index": 0, "text": "what version of Gemfibrozil is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "SILICON DIOXIDE,CROSCARMELLOSE SODIUM,CALCIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,METHYLCELLULOSE (15 CPS),HYPROMELLOSE 2910 (3 MPA.S),HYPROMELLOSE 2910 (6 MPA.S),POLYETHYLENE GLYCOL 400,POLYSORBATE 80,GEMFIBROZIL", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is bruising a common side effect of 5%?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "5%"], ["<symptom>", "bruising"]], "act": "question"}]}
{"index": 1, "text": "bruising is a common side effect of 5%. Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. Too rapid infusion of hypertonic solutions may cause local pain and venous irritation. Rate of administration should be adjusted according to tolerance. Use of the largest peripheral vein and a small bore needle is recommended. (See DOSAGE AND ADMINISTRATION .) Symptoms may result from an excess or deficit of one or more of the ions present in the solution; therefore, frequent monitoring of electrolyte levels is essential. Hypernatremia may be asso", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the side effects of Lidocaine?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of Lidocaine: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "hallucinations", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "hallucinations"]], "act": "inform"}]}
{"index": 1, "text": "hallucinations is a dangerous side effect of Lidocaine. Localized Reactions: During or immediately after treatment with lidocaine and prilocaine cream on intact skin, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation. Rare cases of discrete purpuric or petechial reactions at the application site have been reported. Rare cases of hyperpigmentation following the use of lidocaine and prilocaine cream have been reported. The relationship to lidocaine and prilocaine cream or the underlying procedure has not been established. In clinical studies on intact skin involving over 1,300 lidocaine and prilocaine cream-treated subjects, one or more such local reactions were noted in 56% of patients, and w", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Potassium safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "question"}]}
{"index": 1, "text": "Potassium may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "liver_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "inform"}]}
{"index": 2, "text": "One of the most severe adverse effects is hyperkalemia (see CONTRAINDICATIONS , WARNINGS and OVERDOSAGE ). There have also been reports of upper and lower gastrointestinal conditions including obstruction, bleeding, ulceration, and perforation (see CONTRAINDICATIONS and WARNINGS ). The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. These symptoms are due to irritation of the gastrointestinal tract and are best managed by diluting the preparation further, taking the dose with meals or reducing the amount taken at one time.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant OXYCODONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "OXYCODONE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant glaucoma", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Albuterol?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Albuterol"]], "act": "question"}]}
{"index": 1, "text": "Albuterol Sulfate Syrup is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant NAPROXEN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "NAPROXEN"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Carefully consider the potential benefits and risks of naproxen delayed-release tablets and other treatment options before deciding to use naproxen delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Naproxen delayed-release tablets are indicated: For the relief of the signs and symptoms of rheumatoid arthritis For the relief of the signs and symptoms of osteoarthritis For the relief of the signs and symptoms of ankylosing spondylitis For the relief of the signs and symptoms of juvenile arthritis Naproxen as naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain t", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Ropivacaine cause itchy_skin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ropivacaine"], ["<symptom>", "itchy_skin"]], "act": "question"}]}
{"index": 0, "text": "itchy_skin is a mild side effect of Ropivacaine. Reactions to ropivacaine are characteristic of those associated with other amide-type local anesthetics. A major cause of adverse reactions to this group of drugs may be associated with excessive plasma levels, which may be due to overdosage, unintentional intravascular injection or slow metabolic degradation. The reported adverse events are derived from clinical studies conducted in the U.S. and other countries. The reference drug was usually bupivacaine. The studies used a variety of premedications, sedatives, and surgical procedures of varying length. A total of 3,988 patients have been exposed to ropivacaine hydrochloride at concentrations up to 1% in clinical trials. Each patient was co", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant vomiting", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant Ampicillin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ampicillin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "vomiting is a serious side effect of Ampicillin. Adult Patients Ampicillin and sulbactam for injection is generally well tolerated. The following adverse reactions have been reported in clinical trials. Local Adverse Reactions Pain at IM injection site \u2013 16% Pain at IV injection site \u2013 3% Thrombophlebitis \u2013 3% Phlebitis \u2013 1.2% Systemic Adverse Reactions The most frequently reported adverse reactions were diarrhea in 3% of the patients and rash in less than 2% of the patients. Additional systemic reactions reported in less than 1% of the patients were: itching, nausea, vomiting, candidiasis, fatigue, malaise, headache, chest pain, flatulence, abdominal distension, glossitis, urine retention, dysuria, edema, facial swelling, erythema, chills", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "what is the dose for Phenazopyridine?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Phenazopyridine"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 1, "text": "what version of Phenazopyridine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Phenazopyridine is 3 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant elderly", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant AMOXICILLIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "AMOXICILLIN"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for AMOXICILLIN is 4 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "does Cabergoline contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cabergoline"]], "act": "question"}]}
{"index": 0, "text": "what version of Cabergoline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "CABERGOLINE,LEUCINE,LACTOSE,MAGNESIUM STEARATE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what do I do with Cyproheptadine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cyproheptadine"]], "act": "question"}]}
{"index": 0, "text": "what version of Cyproheptadine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND THE RESPONSE OF THE PATIENT. Although intended primarily for administration to children, the syrup is also used for administration to adults who cannot swallow tablets. Children: The total daily dosage for children may be calculated on the basis of body weight or body area using approximately 0.25 mg/kg/day (0.11 mg/lb/day) or 8 mg per square meter of body surface (8 mg/m 2 ). Age 2 to 6 years: The usual dose is 2 mg (one teaspoonful) two or three times a day, adjusted as necessary to the size and response of the patient. The dose is not to exceed 12 mg a day. Age 7 to 14 years: The usual dose is 4 mg (two teaspoonsful) two or three ", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Sterile", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sterile"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "FOR INTRAVENOUS ADMINISTRATION ONLY. Dosage recommendations for closure of the ductus arteriosus depend on the age of the infant at the time of therapy. A course of therapy is defined as three intravenous doses of indomethacin for injection given at 12-24 hour intervals, with careful attention to urinary output. If anuria or marked oliguria (urinary output <0.6 mL/kg/hr) is evident at the scheduled time of the second or third dose of indomethacin for injection, no additional doses should be given until laboratory studies indicate that renal function has returned to normal (see WARNINGS , Renal Effects ). Dosage according to age is as follows: AGE at 1st dose DOSAGE (mg/kg) Less than 48 hours", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "What is DILANTIN?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DILANTIN"]], "act": "question"}]}
{"index": 0, "text": "Dilantin is indicated for the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. Phenytoin serum level determinations may be necessary for optimal dosage adjustments (see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY sections).", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Carnitor  if I am tourettes?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Carnitor"], ["<condition>", "tourettes"]], "act": "question"}]}
{"index": 1, "text": "Various mild gastrointestinal complaints have been reported during the long-term administration of oral L- or D,L-carnitine; these include transient nausea and vomiting, abdominal cramps, and diarrhea. Mild myasthenia has been described only in uremic patients receiving D,L-carnitine. Gastrointestinal adverse reactions with CARNITOR  (levocarnitine) Oral Solution or CARNITOR  SF (levocarnitine) Sugar-Free Oral Solution dissolved in liquids might be avoided by a slow consumption of the solution or by a greater dilution. Decreasing the dosage often diminishes or eliminates drug-related patient body odor or gastrointestinal symptoms when present. Tolerance should be monitored very closely durin", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "can i take Proparacaine?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Proparacaine"]], "act": "question"}]}
{"index": 0, "text": "Proparacaine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "pregnant", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "inform"}]}
{"index": 1, "text": "Occasional temporary stinging, burning and conjunctival redness may occur with the use of proparacaine. A rare, severe, immediate-type, apparently hyperallergic corneal reaction characterized by acute, intense and diffuse epithelial keratitis, a gray, ground glass appearance, sloughing of large areas of necrotic epithelium, corneal filaments and sometimes iritis with descemetitis has been reported. Allergic contact dermatitis from proparacaine with drying and fissuring of the fingertips has been reported. To report SUSPECTED ADVERSE REACTIONS, contact Bausch + Lomb, a division of Valeant Pharmaceuticals North America LLC, at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use SOLU-MEDROL?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SOLU-MEDROL"]], "act": "question"}]}
{"index": 0, "text": "what version of SOLU-MEDROL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "NOTE: Some of the SOLU-MEDROL formulations contain benzyl alcohol (see DESCRIPTION , WARNINGS and PRECAUTIONS, Pediatric Use ) Because of possible physical incompatibilities, SOLU-MEDROL should not be diluted or mixed with other solutions. Use only the accompanying diluent or Bacteriostatic Water For Injection with Benzyl Alcohol when reconstituting SOLU-MEDROL (see DESCRIPTION ). Use within 48 hours after mixing. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. This preparation may be administered by intravenous injection, by intravenous infusion, or by intramuscular injection, the", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant LEVOCARNITINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "LEVOCARNITINE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Levocarnitine Injection, USP is administered intravenously. Metabolic Disorders: The recommended dose is 50 mg/kg given as a slow 2 to 3 minute bolus injection or by infusion. Often a loading dose is given in patients with severe metabolic crisis, followed by an equivalent dose over the following 24 hours. It should be administered every 3 hours or every 4 hours, and never less than every 6 hours either by infusion or by intravenous injection. All subsequent daily doses are recommended to be in the range of 50 mg/kg or as therapy may require. The highest dose administered has been 300 mg/kg. It is recommended that a plasma carnitine concentration be obtained prior to beginning this parentera", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "how do I store Diclofenac?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Diclofenac"]], "act": "question"}]}
{"index": 0, "text": "what version of Diclofenac is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Diclofenac", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "What is 50%?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "50%"]], "act": "question"}]}
{"index": 0, "text": "50% Dextrose Injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels. The solution is also indicated, after dilution, for intravenous infusion as a source of carbohydrate calories in patients whose oral intake is restricted or inadequate to maintain nutritional requirements. Slow infusion of hypertonic solutions is essential to insure proper utilization of dextrose and avoid production of hyperglycemia.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "what is in Nisoldipine?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nisoldipine"]], "act": "question"}]}
{"index": 0, "text": "what version of Nisoldipine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "NISOLDIPINE,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (1200000 MW),HYPROMELLOSE, UNSPECIFIED,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,FD&C BLUE NO. 2,FD&C YELLOW NO. 6,TRIACETIN,POLYDEXTROSE,POLYETHYLENE GLYCOL, UNSPECIFIED,TITANIUM DIOXIDE,NISOLDIPINE,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (1200000 MW),HYPROMELLOSE, UNSPECIFIED,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,TRIACETIN,POLYDEXTROSE,POLYETHYLENE GLYCOL, UNSPECIFIED,FERRIC OXIDE RED,TITANIUM DIOXIDE,FERRIC OXIDE YELLOW,NISOLDIPINE,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (1200000 MW),HYPROMELLOSE, UNSPECIFIED,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,D&C YELLOW NO. 10,FD&C BLUE NO. 2,FD&C YELLOW NO. 6,POLYDEXTROSE,POLYETHYLENE GLYCOL, UNSPECI", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Cholestyramine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cholestyramine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Kit?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Kit"]], "act": "question"}]}
{"index": 1, "text": "Technetium Tc 99m Mebrofenin is indicated as a hepatobiliary imaging agent.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Acetaminophen", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Acetaminophen"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Acetaminophen and codeine phosphate tablets are indicated for the relief of mild to moderately severe pain.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is CYCLOBENZAPRINE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CYCLOBENZAPRINE"]], "act": "question"}]}
{"index": 0, "text": "Cyclobenzaprine hydrochloride tablets are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living. Cyclobenzaprine hydrochloride tablets should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer p", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant ADAPALENE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ADAPALENE"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Adapalene Gel is indicated for the topical treatment of acne vulgaris.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "can i take Hydrocortisone?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrocortisone"]], "act": "question"}]}
{"index": 0, "text": "Hydrocortisone may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "pregnant", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "inform"}]}
{"index": 1, "text": "The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria. To report SUSPECTED ADVERSE REACTIONS, contact Crown Laboratories, Inc. at 1-423-926-4413 or FDA at 1-800-FDA-1088 or https://www.fda.gov/Safety/MedWatch/", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Potassium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant pregnant", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Abdominal discomfort, diarrhea, vomiting, and nausea are the most common adverse reactions to oral potassium supplements. These adverse reactions occur most frequently when the preparation is not taken with food, is not properly diluted, or not completely dissolved. Hyperkalemia occurs infrequently in patients with normal renal function who receive oral potassium supplements. The following are symptoms of hyperkalemia: mental confusion, unexplained anxiety, cardiac arrhythmias, numbness or tingling in lips, feet, or hands, difficult breathing or shortness of breath, weakness or heaviness of legs, and unusual fatigue or weakness. (See Contraindications, Warnings, and Overdosage).", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Gabapentin  for someone with anxiety?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Gabapentin"], ["<condition>", "anxiety"]], "act": "question"}]}
{"index": 1, "text": "The following serious adverse reactions are discussed in greater detail in other sections: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity [see Warnings and Precautions ( 5.1 )] Anaphylaxis and Angioedema [see Warnings and Precautions ( 5.2 )] Somnolence/Sedation and Dizziness [see Warnings and Precautions ( 5.4 )] Withdrawal Precipitated Seizure, Status Epilepticus [see Warnings and Precautions ( 5.5 )] Suicidal Behavior and Ideation [see Warnings and Precautions ( 5.6 )] Neuropsychiatric Adverse Reactions (Pediatric Patients 3-12 Years of Age) [see Warnings and Precautions ( 5.7 )] Sudden and Unexplained Death in Patients with Epilepsy [ see Warnin", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Hydroxyzine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydroxyzine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Therapeutic doses of hydroxyzine seldom produce impairment of mental alertness. However, drowsiness may occur; if so, it is usually transitory and may disappear in a few days of continued therapy or upon reduction of the dose. Dryness of the mouth may be encountered at higher doses. Extensive clinical use has substantiated the absence of toxic effects on the liver or bone marrow when administered in the recommended doses for over four years of uninterrupted therapy. The absence of adverse effects has been further demonstrated in experimental studies in which excessively high doses were administered. Involuntary motor activity, including rare instances of tremor and convulsions, has been repo", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is benzonatate?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "benzonatate"]], "act": "question"}]}
{"index": 1, "text": "Benzonatate USP is indicated for the symptomatic relief of cough.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Diclofenac", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Diclofenac"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS: Gastrointestinal Bleeding, Ulceration and Perforation ). Diclofenac sodium delayed-release tablets are indicated:  For relief of the signs and symptoms of osteoarthritis  For relief of the signs and symptoms of rheumatoid arthritis  For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Paclitaxel?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Paclitaxel"]], "act": "question"}]}
{"index": 1, "text": "what version of Paclitaxel is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Paclitaxel", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant Sodium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sodium"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "storage instructions for drug Sodium", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have bruising with Metoprolol?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metoprolol"], ["<symptom>", "bruising"]], "act": "question"}]}
{"index": 1, "text": "bruising is a common side effect of Metoprolol. Hypertension and Angina These adverse reactions were reported for treatment with oral metoprolol tartrate. Most adverse effects have been mild and transient. Central Nervous System Tiredness and dizziness have occurred in about 10 of 100 patients. Depression has been reported in about 5 of 100 patients. Mental confusion and short-term memory loss have been reported. Headache, nightmares, and insomnia have also been reported. Cardiovascular Shortness of breath and bradycardia have occurred in approximately 3 of 100 patients. Cold extremities; arterial insufficiency, usually of the Raynaud type; palpitations; congestive heart failure; peripheral edema; and hypotension have been reported in abo", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Labetalol?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Labetalol"]], "act": "question"}]}
{"index": 0, "text": "Labetalol hydrochloride injection is indicated for control of blood pressure in severe hypertension.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "is bleeding a common side effect of Sumatriptan?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sumatriptan"], ["<symptom>", "bleeding"]], "act": "question"}]}
{"index": 0, "text": "bleeding is a common side effect of Sumatriptan. Serious cardiac events, including some that have been fatal, have occurred following the use of sumatriptan succinate injection or tablets. These events are extremely rare and most have been reported in patients with risk factors predictive of CAD. Events reported have included coronary artery vasospasm, transient myocardial ischemia, myocardial infarction, ventricular tachycardia, and ventricular fibrillation (see CONTRAINDICATIONS , WARNINGS , and PRECAUTIONS ) . Significant hypertensive episodes, including hypertensive crises, have been reported on rare occasions in patients with or without a history of hypertension (see WARNINGS ).", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have depression with GEMFIBROZIL?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "GEMFIBROZIL"], ["<symptom>", "depression"]], "act": "question"}]}
{"index": 1, "text": "depression is a serious side effect of GEMFIBROZIL. In the double-blind controlled phase of the primary prevention component of the Helsinki Heart Study, 2046 patients received gemfibrozil for up to five years. In that study, the following adverse reactions were statistically more frequent in subjects in the gemfibrozil group: Gemfibrozil (N=2046) PLACEBO (N=2035) Frequency in percent of subject Gastrointestinal reaction 34.2 23.8 Dyspepsia 19.6 11.9 Abdominal pain 9.8 5.6 Acute appendicitis (Histological confirmed in most cases where data were available) 1.2 0.6 Atrial fibrillation 0.7 0.1 Adverse event reported by more than 1% of subject, but without a significant difference between groups: Diarrhea 7.2 6.5 Fatigue 3.8 3.5 Nausea/Vomiting 2", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Diclofenac is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Diclofenac"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 2, "text": "what version of Diclofenac is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Diclofenac is 2 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant Tamoxifen", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Tamoxifen"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 6, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 7, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 7, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 8, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 8, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is fever a common side effect of ALLOPURINOL?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ALLOPURINOL"], ["<symptom>", "fever"]], "act": "question"}]}
{"index": 1, "text": "fever is a mild side effect of ALLOPURINOL. Data upon which the following estimates of incidence of adverse reactions are made are derived from experiences reported in the literature, unpublished clinical trials and voluntary reports since marketing of allopurinol began. Past experience suggested that the most frequent event following the initiation of allopurinol treatment was an increase in acute attacks of gout (average 6% in early studies). An analysis of current usage suggests that the incidence of acute gouty attacks has diminished to less than 1%. The explanation for this decrease has not been determined but may be due in part to initiating therapy more gradually (see PRECAUTIONS and DOSAGE AND ADMINISTRATION ). The most freque", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use NYSTATIN?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NYSTATIN"]], "act": "question"}]}
{"index": 1, "text": "what version of NYSTATIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "Very moist lesions are best treated with nystatin topical dusting powder.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Chlordiazepoxide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Chlordiazepoxide"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Because of the varied individual responses to tranquilizers and anticholinergics, the optimum dosage of Chlordiazepoxide HCl/Clidinium Bromide varies with the diagnosis and response of the individual patient. The dosage, therefore, should be individualized for maximum beneficial effects. The usual maintenance dose is 1 or 2 capsules, 3 or 4 times a day administered before meals and at bedtime.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Amantadine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amantadine"]], "act": "question"}]}
{"index": 1, "text": "what version of Amantadine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "The dose of amantadine hydrochloride capsules may need reduction in patients with congestive heart failure, peripheral edema, orthostatic hypotension, or impaired renal function (see Dosage for Impaired Renal Function ).", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Pravastatin in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Pravastatin"]], "act": "question"}]}
{"index": 1, "text": "what version of Pravastatin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Pravastatin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Timolol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Timolol"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "storage instructions for drug Timolol", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is the dose for ProCentra?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ProCentra"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 1, "text": "what version of ProCentra is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for ProCentra is 3 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Orphenadrine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Orphenadrine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Orphenadrine is 3 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is fever a common side effect of Minocycline?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Minocycline"], ["<symptom>", "fever"]], "act": "question"}]}
{"index": 0, "text": "fever is a dangerous side effect of Minocycline. Due to oral minocycline\u2019s virtually complete absorption, side effects to the lower bowel, particularly diarrhea, have been infrequent. The following adverse reactions have been observed in patients receiving tetracyclines. Body as a whole: Fever, and discoloration of secretions. Gastrointestinal : Anorexia, nausea, vomiting, diarrhea, dyspepsia, stomatitis, glossitis, dysphagia, enamel hypoplasia, enterocolitis, pseudomembranous colitis, pancreatitis, inflammatory lesions (with monilial overgrowth) in the oral and anogenital regions. Instances of esophagitis and esophageal ulcerations have been reported in patients taking the tetracycline-class antibiotics in capsule and tablet form. Most of", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant Brimonidine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Brimonidine"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Trientine in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Trientine"]], "act": "question"}]}
{"index": 1, "text": "what version of Trientine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Trientine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "what are the ingredients of CHLOROQUINE?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CHLOROQUINE"]], "act": "question"}]}
{"index": 0, "text": "what version of CHLOROQUINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "CHLOROQUINE PHOSPHATE,SILICON DIOXIDE,ANHYDROUS DIBASIC CALCIUM PHOSPHATE,HYPROMELLOSES,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POLYETHYLENE GLYCOL,POLYSORBATE 80,STARCH, CORN,SODIUM STARCH GLYCOLATE TYPE A POTATO,TITANIUM DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Taclonex", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Taclonex"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "CALCIPOTRIENE HYDRATE,BETAMETHASONE DIPROPIONATE,.ALPHA.-TOCOPHEROL, DL-,MINERAL OIL,PETROLATUM,PPG-11 STEARYL ETHER,BUTYLATED HYDROXYTOLUENE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "how do I take PIROXICAM?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PIROXICAM"]], "act": "question"}]}
{"index": 0, "text": "what version of PIROXICAM is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "Carefully consider the potential benefits and risks of piroxicam and other treatment options before deciding to use piroxicam. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [ see Warnings and Precautions ( 5 )] . After observing the response to initial therapy with piroxicam, the dose and frequency should be adjusted to suit an individual patient\u2019s needs. For the relief of rheumatoid arthritis and osteoarthritis, the dosage is 20 mg given orally once per day. If desired, the daily dose may be divided. Because of the long half-life of piroxicam, steady-state blood levels are not reached for 7 to 12 days. Therefore, although the th", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "what is in LINDANE?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LINDANE"]], "act": "question"}]}
{"index": 0, "text": "what version of LINDANE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Lindane,acetone,polysorbate 60,trolamine lauryl sulfate,water,hydrochloric acid,Sodium Hydroxide", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Metronidazole", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Metronidazole"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "METRONIDAZOLE,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (TYPE H),MICROCRYSTALLINE CELLULOSE,STARCH, CORN,SODIUM STARCH GLYCOLATE TYPE A POTATO,STEARIC ACID,METRONIDAZOLE,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (TYPE H),MICROCRYSTALLINE CELLULOSE,STARCH, CORN,SODIUM STARCH GLYCOLATE TYPE A POTATO,STEARIC ACID", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Nitroglycerin safe  for someone with liver_problems?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nitroglycerin"], ["<condition>", "liver_problems"]], "act": "question"}]}
{"index": 1, "text": "Headache which may be severe and persistent may occur immediately after use. Vertigo, weakness, palpitation and other manifestations of postural hypotension may develop occasionally, particularly in erect, immobile patients. Marked sensitivity to the hypotensive effects of nitrates (manifested by nausea, vomiting, weakness, diaphoresis, pallor and collapse) may occur at therapeutic doses. Syncope due to nitrate vasodilation has been reported. Flushing, drug rash, and exfoliative dermatitis have been reported in patients receiving nitrate therapy.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "What is Xylocaine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Xylocaine"]], "act": "question"}]}
{"index": 0, "text": "4% Xylocaine (lidocaine HCl) Topical Solution is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Thiamine in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Thiamine"]], "act": "question"}]}
{"index": 1, "text": "what version of Thiamine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Thiamine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many AcetaZOLAMIDE is the correct dose for a child?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "AcetaZOLAMIDE"], ["<age_group>", "child"]], "act": "question"}]}
{"index": 1, "text": "what version of AcetaZOLAMIDE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for AcetaZOLAMIDE is 2 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant AMOXICILLIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "AMOXICILLIN"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for AMOXICILLIN is 2 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 7, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is the dose for Sterile for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sterile"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 0, "text": "what version of Sterile is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Sterile is 4 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant OXALIPLATIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "OXALIPLATIN"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant 70", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for OXALIPLATIN is 4 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "is suicidal a common side effect of Calcipotriene?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Calcipotriene"], ["<symptom>", "suicidal"]], "act": "question"}]}
{"index": 0, "text": "suicidal is a serious side effect of Calcipotriene.  Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "how do I use Butalbital,?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Butalbital,"]], "act": "question"}]}
{"index": 0, "text": "what version of Butalbital, is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "One or 2 capsules every 4 hours. Total daily dose should not exceed 6 capsules. Extended and repeated use of this product is not recommended because of the potential for physical dependence.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Keveyis", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Keveyis"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Initiate dosing at 50 mg twice daily. The initial dose may be increased or decreased based on individual response, at weekly intervals (or sooner in case of adverse reaction). The maximum recommended total daily dose is 200 mg. Primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants are a heterogeneous group of conditions, for which the response to KEVEYIS may vary. Therefore, prescribers should evaluate the patient's response to KEVEYIS after 2 months of treatment to decide whether KEVEYIS should be continued.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Flucytosine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Flucytosine"]], "act": "question"}]}
{"index": 0, "text": "Flucytosine Capsules are indicated only in the treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus . Candida: Septicemia, endocarditis and urinary system infections have been effectively treated with flucytosine. Limited trials in pulmonary infections justify the use of flucytosine Cryptococcus: Meningitis and pulmonary infections have been treated effectively. Studies in septicemias and urinary tract infections are limited, but good responses have been reported. Flucytosine Capsules should be used in combination with amphotericin B for the treatment of systemic candidiasis and cryptococcosis because of the emergence of resistance to Flucytosine Capsu", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "how do I take Avalide?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Avalide"]], "act": "question"}]}
{"index": 0, "text": "what version of Avalide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Enter section text here", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "where should I keep Cabergoline?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cabergoline"]], "act": "question"}]}
{"index": 0, "text": "what version of Cabergoline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Cabergoline", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Naltrexone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Naltrexone"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how many Lidocaine is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 1, "text": "what version of Lidocaine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Lidocaine is 2 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant amoxicillin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "amoxicillin"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Daliresp?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Daliresp"]], "act": "question"}]}
{"index": 1, "text": "DALIRESP  is indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant CEFTRIAXONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CEFTRIAXONE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Before instituting treatment with ceftriaxone, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing. To reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection USP and other antibacterial drugs, ceftriaxone for injection USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial thera", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much NYSTATIN should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NYSTATIN"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of NYSTATIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for NYSTATIN is 4 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant child", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for NYSTATIN is 2 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take 1.5%  if I have TB?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "1.5%"], ["<condition>", "TB"]], "act": "question"}]}
{"index": 1, "text": "Adverse reactions may result from intravascular absorption of glycine. Large intravenous doses of glycine are known to cause salivation, nausea and lightheadedness. Other consequences of absorption of urologic irrigating solutions include fluid and electrolyte disturbances such as acidosis, electrolyte loss, marked diuresis, urinary retention, edema, dryness of mouth, thirst, dehydration, coma from hyponatremia, secondary hyponatremia due to fluid overload, and hyper- ammonemia with resultant coma and/or encephalopathy; cardiovascular disorders such as hypotension, tachycardia, angina-like pains; pulmonary disorders such as pulmonary congestion; and other general reactions such as blurred vi", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Metformin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Metformin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "In a U.S. double-blind clinical study of metformin hydrochloride tablets in patients with type 2 diabetes, a total of 141 patients received metformin hydrochloride tablets therapy (up to 2550 mg per day) and 145 patients received placebo. Adverse reactions reported in greater than 5% of the metformin hydrochloride tablets patients, and that were more common in metformin hydrochloride tablets- than placebo-treated patients, are listed in Table 7 . Table 7: Most Common Adverse Reactions (>5 Percent) in a Placebo-Controlled Clinical Study of Metformin Hydrochloride Tablets Monotherapy* Adverse Reaction Metformin Hydrochloride Tablets Monotherapy (n = 141) Placebo (n = 145) % of Patients * React", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Minolira?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Minolira"]], "act": "question"}]}
{"index": 1, "text": "MINOLIRA is indicated to treat the inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. Limitations of Use This formulation of minocycline has not been evaluated in the treatment of infections. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, MINOLIRA should be used only as indicated [see Warnings and Precautions ( 5.13 )].", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Levobunolol?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Levobunolol"]], "act": "question"}]}
{"index": 1, "text": "Levobunolol may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 2, "text": "In clinical trials the use of Levobunolol Hydrochloride Ophthalmic Solution has been associated with transient ocular burning and stinging in up to 1 in 3 patients, and with blepharoconjunctivitis in up to 1 in 20 patients. Decreases in heart rate and blood pressure have been reported (see CONTRAINDICATIONS and WARNINGS ). The following adverse reactions have been reported rarely with the use of Levobunolol Hydrochloride Ophthalmic Solution: iridocyclitis, headache, transient ataxia, dizziness, lethargy, urticaria and pruritus. Decreased corneal sensitivity has been noted in a small number of patients. Although levobunolol has minimal membrane-stabilizing activity, there remains a possibilit", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant liver_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "In clinical trials the use of Levobunolol Hydrochloride Ophthalmic Solution has been associated with transient ocular burning and stinging in up to 1 in 3 patients, and with blepharoconjunctivitis in up to 1 in 20 patients. Decreases in heart rate and blood pressure have been reported (see CONTRAINDICATIONS and WARNINGS ). The following adverse reactions have been reported rarely with the use of Levobunolol Hydrochloride Ophthalmic Solution: iridocyclitis, headache, transient ataxia, dizziness, lethargy, urticaria and pruritus. Decreased corneal sensitivity has been noted in a small number of patients. Although levobunolol has minimal membrane-stabilizing activity, there remains a possibilit", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Fluocinonide in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluocinonide"]], "act": "question"}]}
{"index": 1, "text": "what version of Fluocinonide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Fluocinonide", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Fluocinonide", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "is it normal to have itchy_skin with HYDROXYZINE?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROXYZINE"], ["<symptom>", "itchy_skin"]], "act": "question"}]}
{"index": 0, "text": "itchy_skin is a mild side effect of HYDROXYZINE. Side effects reported with the administration of hydroxyzine pamoate are usually mild and transitory in nature.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much Granisetron should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Granisetron"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 1, "text": "what version of Granisetron is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Granisetron is 3 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant 30", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Granisetron is 3 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 7, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is AMOXICILLIN?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "AMOXICILLIN"]], "act": "question"}]}
{"index": 1, "text": "Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY \u03b2-lactamase-negative) strains of the designated microorganisms in the conditions listed below: Infections of the ear, nose, and throat - due to Streptococcus spp. (\u03b1- and \u03b2-hemolytic strains only), S. pneumoniae , Staphylococcus spp., or H. influenzae. Infections of the genitourinary tract - due to E. coli , P. mirabilis , or E. faecalis. Infections of the skin and skin structure - due to Streptococcus spp. (\u03b1- and \u03b2-hemolytic strains only), Staphylococcus spp., or E. coli. Infections of the lower respiratory tract - due to Streptococcus spp. (\u03b1- and \u03b2-hemolytic strains only), S. pneumoniae , Staphylococcus spp.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Minocycline?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Minocycline"]], "act": "question"}]}
{"index": 1, "text": "what version of Minocycline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "THE USUAL DOSAGE AND FREQUENCY OF ADMINISTRATION OF MINOCYCLINE DIFFERS FROM THAT OF THE OTHER TETRACYCLINES. EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE OF SIDE EFFECTS. Minocycline hydrochloride tablets may be taken with or without food (see CLINICAL PHARMACOLOGY ). Ingestion of adequate amounts of fluids along with capsule and tablet forms of drugs in the tetracycline-class is recommended to reduce the risk of esophageal irritation and ulceration. The tablets should be swallowed whole. For Pediatric Patients Above 8 Years of Age Usual pediatric dose: 4 mg/kg initially followed by 2 mg/kg every 12 hours, not to exceed the usual adult dose. Adults The usual dosage ", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Calcipotriene", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Calcipotriene"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Cromolyn?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cromolyn"]], "act": "question"}]}
{"index": 1, "text": "what version of Cromolyn is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "CROMOLYN SODIUM,EDETATE DISODIUM,WATER,HYDROCHLORIC ACID,SODIUM HYDROXIDE,BENZALKONIUM CHLORIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "where should I keep Labetalol?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Labetalol"]], "act": "question"}]}
{"index": 0, "text": "what version of Labetalol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Labetalol", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Minocycline?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Minocycline"]], "act": "question"}]}
{"index": 1, "text": "Minocycline may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "anxiety", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "inform"}]}
{"index": 2, "text": "Due to oral minocycline\u2019s virtually complete absorption, side effects to the lower bowel, particularly diarrhea, have been infrequent. The following adverse reactions have been observed in patients receiving tetracyclines. Body as a Whole : Fever, and discoloration of secretions. Gastrointestinal : Anorexia, nausea, vomiting, diarrhea, dyspepsia, stomatitis, glossitis, dysphagia, enamel hypoplasia, enterocolitis, pseudomembranous colitis, pancreatitis, inflammatory lesions (with monilial overgrowth) in the oral and anogenital regions. Instances of esophagitis and esophageal ulcerations have been reported in patients taking the tetracycline-class antibiotics in capsule and tablet form. Most o", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant Revesta", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Revesta"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant heart_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Diclofenac?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Diclofenac"]], "act": "question"}]}
{"index": 1, "text": "what version of Diclofenac is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Carefully consider the potential benefits and risks of diclofenac sodium and misoprostol delayed-release tablets and other treatment options before deciding to use diclofenac sodium and misoprostol delayed-release tablets. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions (5) ]. After observing the response to initial therapy with diclofenac sodium and misoprostol delayed-release tablets, the dose and frequency should be adjusted to suit an individual patient\u2019s needs. For the relief of rheumatoid arthritis and osteoarthritis, the dosage is given below. Diclofenac sodium and misoprostol delayed-release ta", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant BETAMETHASONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "BETAMETHASONE"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Apply a thin film of Betamethasone Valerate Cream or Ointment to the affected skin areas one to three times a day. Dosage once or twice a day is often effective. Apply a few drops of Betamethasone Valerate Lotion to the affected area and massage lightly until it disappears. Apply twice daily, in the morning and at night. Dosage may be increased in stubborn cases. Following improvement, apply once daily. For the most effective and economical use, apply nozzle very close to affected area and gently squeeze bottle.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Metronidazole  if I have IBD?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metronidazole"], ["<condition>", "IBD"]], "act": "question"}]}
{"index": 1, "text": "In a controlled clinical trial, safety data from 141 patients who used Metronidazole Lotion Topical Lotion (n=71), or the lotion vehicle (n=70), twice daily and experienced a local cutaneous adverse event which may or may not have been related to the treatments include: local allergic reaction, Metronidazole Topical Lotion 2 (3%), lotion vehicle 0; contact dermatitis, Metronidazole Lotion Topical Lotion 2 (3%), lotion vehicle 1 (1%); pruritus, Metronidazole Lotion Topical Lotion 1 (1%), lotion vehicle 0; skin discomfort (burning and stinging), Metronidazole Lotion Topical Lotion 1 (1%), lotion vehicle 2 (3%); erythema, Metronidazole Lotion Topical Lotion 4 (6%), lotion vehicle 0; dry skin, M", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant liver_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is BUTALBITAL,?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BUTALBITAL,"]], "act": "question"}]}
{"index": 1, "text": "Butalbital, acetaminophen and caffeine tablets are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Nateglinide?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nateglinide"]], "act": "question"}]}
{"index": 1, "text": "Nateglinide Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is hallucinations a common side effect of Methergine?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methergine"], ["<symptom>", "hallucinations"]], "act": "question"}]}
{"index": 1, "text": "hallucinations is a serious side effect of Methergine. The most common adverse reaction is hypertension associated in several cases with seizure and/or headache. Hypotension has also been reported. Abdominal pain (caused by uterine contractions), nausea and vomiting have occurred occasionally. Rarely observed reactions have included: acute myocardial infarction, transient chest pains, vasoconstriction, vasospasm, coronary arterial spasm, bradycardia, tachycardia, dyspnea, hematuria, thrombophlebitis, water intoxication, hallucinations, leg cramps, dizziness, tinnitus, nasal congestion, diarrhea, diaphoresis, palpitation, rash, and foul taste. 1 There have been rare isolated reports of anaphylaxis, without a proven causal relationship to the drug", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Clindamycin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Clindamycin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant aggression", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "aggression"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "aggression is a serious side effect of Clindamycin. In 18 clinical studies of various formulations of clindamycin phosphate using placebo vehicle and/or active comparator drugs as controls, patients experienced a number of treatment emergent adverse dermatologic events [see table below]. Number of Patients Reporting Events Treatment Emergent Adverse Event Solution n=553(%) Gel N=148(%) Suspension N=160(%) Burning 62(11) 15(10) 17(11) Itching 36(7) 15(10) 17(11) Burning/Stinging 60(11) not recorded (-) (-) Dryness 105(19) 34(23) 29(18) Erythema 86(16) 10(7) 22(14) Oiliness/Oily Skin 8(1) 26(18) 12 of 126 subjects (10) Peeling 61(11) (-) 11(7) Orally and parenterally administered clindamycin has been associated with severe colitis which may end", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is LISINOPRIL?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LISINOPRIL"]], "act": "question"}]}
{"index": 1, "text": "Lisinopril and Hydrochlorothiazide Tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including lisinopril and hydrochlorothiazide. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 d", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Loperamide?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Loperamide"]], "act": "question"}]}
{"index": 1, "text": "Loperamide hydrochloride capsules are indicated for the control and symptomatic relief of acute nonspecific diarrhea in patients 2 years of age and older and of chronic diarrhea in adults associated with inflammatory bowel disease. Loperamide hydrochloride is also indicated for reducing the volume of discharge from iloestomies.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the ingredients of DiphenhydrAMINE?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DiphenhydrAMINE"]], "act": "question"}]}
{"index": 0, "text": "what version of DiphenhydrAMINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "DIPHENHYDRAMINE HYDROCHLORIDE,SODIUM HYDROXIDE,HYDROCHLORIC ACID", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Evamist", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Evamist"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Anectine for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Anectine"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 1, "text": "what version of Anectine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Anectine is 1 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant ZINC", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ZINC"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant adult", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how many Heparin is the correct dose for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Heparin"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 0, "text": "what version of Heparin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Heparin is 1 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant 90", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Amlodipine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Amlodipine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Amlodipine is 1 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Should I take Lorazepam  for someone with anxiety?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lorazepam"], ["<condition>", "anxiety"]], "act": "question"}]}
{"index": 0, "text": "Most adverse reactions to benzodiazepines, including CNS effects and respiratory depression, are dose dependent, with more severe effects occurring with high doses. In a sample of about 3500 patients treated for anxiety, the most frequent adverse reaction to lorazepam was sedation (15.9%), followed by dizziness (6.9%), weakness (4.2%), and unsteadiness (3.4%). The incidence of sedation and unsteadiness increased with age. Other adverse reactions to benzodiazepines, including lorazepam are fatigue, drowsiness, amnesia, memory impairment, confusion, disorientation, depression, unmasking of depression, disinhibition, euphoria, suicidal ideation/attempt, ataxia, asthenia, extrapyramidal symptoms", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant heart_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant Lisinopril", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lisinopril"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Lisinopril has been found to be generally well tolerated in controlled clinical trials involving 1969 patients with hypertension or heart failure. For the most part, adverse experiences were mild and transient. Hypertension In clinical trials in patients with hypertension treated with lisinopril, discontinuation of therapy due to clinical adverse experiences occurred in 5.7% of patients. The overall frequency of adverse experiences could not be related to total daily dosage within the recommended therapeutic dosage range. For adverse experiences occurring in greater than 1% of patients with hypertension treated with lisinopril or lisinopril plus hydrochlorothiazide in controlled clinical tri", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Acetaminophen?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Acetaminophen"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 2, "text": "what version of Acetaminophen is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "90", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Acetaminophen is 2 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Hydrocodone cause stomach_ache?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrocodone"], ["<symptom>", "stomach_ache"]], "act": "question"}]}
{"index": 1, "text": "stomach_ache is a serious side effect of Hydrocodone. Central Nervous System: Sedation, drowsiness, mental clouding, lethargy, impairment of mental and physical performance, anxiety, fear, dysphoria, dizziness, psychic dependence, mood changes. Gastrointestinal System: Nausea and vomiting may occur; they are more frequent in ambulatory than in recumbent patients. Prolonged administration of Hydrocodone Bitartrate and Homatropine Methylbromide tablets may produce constipation. Genitourinary System: Ureteral spasm, spasm of vesicle sphincters and urinary retention have been reported with opiates. Respiratory Depression: Hydrocodone Bitartrate and Homatropine Methylbromide tablets may produce dose-related respiratory depression by acting directly ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant stomach_ache", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "stomach_ache"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Metformin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Metformin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "stomach_ache is a dangerous side effect of Metformin. In a US double-blind clinical study of metformin hydrochloride tablets in patients with type 2 diabetes, a total of 141 patients received metformin hydrochloride tablets therapy (up to 2550 mg per day) and 145 patients received placebo. Adverse reactions reported in greater than 5% of the metformin hydrochloride tablets patients, and that were more common in metformin hydrochloride tablets than placebo-treated patients, are listed in Table 7 . Table 7: Most Common Adverse Reactions (>5.0 Percent) in a Placebo-Controlled Clinical Study of Metformin Hydrochloride Tablets Monotherapy* Adverse Reaction Metformin Hydrochloride Tablets Monotherapy (n=141) Placebo (n=145) % of Patients * Reactions ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "Is Oxycodone safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxycodone"]], "act": "question"}]}
{"index": 0, "text": "Oxycodone may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "infection", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "inform"}]}
{"index": 1, "text": "Oxycodone hydrochloride tablets have been evaluated in open label clinical trials in patients with cancer and nonmalignant pain. Oxycodone hydrochloride tablets are associated with adverse experiences similar to those seen with other opioids. Serious adverse reactions that may be associated with oxycodone hydrochloride therapy in clinical use are those observed with other opioid analgesics and include: respiratory depression, respiratory arrest, circulatory depression, cardiac arrest, hypotension, and/or shock (see OVERDOSAGE and WARNINGS ). The less severe adverse events seen on initiation of therapy with oxycodone hydrochloride are also typical opioid side effects. These events are dose de", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Hydrochlorothiazide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrochlorothiazide"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant IBD", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The adverse reactions associated with hydrochlorothiazide have been shown to be dose related. In controlled clinical trials, the adverse events reported with doses of 12.5 mg hydrochlorothiazide once daily were comparable to placebo. The following adverse reactions have been reported for doses of hydrochlorothiazide 25 mg and greater and, within each category, are listed in the order of decreasing severity. Body as a whole: Weakness. Cardiovascular: Hypotension including orthostatic hypotension (may be aggravated by alcohol, barbiturates, narcotics or antihypertensive drugs). Digestive: Pancreatitis, jaundice (intrahepatic cholestatic jaundice), diarrhea, vomiting, sialadenitis, cramping, co", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Tiagabine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tiagabine"]], "act": "question"}]}
{"index": 1, "text": "what version of Tiagabine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "General The blood level of tiagabine obtained after a given dose depends on whether the patient also is receiving a drug that induces the metabolism of tiagabine. The presence of an inducer means that the attained blood level will be substantially reduced. Dosing should take the presence of concomitant medications into account. Tiagabine HCl is recommended as adjunctive therapy for the treatment of partial seizures in patients 12 years and older. The following dosing recommendations apply to all patients taking tiagabine HCl: Tiagabine HCl is given orally and should be taken with food. Do not use a loading dose of tiagabine HCl. Dose titration: Rapid escalation and/or large dose increments o", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Cefazolin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cefazolin"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Note: Cefazolin Injection, USP in GALAXY Container (PL 2040 Plastic) is intended for intravenous infusion. Usual Adult Dosage: Type of Infection Dose Frequency Moderate to severe infections 500 mg to 1 gram every 6 to 8 hrs. Mild infections caused by susceptible gram-positive cocci 250 mg to 500 mg every 8 hours Acute, uncomplicated urinary tract infections 1 gram every 12 hours Pneumococcal pneumonia 500 mg every 12 hours Severe, life-threatening infections ( e.g. , endocarditis, septicemia) In rare instances, doses of up to 12 grams of cefazolin per day have been used. 1 gram to 1.5 grams every 6 hours", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Is Lidocaine safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "question"}]}
{"index": 0, "text": "Lidocaine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "tourettes", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "inform"}]}
{"index": 1, "text": "To report SUSPECTED ADVERSE REACTIONS, contact Hi-Tech Pharmacal Co., Inc. at 1-800-262-9010 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Localized Reactions: During or immediately after treatment with lidocaine 2.5% and prilocaine 2.5% cream on intact skin, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation. Rare cases of discrete purpuric or petechial reactions at the application site have been reported. Rare cases of hyperpigmentation following the use of lidocaine 2.5% and prilocaine 2.5% cream have been reported. The relationship to lidocaine 2.5% and prilocaine 2.5% cream or the underlying procedure has not been established. I", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have nausea with 277?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "277"], ["<symptom>", "nausea"]], "act": "question"}]}
{"index": 1, "text": "nausea is a common side effect of 277. The following adverse reactions have been reported and, within each category, are listed in order of decreasing severity.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant hallucinations", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "hallucinations"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how much Azathioprine should i take for a child?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Azathioprine"], ["<age_group>", "child"]], "act": "question"}]}
{"index": 0, "text": "what version of Azathioprine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "10", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Azathioprine is 2 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant 60", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The dosage for Azathioprine is 2 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is NDC?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NDC"]], "act": "question"}]}
{"index": 1, "text": "SITAVIG is indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults (1) .", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "What is Not?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Not"]], "act": "question"}]}
{"index": 0, "text": "Omeprazole and sodium bicarbonate is a proton pump inhibitor indicated for: Short-term treatment of active duodenal ulcer ( 1.1 ) Short-term treatment of active benign gastric ulcer ( 1.2 ) Treatment of gastroesophageal reflux disease (GERD) ( 1.3 ) Maintenance of healing of erosive esophagitis (1.4) The safety and effectiveness of omeprazole and sodium bicarbonate capsules in pediatric patients (<18 years of age) have not been established. ( 8.4 )", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant OVIDREL", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "OVIDREL"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Ovidrel  PreFilled Syringe (choriogonadotropin alfa injection) is indicated for the induction of final follicular maturation and early luteinization in infertile women who have undergone pituitary desensitization and who have been appropriately pretreated with follicle stimulating hormones as part of an Assisted Reproductive Technology (ART) program such as in vitro fertilization and embryo transfer. Ovidrel  PreFilled Syringe is also indicated for the induction of ovulation (OI) and pregnancy in anovulatory infertile patients in whom the cause of infertility is functional and not due to primary ovarian failure.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "What is Cefuroxime?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cefuroxime"]], "act": "question"}]}
{"index": 0, "text": "Cefuroxime for Injection, USP is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: Lower Respiratory Tract Infections, including pneumonia, caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes , and Escherichia coli . Urinary Tract Infections caused by Escherichia coli and Klebsiella spp. Skin and Skin Structure Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes , E", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Sterile?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sterile"]], "act": "question"}]}
{"index": 1, "text": "what version of Sterile is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "This solution is for intravenous use only. Do not inject until made approximately isotonic by addition of appropriate solute. The dosage and administration of Sterile Water for Injection USP is dependent upon the recommended dosage and administration of the solute used. Fluid administration should be based on calculated maintenance or replacement fluid requirements for each patient. Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant EXTENDED", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "EXTENDED"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Evamist?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Evamist"]], "act": "question"}]}
{"index": 0, "text": "what version of Evamist is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "ESTRADIOL,OCTISALATE,ALCOHOL", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "where should I keep Methenamine?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methenamine"]], "act": "question"}]}
{"index": 1, "text": "what version of Methenamine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Methenamine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant AMINOCAPROIC", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "AMINOCAPROIC"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Hydromorphone safe  if I am infection?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydromorphone"], ["<condition>", "infection"]], "act": "question"}]}
{"index": 1, "text": "The major hazards of hydromorphone hydrochloride tablets and oral solution include respiratory depression and apnea. To a lesser degree, circulatory depression, respiratory arrest, shock and cardiac arrest have occurred. The most frequently observed adverse effects are light-headedness, dizziness, sedation, nausea, vomiting, sweating, flushing, dysphoria, euphoria, dry mouth, and pruritus. These effects seem to be more prominent in ambulatory patients and in those not experiencing severe pain.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant tourettes", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant OXYCODONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "OXYCODONE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Quinapril?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Quinapril"]], "act": "question"}]}
{"index": 1, "text": "Quinapril may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "pregnant", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "inform"}]}
{"index": 2, "text": "Quinapril Hydrochloride and Hydrochlorothiazide Tablets has been evaluated for safety in 1571 patients in controlled and uncontrolled studies. Of these, 498 were given quinapril plus hydrochlorothiazide for at least 1 year, with 153 patients extending combination therapy for over 2 years. In clinical trials with Quinapril Hydrochloride and Hydrochlorothiazide Tablets, no adverse experience specific to the combination has been observed. Adverse experiences that have occurred have been limited to those that have been previously reported with quinapril or hydrochlorothiazide. Adverse experiences were usually mild and transient, and there was no relationship between side effects and age, sex, ra", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant liver_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Trandolapril/Verapamil", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Trandolapril/Verapamil"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "is depression a common side effect of Bactrim?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Bactrim"], ["<symptom>", "depression"]], "act": "question"}]}
{"index": 0, "text": "depression is a mild side effect of Bactrim. The most common adverse effects are gastrointestinal disturbances (nausea, vomiting, anorexia) and allergic skin reactions (such as rash and urticaria). FATALITIES ASSOCIATED WITH THE ADMINISTRATION OF SULFONAMIDES, ALTHOUGH RARE, HAVE OCCURRED DUE TO SEVERE REACTIONS, INCLUDING STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, FULMINANT HEPATIC NECROSIS, AGRANULOCYTOSIS, APLASTIC ANEMIA AND OTHER BLOOD DYSCRASIAS (SEE WARNINGS SECTION). Hematologic: Agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia, neutropenia, hemolytic anemia, megaloblastic anemia, hypoprothrombinemia, methemoglobinemia, eosinophilia. Allergic Reactions: Stevens-Johnson syndrome, toxic epidermal necrolys", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant Pacerone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Pacerone"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how much Quetiapine should i take for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Quetiapine"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 0, "text": "what version of Quetiapine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Quetiapine is 1 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant 80", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "What is Caffeine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Caffeine"]], "act": "question"}]}
{"index": 0, "text": "Caffeine citrate injection and caffeine citrate oral solution are indicated for the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "how do I take Nitrofurantoin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nitrofurantoin"]], "act": "question"}]}
{"index": 0, "text": "what version of Nitrofurantoin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Nitrofurantoin should be given with food to improve drug absorption and, in some patients, tolerance. Adults 50 to 100 mg four times a day -- the lower dosage level is recommended for uncomplicated urinary tract infections. Pediatric Patients 5 to 7 mg/kg of body weight per 24 hours, given in four divided doses (contraindicated under one month of age). The following table is based on an average weight in each range receiving 5 to 6 mg/kg of body weight per 24 hours, given in four divided doses. It can be used to calculate an average dose of nitrofurantoin oral suspension (25 mg/5 mL) for pediatric patients. Table 3: Pediatric Dosing Table Pediatric Doses (milliliters) and Weight in Kilograms", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many Epinephrine is the correct dose for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Epinephrine"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 0, "text": "what version of Epinephrine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Epinephrine is 3 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what do I do with Nateglinide?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nateglinide"]], "act": "question"}]}
{"index": 0, "text": "what version of Nateglinide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Nateglinide Tablets USP should be taken 1 to 30 minutes prior to meals.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "how do I use Halobetasol?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Halobetasol"]], "act": "question"}]}
{"index": 0, "text": "what version of Halobetasol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "Apply a thin layer of Halobetasol Propionate Ointment to the affected skin once or twice daily, as directed by your physician, and rub in gently and completely. Halobetasol Propionate Ointment is a super-high potency topical corticosteroid; therefore, treatment should be limited to two weeks, and amounts greater than 50 g/wk should not be used. As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Halobetasol Propionate Ointment should not be used with occlusive dressings.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Apply a thin layer of Halobetasol Propionate Ointment to the affected skin once or twice daily, as directed by your physician, and rub in gently and completely. Halobetasol Propionate Ointment is a super-high potency topical corticosteroid; therefore, treatment should be limited to two weeks, and amounts greater than 50 g/wk should not be used. As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Halobetasol Propionate Ointment should not be used with occlusive dressings.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Nitroglycerin?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nitroglycerin"]], "act": "question"}]}
{"index": 1, "text": "Nitroglycerin may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "infection", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "inform"}]}
{"index": 2, "text": "Headache that may be severe and persistent may occur immediately after use. Vertigo, dizziness, weakness, palpitation, and other manifestations of postural hypotension may develop occasionally, particularly in erect, immobile patients. Marked sensitivity to the hypotensive effects of nitrates (manifested by nausea, vomiting, weakness, diaphoresis, pallor, and collapse) may occur at therapeutic doses. Syncope due to nitrate vasodilatation has been reported. Flushing, drug rash, and exfoliative dermatitis have been reported in patients receiving nitrate therapy.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Extended safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Extended"]], "act": "question"}]}
{"index": 1, "text": "Extended may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "glaucoma", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "inform"}]}
{"index": 2, "text": "Central Nervous System: The most common manifestations encountered with phenytoin therapy are referable to this system and are usually dose-related. These include nystagmus, ataxia, slurred speech, decreased coordination, and mental confusion. Dizziness, insomnia, transient nervousness, motor twitchings, and headaches have also been observed. There have also been rare reports of phenytoin induced dyskinesias, including chorea, dystonia, tremor and asterixis, similar to those induced by phenothiazine and other neuroleptic drugs. A predominantly sensory peripheral polyneuropathy has been observed in patients receiving long-term phenytoin therapy. Gastrointestinal System: Nausea, vomiting, cons", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Carbidopa?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Carbidopa"]], "act": "question"}]}
{"index": 1, "text": "Carbidopa Tablets are indicated for use with carbidopa-levodopa or with levodopa in the treatment of the symptoms of idiopathic Parkinson\u2019s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication. Carbidopa is for use with carbidopa-levodopa in patients for whom the dosage of carbidopa-levodopa provides less than adequate daily dosage (usually 70 mg daily) of carbidopa. Carbidopa is for use with levodopa in the occasional patient whose dosage requirement of carbidopa and levodopa necessitates separate titration of each entity. Carbidopa is used with car", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Hydromorphone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydromorphone"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Hydromorphone hydrochloride tablets and hydromorphone hydrochloride oral solution are indicated for the management of pain in patients where an opioid analgesic is appropriate.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of FLURANDRENOLIDE?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "FLURANDRENOLIDE"]], "act": "question"}]}
{"index": 1, "text": "what version of FLURANDRENOLIDE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "Flurandrenolide,White Wax,Cetyl Alcohol,Sorbitan Sesquioleate,Petrolatum", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant 3%", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "3%"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "HYDROCHLORIC ACID,SODIUM CHLORIDE,SODIUM HYDROXIDE,WATER,MEPIVACAINE HYDROCHLORIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take DEXAMETHASONE?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DEXAMETHASONE"]], "act": "question"}]}
{"index": 1, "text": "DEXAMETHASONE may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "pregnant", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "inform"}]}
{"index": 2, "text": "Fluid and electrolyte disturbances: Sodium retention Fluid retention Congestive heart failure in susceptible patients Potassium loss Hypokalemic alkalosis Hypertension Musculoskeletal: Muscle weakness Steroid myopathy Loss of muscle mass Osteoporosis Vertebral compression fractures Aseptic necrosis of femoral and humeral heads Pathologic fracture of long bones Gastrointestinal: Peptic ulcer with possible subsequent perforation and hemorrhage Pancreatitis Abdominal distention Ulcerative esophagitis Dermatological: Impaired wound healing Thin fragile skin Facial erythema Increased sweating May suppress reactions to skin tests Petechiae and ecchymoses Neurological: Convulsions Increased intracr", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant butalbital", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "butalbital"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant tourettes", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what are the side effects of zaleplon?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "zaleplon"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of zaleplon: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "bruising", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "bruising"]], "act": "inform"}]}
{"index": 1, "text": "bruising is a common side effect of zaleplon. The premarketing development program for zaleplon included zaleplon exposures in patients and/or normal subjects from 2 different groups of studies: approximately 900 normal subjects in clinical pharmacology/pharmacokinetic studies; and approximately 2,900 exposures from patients in placebo-controlled clinical effectiveness studies, corresponding to approximately 450 patient exposure years. The conditions and duration of treatment with zaleplon varied greatly and included (in overlapping categories) open-label and double-blind phases of studies, inpatients and outpatients, and short-term or longer-term exposure. Adverse reactions were assessed by collecting adverse events, results of physica", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Tiagabine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Tiagabine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "anxiety"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Lidocaine contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "question"}]}
{"index": 1, "text": "what version of Lidocaine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "LIDOCAINE,PRILOCAINE,WATER,POLYOXYL 40 HYDROGENATED CASTOR OIL,SODIUM HYDROXIDE,CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Amidate is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amidate"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 2, "text": "what version of Amidate is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Amidate is 3 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take AMIODARONE?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "AMIODARONE"]], "act": "question"}]}
{"index": 1, "text": "AMIODARONE may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 2, "text": "Adverse reactions have been very common in virtually all series of patients treated with amiodarone for ventricular arrhythmias with relatively large doses of drug (400 mg/day and above), occurring in about three-fourths of all patients and causing discontinuation in 7 to 18%. The most serious reactions are pulmonary toxicity, exacerbation of arrhythmia, and rare serious liver injury (see WARNINGS ),but other adverse effects constitute important problems. They are often reversible with dose reduction or cessation of amiodarone treatment. Most of the adverse effects appear to become more frequent with continued treatment beyond six months, although rates appear to remain relatively constant b", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant Tamsulosin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Tamsulosin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant pregnant", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "6.1 Clinical Trials Experience Because clinical studies are conducted under widely varying conditions, adverse reactions rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice. The incidence of treatment-emergent adverse events has been ascertained from six short-term U.S. and European placebo-controlled clinical trials in which daily doses of 0.1 to 0.8 mg tamsulosin hydrochloride capsules were used. These studies evaluated safety in 1783 patients treated with tamsulosin hydrochloride capsules and 798 patients administered placebo. Table 1 summarizes the treatment-emerge", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of Sodium?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sodium"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of Sodium: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "nausea", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "nausea"]], "act": "inform"}]}
{"index": 2, "text": "nausea is a serious side effect of Sodium. Adverse reactions involve the possibility of phosphate intoxication. Phosphate intoxication results in a reduction of serum calcium and the symptoms are those of hypocalcemic tetany (see WARNINGS ).", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Potassium contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "question"}]}
{"index": 1, "text": "what version of Potassium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "POTASSIUM CHLORIDE,DEXTROSE MONOHYDRATE,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use Fluocinonide?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluocinonide"]], "act": "question"}]}
{"index": 0, "text": "what version of Fluocinonide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Fluocinonide Ointment USP, 0.05% is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of the occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Gabapentin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Gabapentin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Betamethasone?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Betamethasone"]], "act": "question"}]}
{"index": 1, "text": "what version of Betamethasone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Betamethasone", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Pamidronate safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Pamidronate"]], "act": "question"}]}
{"index": 1, "text": "Pamidronate may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "pregnant", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "inform"}]}
{"index": 2, "text": "Clinical Studies Hypercalcemia of Malignancy Transient mild elevation of temperature by at least 1\u00b0C was noted 24 to 48 hours after administration of pamidronate disodium in 34% of patients in clinical trials. In the saline trial, 18% of patients had a temperature elevation of at least 1\u00b0C 24 to 48 hours after treatment. Drug-related local soft-tissue symptoms (redness, swelling or induration and pain on palpation) at the site of catheter insertion were most common in patients treated with 90 mg of pamidronate disodium. Symptomatic treatment resulted in rapid resolution in all patients. Rare cases of uveitis, iritis, scleritis, and episcleritis have been reported, including one case of scler", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is itchy_skin a common side effect of Lidocaine?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"], ["<symptom>", "itchy_skin"]], "act": "question"}]}
{"index": 1, "text": "itchy_skin is a dangerous side effect of Lidocaine. Adverse experiences following the administration of lidocaine are similar in nature to those observed with other amide local anesthetic agents. Adverse experiences may result from high plasma levels caused by excessive dosage or may result from a hypersensitivity, idiosyncrasy or diminished tolerance on the part of the patient. Serious adverse experiences are generally systemic in nature. The following types are those most commonly reported. The adverse experiences under Central Nervous System and Cardiovascular System are listed, in general, in a progression from mild to severe. Central Nervous System: CNS reactions are excitatory and/or depressant and may be characterized by light-headedne", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Desipramine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Desipramine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "can i take Hydrocodone?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrocodone"]], "act": "question"}]}
{"index": 0, "text": "Hydrocodone may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "IBD", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "inform"}]}
{"index": 1, "text": "The following adverse reactions have been identified during post approval use of hydrocodone and acetaminophen tablets and oral solution. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The most frequently reported adverse reactions are light-headedness, dizziness, sedation, nausea and vomiting. Other adverse reactions include: Cardio-Renal: Bradycardia, cardiac arrest, circulatory collapse, renal toxicity, renal tubular necrosis, hypotension. Central Nervous System/Psychiatric: Anxiety, dizziness, drowsiness, dysphoria, euphoria, fear, gen", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "how many METRONIDAZOLE is the correct dose for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "METRONIDAZOLE"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 0, "text": "what version of METRONIDAZOLE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for METRONIDAZOLE is 4 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant ziprasidone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ziprasidone"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The dosage for ziprasidone is 4 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "What is HYDROXYZINE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROXYZINE"]], "act": "question"}]}
{"index": 0, "text": "For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus. As a sedative when used as premedication and following general anesthesia, Hydroxyzine may potentiate meperidine (Demerol  ) and barbiturates , so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. Atropine and other belladonna alkaloids are not affected by the drug. Hydroxyzine is not known to interfere with the action of digitalis in any way a", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Nitrofurantoin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Nitrofurantoin"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Nitrofurantoin oral suspension, USP is specifically indicated for the treatment of urinary tract infections when due to susceptible strains of Escherichia coli , enterococci, Staphylococcus aureus , and certain susceptible strains of Klebsiella and Enterobacter species. Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. Nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. Consequently, many patients who are treated with nitrofurantoin are predisposed to persistence or reappearance of bacteriuria. Urine specimens for culture and susceptibility testing should be obtained before and aft", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Potassium in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "question"}]}
{"index": 1, "text": "what version of Potassium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Potassium", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Lovastatin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lovastatin"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Lodosyn?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lodosyn"]], "act": "question"}]}
{"index": 1, "text": "Lodosyn may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "liver_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "inform"}]}
{"index": 2, "text": "Carbidopa has not been demonstrated to have any overt pharmacodynamic actions in the recommended doses. The only adverse reactions that have been observed have been with concomitant use of carbidopa with other drugs such as levodopa, and with carbidopa-levodopa combination products. When LODOSYN is administered concomitantly with levodopa or carbidopa-levodopa combination products, the most common adverse reactions have included dyskinesias such as choreiform, dystonic, and other involuntary movements, and nausea. Other adverse reactions reported with LODOSYN when administered concomitantly with levodopa alone or carbidopa-levodopa combination products were psychotic episodes including delus", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant CITALOPRAM", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CITALOPRAM"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant low_blood_pressure", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what are the ingredients of Midazolam?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Midazolam"]], "act": "question"}]}
{"index": 0, "text": "what version of Midazolam is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "MIDAZOLAM HYDROCHLORIDE,SODIUM CHLORIDE,HYDROCHLORIC ACID,SODIUM HYDROXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "how do I take Methocarbamol?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methocarbamol"]], "act": "question"}]}
{"index": 0, "text": "what version of Methocarbamol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Methocarbamol tablets, USP, 500 mg \u2013 Adults: Initial dosage: 3 tablets q.i.d. Maintenance dosage: 2 tablets q.i.d. Methocarbamol tablets, USP: 750 mg \u2013 Adults: Initial dosage: 2 tablets q.i.d. Maintenance dosage: 1 tablet q.4h. or 2 tablets t.i.d. Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered). Thereafter, the dosage can usually be reduced to approximately 4 grams a day.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "how many Trandolapril/Verapamil is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Trandolapril/Verapamil"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 1, "text": "what version of Trandolapril/Verapamil is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Trandolapril/Verapamil is 3 mg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant LEVOTHYROXINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "LEVOTHYROXINE"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is 2% safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "2%"]], "act": "question"}]}
{"index": 1, "text": "2% may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "TB", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "inform"}]}
{"index": 2, "text": "Systemic: Adverse experiences following the administration of lidocaine are similar in nature to those observed with other amide local anesthetic agents. These adverse experiences are, in general, dose-related and may result from high plasma levels caused by excessive dosage, rapid absorption or inadvertent intravascular injection, or may result from a hypersensitivity, idiosyncrasy or diminished tolerance on the part of the patient. Serious adverse experiences are generally systemic in nature. The following types are those most commonly reported: Central Nervous System: CNS manifestations are excitatory and/or depressant and may be characterized by lightheadedness, nervousness, apprehension", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant Clobetasol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Clobetasol"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant glaucoma", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how much Clindamycin should i take for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Clindamycin"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 0, "text": "what version of Clindamycin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "10", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Clindamycin is 3 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Cidofovir for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cidofovir"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of Cidofovir is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Cidofovir is 4 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant child", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Cidofovir is 2 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "does FUROSEMIDE cause itchy_skin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "FUROSEMIDE"], ["<symptom>", "itchy_skin"]], "act": "question"}]}
{"index": 0, "text": "itchy_skin is a mild side effect of FUROSEMIDE. Gastrointestinal System Reactions 1. pancreatitis 2. jaundice (intrahepatic cholestatic jaundice) 3. anorexia 4. oral and gastric irritation 5. cramping 6. diarrhea 7. constipation 8. nausea 9. vomiting Systemic Hypersensitivity Reactions 1. systemic vasculitis 2. interstitial nephritis 3. necrotizing angiitis Central Nervous System Reactions 1. tinnitus and hearing loss 2. paresthesias 3. vertigo 4. dizziness 5. headache 6. blurred vision 7. xanthopsia Hematologic Reactions 1. aplastic anemia (rare) 2. thrombocytopenia 3. agranulocytosis (rare) 4. hemolytic anemia 5. leukopenia 6. anemia Dermatologic-Hypersensitivity Reactions 1. exfoliative dermatitis 2. erythema multiforme 3. purpura 4. p", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant blurred_vision", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "blurred_vision"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use Hyoscyamine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hyoscyamine"]], "act": "question"}]}
{"index": 0, "text": "what version of Hyoscyamine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Dosage may be adjusted according to the conditions and severity of symptoms. Adults and pediatric patients 12 years of age and older: 1 to 2 tablets every 12 hours. Do not crush or chew tablets. Do not exceed 4 tablets in 24 hours.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Oxycodone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxycodone"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Important Dosage and Administration Instructions Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see Warnings ]. Initiate the dosing regimen for each patient individually, taking into account the patient's severity of pain, patient response, prior analgesic treatment experience, and risk factors for addiction, abuse, and misuse [see WARNINGS ]. Monitor patients closely for respiratory depression, especially within the first 24 to 72 hours of initiating therapy and following dosage increases with Oxycodone and Acetaminophen Tablets and adjust the dosage accordingly [see WARNINGS ]. Initial Dosage Initiating Treatment with Oxycodone", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many Amoxicillin is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amoxicillin"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 1, "text": "what version of Amoxicillin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Amoxicillin is 3 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Amoxicillin is 3 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "do I need to keep OXALIPLATIN in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "OXALIPLATIN"]], "act": "question"}]}
{"index": 0, "text": "what version of OXALIPLATIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug OXALIPLATIN", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Metoprolol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Metoprolol"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what is in Atenolol?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Atenolol"]], "act": "question"}]}
{"index": 0, "text": "what version of Atenolol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "ATENOLOL,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POVIDONE K30,SODIUM STARCH GLYCOLATE TYPE A POTATO", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Tranexamic", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Tranexamic"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is STRIANT?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "STRIANT"]], "act": "question"}]}
{"index": 1, "text": "Striant  is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired) - testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchidectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone levels and gonadotropins (FSH, LH) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired) -- idiopathic gonadotropin or LHRH deficiency, or pituitary hypothalamic injury from tumors, trauma, or radiation. These patients have low serum testosterone ", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant metformin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "metformin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Metformin hydrochloride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus. Metformin hydrochloride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Carisoprodol?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Carisoprodol"]], "act": "question"}]}
{"index": 0, "text": "what version of Carisoprodol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "Carisoprodol,Aspirin,HYDROXYPROPYL CELLULOSE,ANHYDROUS LACTOSE,SODIUM STARCH GLYCOLATE TYPE A POTATO,STARCH, CORN,SODIUM LAURYL SULFATE,CELLULOSE, MICROCRYSTALLINE,FD&C RED NO. 40,MAGNESIUM STEARATE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Is Malathion safe  if I am pregnant?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Malathion"], ["<condition>", "pregnant"]], "act": "question"}]}
{"index": 0, "text": "Malathion has been shown to be irritating to the skin and scalp. Accidental contact with the eyes can result in mild conjunctivitis. It is not known if Malathion Lotion has the potential to cause contact allergic sensitization.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does METOCLOPRAMIDE contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "METOCLOPRAMIDE"]], "act": "question"}]}
{"index": 1, "text": "what version of METOCLOPRAMIDE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "Metoclopramide Hydrochloride,citric acid monohydrate,FD&C Yellow No. 6,glycerin,methylparaben,propylparaben,water,sorbitol", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have fever with Prazosin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Prazosin"], ["<symptom>", "fever"]], "act": "question"}]}
{"index": 1, "text": "fever is a dangerous side effect of Prazosin. Clinical trials were conducted on more than 900 patients. During these trials and subsequent marketing experience, the most frequent reactions associated with prazosin hydrochloride therapy are: dizziness 10.3%, headache 7.8%, drowsiness 7.6%, lack of energy 6.9%, weakness 6.5%, palpitations 5.3%, and nausea 4.9%. In most instances, side effects have disappeared with continued therapy or have been tolerated with no decrease in dose of drug. Less frequent adverse reactions which are reported to occur in 1\u20134% of patients are: Gastrointestinal: vomiting, diarrhea, constipation. Cardiovascular: edema, orthostatic hypotension, dyspnea, syncope. Central Nervous System: vertigo, depression, nervous", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Hydrochlorothiazide safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrochlorothiazide"]], "act": "question"}]}
{"index": 1, "text": "Hydrochlorothiazide may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "IBD", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "inform"}]}
{"index": 2, "text": "The adverse reactions associated with hydrochlorothiazide have been shown to be dose related. In controlled clinical trials, the adverse events reported with doses of 12.5 mg hydrochlorothiazide once daily were comparable to placebo. The following adverse reactions have been reported for doses of hydrochlorothiazide 25 mg and greater and, within each category, are listed in the order of decreasing severity. Body as a whole: Weakness. Cardiovascular: Hypotension including orthostatic hypotension (may be aggravated by alcohol, barbiturates, narcotics or antihypertensive drugs). Digestive: Pancreatitis, jaundice (intrahepatic cholestatic jaundice), diarrhea, vomiting, sialadenitis, cramping, co", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant Glycopyrrolate", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Glycopyrrolate"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant TB", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Anticholinergics produce certain effects, most of which are extensions of their fundamental pharmacological actions. Adverse reactions to anticholinergics in general may include xerostomia; decreased sweating; urinary hesitancy and retention; blurred vision; tachycardia; palpitations; dilatation of the pupil; cycloplegia; increased ocular tension; loss of taste; headaches; nervousness; mental confusion; drowsiness; weakness; dizziness; insomnia; nausea; vomiting; constipation; bloated feeling; impotence; suppression of lactation; severe allergic reaction or drug idiosyncrasies including anaphylaxis, urticaria and other dermal manifestations. Glycopyrrolate is chemically a quaternary ammonium", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is tiredness a common side effect of Aminophylline?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Aminophylline"], ["<symptom>", "tiredness"]], "act": "question"}]}
{"index": 1, "text": "tiredness is a mild side effect of Aminophylline. Adverse reactions associated with theophylline are generally mild when peak serum theophylline concentrations are less than 20 mcg/mL and mainly consist of transient caffeine-like adverse effects such as nausea, vomiting, headache, and insomnia. When peak serum theophylline concentrations exceed 20 mcg/mL, however, theophylline produces a wide range of adverse reactions including persistent vomiting, cardiac arrhythmias, and intractable seizures which can be lethal (see OVERDOSAGE). Other adverse reactions that have been reported at serum theophylline concentrations less than 20 mcg/mL include diarrhea, irritability, restlessness, fine skeletal muscle tremors, and transient diuresis. In pati", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant bleeding", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "bleeding"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Betamethasone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Betamethasone"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "bleeding is a serious side effect of Betamethasone. The following local adverse reactions are reported infrequently when betamethasone dipropionate lotion 0.05% is used as recommended in the DOSAGE AND ADMINISTRATION section. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, miliaria. Adverse reactions reported to be possibly or probably related to treatment with betamethasone dipropionate lotion 0.05% during a pediatric study include: paresthesia (burning), erythema, erythematous rash, and dry ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "what is the dose for Rivastigmine?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Rivastigmine"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 1, "text": "what version of Rivastigmine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Rivastigmine is 2 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take POTASSIUM?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "POTASSIUM"]], "act": "question"}]}
{"index": 1, "text": "what version of POTASSIUM is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "The usual dietary intake of potassium by the average adult is 50 to 100 mEq per day. Potassium depletion sufficient to cause hypokalemia usually requires the loss of 200 or more mEq of potassium from the total body store. Dosage must be adjusted to the individual needs of each patients. The dose for the prevention of hypokalemia is typically in the range of 20 mEq per day. Doses of 40 to 100 mEq per day or more are used for the treatment of potassium depletion. Dosage should be divided if more than 20 mEq per day is given such that no more than 20 mEq is given in a single dose. Because of the potential for gastric irritation (see WARNINGS ) , potassium chloride extended-release capsules, 600", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant CLINDAMYCIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CLINDAMYCIN"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for escitalopram?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "escitalopram"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 2, "text": "what version of escitalopram is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for escitalopram is 1 mg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "what is in Metformin?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metformin"]], "act": "question"}]}
{"index": 0, "text": "what version of Metformin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "METFORMIN HYDROCHLORIDE,POVIDONE,CELLULOSE, MICROCRYSTALLINE,MAGNESIUM STEARATE,POLYVINYL ALCOHOL,TALC,TITANIUM DIOXIDE,POLYETHYLENE GLYCOLS,METFORMIN HYDROCHLORIDE,POVIDONE,CELLULOSE, MICROCRYSTALLINE,MAGNESIUM STEARATE,POLYETHYLENE GLYCOLS,POLYVINYL ALCOHOL,TALC,TITANIUM DIOXIDE,METFORMIN HYDROCHLORIDE,POVIDONE,CELLULOSE, MICROCRYSTALLINE,MAGNESIUM STEARATE,POLYETHYLENE GLYCOLS,POLYVINYL ALCOHOL,TALC,TITANIUM DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Clindamycin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Clindamycin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "CLINDAMYCIN PHOSPHATE,ISOPROPYL ALCOHOL,PROPYLENE GLYCOL,WATER,CLINDAMYCIN PHOSPHATE,CETOSTEARYL ALCOHOL,GLYCERIN,ISOSTEARYL ALCOHOL,METHYLPARABEN,SODIUM LAUROYL SARCOSINATE,STEARIC ACID,WATER,CLINDAMYCIN PHOSPHATE,ALLANTOIN,CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED),METHYLPARABEN,POLYETHYLENE GLYCOL 400,PROPYLENE GLYCOL,SODIUM HYDROXIDE,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "where should I keep ETHAMBUTOL?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ETHAMBUTOL"]], "act": "question"}]}
{"index": 0, "text": "what version of ETHAMBUTOL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug ETHAMBUTOL", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Lidocaine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Lidocaine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of Bupropion?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Bupropion"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of Bupropion: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "anxiety", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "anxiety"]], "act": "inform"}]}
{"index": 2, "text": "anxiety is a serious side effect of Bupropion. (See also WARNINGS and PRECAUTIONS .) The information included under the Incidence in Controlled Trials subsection of ADVERSE REACTIONS is based primarily on data from controlled clinical trials with bupropion hydrochloride extended-release tablets (SR). Information on additional adverse events associated with the sustained-release formulation of bupropion in smoking cessation trials, as well as the immediate-release formulation of bupropion, is included in a separate section (see Other Events Observed During the Clinical Development and Postmarketing Experience of Bupropion). Incidence in Controlled Trials With Bupropion: Adverse Events Associated With Discontinuation of Treatment Among Pat", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "actually i meant Nevirapine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Nevirapine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Cyanocobalamin?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cyanocobalamin"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 2, "text": "what version of Cyanocobalamin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Cyanocobalamin is 4 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant Lidoderm", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidoderm"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 7, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with METRONIDAZOLE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "METRONIDAZOLE"]], "act": "question"}]}
{"index": 1, "text": "what version of METRONIDAZOLE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "In elderly patients the pharmacokinetics of metronidazole may be altered and, therefore, monitoring of serum levels may be necessary to adjust the metronidazole dosage accordingly. Treatment of Anaerobic Bacterial Infections: The recommended dosage schedule for Adults is: Loading Dose 15 mg/kg infused over one hour (approximately 1 g for a 70-kg adult). Maintenance Dose 7.5 mg/kg infused over one hour every six hours (approximately 500 mg for a 70-kg adult). The first maintenance dose should be instituted six hours following the initiation of the loading dose. Parenteral therapy may be changed to oral metronidazole when conditions warrant, based upon the severity of the disease and the respo", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Trelegy", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Trelegy"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "TRELEGY ELLIPTA should be administered as 1 inhalation once daily by the orally inhaled route only. After inhalation, the patient should rinse his/her mouth with water without swallowing to help reduce the risk of oropharyngeal candidiasis. TRELEGY ELLIPTA should be used at the same time every day. Do not use TRELEGY ELLIPTA more than 1 time every 24 hours. No dosage adjustment is required for geriatric patients, patients with renal impairment, or patients with moderate hepatic impairment [see Clinical Pharmacology (12.3)] .", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Metolazone?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metolazone"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 2, "text": "what version of Metolazone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "10", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Metolazone is 2 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant baby", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Metolazone is 1 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 7, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is 50%?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "50%"]], "act": "question"}]}
{"index": 0, "text": "50% Dextrose Injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels. The solution is also indicated, after dilution, for intravenous infusion as a source of carbohydrate calories in patients whose oral intake is restricted or inadequate to maintain nutritional requirements. Slow infusion of hypertonic solutions is essential to insure proper utilization of dextrose and avoid production of hyperglycemia.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant STERILE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "STERILE"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Timolol Maleate Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the ingredients of SULINDAC?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SULINDAC"]], "act": "question"}]}
{"index": 0, "text": "what version of SULINDAC is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "SULINDAC,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,STARCH, CORN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Pyridostigmine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Pyridostigmine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "PYRIDOSTIGMINE BROMIDE,ANHYDROUS LACTOSE,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED,STEARIC ACID", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Mexiletine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Mexiletine"]], "act": "question"}]}
{"index": 1, "text": "Mexiletine hydrochloride capsules are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. Because of the proarrhythmic effects of mexiletine, its use with lesser arrhythmias is generally not recommended. Treatment of patients with asymptomatic ventricular premature contractions should be avoided. Initiation of mexiletine treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. Antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Eletriptan", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Eletriptan"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Eletriptan hydrobromide tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use:  Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with eletriptan hydrobromide tablets, reconsider the diagnosis of migraine before eletriptan hydrobromide tablets are administered to treat any subsequent attacks.  Eletriptan hydrobromide tablets are not intended for the prevention of migraine attacks.  Safety and effectiveness of eletriptan hydrobromide tablets have not been established for cluster headache.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does NatelleOne cause suicidal?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NatelleOne"], ["<symptom>", "suicidal"]], "act": "question"}]}
{"index": 0, "text": "suicidal is a serious side effect of NatelleOne. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant depression", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "depression"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant Once", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Once"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the side effects of clarithromycin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "clarithromycin"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of clarithromycin: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "hallucinations", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "hallucinations"]], "act": "inform"}]}
{"index": 1, "text": "hallucinations is a mild side effect of clarithromycin. The most frequent and common adverse reactions related to clarithromycin therapy for both adult and pediatric populations are abdominal pain, diarrhea, nausea, vomiting and dysgeusia. These adverse reactions are consistent with the known safety profile of macrolide antibiotics. There was no significant difference in the incidence of these gastrointestinal adverse reactions during clinical trials between the patient population with or without preexisting mycobacterial infections. Adverse Reactions Observed During Clinical Trials of Clarithromycin The following adverse reactions were observed in clinical trials with clarithromycin at a rate greater than or equal to 1%: Gastrointestinal Disorde", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Namenda", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Namenda"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Dextroamphetamine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dextroamphetamine"]], "act": "question"}]}
{"index": 1, "text": "Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Doxepin contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxepin"]], "act": "question"}]}
{"index": 1, "text": "what version of Doxepin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "DOXEPIN HYDROCHLORIDE,SILICON DIOXIDE,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,STARCH, CORN,SODIUM LAURYL SULFATE,D&C YELLOW NO. 10,GELATIN, UNSPECIFIED,TITANIUM DIOXIDE,FD&C YELLOW NO. 6,FERROSOFERRIC OXIDE,FD&C BLUE NO. 1,FD&C BLUE NO. 2,FD&C RED NO. 40,PROPYLENE GLYCOL,SHELLAC,DOXEPIN HYDROCHLORIDE,SILICON DIOXIDE,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,STARCH, CORN,SODIUM LAURYL SULFATE,D&C YELLOW NO. 10,GELATIN, UNSPECIFIED,TITANIUM DIOXIDE,FD&C YELLOW NO. 6,FERROSOFERRIC OXIDE,FD&C BLUE NO. 1,FD&C BLUE NO. 2,FD&C RED NO. 40,PROPYLENE GLYCOL,SHELLAC,DOXEPIN HYDROCHLORIDE,SILICON DIOXIDE,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,STARCH, CORN,SODIUM LAURYL SULFATE,D&C YELLO", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant ELMIRON", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ELMIRON"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Promethazine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Promethazine"]], "act": "question"}]}
{"index": 1, "text": "Promethazine HCl Injection is indicated for the following conditions: Amelioration of allergic reactions to blood or plasma. In anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled. For other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. For sedation and relief of apprehension and to produce light sleep from which the patient can be easily aroused. Active treatment of motion sickness. Prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. As an adjunct to analgesics for the control of postoperative pain. Preoperative, post", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Metaproterenol?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metaproterenol"]], "act": "question"}]}
{"index": 1, "text": "Metaproterenol sulfate syrup is indicated as a bronchodilator for bronchial asthma and for reversible bronchospasm which may occur in association with bronchitis and emphysema.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Relpax?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Relpax"]], "act": "question"}]}
{"index": 1, "text": "RELPAX is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with RELPAX, reconsider the diagnosis of migraine before RELPAX is administered to treat any subsequent attacks. RELPAX is not intended for the prevention of migraine attacks. Safety and effectiveness of RELPAX have not been established for cluster headache.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "can i take Vibramycin?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Vibramycin"]], "act": "question"}]}
{"index": 0, "text": "Vibramycin may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 1, "text": "Due to oral doxycycline's virtually complete absorption, side effects of the lower bowel, particularly diarrhea, have been infrequent. The following adverse reactions have been observed in patients receiving tetracyclines: Gastrointestinal: anorexia, nausea, vomiting, diarrhea, glossitis, dysphagia, enterocolitis, inflammatory lesions (with monilial overgrowth) in the anogenital region, and pancreatitis. Hepatotoxicity has been reported rarely. These reactions have been caused by both the oral and parenteral administration of tetracyclines. Superficial discoloration of the adult permanent dentition, reversible upon drug discontinuation and professional dental cleaning has been reported. Perm", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Chlordiazepoxide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Chlordiazepoxide"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "The necessity of discontinuing therapy because of undesirable effects has been rare. Drowsiness, ataxia and confusion have been reported in some patients \u2014 particularly the elderly and debilitated. While these effects can be avoided in almost all instances by proper dosage adjustment, they have occasionally been observed at the lower dosage ranges. In a few instances syncope has been reported. Other adverse reactions reported during therapy include isolated instances of skin eruptions, edema, minor menstrual irregularities, nausea and constipation, extrapyramidal symptoms, as well as increased and decreased libido. Such side effects have been infrequent, and are generally controlled with red", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "do I need to keep TETRABENAZINE in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TETRABENAZINE"]], "act": "question"}]}
{"index": 0, "text": "what version of TETRABENAZINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug TETRABENAZINE", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Lovastatin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lovastatin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Lovastatin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "do I need to keep Probenecid in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Probenecid"]], "act": "question"}]}
{"index": 0, "text": "what version of Probenecid is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Probenecid", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant HYDROCODONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROCODONE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "storage instructions for drug HYDROCODONE", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Etodolac contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Etodolac"]], "act": "question"}]}
{"index": 1, "text": "what version of Etodolac is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "ETODOLAC,SILICON DIOXIDE,HYPROMELLOSE 2910 (3 MPA.S),HYPROMELLOSE 2910 (5 MPA.S),LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POLYETHYLENE GLYCOL 400,POLYETHYLENE GLYCOL 6000,POLYSORBATE 80,POVIDONE K30,SODIUM STARCH GLYCOLATE TYPE A POTATO,TITANIUM DIOXIDE,FD&C RED NO. 40,ALUMINUM OXIDE,FD&C BLUE NO. 2,INDIGOTINDISULFONATE SODIUM,D&C YELLOW NO. 10", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant DEXTROAMPHETAMINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "DEXTROAMPHETAMINE"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "DEXTROAMPHETAMINE SULFATE,CALCIUM SULFATE,SILICON DIOXIDE,SUCROSE,STARCH, CORN,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,D&C YELLOW NO. 10,FD&C RED NO. 40,DEXTROAMPHETAMINE SULFATE,CALCIUM SULFATE,SILICON DIOXIDE,SUCROSE,STARCH, CORN,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,FD&C RED NO. 40,FD&C YELLOW NO. 6", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of 50%?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "50%"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of 50%: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "vomiting", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "inform"}]}
{"index": 2, "text": "vomiting is a mild side effect of 50%. Hyperosmolar syndrome, resulting from excessively rapid administration of concentrated dextrose may cause mental confusion and/or loss of consciousness. Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "actually i meant IMITREX", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "IMITREX"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant stomach_ache", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "stomach_ache"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what are the side effects of Penicillin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Penicillin"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of Penicillin: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "anxiety", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "anxiety"]], "act": "inform"}]}
{"index": 1, "text": "anxiety is a mild side effect of Penicillin. Although the incidence of reactions to oral penicillins has been reported with much less frequency than following parenteral therapy, it should be remembered that all degrees of hypersensitivity, including fatal anaphylaxis, have been reported with oral penicillin. The most common reactions to oral penicillin are nausea, vomiting, epigastric distress, diarrhea, and black hairy tongue. The hypersensitivity reactions reported are skin eruptions (maculopapular to exfoliative dermatitis), urticaria and other serum-sicknesslike reactions, laryngeal edema, and anaphylaxis. Fever and eosinophilia may frequently be the only reaction observed. Hemolytic anemia, leukopenia, thrombocytopenia, neuropath", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant CEFTRIAXONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CEFTRIAXONE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "Should I take KETOROLAC?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "KETOROLAC"]], "act": "question"}]}
{"index": 0, "text": "KETOROLAC may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "low_blood_pressure", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "inform"}]}
{"index": 1, "text": "Adverse reaction rates increase with higher doses of ketorolac tromethamine. Practitioners should be alert for the severe complications of treatment with ketorolac tromethamine, such as GI ulceration, bleeding and perforation, postoperative bleeding, acute renal failure, anaphylactic and anaphylactoid reactions and liver failure (see Boxed WARNING , WARNINGS , PRECAUTIONS , and DOSAGE AND ADMINISTRATION ). These NSAID-related complications can be serious in certain patients for whom ketorolac tromethamine is indicated, especially when the drug is used inappropriately. In patients taking ketorolac tromethamine or other NSAIDs in clinical trials, the most frequently reported adverse experience", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Besivance", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Besivance"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in one clinical trial of a drug cannot be directly compared with the rates in the clinical trials of the same or another drug and may not reflect the rates observed in practice. The data described below reflect exposure to Besivance in approximately 1,000 patients between 1 and 98 years old with clinical signs and symptoms of bacterial conjunctivitis. The most frequently reported ocular adverse reaction was conjunctival redness, reported in approximately 2% of patients. Other adverse reactions reported in patients receiving Besivance occurring in approximately 1-2% of patients included: blu", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "do I need to keep BACITRACIN in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BACITRACIN"]], "act": "question"}]}
{"index": 0, "text": "what version of BACITRACIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug BACITRACIN", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store ERYTHROMYCIN?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ERYTHROMYCIN"]], "act": "question"}]}
{"index": 1, "text": "what version of ERYTHROMYCIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug ERYTHROMYCIN", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "what do I do with Naltrexone?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Naltrexone"]], "act": "question"}]}
{"index": 0, "text": "what version of Naltrexone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "To reduce the risk of precipitated withdrawal in patients dependent on opioids, or exacerbation of a preexisting subclinical withdrawal syndrome, opioid-dependent patients, including those being treated for alcohol dependence, should be opioid-free (including tramadol) before starting naltrexone hydrochloride treatment. An opioid-free interval of a minimum of 7 to 10 days is recommended for patients previously dependent on short-acting opioids. Switching from Buprenorphine, Buprenorphine/Naloxone, or Methadone There are no systematically collected data that specifically address the switch from buprenorphine or methadone to naltrexone hydrochloride; however, review of postmarketing case repor", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "What is TECHNETIUM?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TECHNETIUM"]], "act": "question"}]}
{"index": 0, "text": "Myocardial Imaging: Kit for the preparation of Technetium Tc 99m Sestamibi Injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. Technetium Tc 99m Sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agents labeling). It is usually not possible to determine the age of a myocardial infarction or to differentiate a r", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Carnitor", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Carnitor"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "CARNITOR  (levocarnitine) is indicated in the treatment of primary systemic carnitine deficiency. In the reported cases, the clinical presentation consisted of recurrent episodes of Reye-like encephalopathy, hypoketotic hypoglycemia, and/or cardiomyopathy. Associated symptoms included hypotonia, muscle weakness and failure to thrive. A diagnosis of primary carnitine deficiency requires that serum, red cell and/or tissue carnitine levels be low and that the patient does not have a primary defect in fatty acid or organic acid oxidation (see Clinical Pharmacology). In some patients, particularly those presenting with cardiomyopathy, carnitine supplementation rapidly alleviated signs and symptom", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Carac  if I am tourettes?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Carac"], ["<condition>", "tourettes"]], "act": "question"}]}
{"index": 1, "text": "The following were adverse events considered to be drug related and occurring with a frequency of \u22651% with Carac: application site reaction (94.6%), and eye irritation (5.4%). The signs and symptoms of facial irritation (i.e., application site reaction) are presented below. Summary of Facial Irritation Signs and Symptoms - Pooled Phase 3 Studies Clinical Sign or Symptom Active 1 Week N=85 Active 2 Week N=87 Active 4 Week N=85 ALL Active Treatments N=257 Vehicle Treatments N=127 n (%) n (%) n (%) n (%) n (%) Erythema 76 (89.4) 82 (94.3) 82 (96.5) 240 (93.4) 76 (59.8) Dryness 59 (69.4) 76 (87.4) 79 (92.9) 214 (83.3) 60 (47.2) Burning 51 (60.0) 70 (80.5) 71 (83.5) 192 (74.7) 28 (22.0) Erosion 2", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with PERPHENAZINE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PERPHENAZINE"]], "act": "question"}]}
{"index": 1, "text": "what version of PERPHENAZINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Dosage must be individualized and adjusted according to the severity of the condition and the response obtained. As with all potent drugs, the best dose is the lowest dose that will produce the desired clinical effect. Since extrapyramidal symptoms increase in frequency and severity with increased dosage, it is important to employ the lowest effective dose. These symptoms have disappeared upon reduction of dosage, withdrawal of the drug, or administration of an antiparkinsonian agent. Prolonged administration of doses exceeding 24 mg daily should be reserved for hospitalized patients or patients under continued observation for early detection and management of adverse reactions. An antiparki", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Lidocaine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Adult Patients-Intact Skin: A thick layer of lidocaine and prilocaine cream is applied to intact skin and covered with an occlusive dressing (see INSTRUCTIONS FOR APPLICATION). Minor Dermal Procedures: For minor procedures such as intravenous cannulation and venipuncture, apply 2.5 grams of lidocaine and prilocaine cream (1/2 the 5 g tube) over 20 to 25 cm 2 of skin surface for at least 1 hour. In controlled clinical trials using lidocaine and prilocaine cream, two sites were usually prepared in case there was a technical problem with cannulation or venipuncture at the first site. Major Dermal Procedures: For more painful dermatological procedures involving a larger skin area such as split t", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take INDOMETHACIN?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "INDOMETHACIN"]], "act": "question"}]}
{"index": 1, "text": "what version of INDOMETHACIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Carefully consider the potential benefits and risks of indomethacin and other treatment options before deciding to use indomethacin. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). After observing the response to initial therapy with indomethacin, the dose and frequency should be adjusted to suit an individual patient's needs. Indomethacin is available as 25 mg and 50 mg capsules. Adverse reactions appear to correlate with the size of the dose of indomethacin in most patients but not all. Therefore, every effort should be made to determine the smallest effective dosage for the individual patient.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant EXTENDED", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "EXTENDED"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what do I do with CHLOROTHIAZIDE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CHLOROTHIAZIDE"]], "act": "question"}]}
{"index": 0, "text": "what version of CHLOROTHIAZIDE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "what do I do with Butalbital?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Butalbital"]], "act": "question"}]}
{"index": 0, "text": "what version of Butalbital is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "Butalbital and Acetaminophen, 50 mg/ 325 mg tablets: One or two tablets every four hours as needed. Do not exceed not exceed 6 tablets per day. Extended and repeated use of these products is not recommended because of the potential for physical dependence.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Dextroamphetamine?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dextroamphetamine"]], "act": "question"}]}
{"index": 1, "text": "what version of Dextroamphetamine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Dextroamphetamine saccharate,Amphetamine aspartate,Dextroamphetamine sulfate,Amphetamine sulfate,CROSPOVIDONE (15 MPA.S AT 5%),magnesium stearate,MICROCRYSTALLINE CELLULOSE,POVIDONE, UNSPECIFIED,starch, corn,D&C YELLOW NO. 10,FD&C BLUE NO. 1,Dextroamphetamine saccharate,Amphetamine aspartate,Dextroamphetamine sulfate,Amphetamine sulfate,CROSPOVIDONE (15 MPA.S AT 5%),magnesium stearate,MICROCRYSTALLINE CELLULOSE,POVIDONE, UNSPECIFIED,starch, corn,D&C YELLOW NO. 10,FD&C BLUE NO. 1,Dextroamphetamine saccharate,Amphetamine aspartate,Dextroamphetamine sulfate,Amphetamine sulfate,CROSPOVIDONE (15 MPA.S AT 5%),magnesium stearate,MICROCRYSTALLINE CELLULOSE,POVIDONE, UNSPECIFIED,starch, corn,D&C YELL", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Is Allergenic safe  if I have TB?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Allergenic"], ["<condition>", "TB"]], "act": "question"}]}
{"index": 0, "text": "Adverse reactions include, but are not limited to urticaria; itching; edema of extremities; respiratory wheezing or asthma; dyspnea; cyanosis; tachycardia; lacrimation; marked perspiration; flushing of face, neck or upper chest; mild persistent clearing of throat; hacking cough or persistent sneezing. 1) Local Reactions A mild burning immediately after injection is expected; this usually subsides in 10-20 seconds. Prolonged pain or pain radiating up arm is usually the result of intramuscular injection, making this injection route undesirable. Subcutaneous injection is the recommended route. Small amounts of erythema and swelling at the site of injection are common. Reactions should not be co", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is BACLOFEN?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BACLOFEN"]], "act": "question"}]}
{"index": 1, "text": "Baclofen is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. Baclofen may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Baclofen is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. The efficacy of baclofen in stroke, cerebral palsy, and Parkinson's disease has not been established and, therefore, it is not recommended for these conditions.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Erythrocin?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Erythrocin"]], "act": "question"}]}
{"index": 1, "text": "what version of Erythrocin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "ERYTHROMYCIN LACTOBIONATE,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "Should I take Pentoxifylline  if I am TB?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Pentoxifylline"], ["<condition>", "TB"]], "act": "question"}]}
{"index": 0, "text": "Clinical trials were conducted using either extended-release pentoxifylline tablets for up to 60 weeks or immediate-release pentoxifylline capsules for up to 24 weeks. Dosage ranges in the tablet studies were 400 mg bid to tid and in the capsule studies, 200 to 400 mg tid. The table summarizes the incidence (in percent) of adverse reactions considered drug related, as well as the numbers of patients who received extended-release pentoxifylline tablets, immediate-release pentoxifylline capsules, or the corresponding placebos. The incidence of adverse reactions was higher in the capsule studies (where dose related increases were seen in digestive and nervous system side effects) than in the ta", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant ALPRAZOLAM", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ALPRAZOLAM"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Quinidine cause suicidal?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Quinidine"], ["<symptom>", "suicidal"]], "act": "question"}]}
{"index": 0, "text": "suicidal is a serious side effect of Quinidine. Quinidine preparations have been used for many years, but there are only sparse data from which to estimate the incidence of various adverse reactions. The adverse reactions most frequently reported have consistently been gastrointestinal, including diarrhea, nausea, vomiting, and heartburn/esophagitis. In one study of 245 adult outpatients who received quinidine to suppress premature ventricular contractions, the incidences of reported adverse experiences were as shown in the table below. The most serious quinidine-associated adverse reactions are described above under WARNINGS . Adverse Experiences in a 245-Patient PVC Trial Incidence (%) Incidence (%) diarrhea 85 (35) upper gastrointestin", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "what are the ingredients of Fluocinonide?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluocinonide"]], "act": "question"}]}
{"index": 0, "text": "what version of Fluocinonide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "FLUOCINONIDE,PETROLATUM,PROPYLENE GLYCOL,GLYCERYL MONOSTEARATE,PROPYLENE CARBONATE,WHITE WAX", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "FLUOCINONIDE,citric acid monohydrate,glycerin,1,2,6-hexanetriol,polyethylene glycol 3350,polyethylene glycol 8000,propylene glycol,stearyl alcohol", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does ADAPALENE contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ADAPALENE"]], "act": "question"}]}
{"index": 0, "text": "what version of ADAPALENE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "ADAPALENE,CARBOMER HOMOPOLYMER TYPE C,EDETATE DISODIUM,METHYLPARABEN,POLOXAMER 182,PROPYLENE GLYCOL,WATER,SODIUM HYDROXIDE,HYDROCHLORIC ACID", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant chlorzoxazone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "chlorzoxazone"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take CELECOXIB?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CELECOXIB"]], "act": "question"}]}
{"index": 1, "text": "what version of CELECOXIB is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "2.1 General Dosing Instructions Carefully consider the potential benefits and risks of celecoxib capsules and other treatment options before deciding to use celecoxib capsules. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions (5)]. These doses can be given without regard to timing of meals. 2.2 Osteoarthritis For OA, the dosage is 200 mg per day administered as a single dose or as 100 mg twice daily. 2.3 Rheumatoid Arthritis For RA, the dosage is 100 to 200 mg twice daily. 2.4 Juvenile Rheumatoid Arthritis For JRA, the dosage for pediatric patients (age 2 years and older) is based on weight. For patient", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Dextroamphetamine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Dextroamphetamine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Regardless of indication, amphetamines should be administered at the lowest effective dosage, and dosage should be individually adjusted according to the therapeutic needs and response of the patient. Late evening doses should be avoided because of the resulting insomnia.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Benzonatate cause suicidal?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Benzonatate"], ["<symptom>", "suicidal"]], "act": "question"}]}
{"index": 1, "text": "suicidal is a mild side effect of Benzonatate. Potential Adverse Reactions to BENZONATATE may include: Hypersensitivity reactions including bronchospasm, laryngospasm and cardiovascular collapse possibly related to local anesthesia from chewing or sucking the capsule. CNS: sedation; headache; dizziness; mental confusion; visual hallucinations. GI: constipation; nausea; GI upset. Dermatologic: pruritus; skin eruptions. Other: nasal congestion; sensation of burning in the eyes; vague \"chilly\" sensation; numbness of the chest; hypersensitivity. Deliberate or accidental overdose has resulted in death, particularly in children. To report SUSPECTED ADVERSE REACTIONS, contact Bionpharma at 1-888-235-2466 or FDA at 1-800-FDA-1088 or www.fda.gov/", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant cyanocobalamine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "cyanocobalamine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "What is Cifrazol?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cifrazol"]], "act": "question"}]}
{"index": 0, "text": "Cifrazol is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels, Vitamin D deficiency or are in need of Vitamin D supplementation and other nutritional supplementation.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Zoledronic?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Zoledronic"]], "act": "question"}]}
{"index": 1, "text": "Zoledronic may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "anxiety", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "inform"}]}
{"index": 2, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant tourettes", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "does Dehydrated cause hallucinations?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dehydrated"], ["<symptom>", "hallucinations"]], "act": "question"}]}
{"index": 0, "text": "hallucinations is a mild side effect of Dehydrated. The most commonly encountered side effects are post-injection neuritis with persistent pain, hyperesthesia and paresthesia. Subarachnoid neurolysis and lumbar sympathetic block may be followed by motor paralysis, bladder or rectal incontinence and impotence. Severe hypotension may follow celiac ganglion injection. Corneal anesthesia, meningitis or cranial nerve palsy may follow injection of the gasserian ganglion.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant blurred_vision", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "blurred_vision"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "Is ROCURONIUM safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ROCURONIUM"]], "act": "question"}]}
{"index": 0, "text": "ROCURONIUM may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "IBD", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "inform"}]}
{"index": 1, "text": "In clinical trials, the most common adverse reactions (2%) are transient hypotension and hypertension. The following adverse reactions are described, or described in greater detail, in other sections:  Anaphylaxis [ see Warnings and Precautions (5.2) ]  Residual paralysis [ see Warnings and Precautions (5.4) ]  Myopathy [ see Warnings and Precautions (5.5) ]  Increased pulmonary vascular resistance [ see Warnings and Precautions (5.11) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Mepivacaine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Mepivacaine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Reactions to MEPIVACAINE are characteristic of those associated with other amide-type local anesthetics. Systemic adverse reactions involving the central nervous system and the cardiovascular system usually result from high plasma levels (which may be due to excessive dosage, rapid absorption, inadvertent intravascular injection, or slow metabolic degradation), injection technique, or volume of injection. A small number of reactions may result from hypersensitivity, idiosyncrasy or diminished tolerance to normal dosage on the part of the patient. Persistent paresthesias of the lips, tongue, and oral tissues have been reported with the use of mepivacaine, with slow, incomplete, or no recovery", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "how do I store Prazosin?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Prazosin"]], "act": "question"}]}
{"index": 0, "text": "what version of Prazosin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Prazosin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant TARGADOX", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "TARGADOX"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug TARGADOX", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Diltiazem for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Diltiazem"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 1, "text": "what version of Diltiazem is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Diltiazem is 1 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant 70", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Diltiazem is 1 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Clindamycin is the correct dose for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Clindamycin"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of Clindamycin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Clindamycin is 4 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "What is TETRABENAZINE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TETRABENAZINE"]], "act": "question"}]}
{"index": 0, "text": "Tetrabenazine tablets are indicated for the treatment of chorea associated with Huntington\u2019s disease.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant PredniSONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "PredniSONE"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Prednisone tablets are indicated in the following conditions: 1. Endocrine Disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer 2. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Psoriatic arthritis Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "where should I keep cilostazol?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "cilostazol"]], "act": "question"}]}
{"index": 0, "text": "what version of cilostazol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug cilostazol", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Albumin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Albumin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Albumin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I take Doxycycline?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxycycline"]], "act": "question"}]}
{"index": 0, "text": "what version of Doxycycline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "THE USUAL DOSAGE AND FREQUENCY OF ADMINISTRATION OF DOXYCYCLINE DIFFERS FROM THAT OF THE OTHER TETRACYCLINES. EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE OF SIDE EFFECTS. Adults: The usual dose of oral doxycycline is 200 mg on the first day of treatment (administered 100 mg every 12 hours or 50 mg every 6 hours) followed by a maintenance dose of 100 mg/day. The maintenance dose may be administered as a single dose or as 50 mg every 12 hours. In the management of more severe infections (particularly chronic infections of the urinary tract), 100 mg every 12 hours is recommended. Pediatric Patients: For all pediatric patients weighing less than 45 kg with severe or lif", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Glycopyrrolate", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Glycopyrrolate"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "What is SIMVASTATIN?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SIMVASTATIN"]], "act": "question"}]}
{"index": 0, "text": "Lipid-altering agents should be used in addition to a diet restricted in saturated fat and cholesterol (see National Cholesterol Education Program [NCEP] Treatment Guidelines , below). In patients with CHD or at high risk of CHD, simvastatin can be started simultaneously with diet.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Acetazolamide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Acetazolamide"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acetazolamide Tablets are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those who are very susceptible to acute mountain sickness despite gradual ascent.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many LOVASTATIN is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LOVASTATIN"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 2, "text": "what version of LOVASTATIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for LOVASTATIN is 1 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much LMD should i take for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LMD"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 0, "text": "what version of LMD is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for LMD is 3 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Clindamycin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Clindamycin"]], "act": "question"}]}
{"index": 1, "text": "Clindamycin phosphate topical solution, clindamycin phosphate topical gel and clindamycin phosphate topical lotion are indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see CONTRAINDICATIONS , WARNINGS and ADVERSE REACTIONS ).", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take Cidofovir?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cidofovir"]], "act": "question"}]}
{"index": 0, "text": "Cidofovir may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "anxiety", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "inform"}]}
{"index": 1, "text": "Nephrotoxicity: Renal toxicity, as manifested by \u22652+ proteinuria, serum creatinine elevations of \u22650.4 mg/dL, or decreased creatinine clearance \u226455 mL/min, occurred in 79 of 135 (59%) patients receiving cidofovir injection at a maintenance dose of 5 mg/kg every other week. Maintenance dose reductions from 5 mg/kg to 3 mg/kg due to proteinuria or serum creatinine elevations were made in 12 of 41 (29%) patients who had not received prior therapy for CMV retinitis (Study 106) and in 19 of 74 (26%) patients who had received prior therapy for CMV retinitis (Study 107). Prior foscarnet use has been associated with an increased risk of nephrotoxicity; therefore, such patients must be monitored close", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant low_blood_pressure", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Nephrotoxicity: Renal toxicity, as manifested by \u22652+ proteinuria, serum creatinine elevations of \u22650.4 mg/dL, or decreased creatinine clearance \u226455 mL/min, occurred in 79 of 135 (59%) patients receiving cidofovir injection at a maintenance dose of 5 mg/kg every other week. Maintenance dose reductions from 5 mg/kg to 3 mg/kg due to proteinuria or serum creatinine elevations were made in 12 of 41 (29%) patients who had not received prior therapy for CMV retinitis (Study 106) and in 19 of 74 (26%) patients who had received prior therapy for CMV retinitis (Study 107). Prior foscarnet use has been associated with an increased risk of nephrotoxicity; therefore, such patients must be monitored close", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is fever a common side effect of ALLOPURINOL?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ALLOPURINOL"], ["<symptom>", "fever"]], "act": "question"}]}
{"index": 1, "text": "fever is a mild side effect of ALLOPURINOL. Data upon which the following estimates of incidence of adverse reactions are made are derived from experiences reported in the literature, unpublished clinical trials and voluntary reports since marketing of allopurinol began. Past experience suggested that the most frequent event following the initiation of allopurinol treatment was an increase in acute attacks of gout (average 6% in early studies). An analysis of current usage suggests that the incidence of acute gouty attacks has diminished to less than 1%. The explanation for this decrease has not been determined but may be due in part to initiating therapy more gradually (see PRECAUTIONS and DOSAGE AND ADMINISTRATION ). The most freque", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Brimonidine in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Brimonidine"]], "act": "question"}]}
{"index": 1, "text": "what version of Brimonidine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Brimonidine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "Should I take Metaproterenol?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metaproterenol"]], "act": "question"}]}
{"index": 0, "text": "Metaproterenol may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 1, "text": "Adverse reactions are similar to those noted with other sympathomimetic agents. The following table of adverse experiences is derived from 44 clinical trials involving 1,120 patients treated with metaproterenol sulfate syrup: Metaproterenol Sulfate Syrup Incidence of Adverse Events Occurring in at least 1% of Patients Adverse Experience Incidence Number of Patients % Cardiovascular Tachycardia 68 6.1 Central Nervous System Headache 12 1.1 Nervousness 54 4.8 Gastrointestinal Nausea 15 1.3 Musculoskeletal Tremor 18 1.6", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in chlorzoxazone?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "chlorzoxazone"]], "act": "question"}]}
{"index": 1, "text": "what version of chlorzoxazone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "ANHYDROUS LACTOSE,CELLULOSE, MICROCRYSTALLINE,CROSCARMELLOSE SODIUM,DOCUSATE SODIUM,MAGNESIUM STEARATE,SODIUM BENZOATE,STARCH, CORN,CHLORZOXAZONE,ANHYDROUS LACTOSE,CELLULOSE, MICROCRYSTALLINE,CROSCARMELLOSE SODIUM,DOCUSATE SODIUM,MAGNESIUM STEARATE,SODIUM BENZOATE,STARCH, CORN,CHLORZOXAZONE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the ingredients of BUPAP?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BUPAP"]], "act": "question"}]}
{"index": 0, "text": "what version of BUPAP is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "BUTALBITAL,ACETAMINOPHEN,STARCH, CORN,CROSCARMELLOSE SODIUM,MAGNESIUM STEARATE,D&C YELLOW NO. 10,FD&C RED NO. 40,MICROCRYSTALLINE CELLULOSE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "does Indapamide contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Indapamide"]], "act": "question"}]}
{"index": 0, "text": "what version of Indapamide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "INDAPAMIDE,STARCH, CORN,HYPROMELLOSES,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POLYETHYLENE GLYCOLS,TALC,TITANIUM DIOXIDE,TRIACETIN,FD&C YELLOW NO. 6,INDAPAMIDE,STARCH, CORN,HYPROMELLOSES,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POLYETHYLENE GLYCOLS,TALC,TITANIUM DIOXIDE,TRIACETIN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for CALAN?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CALAN"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 2, "text": "what version of CALAN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for CALAN is 4 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "what do I do with Amitriptyline?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amitriptyline"]], "act": "question"}]}
{"index": 0, "text": "what version of Amitriptyline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Dosage should be initiated at a low level and increased gradually, noting carefully the clinical response and any evidence of intolerance.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Dipentum", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Dipentum"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The usual dosage in adults for maintenance of remission is 1.0 g/day in two divided doses.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in SODIUM?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SODIUM"]], "act": "question"}]}
{"index": 0, "text": "what version of SODIUM is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "SODIUM ACETATE ANHYDROUS,WATER,ACETIC ACID", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many SODIUM is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SODIUM"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 1, "text": "what version of SODIUM is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for SODIUM is 1 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Cefprozil safe  for someone with anxiety?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cefprozil"], ["<condition>", "anxiety"]], "act": "question"}]}
{"index": 1, "text": "The adverse reactions to cefprozil are similar to those observed with other orally administered cephalosporins. Cefprozil was usually well tolerated in controlled clinical trials. Approximately 2% of patients discontinued cefprozil therapy due to adverse events. The most common adverse effects observed in patients treated with cefprozil are: Gastrointestinal: Diarrhea (2.9%), nausea (3.5%), vomiting (1%), and abdominal pain (1%). Hepatobiliary: Elevations of AST (SGOT) (2%), ALT (SGPT) (2%), alkaline phosphatase (0.2%), and bilirubin values (<0.1%). As with some penicillins and some other cephalosporin antibiotics, cholestatic jaundice has been reported rarely. Hypersensitivity: Rash (0.9%),", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant TB", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Diphenoxylate", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Diphenoxylate"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "Is lorazepam safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "lorazepam"]], "act": "question"}]}
{"index": 0, "text": "lorazepam may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "infection", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "inform"}]}
{"index": 1, "text": "Most adverse reactions to benzodiazepines, including CNS effects and respiratory depression, are dose dependent, with more severe effects occurring with high doses. In a sample of about 3500 patients treated for anxiety, the most frequent adverse reaction to lorazepam was sedation (15.9%), followed by dizziness (6.9%), weakness (4.2%), and unsteadiness (3.4%). The incidence of sedation and unsteadiness increased with age. Other adverse reactions to benzodiazepines, including lorazepam are fatigue, drowsiness, amnesia, memory impairment, confusion, disorientation, depression, unmasking of depression, disinhibition, euphoria, suicidal ideation/attempt, ataxia, asthenia, extrapyramidal symptoms", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant infection", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Most adverse reactions to benzodiazepines, including CNS effects and respiratory depression, are dose dependent, with more severe effects occurring with high doses. In a sample of about 3500 patients treated for anxiety, the most frequent adverse reaction to lorazepam was sedation (15.9%), followed by dizziness (6.9%), weakness (4.2%), and unsteadiness (3.4%). The incidence of sedation and unsteadiness increased with age. Other adverse reactions to benzodiazepines, including lorazepam are fatigue, drowsiness, amnesia, memory impairment, confusion, disorientation, depression, unmasking of depression, disinhibition, euphoria, suicidal ideation/attempt, ataxia, asthenia, extrapyramidal symptoms", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Piroxicam contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Piroxicam"]], "act": "question"}]}
{"index": 0, "text": "what version of Piroxicam is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "piroxicam,GELATIN, UNSPECIFIED,FD&C BLUE NO. 1,FD&C RED NO. 40,D&C YELLOW NO. 10,TITANIUM DIOXIDE,STARCH, CORN,LACTOSE MONOHYDRATE,SODIUM LAURYL SULFATE,MAGNESIUM STEARATE,piroxicam,GELATIN, UNSPECIFIED,FD&C BLUE NO. 1,FD&C RED NO. 40,D&C YELLOW NO. 10,TITANIUM DIOXIDE,STARCH, CORN,LACTOSE MONOHYDRATE,SODIUM LAURYL SULFATE,MAGNESIUM STEARATE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "does Gemfibrozil cause insomnia?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Gemfibrozil"], ["<symptom>", "insomnia"]], "act": "question"}]}
{"index": 0, "text": "insomnia is a dangerous side effect of Gemfibrozil. In the double-blind controlled phase of the primary prevention component of the Helsinki Heart Study, 2046 patients received gemfibrozil for up to five years. In that study, the following adverse reactions were statistically more frequent in subjects in the gemfibrozil group: GEMFIBROZIL ( N = 2046 ) PLACEBO ( N = 2035 ) Frequency in percent of subjects Gastrointestinal reactions 34.2 23.8 Dyspepsia 19.6 11.9 Abdominal pain 9.8 5.6 Acute appendicitis 1.2 0.6 (histologically confirmed in most cases where data were available) Atrial fibrillation 0.7 0.1 Adverse events reported by more than 1% of subjects, but without a significant difference between groups: Diarrhea 7.2 6.5 Fatigue 3.8 3.5 Nau", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Mesalamine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Mesalamine"]], "act": "question"}]}
{"index": 0, "text": "Mesalamine is indicated for the induction of remission and for the treatment of patients with mildly to moderately active ulcerative colitis.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Sodium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sodium"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Sodium Phosphates Injection, USP is indicated as a source of phosphate, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. The concomitant amount of sodium (4 mEq/mL) must be calculated into total electrolyte dose of such prepared solutions.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "does Cefoxitin contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cefoxitin"]], "act": "question"}]}
{"index": 0, "text": "what version of Cefoxitin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "CEFOXITIN SODIUM,CEFOXITIN SODIUM", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "where should I keep CARBIDOPA?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CARBIDOPA"]], "act": "question"}]}
{"index": 0, "text": "what version of CARBIDOPA is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug CARBIDOPA", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Doxycycline contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxycycline"]], "act": "question"}]}
{"index": 0, "text": "what version of Doxycycline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Doxycycline,Microcrystalline Cellulose,Sodium Starch Glycolate Type A Potato,Magnesium Stearate,Silicon Dioxide,Titanium Dioxide,Gelatin, Unspecified,Shellac,Propylene Glycol,Ferric Oxide Yellow,Ferrosoferric Oxide,Doxycycline,Microcrystalline Cellulose,Sodium Starch Glycolate Type A Potato,Magnesium Stearate,Silicon Dioxide,Titanium Dioxide,Gelatin, Unspecified,Ferric Oxide Red,Ferrosoferric Oxide,Ferric Oxide Yellow,Shellac,Propylene Glycol,Doxycycline,Microcrystalline Cellulose,Sodium Starch Glycolate Type A Potato,Magnesium Stearate,Silicon Dioxide,Titanium Dioxide,Gelatin, Unspecified,Ferric Oxide Red,Ferrosoferric Oxide,Ferric Oxide Yellow,Shellac,Propylene Glycol", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Hydroxyzine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydroxyzine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Hydroxyzine Hydrochloride", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Hyoscyamine is the correct dose for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hyoscyamine"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 1, "text": "what version of Hyoscyamine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Hyoscyamine is 1 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of Quetiapine?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Quetiapine"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of Quetiapine: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "anxiety", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "anxiety"]], "act": "inform"}]}
{"index": 2, "text": "anxiety is a dangerous side effect of Quetiapine. The following adverse reactions are discussed in more detail in other sections of the labeling:  Increased Mortality in Elderly Patients with Dementia-Related Psychosis [see WARNINGS AND PRECAUTIONS (5.1)]  Suicidal Thoughts and Behaviors in Adolescents and Young Adults [see WARNINGS AND PRECAUTIONS (5.2)]  Cerebrovascular Adverse Reactions, Including Stroke in Elderly Patients with Dementia-Related Psychosis [see WARNINGS AND PRECAUTIONS (5.3)]  Neuroleptic Malignant Syndrome (NMS) [see WARNINGS AND PRECAUTIONS (5.4)]  Metabolic Changes (Hyperglycemia, Dyslipidemia, Weight Gain) [see WARNINGS AND PRECAUTIONS (5.5)]  Tardive Dyskinesia [see WARNINGS AND PRECAUTIONS (5.6)]  Hypotension [see W", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "actually i meant depression", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "depression"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how do I use Hyoscyamine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hyoscyamine"]], "act": "question"}]}
{"index": 0, "text": "what version of Hyoscyamine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Dosage may be adjusted according to the conditions and severity of symptoms. Adults and pediatric patients 12 years of age and older: 1 to 2 tablets every 12 hours. Do not crush or chew tablets. Do not exceed 4 tablets in 24 hours.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant GLIPIZIDE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "GLIPIZIDE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "There is no fixed dosage regimen for the management of diabetes mellitus with glipizide or any other hypoglycemic agent. In addition to the usual monitoring of urinary glucose, the patient's blood glucose must also be monitored periodically to determine the minimum effective dose for the patient; to detect primary failure, i.e., inadequate lowering of blood glucose at the maximum recommended dose of medication; and to detect secondary failure, i.e., loss of an adequate blood-glucose-lowering response after an initial period of effectiveness. Glycosylated hemoglobin levels may also be of value in monitoring the patient's response to therapy. Short-term administration of glipizide may be suffi", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Gemfibrozil safe  if I have anxiety?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Gemfibrozil"], ["<condition>", "anxiety"]], "act": "question"}]}
{"index": 1, "text": "In the double-blind controlled phase of the primary prevention component of the Helsinki Heart Study, 2046 patients received gemfibrozil for up to five years. In that study, the following adverse reactions were statistically more frequent in subjects in the gemfibrozil group: GEMFIBROZIL (N = 2046) PLACEBO (N = 2035) Frequency in percent of subjects Gastrointestinal reactions 34.2 23.8 Dyspepsia 19.6 11.9 Abdominal pain 9.8 5.6 Acute appendicitis 1.2 0.6 (histologically confirmed in most cases where data were available) Atrial fibrillation 0.7 0.1 Adverse events reported by more than 1% of subjects, but without a significant difference between groups: Diarrhea 7.2 6.5 Fatigue 3.8 3.5 Nausea/", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant 10%", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "10%"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant pregnant", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "where should I keep Ipratropium?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ipratropium"]], "act": "question"}]}
{"index": 1, "text": "what version of Ipratropium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Ipratropium", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant Potassium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "storage instructions for drug Potassium", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep OXALIPLATIN in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "OXALIPLATIN"]], "act": "question"}]}
{"index": 1, "text": "what version of OXALIPLATIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug OXALIPLATIN", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant indomethacin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "indomethacin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much Atrovent should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Atrovent"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 2, "text": "what version of Atrovent is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Atrovent is 4 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant baby", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Atrovent is 1 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 7, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is ReadySharp?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ReadySharp"]], "act": "question"}]}
{"index": 0, "text": "Carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Acute Pain in Adult Patients Ketorolac tromethamine is indicated for the short-term (\u22645 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. Therapy should always be initiated with intravenous or intramuscular dosing of ketorolac tromethamine, and oral ketorolac tromethamine is to be used only as continuation treatment, if necessary. The total combined dura", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant GEMFIBROZIL", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "GEMFIBROZIL"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Gemfibrozils tablets, USP are indicated as adjunctive therapy to diet for: 1. Treatment of adult patients with very high elevations of serum triglyceride levels (Types IV and V hyperlipidemia) who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them. Patients who present such risk typically have serum triglycerides over 2000 mg/dL and have elevations of VLDL-cholesterol as well as fasting chylomicrons (Type V hyperlipidemia). Subjects who consistently have total serum or plasma triglycerides below 1000 mg/dL are unlikely to present a risk of pancreatitis. Gemfibrozil tablets therapy may be considered for those subjects with triglycer", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what do I do with Ibuprofen?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ibuprofen"]], "act": "question"}]}
{"index": 0, "text": "what version of Ibuprofen is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Carefully consider the potential benefits and risks of Ibuprofen tablets and other treatment options before deciding to use Ibuprofen tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). After observing the response to initial therapy with Ibuprofen tablets, the dose and frequency should be adjusted to suit an individual patient\u2019s needs. Do not exceed 3200 mg total daily dose. If gastrointestinal complaints occur, administer Ibuprofen tablets with meals or milk. Rheumatoid arthritis and osteoarthritis, including flare-ups of chronic disease: Suggested Dosage : 1200 mg-3200 mg daily (400 mg, 600 mg or 800 mg tid o", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "Should I take ZESTORETIC  if I have infection?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ZESTORETIC"], ["<condition>", "infection"]], "act": "question"}]}
{"index": 0, "text": "ZESTORETIC has been evaluated for safety in 930 patients including 100 patients treated for 50 weeks or more. In clinical trials with ZESTORETIC no adverse experiences peculiar to this combination drug have been observed. Adverse experiences that have occurred have been limited to those that have been previously reported with lisinopril or hydrochlorothiazide. The most frequent clinical adverse experiences in controlled trials (including open label extensions) with any combination of lisinopril and hydrochlorothiazide were: dizziness (7.5%), headache (5.2%), cough (3.9%), fatigue (3.7%) and orthostatic effects (3.2%) all of which were more common than in placebo-treated patients. Generally, ", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant infection", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant Cetirizine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cetirizine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Pediatric studies were conducted with cetirizine hydrochloride. More than 1300 pediatric patients aged 6 to 11 years with more than 900 treated with cetirizine hydrochloride at doses of 1.25 to 10 mg per day were included in controlled and uncontrolled clinical trials conducted in the United States. The duration of treatment ranged from 2 to 12 weeks. Placebo-controlled trials up to 4 weeks duration included 168 pediatric patients aged 2 to 5 years who received cetirizine, the majority of whom received single daily doses of 5 mg. A placebo-controlled trial 18 months in duration included 399 patients aged 12 to 24 months treated with cetirizine (0.25 mg/kg bid), and another placebo-controlled", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "can i take Griseofulvin  if I have low_blood_pressure?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Griseofulvin"], ["<condition>", "low_blood_pressure"]], "act": "question"}]}
{"index": 0, "text": "There have been post-marketing reports of severe skin and hepatic adverse events associated with griseofulvin use (see WARNINGS section). When adverse reactions occur, they are most commonly of the hypersensitivity type, such as skin rashes, urticaria, and rarely, angioneurotic edema, and erythema multiforme. These may necessitate withdrawal of therapy and appropriate countermeasures. Peripheral neuropathy and paresthesias of the hands and feet have been reported and may be related to treatment duration. Most patients treated with griseofulvin for less than six months experienced improvement or resolution of their neuropathy upon withdrawal of the griseofulvin. Other side effects reported oc", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take TRIAMCINOLONE?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TRIAMCINOLONE"]], "act": "question"}]}
{"index": 1, "text": "TRIAMCINOLONE may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "low_blood_pressure", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "inform"}]}
{"index": 2, "text": "The following local adverse reactions may occur with corticosteroid-containing dental pastes: burning, itching, irritation, dryness, blistering or peeling not present prior to therapy, perioral dermatitis, allergic contact dermatitis, maceration of the oral mucosa, secondary infection, and atrophy of the oral mucosa. Also, see PRECAUTIONS for potential effects of systemic absorption.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant low_blood_pressure", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The following local adverse reactions may occur with corticosteroid-containing dental pastes: burning, itching, irritation, dryness, blistering or peeling not present prior to therapy, perioral dermatitis, allergic contact dermatitis, maceration of the oral mucosa, secondary infection, and atrophy of the oral mucosa. Also, see PRECAUTIONS for potential effects of systemic absorption.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does SULFAMETHOXAZOLE cause mood_swings?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SULFAMETHOXAZOLE"], ["<symptom>", "mood_swings"]], "act": "question"}]}
{"index": 1, "text": "mood_swings is a common side effect of SULFAMETHOXAZOLE. The most common adverse effects are gastrointestinal disturbances (nausea, vomiting, anorexia) and allergic skin reactions (such as rash and urticaria). FATALITIES ASSOCIATED WITH THE ADMINISTRATION OF SULFONAMIDES, ALTHOUGH RARE, HAVE OCCURRED DUE TO SEVERE REACTIONS, INCLUDING STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, FULMINANT HEPATIC NECROSIS, AGRANULOCYTOSIS, APLASTIC ANEMIA AND OTHER BLOOD DYSCRASIAS (see WARNINGS section). Hematologic: Agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia, neutropenia, hemolytic anemia, megaloblastic anemia, hypoprothrombinemia, methemoglobinemia, eosinophilia. Allergic Reactions: Stevens-Johnson syndrome, toxic epidermal necrolys", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant stomach_ache", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "stomach_ache"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is METOCLOPRAMIDE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "METOCLOPRAMIDE"]], "act": "question"}]}
{"index": 1, "text": "The use of Metoclopramide Oral Solution is recommended for adults only. Therapy should not exceed 12 weeks in duration.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant NALOXONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "NALOXONE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Naloxone Hydrochloride Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol and cyclazocine. Naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage. Naloxone may be useful as an adjunctive agent to increase blood pressure in the management of septic shock (see CLINICAL PHARMACOLOGY, Adjunctive Use in Septic Shock ).", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is aggression a common side effect of HALOPERIDOL?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HALOPERIDOL"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 0, "text": "aggression is a serious side effect of HALOPERIDOL. The following adverse reactions are discussed in more detail in other sections of the labeling: WARNINGS, Increased mortality in Elderly Patients with Dementia-Related Psychosis WARNINGS, Cardiovascular Effects WARNINGS, Tardive Dyskinesia WARNINGS, Neuroleptic Malignant Syndrome WARNINGS, Falls WARNINGS, Combined Use of Haloperidol and Lithium WARNINGS, General PRECAUTIONS, Leukopenia, Neutropenia, and Agranulocytosis PRECAUTIONS, Other PRECAUTIONS, Usage in Pregnancy", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant insomnia", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "insomnia"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant ALLOPURINOL", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ALLOPURINOL"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "insomnia is a mild side effect of ALLOPURINOL. Data upon which the following estimates of incidence of adverse reactions are made are derived from experiences reported in the literature, unpublished clinical trials and voluntary reports since marketing of allopurinol began. Past experience suggested that the most frequent event following the initiation of allopurinol treatment was an increase in acute attacks of gout (average 6% in early studies). An analysis of current usage suggests that the incidence of acute gouty attacks has diminished to less than 1%. The explanation for this decrease has not been determined but may be due in part to initiating therapy more gradually (see PRECAUTIONS and DOSAGE AND ADMINISTRATION ). The most freque", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is the dose for Solu-Medrol for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Solu-Medrol"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 0, "text": "what version of Solu-Medrol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "10", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Solu-Medrol is 3 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Dexmethylphenidate?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dexmethylphenidate"]], "act": "question"}]}
{"index": 1, "text": "what version of Dexmethylphenidate is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "Dexmethylphenidate hydrochloride tablets are administered twice daily, at least 4 hours apart. Dexmethylphenidate hydrochloride tablets may be administered with or without food. Dosage should be individualized according to the needs and responses of the patient. Patients New to Methylphenidate The recommended starting dose of dexmethylphenidate hydrochloride tablets for patients who are not currently taking racemic methylphenidate, or for patients who are on stimulants other than methylphenidate, is 5 mg/day (2.5 mg twice daily). Dosage may be adjusted in 2.5 to 5 mg increments to a maximum of 20 mg/day (10 mg twice daily). In general, dosage adjustments may proceed at approximately weekly i", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep divalproex in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "divalproex"]], "act": "question"}]}
{"index": 1, "text": "what version of divalproex is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug divalproex", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Lactulose?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lactulose"]], "act": "question"}]}
{"index": 1, "text": "For the treatment of constipation. In patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant VITAMIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "VITAMIN"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Ergocalciferol Capsules, USP are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does KETOROLAC contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "KETOROLAC"]], "act": "question"}]}
{"index": 1, "text": "what version of KETOROLAC is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "HYDROXYPROPYL CELLULOSE (TYPE H),HYPROMELLOSE 2910 (3 MPA.S),HYPROMELLOSE 2910 (50 MPA.S),LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POLYETHYLENE GLYCOL 400,TITANIUM DIOXIDE,KETOROLAC TROMETHAMINE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "how many Lamotrigine is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lamotrigine"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of Lamotrigine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Lamotrigine is 4 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Deferoxamine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Deferoxamine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "do I need to keep METHOCARBAMOL in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "METHOCARBAMOL"]], "act": "question"}]}
{"index": 0, "text": "what version of METHOCARBAMOL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug METHOCARBAMOL", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is hallucinations a common side effect of clarithromycin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "clarithromycin"], ["<symptom>", "hallucinations"]], "act": "question"}]}
{"index": 1, "text": "hallucinations is a mild side effect of clarithromycin. The most frequent and common adverse reactions related to clarithromycin therapy for both adult and pediatric populations are abdominal pain, diarrhea, nausea, vomiting and dysgeusia. These adverse reactions are consistent with the known safety profile of macrolide antibiotics. There was no significant difference in the incidence of these gastrointestinal adverse reactions during clinical trials between the patient population with or without preexisting mycobacterial infections. Adverse Reactions Observed During Clinical Trials of Clarithromycin The following adverse reactions were observed in clinical trials with clarithromycin at a rate greater than or equal to 1%: Gastrointestinal Disorde", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does atenolol cause anxiety?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "atenolol"], ["<symptom>", "anxiety"]], "act": "question"}]}
{"index": 1, "text": "anxiety is a dangerous side effect of atenolol. Most adverse effects have been mild and transient. The frequency estimates in the following table were derived from controlled studies in hypertensive patients in which adverse reactions were either volunteered by the patient (US studies) or elicited, e.g., by checklist (foreign studies). The reported frequency of elicited adverse effects was higher for both atenolol and placebo-treated patients than when these reactions were volunteered. Where frequency of adverse effects of atenolol and placebo is similar, causal relationship to atenolol is uncertain. Volunteered (US Studies) Total-Volunteered and Elicited (Foreign + US Studies) Atenolol (n = 164) % Placebo (n = 206) % Atenolol (n = 399) %", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant depression", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "depression"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant DOXYCYCLINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "DOXYCYCLINE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Fioricet in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fioricet"]], "act": "question"}]}
{"index": 1, "text": "what version of Fioricet is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Fioricet", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Pyridium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Pyridium"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "storage instructions for drug Pyridium", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is DOXYCYCLINE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DOXYCYCLINE"]], "act": "question"}]}
{"index": 1, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Lidocaine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Lidocaine hydrochloride injection administered intravenously or intramuscularly, is specifically indicated in the acute management of ventricular arrhythmias such as those occurring in relation to acute myocardial infarction, or during cardiac manipulation, such as cardiac surgery.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with PROMETHAZINE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PROMETHAZINE"]], "act": "question"}]}
{"index": 1, "text": "what version of PROMETHAZINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Promethazine hydrochloride and phenylephrine hydrochloride syrup is contraindicated for children under 2 years of age ( see WARNINGS \u2013 Black Box Warning and Use In Pediatric Patients ). The recommended doses are given in the following table: Adults And Children 12 Years And Over 1 teaspoonful (5 mL) every 4 to 6 hours, not to exceed 6 teaspoonsful (30 mL) in 24 hours. Children 6 To Under 12 Years Of Age \u00bd to 1 teaspoonful (2.5 to 5 mL) every 4 to 6 hours, not to exceed 6 teaspoonsful (30 mL) in 24 hours. Children 2 To Under 6 Years Of Age \u00bc to \u00bd teaspoonful (1.25 to 2.5 mL) every 4 to 6 hours.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Fludrocortisone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Fludrocortisone"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Proventil is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Proventil"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 2, "text": "what version of Proventil is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Proventil is 4 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Proventil is 4 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "how do I take Anastrozole?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Anastrozole"]], "act": "question"}]}
{"index": 0, "text": "what version of Anastrozole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "do I need to keep ProAmatine in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ProAmatine"]], "act": "question"}]}
{"index": 0, "text": "what version of ProAmatine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug ProAmatine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Gentamicin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Gentamicin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Gentamicin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Benazepril?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Benazepril"]], "act": "question"}]}
{"index": 0, "text": "Benazepril HCl and Hydrochlorothiazide is indicated for the treatment of hypertension. This fixed combination drug is not indicated for the initial therapy of hypertension (see DOSAGE AND ADMINISTRATION ).", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Nexterone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Nexterone"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "NEXTERONE is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy. NEXTERONE also can be used to treat patients with VT/VF for whom oral amiodarone is indicated, but who are unable to take oral medication. During or after treatment with NEXTERONE, patients may be transferred to oral amiodarone therapy [see Dosage and Administration (2) ]. Use NEXTERONE for acute treatment until the patient's ventricular arrhythmias are stabilized. Most patients will require this therapy for 48 to 96 hours, but NEXTERONE may be safely administered for longer ", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "do I need to keep ZEMPLAR in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ZEMPLAR"]], "act": "question"}]}
{"index": 0, "text": "what version of ZEMPLAR is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug ZEMPLAR", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Carbidopa", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Carbidopa"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "storage instructions for drug Carbidopa", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is it normal to have aggression with Isordil?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Isordil"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 0, "text": "aggression is a mild side effect of Isordil. Adverse reactions to isosorbide dinitrate are generally dose-related, and almost all of these reactions are the result of isosorbide dinitrate's activity as a vasodilator. Headache, which may be severe, is the most commonly reported side effect. Headache may be recurrent with each daily dose, especially at higher doses. Transient episodes of lightheadedness, occasionally related to blood pressure changes, may also occur. Hypotension occurs infrequently, but in some patients it may be severe enough to warrant discontinuation of therapy. Syncope, crescendo angina, and rebound hypertension have been reported but are uncommon. Extremely rarely, ordinary doses of organic nitrates have caused meth", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Cyclopentolate?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cyclopentolate"]], "act": "question"}]}
{"index": 1, "text": "what version of Cyclopentolate is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "Adults: Instill one or two drops of 1% solution in the eye which may be repeated in five to ten minutes if necessary. Complete recovery usually occurs in 24 hours. Complete recovery from mydriasis in some individuals may require several days. Children: Instill one or two drops of 1% solution in the eye, which may be repeated five to ten minutes later by a second application of 1% solution if necessary. Individuals with heavily pigmented irides may require higher strengths.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Butalbital", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Butalbital"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Butalbital and Acetaminophen, 50 mg/ 325 mg tablets: One or two tablets every four hours as needed. Do not exceed not exceed 6 tablets per day. Extended and repeated use of these products is not recommended because of the potential for physical dependence.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "Should I take ProCentra  if I have infection?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ProCentra"], ["<condition>", "infection"]], "act": "question"}]}
{"index": 0, "text": "To report SUSPECTED ADVERSE REACTIONS, contact FSC Laboratories, Inc. at 1-866-764-7822, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Cardiovascular: Palpitations, tachycardia, elevation of blood pressure. There have been isolated reports of cardiomyopathy associated with chronic amphetamine use. Central Nervous System: Psychotic episodes at recommended doses (rare), overstimulation, restlessness, dizziness, insomnia, euphoria, dyskinesia, dysphoria, tremor, headache, exacerbation of motor and phonic tics and Tourette's syndrome. Gastrointestinal: Dryness of the mouth, unpleasant taste, diarrhea, constipation, other gastrointestinal disturbances. Anorexia and weight loss may occur as un", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is LIDOCAINE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LIDOCAINE"]], "act": "question"}]}
{"index": 0, "text": "Lidocaine Hydrochloride Jelly USP, 2% is indicated for prevention and control of pain in procedures involving the male and female urethra for topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation (oral and nasal).", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Demeclocycline  if I have glaucoma?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Demeclocycline"], ["<condition>", "glaucoma"]], "act": "question"}]}
{"index": 1, "text": "The following reactions have been reported in patients receiving tetracyclines: Gastrointestinal: Anorexia, nausea, vomiting, diarrhea, glossitis, dysphagia, enterocolitis, pancreatitis, and inflammatory lesions (with monilial overgrowth) in the anogenital region, increases in liver enzymes, and hepatic toxicity have been reported rarely. Rarely, hepatitis and liver failure have been reported. These reactions have been caused by both the oral and parenteral administration of tetracyclines. Instances of esophageal ulcerations have been reported in patients receiving oral tetracyclines. Most of the patients were reported to have taken the medication immediately before lying down. (See DOSAGE A", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant ACD-A", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ACD-A"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep FLUOROPLEX in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "FLUOROPLEX"]], "act": "question"}]}
{"index": 1, "text": "what version of FLUOROPLEX is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug FLUOROPLEX", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Imipramine contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Imipramine"]], "act": "question"}]}
{"index": 1, "text": "what version of Imipramine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "IMIPRAMINE HYDROCHLORIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant Cyclobenzaprine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cyclobenzaprine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Cyclobenzaprine Hydrochloride,Carnauba Wax,Croscarmellose Sodium,Fd&c Yellow No. 6,Ferric Oxide Yellow,Lactose Monohydrate,Lecithin, Soybean,Polyethylene Glycol, Unspecified,Magnesium Stearate,Cellulose, Microcrystalline,Polyvinyl Alcohol, Unspecified,Silicon Dioxide,Talc,Titanium Dioxide,Cyclobenzaprine Hydrochloride,Carnauba Wax,Croscarmellose Sodium,D&c Yellow No. 10,Fd&c Yellow No. 6,Hypromelloses,Ferric Oxide Yellow,Lactose Monohydrate,Polyethylene Glycol, Unspecified,Magnesium Stearate,Cellulose, Microcrystalline,Silicon Dioxide,Titanium Dioxide,Methylparaben,Polysorbate 80,Potassium Sorbate,Propylparaben,Propylene Glycol,Sodium Citrate, Unspecified Form,Xanthan Gum", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does COMETRIQ contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "COMETRIQ"]], "act": "question"}]}
{"index": 0, "text": "what version of COMETRIQ is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "cabozantinib s-malate,cellulose, microcrystalline,croscarmellose sodium,sodium starch glycolate type a potato,silicon dioxide,stearic acid,gelatin,ferrosoferric oxide,titanium dioxide,shellac,butyl alcohol,isopropyl alcohol,propylene glycol,ammonia", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Naproxen", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Naproxen"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "NAPROXEN,CROSCARMELLOSE SODIUM,POVIDONE, UNSPECIFIED,SILICON DIOXIDE,MAGNESIUM STEARATE,FERRIC OXIDE RED", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Omeprazole?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Omeprazole"]], "act": "question"}]}
{"index": 0, "text": "what version of Omeprazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "OMEPRAZOLE,CROSPOVIDONE (15 MPA.S AT 5%),HYPROMELLOSE, UNSPECIFIED,magnesium stearate,mannitol,meglumine,methacrylic acid - ethyl acrylate copolymer (1:1) type A,shellac,poloxamer 407,POVIDONE, UNSPECIFIED,triethyl citrate,D&C Red No. 28,FD&C Blue No. 1,FD&C Red No. 40,FD&C Yellow No. 6,ferric oxide yellow,GELATIN, UNSPECIFIED,silicon dioxide,sodium lauryl sulfate,titanium dioxide,butyl alcohol,propylene glycol", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Alprazolam", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Alprazolam"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "ALPRAZOLAM,SILICON DIOXIDE,HYPROMELLOSE 2208 (4000 MPA.S),HYPROMELLOSE 2208 (100 MPA.S),LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,ALPRAZOLAM,SILICON DIOXIDE,HYPROMELLOSE 2208 (4000 MPA.S),HYPROMELLOSE 2208 (100 MPA.S),LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,D&C YELLOW NO. 10,ALPRAZOLAM,SILICON DIOXIDE,HYPROMELLOSE 2208 (4000 MPA.S),HYPROMELLOSE 2208 (100 MPA.S),LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,FD&C BLUE NO. 2,ALPRAZOLAM,SILICON DIOXIDE,HYPROMELLOSE 2208 (4000 MPA.S),HYPROMELLOSE 2208 (100 MPA.S),LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,D&C YELLOW NO. 10,FD&C BLUE NO. 2", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many PREDNISOLONE is the correct dose for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PREDNISOLONE"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 0, "text": "what version of PREDNISOLONE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for PREDNISOLONE is 1 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant elderly", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant 90", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how do I store DOTAREM?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DOTAREM"]], "act": "question"}]}
{"index": 0, "text": "what version of DOTAREM is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug DOTAREM", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the side effects of ziprasidone?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ziprasidone"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of ziprasidone: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "insomnia", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "insomnia"]], "act": "inform"}]}
{"index": 1, "text": "insomnia is a serious side effect of ziprasidone.  Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant stomach_ache", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "stomach_ache"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Nifediac", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Nifediac"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how much Ala should i take for a child?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ala"], ["<age_group>", "child"]], "act": "question"}]}
{"index": 0, "text": "what version of Ala is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Ala is 2 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant PROPOXYPHENE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "PROPOXYPHENE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Nisoldipine?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nisoldipine"]], "act": "question"}]}
{"index": 1, "text": "what version of Nisoldipine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "NISOLDIPINE,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (1200000 MW),HYPROMELLOSE, UNSPECIFIED,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,FD&C BLUE NO. 2,FD&C YELLOW NO. 6,TRIACETIN,POLYDEXTROSE,POLYETHYLENE GLYCOL, UNSPECIFIED,TITANIUM DIOXIDE,NISOLDIPINE,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (1200000 MW),HYPROMELLOSE, UNSPECIFIED,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,TRIACETIN,POLYDEXTROSE,POLYETHYLENE GLYCOL, UNSPECIFIED,FERRIC OXIDE RED,TITANIUM DIOXIDE,FERRIC OXIDE YELLOW,NISOLDIPINE,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (1200000 MW),HYPROMELLOSE, UNSPECIFIED,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,D&C YELLOW NO. 10,FD&C BLUE NO. 2,FD&C YELLOW NO. 6,POLYDEXTROSE,POLYETHYLENE GLYCOL, UNSPECI", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take HYDROCHLOROTHIAZIDE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROCHLOROTHIAZIDE"]], "act": "question"}]}
{"index": 1, "text": "what version of HYDROCHLOROTHIAZIDE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Pindolol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Pindolol"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Should I take clobetasol?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "clobetasol"]], "act": "question"}]}
{"index": 0, "text": "clobetasol may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "tourettes", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "inform"}]}
{"index": 1, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is insomnia a common side effect of Mafenide?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Mafenide"], ["<symptom>", "insomnia"]], "act": "question"}]}
{"index": 1, "text": "insomnia is a mild side effect of Mafenide. In the clinical setting of severe burns, it is often difficult to distinguish between an adverse reaction to Mafenide Acetate and burn sequelae. In a clinical study of pediatric patients with acute burns requiring autografts who received Mafenide Acetate 5% Topical Solution in addition to double antibiotic solution (DAB) wound therapy (neomycin sulfate 40 mg and polymyxin B 200,000 units/liter), the incidence of rash (4.6%) and itching (2.8%) in the group which received Mafenide Acetate 5% Topical Solution was not different from that experienced with (DAB) dressings alone (5.7% and 1.3%, respectively). From other clinical settings, a single case of bone marrow depression and a single case of", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant itchy_skin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "itchy_skin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "itchy_skin is a mild side effect of Mafenide. In the clinical setting of severe burns, it is often difficult to distinguish between an adverse reaction to Mafenide Acetate and burn sequelae. In a clinical study of pediatric patients with acute burns requiring autografts who received Mafenide Acetate 5% Topical Solution in addition to double antibiotic solution (DAB) wound therapy (neomycin sulfate 40 mg and polymyxin B 200,000 units/liter), the incidence of rash (4.6%) and itching (2.8%) in the group which received Mafenide Acetate 5% Topical Solution was not different from that experienced with (DAB) dressings alone (5.7% and 1.3%, respectively). From other clinical settings, a single case of bone marrow depression and a single case of", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "Should I take Prevalite  for someone with IBD?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Prevalite"], ["<condition>", "IBD"]], "act": "question"}]}
{"index": 0, "text": "The most common adverse reaction is constipation. When used as a cholesterol-lowering agent, predisposing factors for most complaints of constipation are high dose and increased age (more than 60 years old). Most instances of constipation are mild, transient and controlled with conventional therapy. Some patients require a temporary decrease in dosage or discontinuation of therapy. Less Frequent Adverse Reactions: Abdominal discomfort and/or pain, flatulence, nausea, vomiting, diarrhea, eructation, anorexia, steatorrhea, bleeding tendencies due to hypoprothrombinemia (Vitamin K deficiency) as well as Vitamin A (one case of night blindness reported) and D deficiencies, hyperchloremic acidosis", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant TB", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant Sodium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sodium"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with HYDROCORTISONE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROCORTISONE"]], "act": "question"}]}
{"index": 1, "text": "what version of HYDROCORTISONE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "The initial dosage of hydrocortisone tablets may vary from 20 mg to 240 mg of hydrocortisone per day depending on the specific disease entity being treated. In situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time there is a lack of satisfactory clinical response, hydrocortisone should be discontinued and the patient transferred to other appropriate therapy. IT SHOULD BE EMPHASIZED THAT DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE INDIVIDUALIZED ON THE BASIS OF THE DISEASE UNDER TREATMENT AND", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use THEOPHYLLINE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "THEOPHYLLINE"]], "act": "question"}]}
{"index": 0, "text": "what version of THEOPHYLLINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "General Considerations : The steady-state peak serum theophylline concentration is a function of the dose, the dosing interval, and the rate of theophylline absorption and clearance in the individual patient. Because of marked individual differences in the rate of theophylline clearance, the dose required to achieve a peak serum theophylline concentration in the 10-20 mcg/mL range varies fourfold among otherwise similar patients in the absence of factors known to alter theophylline clearance (e.g., 400- 1600 mg/day in adults <60 years old and 10-36 mg/kg/day in children 1-9 years old). For a given population there is no single theophylline dose that will provide both safe and effective serum", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Chlorzoxazone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Chlorzoxazone"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Usual Adult Dosage : One tablet (250 mg) three or four times daily. Initial dosage for painful musculoskeletal conditions should be two tablets (500 mg) three or four times daily. If adequate response is not obtained with this dose, it may be increased to three tablets (750 mg) three or four times daily. As improvement occurs dosage can usually be reduced.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is aggression a common side effect of Carbocaine?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Carbocaine"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 1, "text": "aggression is a dangerous side effect of Carbocaine. Reactions to CARBOCAINE are characteristic of those associated with other amide-type local anesthetics. Systemic adverse reactions involving the central nervous system and the cardiovascular system usually result from high plasma levels (which may be due to excessive dosage, rapid absorption, inadvertent intravascular injection, or slow metabolic degradation), injection technique, or volume of injection. A small number of reactions may result from hypersensitivity, idiosyncrasy or diminished tolerance to normal dosage on the part of the patient. Persistent paresthesias of the lips, tongue, and oral tissues have been reported with the use of mepivacaine, with slow, incomplete, or no recovery.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Erythromycin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Erythromycin"]], "act": "question"}]}
{"index": 1, "text": "Erythromycin is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below: Upper respiratory tract infections of mild to moderate degree caused by Streptococcus pyogenes, Streptococcus pneumoniae, or Haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of H. influenzae are not susceptible to the erythromycin concentrations ordinarily achieved) (see appropriate sulfonamide labeling for prescribing information). Lower respiratory tract infections of mild to moderate severity caused by Streptococcus pneumoniae or Streptococcus pyogenes. Listeriosis caused by Listeria monocyto", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Metaproterenol for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metaproterenol"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 1, "text": "what version of Metaproterenol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Metaproterenol is 3 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Dextroamphetamine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Dextroamphetamine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant adult", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Dextroamphetamine is 3 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 7, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use 3.3%?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "3.3%"]], "act": "question"}]}
{"index": 1, "text": "what version of 3.3% is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "As required for urologic irrigation. 3.3% Sorbitol Irrigation should be administered only by the appropriate transurethraI urologic instrumentation. Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store. Solutions should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permits.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Fludeoxyglucose?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fludeoxyglucose"]], "act": "question"}]}
{"index": 1, "text": "what version of Fludeoxyglucose is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "FLUDEOXYGLUCOSE F-18", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "FLUDEOXYGLUCOSE F-18", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is AMOXICILLIN safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "AMOXICILLIN"]], "act": "question"}]}
{"index": 1, "text": "AMOXICILLIN may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "anxiety", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "inform"}]}
{"index": 2, "text": "As with other penicillins, it may be expected that untoward reactions will be essentially limited to sensitivity phenomena. They are more likely to occur in individuals who have previously demonstrated hypersensitivity to penicillins and in those with a history of allergy, asthma, hay fever, or urticaria. The following adverse reactions have been reported as associated with the use of penicillins: Infections and Infestations: Mucocutaneous candidiasis. Gastrointestinal: Nausea, vomiting, diarrhea, black hairy tongue, and hemorrhagic/pseudomembranous colitis. Onset of pseudomembranous colitis symptoms may occur during or after antibiotic treatment. (See WARNINGS .) Hypersensitivity Reactions:", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Perphenazine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Perphenazine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Not all of the following adverse reactions have been reported with this specific drug; however, pharmacological similarities among various phenothiazine derivatives require that each be considered. With the piperazine group (of which perphenazine is an example), the extrapyramidal symptoms are more common, and others (e.g., sedative effects, jaundice, and blood dyscrasias) are less frequently seen. CNS Effects Extrapyramidal Reactions opisthotonus, trismus, torticollis, retrocollis, aching and numbness of the limbs, motor restlessness, oculogyric crisis, hyperreflexia, dystonia, including protrusion, discoloration, aching and rounding of the tongue, tonic spasm of the masticatory muscles, ti", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "What is Tizanidine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tizanidine"]], "act": "question"}]}
{"index": 0, "text": "Tizanidine hydrochloride is a short-acting drug for the management of spasticity. Because of the short duration of effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important (see DOSAGE AND ADMINISTRATION ).", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant CLEOCIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CLEOCIN"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the BOXED WARNING , before selecting clindamycin, the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). Anaerobes: Serious respiratory tract infections such as empyema, anaero", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take CYTARABINE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CYTARABINE"]], "act": "question"}]}
{"index": 1, "text": "what version of CYTARABINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "Cytarabine Injection (non-preserved) can be administered by intravenous injection or infusion, subcutaneously, or intrathecally. However, the intent of this Pharmacy Bulk Package is for the preparation of solutions for intravenous infusion only. Intrathecal use of cytarabine requires the use of single-dose, unpreserved solutions only. Cytarabine Injection is not active orally. The schedule and method of administration varies with the program of therapy to be used. While Cytarabine Injection may be given by intravenous infusion or injection, or subcutaneously or intrathecally, THE PURPOSE OF THE PHARMACY BULK PACKAGE IS FOR THE PREPARATION OF INTRAVENOUS INFUSIONS. Thrombophlebitis has occurr", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Vancomycin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Vancomycin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Chlorzoxazone?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Chlorzoxazone"]], "act": "question"}]}
{"index": 1, "text": "what version of Chlorzoxazone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "CHLORZOXAZONE,ANHYDROUS LACTOSE,CELLULOSE, MICROCRYSTALLINE,CROSCARMELLOSE SODIUM,DOCUSATE SODIUM,MAGNESIUM STEARATE,SODIUM BENZOATE,STARCH, CORN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant Lisinopril", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lisinopril"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "HYDROCHLOROTHIAZIDE,LISINOPRIL,ANHYDROUS DIBASIC CALCIUM PHOSPHATE,SILICON DIOXIDE,STARCH, CORN,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,MANNITOL,SODIUM STARCH GLYCOLATE TYPE A POTATO,FERRIC OXIDE YELLOW", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "can i take Sulfasalazine?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sulfasalazine"]], "act": "question"}]}
{"index": 0, "text": "Sulfasalazine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "tourettes", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "inform"}]}
{"index": 1, "text": "The most common adverse reactions associated with sulfasalazine are anorexia, headache, nausea, vomiting, gastric distress, and apparently reversible oligospermia. These occur in about one-third of the patients. Less frequent adverse reactions are skin rash, pruritus, urticaria, fever, Heinz body anemia, hemolytic anemia, and cyanosis, which may occur at a frequency of one in every thirty patients or less. Experience suggests that with a daily dosage of 4 g or more, or total serum sulfapyridine levels above 50 \u03bcg/mL, the incidence of adverse reactions tends to increase. Although the listing which follows includes a few adverse reactions which have not been reported with this specific drug, t", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Desoxyn", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Desoxyn"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what are the side effects of NEOMYCIN?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NEOMYCIN"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of NEOMYCIN: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "vomiting", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "inform"}]}
{"index": 1, "text": "vomiting is a serious side effect of NEOMYCIN. Neomycin occasionally causes skin sensitization when applied topically; however, topical application to mucus membranes rarely results in local or systemic hypersensitivity reactions. Irritation of the urinary bladder mucosa has been reported. Signs of ototoxicity and nephrotoxicity have been reported following parenteral use of these drugs and following the oral and topical use of neomycin (See WARNINGS ).", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Brompheniramine cause vomiting?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Brompheniramine"], ["<symptom>", "vomiting"]], "act": "question"}]}
{"index": 1, "text": "vomiting is a dangerous side effect of Brompheniramine. The most frequent adverse reactions to brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup 2 mg/30 mg/10 mg per 5 mL are: sedation; dryness of mouth, nose and throat; thickening of bronchial secretions; dizziness. Other adverse reactions may include: Dermatologic: Urticaria, drug rash, photosensitivity, pruritus. Cardiovascular System: Hypotension, hypertension, cardiac arrhythmias, palpitation. CNS: Disturbed coordination, tremor, irritability, insomnia, visual disturbances, weakness, nervousness, convulsions, headache, euphoria, and dysphoria. G.U. System: Urinary frequency, difficult urination. G.I. System: Epigastric discomfort, anorexia, nause", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Omeprazole?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Omeprazole"]], "act": "question"}]}
{"index": 0, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "does Isosorbide contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Isosorbide"]], "act": "question"}]}
{"index": 0, "text": "what version of Isosorbide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "ISOSORBIDE MONONITRATE,LACTOSE,TALC,SILICON DIOXIDE,CELLULOSE, MICROCRYSTALLINE,ALUMINUM STEARATE,ISOSORBIDE MONONITRATE,LACTOSE,TALC,SILICON DIOXIDE,CELLULOSE, MICROCRYSTALLINE,ALUMINUM STEARATE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Metformin contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metformin"]], "act": "question"}]}
{"index": 1, "text": "what version of Metformin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "METFORMIN HYDROCHLORIDE,POVIDONE,CELLULOSE, MICROCRYSTALLINE,MAGNESIUM STEARATE,POLYVINYL ALCOHOL,TALC,TITANIUM DIOXIDE,POLYETHYLENE GLYCOLS,METFORMIN HYDROCHLORIDE,POVIDONE,CELLULOSE, MICROCRYSTALLINE,MAGNESIUM STEARATE,POLYETHYLENE GLYCOLS,POLYVINYL ALCOHOL,TALC,TITANIUM DIOXIDE,METFORMIN HYDROCHLORIDE,POVIDONE,CELLULOSE, MICROCRYSTALLINE,MAGNESIUM STEARATE,POLYETHYLENE GLYCOLS,POLYVINYL ALCOHOL,TALC,TITANIUM DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant Anthim", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Anthim"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Azathioprine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Azathioprine"]], "act": "question"}]}
{"index": 1, "text": "what version of Azathioprine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "TPMT TESTING CANNOT SUBSTITUTE FOR COMPLETE BLOOD COUNT (CBC) MONITORING IN PATIENTS RECEIVING AZATHIOPRINE TABLETS. TPMT genotyping or phenotyping can be used to identify patients with absent or reduced TPMT activity. Patients with low or absent TPMT activity are at an increased risk of developing severe, life-threatening myelotoxicity from azathioprine tablets if conventional doses are given. Physicians may consider alternative therapies for patients who have low or absent TPMT activity (homozygous for non-functional alleles). Azathioprine tablets should be administered with caution to patients having one non-functional allele (heterozygous) who are at risk for reduced TPMT activity that m", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Potassium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Potassium Chloride in 5% Dextrose Injection, USP is for intravenous infusion. Potassium Chloride in 5% Dextrose Injection, USP should not be administered by intravenous push. Potassium Chloride in 5% Dextrose Injection, USP has an osmolarity of 293 mOsmol/L (calc). The choice of specific potassium chloride and dextrose dosage, volume, rate and duration of administration depends on the age, weight and clinical condition of the patient, concomitant therapy, and administration should be determined by a physician. For patients with electrolyte and glucose abnormalities and for pediatric patients, consult a physician experienced in intravenous fluid therapy. A gradual increase of flow rate should", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "Is NatelleOne safe  if I am glaucoma?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NatelleOne"], ["<condition>", "glaucoma"]], "act": "question"}]}
{"index": 0, "text": "Allergic sensitization has been reported following both oral and parenteral administration of folic acid.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Dipentum?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dipentum"]], "act": "question"}]}
{"index": 0, "text": "Olsalazine is indicated for the maintenance of remission of ulcerative colitis in patients who are intolerant of sulfasalazine.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take VITAMIN  if I am infection?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "VITAMIN"], ["<condition>", "infection"]], "act": "question"}]}
{"index": 1, "text": "Hypervitaminosis D is characterized by effects on the following organ system: Renal: Impairment of renal function with polyuria, nocturia, polydipsia, hypercalciuria, reversible azotemia, hypertension, nephrocalcinosis, generalized vascular calcification, or irreversible renal insufficiency which may result in death. CNS: Mental retardation. Soft Tissues: Widespread calcification of the soft tissues, including the heart, blood vessels, renal tubules, and lungs. Skeletal: Bone demineralization (osteoporosis) in adults occurs concomitantly. Decline in the average rate of linear growth and increased mineralization of bones in infants and children (dwarfism), vague aches, stiffness, and weakness", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant IBD", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant CHOLINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CHOLINE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "is blurred_vision a common side effect of HALOBETASOL?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HALOBETASOL"], ["<symptom>", "blurred_vision"]], "act": "question"}]}
{"index": 0, "text": "blurred_vision is a common side effect of HALOBETASOL. In controlled clinical trials, the most frequent adverse events reported for Halobetasol Propionate Cream included stinging, burning or itching in 4.4% of the patients. Less frequently reported adverse reactions were: dry skin, erythema, skin atrophy, leukoderma, vesicles and rash. The following additional local adverse reactions are reported infrequently with topical corticosteroids, and they may occur more frequently with high potency corticosteroids, such as Halobetasol Propionate Cream. These reactions are listed in an approximate decreasing order of occurrence: folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondar", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant stomach_ache", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "stomach_ache"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant Dextrose", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Dextrose"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "stomach_ache is a dangerous side effect of Dextrose. Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "do I need to keep Etodolac in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Etodolac"]], "act": "question"}]}
{"index": 0, "text": "what version of Etodolac is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Etodolac", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "how do I take Oxybutynin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxybutynin"]], "act": "question"}]}
{"index": 0, "text": "what version of Oxybutynin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Syrup Adults: The usual dose is one teaspoon (5 mg/5 mL) of syrup two to three times a day. The maximum recommended dose is one teaspoon (5 mg/5 mL) of syrup four times a day. A lower starting dose of 2.5 mg two or three times a day is recommended for the frail elderly. Pediatric patients over 5 years of age: The usual dose is one teaspoon (5 mg/5 mL) of syrup two times a day. The maximum recommended dose is one teaspoon (5 mg/5mL) of syrup three times a day.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Ropinirole", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ropinirole"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of SULFASALAZINE?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SULFASALAZINE"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of SULFASALAZINE: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "suicidal", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "suicidal"]], "act": "inform"}]}
{"index": 2, "text": "suicidal is a serious side effect of SULFASALAZINE. The most common adverse reactions associated with sulfasalazine are anorexia, headache, nausea, vomiting, gastric distress, and apparently reversible oligospermia. These occur in about one-third of the patients. Less frequent adverse reactions are skin rash, pruritus, urticaria, fever, Heinz body anemia, hemolytic anemia, and cyanosis, which may occur at a frequency of one in every thirty patients or less. Experience suggests that with a daily dosage of 4 g or more, or total serum sulfapyridine levels above 50 \u00b5g/mL, the incidence of adverse reactions tends to increase. Although the listing which follows includes a few adverse reactions which have not been reported with this specific drug, t", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "actually i meant tiredness", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "tiredness"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much Ibuprofen should i take for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ibuprofen"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 0, "text": "what version of Ibuprofen is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Ibuprofen is 1 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant 90", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant elderly", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I take Ondansetron?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ondansetron"]], "act": "question"}]}
{"index": 0, "text": "what version of Ondansetron is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Instructions for Use/Handling Ondansetron Orally Disintegrating Tablets Do not attempt to push ondansetron orally disintegrating tablets through the foil backing. With dry hands, remove the tablet from the bottle or PEEL BACK the foil backing of 1 blister and GENTLY remove the tablet. IMMEDIATELY place the ondansetron orally disintegrating tablet on top of the tongue where it will dissolve in seconds, then swallow with saliva. Administration with liquid is not necessary. Prevention of Nausea and Vomiting Associated With Highly Emetogenic Cancer Chemotherapy The recommended adult oral dosage of ondansetron orally disintegrating tablets is 24 mg given as three 8 mg tablets administered 30 minu", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Instructions for Use/Handling Ondansetron Orally Disintegrating Tablets Do not attempt to push ondansetron orally disintegrating tablets through the foil backing. With dry hands, remove the tablet from the bottle or PEEL BACK the foil backing of 1 blister and GENTLY remove the tablet. IMMEDIATELY place the ondansetron orally disintegrating tablet on top of the tongue where it will dissolve in seconds, then swallow with saliva. Administration with liquid is not necessary. Prevention of Nausea and Vomiting Associated With Highly Emetogenic Cancer Chemotherapy The recommended adult oral dosage of ondansetron orally disintegrating tablets is 24 mg given as three 8 mg tablets administered 30 minu", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Hydroxychloroquine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydroxychloroquine"]], "act": "question"}]}
{"index": 1, "text": "Malaria Hydroxychloroquine sulfate tablets are indicated for the treatment of uncomplicated malaria due to P. falciparum , P. malariae , P. ovale , and P. vivax . Hydroxychloroquine sulfate tablets are indicated for the prophylaxis of malaria in geographic areas where chloroquine resistance is not reported. Limitations of Use in Malaria Hydroxychloroquine sulfate tablets are not recommended for the treatment of complicated malaria. Hydroxychloroquine sulfate tablets are not effective against chloroquine or hydroxychloroquine-resistant strains of Plasmodium species (see CLINICAL PHARMACOLOGY \u2013 Microbiology ). Hydroxychloroquine sulfate tablets are not recommended for the treatment of malaria ", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Calcium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Calcium"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "These highlights do not include all the information needed to use CALCIUM GLUCONATE INJECTION safely and effectively. See full prescribing information for CALCIUM GLUCONATE INJECTION.CALCIUM GLUCONATE injection, for intravenous use Initial U.S. Approval: 1941 Calcium Gluconate Injection is indicationd for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. Limitations of Use The safety of Calcium Gluconate Injection for long term use has not been established.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store GABAPENTIN?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "GABAPENTIN"]], "act": "question"}]}
{"index": 1, "text": "what version of GABAPENTIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug GABAPENTIN", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Desoximetasone?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Desoximetasone"]], "act": "question"}]}
{"index": 1, "text": "Desoximetasone may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "liver_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "inform"}]}
{"index": 2, "text": "The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria. In controlled clinical studies the incidence of adverse reactions was low (0.3%) for Desoximetasone Gel USP, 0.05% with one subject reporting stinging and burning at the site of application. Toreport SUSPECTED ADVERSE REACT", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant TB", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant HYOSYNE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HYOSYNE"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "All of the following adverse reactions have been reported with hyoscyamine sulfate. Adverse reactions may include dryness of the mouth; urinary hesitancy and retention; blurred vision; tachycardia; palpitations; mydriasis; increased ocular tension; loss of taste; headache; nervousness; drowsiness; weakness; fatigue; dizziness; insomnia; nausea; vomiting; impotence; constipation; bloated feeling; abdominal pain; diarrhea; allergic reactions or drug idiosyncrasies; urticaria and other dermal manifestations; ataxia; speech disturbance; some degree of mental confusion and/or excitement (especially in elderly persons); short-term memory loss; hallucinations; and decreased sweating.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much THEOPHYLLINE should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "THEOPHYLLINE"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 1, "text": "what version of THEOPHYLLINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for THEOPHYLLINE is 1 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "do I need to keep 620 in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "620"]], "act": "question"}]}
{"index": 0, "text": "what version of 620 is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug 620", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much Vitamin should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Vitamin"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 1, "text": "what version of Vitamin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Vitamin is 1 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant 50", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 7, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Oxandrolone?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxandrolone"]], "act": "question"}]}
{"index": 1, "text": "what version of Oxandrolone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Oxandrolone,anhydrous lactose,hypromellose, unspecified,magnesium stearate,starch, corn", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "OXANDROLONE,LACTOSE MONOHYDRATE,STARCH, CORN,MAGNESIUM STEARATE,OXANDROLONE,LACTOSE MONOHYDRATE,STARCH, CORN,MAGNESIUM STEARATE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Nisoldipine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nisoldipine"]], "act": "question"}]}
{"index": 1, "text": "Nisoldipine extended-release tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the side effects of ACYCLOVIR?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ACYCLOVIR"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of ACYCLOVIR: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "stomach_ache", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "stomach_ache"]], "act": "inform"}]}
{"index": 1, "text": "stomach_ache is a mild side effect of ACYCLOVIR.  Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of Naltrexone?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Naltrexone"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of Naltrexone: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "hallucinations", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "hallucinations"]], "act": "inform"}]}
{"index": 2, "text": "hallucinations is a mild side effect of Naltrexone. During two randomized, double-blind placebo-controlled 12 week trials to evaluate the efficacy of naltrexone hydrochloride as an adjunctive treatment of alcohol dependence, most patients tolerated naltrexone hydrochloride well. In these studies, a total of 93 patients received naltrexone hydrochloride at a dose of 50 mg once daily. Five of these patients discontinued naltrexone hydrochloride because of nausea. No serious adverse events were reported during these two trials. While extensive clinical studies evaluating the use of naltrexone hydrochloride in detoxified, formerly opioid-dependent individuals failed to identify any single, serious untoward risk of naltrexone hydrochloride use, pl", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "actually i meant Hydroxychloroquine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydroxychloroquine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "Should I take Rifabutin?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Rifabutin"]], "act": "question"}]}
{"index": 0, "text": "Rifabutin may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "IBD", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "inform"}]}
{"index": 1, "text": "Adverse Reactions from Clinical Trials Rifabutin capsules were generally well tolerated in the controlled clinical trials. Discontinuation of therapy due to an adverse event was required in 16% of patients receiving rifabutin, compared to 8% of patients receiving placebo in these trials. Primary reasons for discontinuation of rifabutin were rash (4% of treated patients), gastrointestinal intolerance (3%), and neutropenia (2%). The following table enumerates adverse experiences that occurred at a frequency of 1% or greater, among the patients treated with rifabutin in studies 023 and 027. Table 3 : Clinical Adverse Experiences Reported in \u2265 1 % of Patients Treated With Rifabutin Adverse event", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant heart_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Adverse Reactions from Clinical Trials Rifabutin capsules were generally well tolerated in the controlled clinical trials. Discontinuation of therapy due to an adverse event was required in 16% of patients receiving rifabutin, compared to 8% of patients receiving placebo in these trials. Primary reasons for discontinuation of rifabutin were rash (4% of treated patients), gastrointestinal intolerance (3%), and neutropenia (2%). The following table enumerates adverse experiences that occurred at a frequency of 1% or greater, among the patients treated with rifabutin in studies 023 and 027. Table 3 : Clinical Adverse Experiences Reported in \u2265 1 % of Patients Treated With Rifabutin Adverse event", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Exelderm?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Exelderm"]], "act": "question"}]}
{"index": 1, "text": "what version of Exelderm is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "A small amount of cream should be gently massaged into the affected and surrounding skin areas once or twice daily, except in tinea pedis, where administration should be twice daily. Early relief of symptoms is experienced by the majority of patients and clinical improvement may be seen fairly soon after treatment is begun; however, tinea corporis/cruris and tinea versicolor should be treated for 3 weeks and tinea pedis for 4 weeks to reduce the possibility of recurrence. If significant clinical improvement is not seen after 4 to 6 weeks of treatment, an alternate diagnosis should be considered.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Calcium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Calcium"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "Should I take LEUKERAN  if I have TB?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LEUKERAN"], ["<condition>", "TB"]], "act": "question"}]}
{"index": 0, "text": "To report SUSPECTED ADVERSE REACTIONS, contact Aspen Global Inc. Toll-Free at 1-855-800-8165 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant glaucoma", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Nalbuphine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nalbuphine"]], "act": "question"}]}
{"index": 1, "text": "what version of Nalbuphine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "Important Dosage and Administration Instructions Nalbuphine Hydrochloride Injection should be administered as a supplement to general anesthesia only by persons specifically trained in the use of intravenous anesthetics and management of the respiratory effects of potent opioids. Naloxone, resuscitative and intubation equipment and oxygen should be readily available. Initiate the dosing regimen for each patient individually, taking into account the patient's severity of pain, patient response, prior analgesic treatment experience, and risk factors for addiction, abuse, and misuse [see WARNINGS ]. Monitor patients closely for respiratory depression, especially within the first 24 to 72 hours ", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "how do I use Econazole?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Econazole"]], "act": "question"}]}
{"index": 0, "text": "what version of Econazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Sufficient ECONAZOLE NITRATE CREAM 1% should be applied to cover affected areas once daily in patients with tinea pedis, tinea cruris, tinea corporis, and tinea versicolor, and twice daily (morning and evening) in patients with cutaneous candidiasis. Early relief of symptoms is experienced by the majority of patients and clinical improvement may be seen fairly soon after treatment is begun; however, candidal infections and tinea cruris and corporis should be treated for two weeks and tinea pedis for one month in order to reduce the possibility of recurrence. If a patient shows no clinical improvement after the treatment period, the diagnosis should be redetermined. Patients with tinea versic", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Sufficient Econazole Nitrate Cream, 1% should be applied to cover affected areas once daily in patients with tinea pedis, tinea cruris, tinea corporis, and tinea versicolor, and twice daily (morning and evening) in patients with cutaneous candidiasis. Early relief of symptoms is experienced by the majority of patients and clinical improvement may be seen fairly soon after treatment is begun; however, candidal infections and tinea cruris and corporis should be treated for two weeks and tinea pedis for one month in order to reduce the possibility of recurrence. If a patient shows no clinical improvement after the treatment period, the diagnosis should be redetermined. Patients with tinea versi", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Escitalopram?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Escitalopram"]], "act": "question"}]}
{"index": 1, "text": "1.1 Major Depressive Disorder Escitalopram tablet USP is indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age [ see Clinical Studies ( 14.1) ]. A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slow", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Ceftriaxone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ceftriaxone"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Before instituting treatment with ceftriaxone, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing. To reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection USP and other antibacterial drugs, ceftriaxone for injection USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial thera", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of PROCAINAMIDE?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PROCAINAMIDE"]], "act": "question"}]}
{"index": 1, "text": "what version of PROCAINAMIDE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "PROCAINAMIDE HYDROCHLORIDE,METHYLPARABEN,SODIUM METABISULFITE,WATER,HYDROCHLORIC ACID,SODIUM HYDROXIDE,PROCAINAMIDE HYDROCHLORIDE,METHYLPARABEN,SODIUM METABISULFITE,WATER,HYDROCHLORIC ACID,SODIUM HYDROXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of PERCOCET?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PERCOCET"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of PERCOCET: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "depression", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "depression"]], "act": "inform"}]}
{"index": 2, "text": "depression is a serious side effect of PERCOCET. Serious adverse reactions that may be associated with PERCOCET tablet use include respiratory depression, apnea, respiratory arrest, circulatory depression, hypotension, and shock (see OVERDOSAGE ). The most frequently observed non-serious adverse reactions include lightheadedness, dizziness, drowsiness or sedation, nausea, and vomiting. These effects seem to be more prominent in ambulatory than in nonambulatory patients, and some of these adverse reactions may be alleviated if the patient lies down. Other adverse reactions include euphoria, dysphoria, constipation, and pruritus. Hypersensitivity reactions may include: Skin eruptions, urticarial, erythematous skin reactions. Hematologic reac", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "actually i meant stomach_ache", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "stomach_ache"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Dextroamphetamine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Dextroamphetamine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is DIGOX?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DIGOX"]], "act": "question"}]}
{"index": 1, "text": "Heart Failure: Digoxin is indicated for the treatment of mild to moderate heart failure. Digoxin increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by exercise capacity and heart failure symptoms as evidenced by exercise capacity and heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, digoxin should be used with a diuretic and an angiotensin-converting enzyme inhibitor, but an optimal order for starting these three drugs cannot be specified. Atrial Fibrillation: Digoxin is indicated for the control of ventricular response rate in patients with chronic atrial fibrillation.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is diarrhea a common side effect of Adenosine?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Adenosine"], ["<symptom>", "diarrhea"]], "act": "question"}]}
{"index": 0, "text": "diarrhea is a mild side effect of Adenosine. The following adverse reactions are discussed in more detail in other sections of the prescribing information: Fatal Cardiac Arrest, Ventricular Arrhythmias, and Myocardial Infarction [see Warnings and Precautions (5.1)] Sinoatrial and Atrioventricular Nodal Block [see Warnings and Precautions (5.2)] Bronchoconstriction [see Warnings and Precautions (5.3) ] Hypotension [see Warnings and Precautions (5.4) ] Cerebrovascular Accident [see Warnings and Precautions (5.5) ] Seizures [see Warnings and Precautions (5.6) ] Hypersensitivity [see Warnings and Precautions (5.7) ] Atrial fibrillation [see Warnings and Precautions (5.8) ] Hypertension [see Warnings and Precautions (5.9) ]", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant Quinapril", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Quinapril"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant fever", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "fever"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Sulfacetamide  if I have heart_problems?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sulfacetamide"], ["<condition>", "heart_problems"]], "act": "question"}]}
{"index": 1, "text": "Adverse reactions have occurred with corticosteroid/anti-infective combination drugs which can be attributed to the corticosteroid component, the anti-infective component, or the combination. Exact incidence figures are not available since no denominator of treated patients is available. Reactions occurring most often from the presence of the anti-infective ingredient are allergic sensitizations. Fatalities have occurred, although rarely, due to severe reactions to sulfonamides including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia, and other blood dyscrasias (see WARNINGS ). Sulfacetamide sodium may cause local irritation", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant low_blood_pressure", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant NUPRO\u2122", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "NUPRO\u2122"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what do I do with Quinapril?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Quinapril"]], "act": "question"}]}
{"index": 0, "text": "what version of Quinapril is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "As individual monotherapy, quinapril is an effective treatment of hypertension in once-daily doses of 10 mg to 80 mg and hydrochlorothiazide is effective in doses of 12.5 mg to 50 mg. In clinical trials of quinapril/hydrochlorothiazide combination therapy using quinapril doses of 2.5 mg to 40 mg and hydrochlorothiazide doses of 6.25 mg to 25 mg, the antihypertensive effects increased with increasing dose of either component. The side effects (see WARNINGS ) of quinapril are generally rare and apparently independent of dose; those of hydrochlorothiazide are a mixture of dose-dependent phenomena (primarily hypokalemia) and dose-independent phenomena (e.g., pancreatitis), the former much more c", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Sirolimus", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sirolimus"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Sirolimus tablets are to be administered orally once daily, consistently with or without food [see Dosage and Administration ( 2.5 ), Clinical Pharmacology (12.3) ]. Tablets should not be crushed, chewed or split. Patients unable to take the tablets should be prescribed the solution and instructed in its use.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Azulfidine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Azulfidine"]], "act": "question"}]}
{"index": 1, "text": "AZULFIDINE EN-tabs Tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; b) for the prolongation of the remission period between acute attacks of ulcerative colitis; c) in the treatment of patients with rheumatoid arthritis who have responded inadequately to salicylates or other nonsteroidal anti-inflammatory drugs (e.g., an insufficient therapeutic response to, or intolerance of, an adequate trial of full doses of one or more nonsteroidal anti-inflammatory drugs); and d) in the treatment of pediatric patients with polyarticular-course 1 juvenile rheumatoid arthritis who have responded inadequately to salicy", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Ketamine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ketamine"]], "act": "question"}]}
{"index": 1, "text": "what version of Ketamine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Note : Barbiturates and ketamine, being chemically incompatible because of precipitate formation, should not be injected from the same syringe. If the ketamine dose is augmented with diazepam, the two drugs must be given separately. Do not mix ketamine hydrochloride and diazepam in syringe or infusion flask. For additional information on the use of diazepam, refer to the WARNINGS and DOSAGE AND ADMINISTRATION Sections of the diazepam insert.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Amikacin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Amikacin"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how much AVANDIA should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "AVANDIA"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of AVANDIA is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for AVANDIA is 4 mg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "Is Lomotil safe  if I have infection?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lomotil"], ["<condition>", "infection"]], "act": "question"}]}
{"index": 0, "text": "At therapeutic doses, the following have been reported; they are listed in decreasing order of severity, but not of frequency: Nervous system: numbness of extremities, euphoria, depression, malaise/lethargy, confusion, sedation/drowsiness, dizziness, restlessness, headache. Allergic: anaphylaxis, angioneurotic edema, urticaria, swelling of the gums, pruritus. Gastrointestinal system: toxic megacolon, paralytic ileus, pancreatitis, vomiting, nausea, anorexia, abdominal discomfort. The following atropine sulfate effects are listed in decreasing order of severity, but not of frequency: hyperthermia, tachycardia, urinary retention, flushing, dryness of the skin and mucous membranes. These effect", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of HYDROCORTISONE?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROCORTISONE"]], "act": "question"}]}
{"index": 1, "text": "what version of HYDROCORTISONE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "HYDROCORTISONE,SILICON DIOXIDE,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM LAURYL SULFATE,SODIUM STARCH GLYCOLATE TYPE A POTATO,HYDROCORTISONE,SILICON DIOXIDE,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM LAURYL SULFATE,SODIUM STARCH GLYCOLATE TYPE A POTATO,HYDROCORTISONE,SILICON DIOXIDE,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM LAURYL SULFATE,SODIUM STARCH GLYCOLATE TYPE A POTATO", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "HYDROCORTISONE,SILICON DIOXIDE,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM LAURYL SULFATE,SODIUM STARCH GLYCOLATE TYPE A POTATO,HYDROCORTISONE,SILICON DIOXIDE,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM LAURYL SULFATE,SODIUM STARCH GLYCOLATE TYPE A POTATO,HYDROCORTISONE,SILICON DIOXIDE,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM LAURYL SULFATE,SODIUM STARCH GLYCOLATE TYPE A POTATO", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Oxacillin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxacillin"]], "act": "question"}]}
{"index": 1, "text": "what version of Oxacillin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Bacteriologic studies to determine the causative organisms and their susceptibility to oxacillin should always be performed. Duration of therapy varies with the type of severity of infection as well as the overall condition of the patient; therefore, it should be determined by the clinical and bacteriological response of the patient. In severe staphylococcal infections, therapy with oxacillin should be continued for at least 14 days. Therapy should be continued for at least 48 hours after the patient has become afebrile, asymptomatic, and cultures are negative. Treatment of endocarditis and osteomyelitis may require a longer duration of therapy. With intravenous administration, particularly ", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Amoxicillin?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amoxicillin"]], "act": "question"}]}
{"index": 1, "text": "Amoxicillin may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "TB", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "inform"}]}
{"index": 2, "text": "As with other penicillins, it may be expected that untoward reactions will be essentially limited to sensitivity phenomena. They are more likely to occur in individuals who have previously demonstrated hypersensitivity to penicillins and in those with a history of allergy, asthma, hay fever, or urticaria. The following adverse reactions have been reported as associated with the use of penicillins: Infections and Infestations: Mucocutaneous candidiasis. Gastrointestinal: Nausea, vomiting, diarrhea, black hairy tongue, and hemorrhagic/ pseudomembranous colitis. Onset of pseudomembranous colitis symptoms may occur during or after antibiotic treatment. (See WARNINGS section.) Hypersensitivity Re", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "how much Hydrocodone should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrocodone"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 1, "text": "what version of Hydrocodone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Hydrocodone is 2 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is ESTRADIOL?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ESTRADIOL"]], "act": "question"}]}
{"index": 1, "text": "Estradiol Valerate Injection is indicated in the: 1. Treatment of moderate to severe vasomotor symptoms associated with the menopause. 2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. 3. Treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure. 4. Treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only).", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Theophylline", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Theophylline"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "what do I do with DIAZEPAM?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DIAZEPAM"]], "act": "question"}]}
{"index": 0, "text": "what version of DIAZEPAM is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Dosage should be individualized for maximum beneficial effect. While the usual daily dosages given below will meet the needs of most patients, there will be some who may require higher doses. In such cases dosage should be increased cautiously to avoid adverse effects. ADULTS: USUAL DAILY DOSE Management of Anxiety Disorders and Relief of Symptoms of Anxiety Depending upon severity of symptoms \u2013 2 mg to 10 mg, 2 to 4 times daily Symptomatic Relief in Acute Alcohol Withdrawal 10 mg, 3 or 4 times during the first 24 hours, reducing to 5 mg, 3 or 4 times daily as needed Adjunctively for Relief of Skeletal Muscle Spasm 2 mg to 10 mg, 3 or 4 times daily Adjunctively in Convulsive Disorders 2 mg t", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much Minocycline should i take for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Minocycline"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 1, "text": "what version of Minocycline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Minocycline is 3 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Verapamil", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Verapamil"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Verapamil is 3 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "does Phentolamine cause itchy_skin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Phentolamine"], ["<symptom>", "itchy_skin"]], "act": "question"}]}
{"index": 0, "text": "itchy_skin is a common side effect of Phentolamine. Acute and prolonged hypotensive episodes, tachycardia, and cardiac arrhythmias have been reported. In addition, weakness, dizziness, flushing, orthostatic hypotension, nasal stuffiness, nausea, vomiting, and diarrhea may occur. To report SUSPECTED ADVERSE REACTIONS, contact TAGI Pharma, Inc. at 1-844-668-3942 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "where should I keep Omeprazole?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Omeprazole"]], "act": "question"}]}
{"index": 0, "text": "what version of Omeprazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Omeprazole", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant AZATHIOPRINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "AZATHIOPRINE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug AZATHIOPRINE", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many Anthim is the correct dose for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Anthim"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 0, "text": "what version of Anthim is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Anthim is 4 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant 60", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Fluoridex", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluoridex"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Losartan?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Losartan"]], "act": "question"}]}
{"index": 0, "text": "Hypertension Losartan potassium tablets are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents, including diuretics. Hypertensive Patients with Left Ventricular Hypertrophy Losartan potassium tablets are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to Black patients. (See PRECAUTIONS, Race and CLINICAL PHARMACOLOGY, Pharmacodynamics and Clinical Effects, Reduction in the Risk of Stroke, Race.) Nephropathy in Type 2 Diabetic Patients Losartan potassium tablets are indicated for the treatment of diabetic nephropathy", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Sulfamethoxazole", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sulfamethoxazole"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim oral suspension, USP and other antibacterial drugs, sulfamethoxazole and trimethoprim oral suspension, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. Urinary Tract Infections For the treatment of urinary tract infections due to susceptib", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many Metronidazole is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metronidazole"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of Metronidazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Metronidazole is 4 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant baby", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant Lidocaine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Lidocaine is 1 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have bruising with HYDROCORTISONE?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROCORTISONE"], ["<symptom>", "bruising"]], "act": "question"}]}
{"index": 1, "text": "bruising is a serious side effect of HYDROCORTISONE. The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in approximate decreasing order of occurrence: Burning Itching Irritation Dryness Folliculitis Hypertrichosis Acneiform eruptions Hypopigmentation Perioral dermatitis Allergic contact dermatitis Maceration of the skin Secondary infection Skin atrophy Striae Miliaria", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant vomiting", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant VITAMIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "VITAMIN"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "vomiting is a dangerous side effect of VITAMIN. Hypervitaminosis D is characterized by effects on the following organ system: Renal: Impairment of renal function with polyuria, nocturia, polydipsia, hypercalciuria, reversible azotemia, hypertension, nephrocalcinosis, generalized vascular calcification, or irreversible renal insufficiency which may result in death. CNS: Mental retardation. Soft Tissues: Widespread calcification of the soft tissues, including the heart, blood vessels, renal tubules, and lungs. Skeletal: Bone demineralization (osteoporosis) in adults occurs concomitantly. Decline in the average rate of linear growth and increased mineralization of bones in infants and children (dwarfism), vague aches, stiffness, and weakness", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Ferralet?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ferralet"]], "act": "question"}]}
{"index": 1, "text": "Ferralet  90 is indicated for the treatment of all anemias that are responsive to oral iron therapy. These include: hypochromic anemia associated with pregnancy, chronic and/or acute blood loss, metabolic disease, postsurgical convalescence, and dietary needs.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Nitroglycerin contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nitroglycerin"]], "act": "question"}]}
{"index": 1, "text": "what version of Nitroglycerin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "NITROGLYCERIN,CALCIUM STEARATE,SILICON DIOXIDE,LACTOSE MONOHYDRATE,STARCH, CORN,Hydrogenated Cottonseed Oil,NITROGLYCERIN,CALCIUM STEARATE,SILICON DIOXIDE,LACTOSE MONOHYDRATE,STARCH, CORN,Hydrogenated Cottonseed Oil,NITROGLYCERIN,CALCIUM STEARATE,SILICON DIOXIDE,LACTOSE MONOHYDRATE,STARCH, CORN,Hydrogenated Cottonseed Oil", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "NITROGLYCERIN,CALCIUM STEARATE,SILICON DIOXIDE,LACTOSE MONOHYDRATE,STARCH, CORN,Hydrogenated Cottonseed Oil,NITROGLYCERIN,CALCIUM STEARATE,SILICON DIOXIDE,LACTOSE MONOHYDRATE,STARCH, CORN,Hydrogenated Cottonseed Oil,NITROGLYCERIN,CALCIUM STEARATE,SILICON DIOXIDE,LACTOSE MONOHYDRATE,STARCH, CORN,Hydrogenated Cottonseed Oil", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "what are the ingredients of (Lactulose?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "(Lactulose"]], "act": "question"}]}
{"index": 0, "text": "what version of (Lactulose is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "LACTULOSE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant AVANDIA", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "AVANDIA"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have tiredness with PLEGISOL?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PLEGISOL"], ["<symptom>", "tiredness"]], "act": "question"}]}
{"index": 1, "text": "tiredness is a serious side effect of PLEGISOL. Intraoperative and perioperative potential hazards of open heart surgery include myocardial infarction, electrocardiographic abnormalities, and arrhythmias, including ventricular fibrillation. Spontaneous recovery after cardioplegic cardiac arrest may be delayed or absent when circulation is restored. Defibrillation by electric shock may be required to restore normal cardiac function.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Cefaclor cause aggression?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cefaclor"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 0, "text": "aggression is a mild side effect of Cefaclor. Adverse effects considered to be related to therapy with cefaclor are listed below: Hypersensitivity reactions have been reported in about 1.5% of patients and include morbilliform eruptions (1 in 100). Pruritus, urticaria, and positive Coombs' tests each occur in less than 1 in 200 patients. Cases of serum-sickness-like reactions have been reported with the use of cefaclor. These are characterized by findings of erythema multiforme, rashes, and other skin manifestations accompanied by arthritis/arthralgia, with or without fever, and differ from classic serum sickness in that there is infrequently associated lymphadenopathy and proteinuria, no circulating immune complexes, and no evidence to", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant Rx", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Rx"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "anxiety"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "anxiety is a mild side effect of Rx. The adverse reactions reported most frequently at the recommended dose of amantadine (5 to 10%) are: nausea, dizziness (lightheadedness), and insomnia. Less frequently (1 to 5%) reported adverse reactions are: depression, anxiety and irritability, hallucinations, confusion, anorexia, dry mouth, constipation, ataxia, livedo reticularis, peripheral edema, orthostatic hypotension, headache, somnolence, nervousness, dream abnormality, agitation, dry nose, diarrhea and fatigue. Infrequently (0.1 to 1%) occurring adverse reactions are: congestive heart failure, psychosis, urinary retention, dyspnea, skin rash, vomiting, weakness, slurred speech, euphoria, thinking abnormality, amnesia, hyperkinesi", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is stomach_ache a common side effect of Eletriptan?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Eletriptan"], ["<symptom>", "stomach_ache"]], "act": "question"}]}
{"index": 0, "text": "stomach_ache is a mild side effect of Eletriptan. The following adverse reactions are described elsewhere in other sections of the prescribing information:  Myocardial ischemia and myocardial infarction, and Prinzmetal\u2019s angina [see Warnings and Precautions ( 5.2 )]  Arrhythmias [see Warnings and Precautions ( 5.3 )]  Chest, throat, neck, and/or jaw pain/tightness/pressure [see Warnings and Precautions ( 5.4 )]  Cerebrovascular events [see Warnings and Precautions ( 5.4 )]  Other vasospasm reactions [see Warnings and Precautions ( 5.5 )]  Medication overuse headache [see Warnings and Precautions ( 5.6 )]  Serotonin syndrome [see Warnings and Precautions ( 5.7 )]  Increase in blood pressure [see Warnings and Precautions ( 5.8 )]  Hypersensit", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant Calcium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Calcium"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Sertraline?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sertraline"]], "act": "question"}]}
{"index": 1, "text": "Sertraline may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "tourettes", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "inform"}]}
{"index": 2, "text": "During its premarketing assessment, multiple doses of sertraline hydrochloride were administered to over 4000 adult subjects as of February 18, 2000. The conditions and duration of exposure to sertraline hydrochloride varied greatly, and included (in overlapping categories) clinical pharmacology studies, open and double-blind studies, uncontrolled and controlled studies, inpatient and outpatient studies, fixed-dose and titration studies, and studies for multiple indications, including major depressive disorder, OCD, panic disorder, PTSD, PMDD and social anxiety disorder. Untoward events associated with this exposure were recorded by clinical investigators using terminology of their own choos", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "Is PRASUGREL safe  for someone with tourettes?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PRASUGREL"], ["<condition>", "tourettes"]], "act": "question"}]}
{"index": 0, "text": "The following serious adverse reactions are also discussed elsewhere in the labeling: Bleeding [see Boxed Warning and Warnings and Precautions ( 5.1 , 5.2 )] Thrombotic thrombocytopenic purpura [see Warnings and Precautions ( 5.4 )] Hypersensitivity Including Angioedema [see Warnings and Precautions ( 5.5 )]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant IBD", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant Desoximetasone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Desoximetasone"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I take Doxycycline?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxycycline"]], "act": "question"}]}
{"index": 0, "text": "what version of Doxycycline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "THE USUAL DOSAGE AND FREQUENCY OF ADMINISTRATION OF DOXYCYCLINE DIFFERS FROM THAT OF THE OTHER TETRACYCLINES. EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE OF SIDE EFFECTS. Adults: The usual dose of oral doxycycline is 200 mg on the first day of treatment (administered 100 mg every 12 hours or 50 mg every 6 hours) followed by a maintenance dose of 100 mg/day. The maintenance dose may be administered as a single dose or as 50 mg every 12 hours. In the management of more severe infections (particularly chronic infections of the urinary tract), 100 mg every 12 hours is recommended. Pediatric Patients: For all pediatric patients weighing less than 45 kg with severe or lif", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Amiloride", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Amiloride"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Amiloride HCl should be administered with food. Amiloride HCl, one 5 mg tablet daily, should be added to the usual antihypertensive or diuretic dosage of a kaliuretic diuretic. The dosage may be increased to 10 mg per day, if necessary. More than two 5 mg tablets of amiloride HCl daily usually are not needed, and there is little controlled experience with such doses. If persistent hypokalemia is documented with 10 mg, the dose can be increased to 15 mg, then 20 mg, with careful monitoring of electrolytes. In treating patients with congestive heart failure after an initial diuresis has been achieved, potassium loss may also decrease and the need for amiloride HCl should be re-evaluated. Dosag", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Naltrexone?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Naltrexone"]], "act": "question"}]}
{"index": 1, "text": "what version of Naltrexone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "To reduce the risk of precipitated withdrawal in patients dependent on opioids, or exacerbation of a preexisting subclinical withdrawal syndrome, opioid-dependent patients, including those being treated for alcohol dependence, should be opioid-free (including tramadol) before starting naltrexone hydrochloride treatment. An opioid-free interval of a minimum of 7 to 10 days is recommended for patients previously dependent on short-acting opioids. Switching from Buprenorphine, Buprenorphine/Naloxone, or Methadone There are no systematically collected data that specifically address the switch from buprenorphine or methadone to naltrexone hydrochloride; however, review of postmarketing case repor", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant POTASSIUM", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "POTASSIUM"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is aggression a common side effect of HALOPERIDOL?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HALOPERIDOL"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 1, "text": "aggression is a serious side effect of HALOPERIDOL. The following adverse reactions are discussed in more detail in other sections of the labeling: WARNINGS, Increased mortality in Elderly Patients with Dementia-Related Psychosis WARNINGS, Cardiovascular Effects WARNINGS, Tardive Dyskinesia WARNINGS, Neuroleptic Malignant Syndrome WARNINGS, Falls WARNINGS, Combined Use of Haloperidol and Lithium WARNINGS, General PRECAUTIONS, Leukopenia, Neutropenia, and Agranulocytosis PRECAUTIONS, Other PRECAUTIONS, Usage in Pregnancy", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant stomach_ache", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "stomach_ache"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Clindamycin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Clindamycin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how many HYDROCORTISONE is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROCORTISONE"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 1, "text": "what version of HYDROCORTISONE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for HYDROCORTISONE is 2 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Ketorolac", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ketorolac"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant adult", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Ketorolac is 3 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 7, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Sevoflurane is the correct dose for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sevoflurane"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of Sevoflurane is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Sevoflurane is 4 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant baby", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Sevoflurane is 1 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Moxifloxacin?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Moxifloxacin"]], "act": "question"}]}
{"index": 1, "text": "Moxifloxacin may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "pregnant", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "inform"}]}
{"index": 2, "text": "The following serious and otherwise important adverse reactions are discussed in greater detail in the warnings and precautions section of the label:  Disabling and Potentially Irreversible Serious Adverse Reactions Including Tendinitis and Tendon Rupture, Peripheral Neuropathy, and Central Nervous System Effects [see Warnings and Precautions (5.1)]  Tendinitis and Tendon Rupture [see Warnings and Precautions (5.2)]  Peripheral Neuropathy [see Warnings and Precautions (5.3)]  Central Nervous System Effects [see Warnings and Precautions (5.4)]  Exacerbation of Myasthenia Gravis [see Warnings and Precautions (5.5)]  QT Prolongation [see Warnings and Precautions (5.6)]  Other Serious and Someti", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant tourettes", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The following serious and otherwise important adverse reactions are discussed in greater detail in the warnings and precautions section of the label:  Disabling and Potentially Irreversible Serious Adverse Reactions Including Tendinitis and Tendon Rupture, Peripheral Neuropathy, and Central Nervous System Effects [see Warnings and Precautions (5.1)]  Tendinitis and Tendon Rupture [see Warnings and Precautions (5.2)]  Peripheral Neuropathy [see Warnings and Precautions (5.3)]  Central Nervous System Effects [see Warnings and Precautions (5.4)]  Exacerbation of Myasthenia Gravis [see Warnings and Precautions (5.5)]  QT Prolongation [see Warnings and Precautions (5.6)]  Other Serious and Someti", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Polyethylene?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Polyethylene"]], "act": "question"}]}
{"index": 1, "text": "what version of Polyethylene is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "POLYETHYLENE GLYCOL 3350", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is PLAQUENIL?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PLAQUENIL"]], "act": "question"}]}
{"index": 1, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in DILANTIN?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DILANTIN"]], "act": "question"}]}
{"index": 1, "text": "what version of DILANTIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "PHENYTOIN SODIUM,LACTOSE MONOHYDRATE,SUCROSE,TALC,MAGNESIUM STEARATE,TITANIUM DIOXIDE,GELATIN,D&C YELLOW NO. 10,FD&C RED NO. 3", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant Amytal", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Amytal"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "AMOBARBITAL SODIUM", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take Nimodipine?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nimodipine"]], "act": "question"}]}
{"index": 0, "text": "Nimodipine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "TB", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "inform"}]}
{"index": 1, "text": "Adverse experiences were reported by 92 of 823 patients with subarachnoid hemorrhage (11.2%) who were given nimodipine. The most frequently reported adverse experience was decreased blood pressure in 4.4% of these patients. Twenty-nine of 479 (6.1%) placebo treated patients also reported adverse experiences. The events reported with a frequency greater than 1% are displayed below by dose. DOSE q4h Number of Patients (%) Nimodipine Sign/Symptom 0.35 mg/kg (n=82) 30 mg (n=71) 60 mg (n=494) 90 mg (n=172) 120 mg (n=4) Placebo (n=479) Decreased Blood Pressure 1 (1.2) 0 19 (3.8) 14 (8.1) 2 (50.0) 6 (1.2) Abnormal Liver Function Test 1 (1.2) 0 2 (0.4) 1 (0.6) 0 7 (1.5) Edema 0 0 2 (0.4) 2 (1.2) 0 3", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much AMOXICILLIN should i take for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "AMOXICILLIN"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of AMOXICILLIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for AMOXICILLIN is 4 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant elderly", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant Bumetanide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Bumetanide"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 7, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Gentamicin  if I have TB?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Gentamicin"], ["<condition>", "TB"]], "act": "question"}]}
{"index": 1, "text": "Bacterial and fungal corneal ulcers have developed during treatment with gentamicin ophthalmic preparations. The most frequently reported adverse reactions are ocular burning and irritation upon drug instillation, non-specific conjunctivitis, conjunctival epithelial defects and conjunctival hyperemia. Other adverse reactions which have occurred rarely are allergic reactions, thrombocytopenic purpura and hallucinations.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Naprosyn", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Naprosyn"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The following adverse reactions are discussed in greater detail in other sections of the labeling: Cardiovascular Thrombotic Events [ see Warnings and Precautions ( 5.1 )] GI Bleeding, Ulceration and Perforation [ see Warnings and Precautions ( 5.2 ) ] Hepatotoxicity [ see Warnings and Precautions ( 5.3 ) ] Hypertension [ see Warnings and Precautions ( 5.4 ) ] Heart Failure and Edema [ see Warnings and Precautions ( 5.5 ) ] Renal Toxicity and Hyperkalemia [ see Warnings and Precautions ( 5.6 ) ] Anaphylactic Reactions [ see Warnings and Precautions ( 5.7 ) ] Serious Skin Reactions [ see Warnings and Precautions ( 5.9 ) ] Hematologic Toxicity [ see Warnings and Precautions ( 5.11 ) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use 0.25%?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "0.25%"]], "act": "question"}]}
{"index": 1, "text": "what version of 0.25% is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "The volume of solution needed will vary with nature and duration of the urologic procedure, according to physician\u2019s instructions. Irrigation drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take FLUCYTOSINE  for someone with anxiety?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "FLUCYTOSINE"], ["<condition>", "anxiety"]], "act": "question"}]}
{"index": 1, "text": "The adverse reactions which have occurred during treatment with Flucytosine Capsules USP are grouped according to organ system affected. Cardiovascular: Cardiac arrest, myocardial toxicity, ventricular dysfunction. Respiratory: Respiratory arrest, chest pain, dyspnea. Dermatologic: Rash, pruritus, urticaria, photosensitivity. Gastrointestinal: Nausea, emesis, abdominal pain, diarrhea, anorexia, dry mouth, duodenal ulcer, gastrointestinal hemorrhage, acute hepatic injury including hepatic necrosis with possible fatal outcome in debilitated patients, hepatic dysfunction, jaundice, ulcerative colitis, enterocolitis, bilirubin elevation, increased hepatic enzymes. Genitourinary: Azotemia, creati", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant glaucoma", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "The adverse reactions which have occurred during treatment with Flucytosine Capsules USP are grouped according to organ system affected. Cardiovascular: Cardiac arrest, myocardial toxicity, ventricular dysfunction. Respiratory: Respiratory arrest, chest pain, dyspnea. Dermatologic: Rash, pruritus, urticaria, photosensitivity. Gastrointestinal: Nausea, emesis, abdominal pain, diarrhea, anorexia, dry mouth, duodenal ulcer, gastrointestinal hemorrhage, acute hepatic injury including hepatic necrosis with possible fatal outcome in debilitated patients, hepatic dysfunction, jaundice, ulcerative colitis, enterocolitis, bilirubin elevation, increased hepatic enzymes. Genitourinary: Azotemia, creati", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "does Norco cause bruising?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Norco"], ["<symptom>", "bruising"]], "act": "question"}]}
{"index": 0, "text": "bruising is a mild side effect of Norco. The most frequently reported adverse reactions are lightheadedness, dizziness, sedation, nausea and vomiting. These effects seem to be more prominent in ambulatory than in nonambulatory patients, and some of these adverse reactions may be alleviated if the patient lies down. Other adverse reactions include: Central Nervous System: Drowsiness, mental clouding, lethargy, impairment of mental and physical performance, anxiety, fear, dysphoria, psychic dependence, mood changes. Gastrointestinal System: Prolonged administration of hydrocodone bitartrate and acetaminophen tablets may produce constipation. Genitourinary System: Ureteral spasm, spasm of vesical sphincters and urinary retention have ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant vomiting", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant Alprazolam", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Alprazolam"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Lidocaine?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "question"}]}
{"index": 1, "text": "Lidocaine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "infection", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "inform"}]}
{"index": 2, "text": "Localized Reactions: During or immediately after treatment with lidocaine and prilocaine cream on intact skin, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation. Rare cases of discrete purpuric or petechial reactions at the application site have been reported. Rare cases of hyperpigmentation following the use of lidocaine and prilocaine cream have been reported. The relationship to lidocaine and prilocaine cream or the underlying procedure has not been established. In clinical studies on intact skin involving over 1,300 lidocaine and prilocaine cream-treated subjects, one or more such local reactions were noted in 56% of patients, and w", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Alprazolam?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Alprazolam"]], "act": "question"}]}
{"index": 0, "text": "what version of Alprazolam is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "ALPRAZOLAM,SILICON DIOXIDE,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,POVIDONE K30,FD&C BLUE NO. 2", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "where should I keep NUCYNTA?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NUCYNTA"]], "act": "question"}]}
{"index": 1, "text": "what version of NUCYNTA is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug NUCYNTA", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant Diclofenac", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Diclofenac"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "storage instructions for drug Diclofenac", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "what is in clindamycin?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "clindamycin"]], "act": "question"}]}
{"index": 0, "text": "what version of clindamycin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "CLINDAMYCIN PHOSPHATE,ALLANTOIN,METHYLPARABEN,POLYETHYLENE GLYCOL 400,PROPYLENE GLYCOL,SODIUM HYDROXIDE,WATER,CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Penicillin?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Penicillin"]], "act": "question"}]}
{"index": 1, "text": "Penicillin may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "infection", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "inform"}]}
{"index": 2, "text": "Body As A Whole The Jarisch-Herxheimer reaction is a systemic reaction, that may occur after the initiation of penicillin therapy in patients with syphilis or other spirochetal infections (i.e., Lyme disease and Relapsing fever). The reaction begins one to two hours after initiation of therapy and disappears within 12 to 24 hours. It is characterized by fever, chills, myalgias, headache, exacerbation of cutaneous lesions, tachycardia, hyperventilation, vasodilation with flushing and mild hypotension. The pathogenesis of the Herxheimer reaction may be due to the release from the spirochetes of heat-stable pyrogen. Hypersensitivity Reactions The reported incidence of allergic reactions to all ", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "how many LEVOPHED is the correct dose for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LEVOPHED"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 0, "text": "what version of LEVOPHED is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "10", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for LEVOPHED is 1 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant elderly", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The dosage for LEVOPHED is 4 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does HALOBETASOL contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HALOBETASOL"]], "act": "question"}]}
{"index": 0, "text": "what version of HALOBETASOL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "HALOBETASOL PROPIONATE,CETYL ALCOHOL,DIAZOLIDINYL UREA,GLYCERIN,ISOPROPYL ISOSTEARATE,ISOPROPYL PALMITATE,METHYLCHLOROISOTHIAZOLINONE,METHYLISOTHIAZOLINONE,STEARETH-21,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Labetalol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Labetalol"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Labetalol Hydrochloride,anhydrous dextrose,edetate sodium,methylparaben,propylparaben,citric acid monohydrate,sodium hydroxide,Labetalol Hydrochloride,anhydrous dextrose,edetate sodium,methylparaben,propylparaben,citric acid monohydrate,sodium hydroxide", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Melphalan?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Melphalan"]], "act": "question"}]}
{"index": 1, "text": "what version of Melphalan is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Melphalan", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant GlipiZIDE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "GlipiZIDE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "storage instructions for drug GlipiZIDE", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have aggression with Cadira?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cadira"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 1, "text": "aggression is a dangerous side effect of Cadira. Localized Reactions: During or immediately after treatment with lidocaine and prilocaine cream on intact skin, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation. Rare cases of discrete purpuric or petechial reactions at the application site have been reported. Rare cases of hyperpigmentation following the use of lidocaine and prilocaine cream have been reported. The relationship to lidocaine and prilocaine cream or the underlying procedure has not been established. In clinical studies on intact skin involving over 1,300 lidocaine and prilocaine cream-treated subjects, one or more such local reactions were noted in 56% of patients, and w", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Oxandrolone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxandrolone"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant fever", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "fever"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "fever is a common side effect of Oxandrolone. Patients with moderate to severe COPD or COPD patients who are unresponsive to bronchodilators should be monitored closely for COPD exacerbation and fluid retention. The following adverse reactions have been associated with use of anabolic steroids:", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Dexamethasone?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dexamethasone"]], "act": "question"}]}
{"index": 1, "text": "Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis and serum sickness. Dermatologic Diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (Stevens-Johnson syndrome). Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of ", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have suicidal with Trianex?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Trianex"], ["<symptom>", "suicidal"]], "act": "question"}]}
{"index": 1, "text": "suicidal is a serious side effect of Trianex. The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning, Itching, Irritation, Dryness, Folliculitis, Hypertrichosis, Acneiform eruptions, Hypopigmentation, Perioral dermatitis, Allergic contact dermatitis, Maceration of the skin, Secondary infection, Skin atrophy, Striae and Miliaria.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Tizanidine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tizanidine"]], "act": "question"}]}
{"index": 1, "text": "what version of Tizanidine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "A single dose of 8 mg of tizanidine reduces muscle tone in patients with spasticity for a period of several hours. The effect peaks at approximately 1 to 2 hours and dissipates between 3 to 6 hours. Effects are dose-related. Although single doses of less than 8 mg have not been demonstrated to be effective in controlled clinical studies, the dose-related nature of tizanidine\u2019s common adverse events make it prudent to begin treatment with single oral doses of 4 mg. Increase the dose gradually (2 mg to 4 mg steps) to optimum effect (satisfactory reduction of muscle tone at a tolerated dose). The dose can be repeated at 6 to 8 hour intervals, as needed, to a maximum of three doses in 24 hours. ", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Caffeine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Caffeine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Prior to initiation of caffeine citrate injection USP, baseline serum levels of caffeine should be measured in infants previously treated with theophylline, since preterm infants metabolize theophylline to caffeine. Likewise, baseline serum levels of caffeine should be measured in infants born to mothers who consumed caffeine prior to delivery, since caffeine readily crosses the placenta. The recommended loading dose and maintenance doses of caffeine citrate injection USP follow. Dose of Caffeine Citrate Injection USP Volume Dose of Caffeine Citrate Injection USP mg/kg Route Frequency Loading Dose 1 mL/kg 20 mg/kg Intravenous * (over 30 minutes) One Time Maintenance Dose 0.25 mL/kg 5 mg/kg I", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Amitriptyline?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amitriptyline"]], "act": "question"}]}
{"index": 0, "text": "For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than are other depressive states.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does CALAN contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CALAN"]], "act": "question"}]}
{"index": 1, "text": "what version of CALAN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "VERAPAMIL HYDROCHLORIDE,MICROCRYSTALLINE CELLULOSE,STARCH, CORN,GELATIN, UNSPECIFIED,HYDROXYPROPYL CELLULOSE (1200000 MW),HYPROMELLOSE, UNSPECIFIED,LACTOSE, UNSPECIFIED FORM,MAGNESIUM STEARATE,POLYETHYLENE GLYCOL, UNSPECIFIED,TALC,TITANIUM DIOXIDE,VERAPAMIL HYDROCHLORIDE,MICROCRYSTALLINE CELLULOSE,STARCH, CORN,GELATIN, UNSPECIFIED,HYDROXYPROPYL CELLULOSE (1200000 MW),HYPROMELLOSE, UNSPECIFIED,LACTOSE, UNSPECIFIED FORM,MAGNESIUM STEARATE,POLYETHYLENE GLYCOL, UNSPECIFIED,TALC,TITANIUM DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does ALLERGENIC cause mood_swings?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ALLERGENIC"], ["<symptom>", "mood_swings"]], "act": "question"}]}
{"index": 0, "text": "mood_swings is a common side effect of ALLERGENIC. Local reactions consisting of erythema, itching, swelling, tenderness and sometimes pain may occur at the injection site. These reactions may appear within a few minutes to hours and persist for several days. Local cold applications and oral antihistamines may be effective treatment. For marked and prolonged local reactions, steroids may be helpful. Adverse systemic reactions usually occur within minutes and consist primarily of allergic symptoms such as generalized skin erythema, urticaria, pruritus, angioedema, rhinitis, wheezing, laryngeal edema and hypotension. Less commonly, nausea, emesis, abdominal cramps, diarrhea and uterine contractions may occur. Severe reactions may cause shock a", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant PerioChip,", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "PerioChip,"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Primlev is the correct dose for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Primlev"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 1, "text": "what version of Primlev is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Primlev is 1 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant elderly", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant Zileuton", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Zileuton"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how do I take Fludrocortisone?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fludrocortisone"]], "act": "question"}]}
{"index": 0, "text": "what version of Fludrocortisone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Dosage depends on the severity of the disease and the response of the patient. Patients should be continually monitored for signs that indicate dosage adjustment is necessary, such as remission or exacerbations of the disease and stress (surgery, infection, trauma)(see WARNINGS and PRECAUTIONS , General ).", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Levophed\u2122", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Levophed\u2122"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Norepinephrine Bitartrate Injection is a concentrated, potent drug which must be diluted in dextrose containing solutions prior to infusion. An infusion of LEVOPHED should be given into a large vein (see PRECAUTIONS ). Restoration of Blood Pressure in Acute Hypotensive States Blood volume depletion should always be corrected as fully as possible before any vasopressor is administered. When, as an emergency measure, intraaortic pressures must be maintained to prevent cerebral or coronary artery ischemia, LEVOPHED can be administered before and concurrently with blood volume replacement. Diluent: LEVOPHED should be diluted in 5 percent dextrose injection or 5 percent dextrose and sodium chlori", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many ZIAGEN is the correct dose for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ZIAGEN"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of ZIAGEN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for ZIAGEN is 4 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Megestrol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Megestrol"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant 80", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Megestrol is 4 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Albumin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Albumin"]], "act": "question"}]}
{"index": 1, "text": "what version of Albumin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Folic", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Folic"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many PredniSONE is the correct dose for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PredniSONE"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 1, "text": "what version of PredniSONE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for PredniSONE is 1 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Lidocaine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Lidocaine is 1 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of TYLENOL?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TYLENOL"]], "act": "question"}]}
{"index": 1, "text": "what version of TYLENOL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "POWDERED CELLULOSE,MAGNESIUM STEARATE,SODIUM METABISULFITE,STARCH, CORN,ACETAMINOPHEN,CODEINE PHOSPHATE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is the dose for Potassium?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of Potassium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "90", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Potassium is 4 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant 70", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Potassium is 4 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Metopirone in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metopirone"]], "act": "question"}]}
{"index": 1, "text": "what version of Metopirone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Metopirone", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much Fluocinonide should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluocinonide"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 2, "text": "what version of Fluocinonide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "10", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Fluocinonide is 2 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "actually i meant 50", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "update"}]}
{"index": 6, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 7, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 7, "text": "The dosage for Fluocinonide is 2 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Atorvastatin is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Atorvastatin"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 2, "text": "what version of Atorvastatin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "10", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Atorvastatin is 1 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Atorvastatin is 1 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Famotidine?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Famotidine"]], "act": "question"}]}
{"index": 1, "text": "Famotidine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "infection", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "inform"}]}
{"index": 2, "text": "The adverse reactions listed below have been reported during domestic and international clinical trials in approximately 2500 patients. In those controlled clinical trials in which famotidine tablets were compared to placebo, the incidence of adverse experiences in the group which received famotidine tablets, 40 mg at bedtime, was similar to that in the placebo group. The following adverse reactions have been reported to occur in more than 1% of patients on therapy with famotidine in controlled clinical trials, and may be causally related to the drug: headache (4.7%), dizziness (1.3%), constipation (1.2%) and diarrhea (1.7%). The following other adverse reactions have been reported infrequen", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant liver_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Sumatriptan", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sumatriptan"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Serious cardiac events, including some that have been fatal, have occurred following the use of sumatriptan succinate injection or tablets. These events are extremely rare and most have been reported in patients with risk factors predictive of CAD. Events reported have included coronary artery vasospasm, transient myocardial ischemia, myocardial infarction, ventricular tachycardia, and ventricular fibrillation (see CONTRAINDICATIONS , WARNINGS , and PRECAUTIONS ) . Significant hypertensive episodes, including hypertensive crises, have been reported on rare occasions in patients with or without a history of hypertension (see WARNINGS ).", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Lidocaine safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "question"}]}
{"index": 1, "text": "Lidocaine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "infection", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "inform"}]}
{"index": 2, "text": "Localized Reactions: During or immediately after treatment with lidocaine and prilocaine cream on intact skin, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation. Rare cases of discrete purpuric or petechial reactions at the application site have been reported. Rare cases of hyperpigmentation following the use of lidocaine and prilocaine cream have been reported. The relationship to lidocaine and prilocaine cream or the underlying procedure has not been established. In clinical studies on intact skin involving over 1,300 lidocaine and prilocaine cream-treated subjects, one or more such local reactions were noted in 56% of patients, and w", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what do I do with Duloxetine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Duloxetine"]], "act": "question"}]}
{"index": 0, "text": "what version of Duloxetine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "Swallow duloxetine delayed-release capsules whole. Do not chew or crush. Do not open the capsule and sprinkle its contents on food or mix with liquids. All of these might affect the enteric coating. Duloxetine delayed-release capsules can be given without regard to meals. If a dose of duloxetine delayed-release capsules is missed, take the missed dose as soon as it is remembered. If it is almost time for the next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses of duloxetine delayed-release capsules at the same time.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Liothyronine?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Liothyronine"]], "act": "question"}]}
{"index": 1, "text": "what version of Liothyronine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Liothyronine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Liothyronine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "where should I keep Cefprozil?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cefprozil"]], "act": "question"}]}
{"index": 0, "text": "what version of Cefprozil is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Cefprozil", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant CYCLOBENZAPRINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CYCLOBENZAPRINE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug CYCLOBENZAPRINE", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is HydrOXYzine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HydrOXYzine"]], "act": "question"}]}
{"index": 0, "text": "For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus. As a sedative when used in premedication and following general anesthesia, Hydroxyzine may potentiate meperidine (Demerol  ) and barbiturates, so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. Atropine and other belladonna alkaloids are not affected by the drug. Hydroxyzine is not known to interfere with the action of digitalis in any way an", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Selenium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Selenium"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "For the treatment of tinea versicolor, seborrheic dermatitis of the scalp, and dandruff.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Nitroglycerin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nitroglycerin"]], "act": "question"}]}
{"index": 1, "text": "Nitroglycerin sublingual tablets are indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant HYDROQUINONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROQUINONE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "HYDROQUINONE 4% CREAM is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "what do I do with Methocarbamol?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methocarbamol"]], "act": "question"}]}
{"index": 0, "text": "what version of Methocarbamol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Methocarbamol tablets, USP, 500 mg \u2013 Adults: Initial dosage: 3 tablets q.i.d. Maintenance dosage: 2 tablets q.i.d. Methocarbamol tablets, USP: 750 mg \u2013 Adults: Initial dosage: 2 tablets q.i.d. Maintenance dosage: 1 tablet q.4h. or 2 tablets t.i.d. Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered). Thereafter, the dosage can usually be reduced to approximately 4 grams a day.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much Lovastatin should i take for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lovastatin"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 0, "text": "what version of Lovastatin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Lovastatin is 4 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant Itraconazole", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Itraconazole"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The dosage for Itraconazole is 4 mg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Methylphenidate contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methylphenidate"]], "act": "question"}]}
{"index": 1, "text": "what version of Methylphenidate is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "METHYLPHENIDATE HYDROCHLORIDE,ANHYDROUS CITRIC ACID,GLYCERIN,POLYETHYLENE GLYCOL 1450,WATER,METHYLPHENIDATE HYDROCHLORIDE,ANHYDROUS CITRIC ACID,GLYCERIN,POLYETHYLENE GLYCOL 1450,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant INDOMETHACIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "INDOMETHACIN"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Indomethacin,Indomethacin", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "do I need to keep Clindamycin in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Clindamycin"]], "act": "question"}]}
{"index": 0, "text": "what version of Clindamycin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Clindamycin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "storage instructions for drug Clindamycin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "What is Ondansetron?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ondansetron"]], "act": "question"}]}
{"index": 0, "text": "Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin \u226550 mg/m 2 . Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. Prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. Prevention of postoperative nausea and/or vomiting. As with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients where nausea and/or vomitin", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Omega-3-acid", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Omega-3-acid"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Omega-3-acid ethyl esters capsules, USP are indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (\u2265500 mg/dL) hypertriglyceridemia (HTG). Usage Considerations: Patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters capsules, USP and should continue this diet during treatment with omega-3-acid ethyl esters capsules, USP. Laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters. Every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Ketorolac safe  for someone with glaucoma?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ketorolac"], ["<condition>", "glaucoma"]], "act": "question"}]}
{"index": 1, "text": "Adverse reaction rates increase with higher doses of ketorolac tromethamine. Practitioners should be alert for the severe complications of treatment with ketorolac tromethamine, such as G.I. ulceration, bleeding and perforation, postoperative bleeding, acute renal failure, anaphylactic and anaphylactoid reactions, and liver failure (see Boxed WARNING, WARNINGS, PRECAUTIONS, and DOSAGE AND ADMINISTRATION). These NSAID-related complications can be serious in certain patients for whom ketorolac tromethamine is indicated, especially when the drug is used inappropriately. In patients taking ketorolac tromethamine or other NSAIDs in clincial trials, the most frequently reported adverse experiences", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Hydrocodone?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrocodone"]], "act": "question"}]}
{"index": 1, "text": "what version of Hydrocodone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Hydrocodone", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant lidocaine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "lidocaine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much TIZANIDINE should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TIZANIDINE"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 2, "text": "what version of TIZANIDINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for TIZANIDINE is 2 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant 40", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for TIZANIDINE is 2 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 7, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Fexofenadine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fexofenadine"]], "act": "question"}]}
{"index": 0, "text": "Seasonal Allergic Rhinitis Fexofenadine Hydrochloride Tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. Symptoms treated effectively were sneezing, rhinorrhea, itchy nose/palate/throat, itchy/watery/red eyes. Chronic Idiopathic Urticaria Fexofenadine Hydrochloride Tablets are indicated for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older. It significantly reduces pruritus and the number of wheals.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of SORBITOL-MANNITOL?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SORBITOL-MANNITOL"]], "act": "question"}]}
{"index": 1, "text": "what version of SORBITOL-MANNITOL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "SORBITOL,MANNITOL,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "Should I take omeprazole  for someone with tourettes?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "omeprazole"], ["<condition>", "tourettes"]], "act": "question"}]}
{"index": 0, "text": "The following serious adverse reactions are described below and elsewhere in labeling:  Acute Interstitial Nephritis [see WARNINGS AND PRECAUTIONS (5.2)]  Clostridium difficile-Associated Diarrhea [see WARNINGS AND PRECAUTIONS (5.3)]  Bone Fracture [see WARNINGS AND PRECAUTIONS (5.4)]  Cutaneous and Systemic Lupus Erythematosus [see WARNINGS AND PRECAUTIONS (5.5)]  Cyanocobalamin (Vitamin B-12) Deficiency [see WARNINGS AND PRECAUTIONS (5.7)]  Hypomagnesemia [see WARNINGS AND PRECAUTIONS (5.8)] 6.1 Clinical Trials Experience with Omeprazole Monotherapy Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant LISINOPRIL", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "LISINOPRIL"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant IBD", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Lisinopril and Hydrochlorothiazide Tablets has been evaluated for safety in 930 patients, including 100 patients treated for 50 weeks or more. In clinical trials with Lisinopril and Hydrochlorothiazide Tablets no adverse experiences peculiar to this combination drug have been observed. Adverse experiences that have occurred have been limited to those that have been previously reported with lisinopril or hydrochlorothiazide. The most frequent clinical adverse experiences in controlled trials (including open label extensions) with any combination of lisinopril and hydrochlorothiazide were: dizziness (7.5 percent), headache (5.2 percent), cough (3.9 percent), fatigue (3.7 percent) and orthostat", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much Amiodarone should i take for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amiodarone"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of Amiodarone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Amiodarone is 4 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Cetirizine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cetirizine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant 50", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 7, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is aggression a common side effect of Propranolol?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Propranolol"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 1, "text": "aggression is a mild side effect of Propranolol. The following adverse events were observed and have been reported in patients using propranolol. Cardiovascular: Bradycardia; congestive heart failure; intensification of AV block; hypotension; paresthesia of hands; thrombocytopenic purpura; arterial insufficiency, usually of the Raynaud type. Central Nervous System: Light-headedness, mental depression manifested by insomnia, lassitude, weakness, fatigue; catatonia; visual disturbances; hallucinations; vivid dreams; an acute reversible syndrome characterized by disorientation for time and place, short-term memory loss, emotional lability, slightly clouded sensorium, and decreased performance on neuropsychometrics. For immediate-release formu", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Itraconazole", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Itraconazole"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant itchy_skin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "itchy_skin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what are the ingredients of BENZONATATE?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BENZONATATE"]], "act": "question"}]}
{"index": 0, "text": "what version of BENZONATATE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "BENZONATATE,CELLULOSE, MICROCRYSTALLINE,SILICON DIOXIDE,CROSCARMELLOSE SODIUM,D&C RED NO. 28,FD&C BLUE NO. 1,GELATIN,HYDROXYPROPYL CELLULOSE (TYPE L),TITANIUM DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "where should I keep Heparin?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Heparin"]], "act": "question"}]}
{"index": 0, "text": "what version of Heparin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Heparin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "storage instructions for drug Heparin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is ERY-TAB?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ERY-TAB"]], "act": "question"}]}
{"index": 1, "text": "To reduce the development of drug-resistant bacteria and maintain the effectiveness of ERY-TAB  and other antibacterial drugs, ERY-TAB  should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ERY-TAB  tablets are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the diseases listed below: Upper respiratory tr", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Solu-Medrol?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Solu-Medrol"]], "act": "question"}]}
{"index": 1, "text": "what version of Solu-Medrol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Solu-Medrol", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "is it normal to have vomiting with Triamcinolone?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Triamcinolone"], ["<symptom>", "vomiting"]], "act": "question"}]}
{"index": 0, "text": "vomiting is a common side effect of Triamcinolone. The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant Busulfan", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Busulfan"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "vomiting is a dangerous side effect of Busulfan. The following adverse reactions are discussed in more detail in other sections of the labeling: Myelosuppression [see Warnings and Precautions (5.1) ] Seizures [see Warnings and Precautions (5.2) ] HVOD [see Warnings and Precautions (5.3) ] Embryo-fetal Toxicity [see Warnings and Precautions (5.4) ] Cardiac Tamponade [see Warnings and Precautions (5.5) ] Bronchopulmonary Dysplasia [see Warnings and Precautions (5.6) ] Cellular Dysplasia [see Warnings and Precautions (5.7) ]", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is the dose for Bacteriostatic for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Bacteriostatic"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 0, "text": "what version of Bacteriostatic is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Bacteriostatic is 4 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant elderly", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The dosage for Bacteriostatic is 4 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "what is the dose for Neomycin for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Neomycin"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 0, "text": "what version of Neomycin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "10", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Neomycin is 3 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant 30", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The dosage for Neomycin is 3 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does SULINDAC cause bruising?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SULINDAC"], ["<symptom>", "bruising"]], "act": "question"}]}
{"index": 1, "text": "bruising is a mild side effect of SULINDAC. The following adverse reactions were reported in clinical trials or have been reported since the drug was marketed. The probability exists of a causal relationship between sulindac tablets and these adverse reactions. The adverse reactions which have been observed in clinical trials encompass observations in 1,865 patients, including 232 observed for at least 48 weeks.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Sodium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sodium"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what are the ingredients of Amrix?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amrix"]], "act": "question"}]}
{"index": 0, "text": "what version of Amrix is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "CYCLOBENZAPRINE HYDROCHLORIDE,DIETHYL PHTHALATE,ETHYLCELLULOSES,GELATIN,SUCROSE,TITANIUM DIOXIDE,D&C YELLOW NO. 10,FD&C GREEN NO. 3,FD&C RED NO. 40,STARCH, CORN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Haloperidol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Haloperidol"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "HALOPERIDOL LACTATE,PROPYLENE GLYCOL,METHYLPARABEN,PROPYLPARABEN,LACTIC ACID,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Moderiba?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Moderiba"]], "act": "question"}]}
{"index": 1, "text": "what version of Moderiba is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "RIBAVIRIN,CELLULOSE, MICROCRYSTALLINE,LACTOSE MONOHYDRATE,CROSCARMELLOSE SODIUM,POVIDONES,MAGNESIUM STEARATE,WATER,POLYVINYL ALCOHOL,TITANIUM DIOXIDE,POLYETHYLENE GLYCOL 3350,TALC,FD&C BLUE NO. 2,CARNAUBA WAX,RIBAVIRIN,CELLULOSE, MICROCRYSTALLINE,LACTOSE MONOHYDRATE,CROSCARMELLOSE SODIUM,POVIDONES,MAGNESIUM STEARATE,WATER,POLYVINYL ALCOHOL,TITANIUM DIOXIDE,POLYETHYLENE GLYCOL 3350,TALC,FD&C BLUE NO. 1,CARNAUBA WAX,RIBAVIRIN,CELLULOSE, MICROCRYSTALLINE,LACTOSE MONOHYDRATE,CROSCARMELLOSE SODIUM,POVIDONES,MAGNESIUM STEARATE,WATER,POLYVINYL ALCOHOL,TITANIUM DIOXIDE,POLYETHYLENE GLYCOL 3350,TALC,FD&C BLUE NO. 1,CARNAUBA WAX", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Metoprolol  if I am anxiety?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metoprolol"], ["<condition>", "anxiety"]], "act": "question"}]}
{"index": 1, "text": "Hypertension and Angina These adverse reactions were reported for treatment with oral metoprolol tartrate. Most adverse effects have been mild and transient. Central Nervous System Tiredness and dizziness have occurred in about 10 of 100 patients. Depression has been reported in about 5 of 100 patients. Mental confusion and short-term memory loss have been reported. Headache, nightmares, and insomnia have also been reported. Cardiovascular Shortness of breath and bradycardia have occurred in approximately 3 of 100 patients. Cold extremities; arterial insufficiency, usually of the Raynaud type; palpitations; congestive heart failure; peripheral edema; and hypotension have been reported in abo", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant glaucoma", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "The following adverse reactions are described elsewhere in labeling: Worsening angina or myocardial infarction. [see Warnings and Precautions (5) ] Worsening heart failure. [see Warnings and Precautions (5) ] Worsening AV block. [see Contraindications (4) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "where should I keep Brevibloc?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Brevibloc"]], "act": "question"}]}
{"index": 1, "text": "what version of Brevibloc is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Brevibloc", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Gabapentin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Gabapentin"]], "act": "question"}]}
{"index": 0, "text": "Gabapentin capsules, USP are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the side effects of Nystatin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nystatin"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of Nystatin: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "blurred_vision", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "blurred_vision"]], "act": "inform"}]}
{"index": 1, "text": "blurred_vision is a mild side effect of Nystatin. Nystatin is well tolerated even with prolonged therapy. Oral irritation and sensitization have been reported (see PRECAUTIONS, General ).", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant diarrhea", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "diarrhea"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is depression a common side effect of Ketamine?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ketamine"], ["<symptom>", "depression"]], "act": "question"}]}
{"index": 0, "text": "depression is a mild side effect of Ketamine. Cardiovascular: Blood pressure and pulse rate are frequently elevated following administration of ketamine alone. However, hypotension and bradycardia have been observed. Arrhythmia has also occurred. Respiration: Although respiration is frequently stimulated, severe depression of respiration or apnea may occur following rapid intravenous administration of high doses of ketamine. Laryngospasms and other forms of airway obstruction have occurred during ketamine anesthesia. Eye: Diplopia and nystagmus have been noted following ketamine administration. It also may cause a slight elevation in intraocular pressure measurement. Psychological: (See Special Note ). Neurological: In some patients, en", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant bleeding", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "bleeding"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant MELOXICAM", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "MELOXICAM"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is cyclobenzaprine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "cyclobenzaprine"]], "act": "question"}]}
{"index": 1, "text": "Cyclobenzaprine hydrochloride tablets are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living. Cyclobenzaprine hydrochloride tablets should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer p", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Adrenalin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Adrenalin"]], "act": "question"}]}
{"index": 0, "text": "Adrenalin \ufeff is available as a single-use 1 mL vial and a multiple-use 30 mL vial for intramuscular and subcutaneous use. Emergency treatment of allergic reactions (Type I), including anaphylaxis, which may result from allergic reactions to insect stings, biting insects, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. The signs and symptoms associated with anaphylaxis include flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with hypotension, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, airway swelling, laryngospasm, bronchospasm, pruritu", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "What is CENTANY?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CENTANY"]], "act": "question"}]}
{"index": 0, "text": "CENTANY  ointment is indicated for the topical treatment of impetigo due to: Staphylococcus aureus and Streptococcus pyogenes .", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant HYDROCORTISONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROCORTISONE"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Hydrocortisone tablets, USP are indicated in the following conditions. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Psoriatic arthritis Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dos", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I take Ibandronate?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ibandronate"]], "act": "question"}]}
{"index": 0, "text": "what version of Ibandronate is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is fever a common side effect of Gemfibrozil?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Gemfibrozil"], ["<symptom>", "fever"]], "act": "question"}]}
{"index": 1, "text": "fever is a mild side effect of Gemfibrozil. In the double-blind controlled phase of the primary prevention component of the Helsinki Heart Study, 2046 patients received gemfibrozil for up to five years. In that study, the following adverse reactions were statistically more frequent in subjects in the gemfibrozil group: GEMFIBROZIL (N = 2046) PLACEBO (N = 2035) Frequency in Percent of Subjects Gastrointestinal reactions 34.2 23.8 Dyspepsia 19.6 11.9 Abdominal pain 9.8 5.6 Acute appendicitis (histologically confirmed in most cases where data were available) 1.2 0.6 Atrial fibrillation 0.7 0.1 Adverse events reported by more than 1% of subjects, but without a significant difference between groups: Diarrhea 7.2 6.5 Fatigue 3.8 3.5 Nausea/", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant vomiting", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "vomiting is a mild side effect of Gemfibrozil. In the double-blind controlled phase of the primary prevention component of the Helsinki Heart Study, 2046 patients received gemfibrozil for up to five years. In that study, the following adverse reactions were statistically more frequent in subjects in the gemfibrozil group: GEMFIBROZIL (N = 2046) PLACEBO (N = 2035) Frequency in percent of subjects Gastrointestinal reactions 34.2 23.8 Dyspepsia 19.6 11.9 Abdominal pain 9.8 5.6 Acute appendicitis 1.2 0.6 (histologically confirmed in most cases where data were available) Atrial fibrillation 0.7 0.1 Adverse events reported by more than 1% of subjects, but without a significant difference between groups: Diarrhea 7.2 6.5 Fatigue 3.8 3.5 Nausea/", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Potassium?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "question"}]}
{"index": 1, "text": "what version of Potassium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Potassium Chloride in 5% Dextrose Injection, USP is for intravenous infusion. Potassium Chloride in 5% Dextrose Injection, USP should not be administered by intravenous push. Potassium Chloride in 5% Dextrose Injection, USP has an osmolarity of 293 mOsmol/L (calc). The choice of specific potassium chloride and dextrose dosage, volume, rate and duration of administration depends on the age, weight and clinical condition of the patient, concomitant therapy, and administration should be determined by a physician. For patients with electrolyte and glucose abnormalities and for pediatric patients, consult a physician experienced in intravenous fluid therapy. A gradual increase of flow rate should", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "What is Chenodal?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Chenodal"]], "act": "question"}]}
{"index": 0, "text": "Chenodal (chenodiol tablets) is indicated for patients with radiolucent stones in well-opacifying gallbladders, in whom selective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age. The likelihood of successful dissolution is far greater if the stones are floatable or small. For patients with nonfloatable stones, dissolution is less likely and added weight should be given to the risk that more emergent surgery might result form a delay due to unsuccessful treatment. Safety of use beyond 24 months is not established. Chenodiol will not dissolve calcified (radiopaque) or radiolucent bile pigment stones.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Amoxicillin?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amoxicillin"]], "act": "question"}]}
{"index": 1, "text": "what version of Amoxicillin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Amoxicillin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Amoxicillin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is ChiRhoStim?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ChiRhoStim"]], "act": "question"}]}
{"index": 1, "text": "ChiRhoStim  is indicated for the stimulation of: pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction. gastrin secretion to aid in the diagnosis of gastrinoma, and pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangiopancreatography (ERCP).", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Dextrose in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dextrose"]], "act": "question"}]}
{"index": 1, "text": "what version of Dextrose is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Dextrose", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "is it normal to have vomiting with Primidone?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Primidone"], ["<symptom>", "vomiting"]], "act": "question"}]}
{"index": 0, "text": "vomiting is a mild side effect of Primidone. The most frequently occurring early side effects are ataxia and vertigo. These tend to disappear with continued therapy, or with reduction of initial dosage. Occasionally, the following have been reported: nausea, anorexia, vomiting, fatigue, hyperirritability, emotional disturbances, sexual impotency, diplopia, nystagmus, drowsiness, and morbilliform skin eruptions. Granulocytopenia, agranulocytosis, and red-cell hypoplasia and aplasia, have been reported rarely. These and, occasionally, other persistent or severe side effects may necessitate withdrawal of the drug. Megaloblastic anemia may occur as a rare idiosyncrasy to primidone and to other anticonvulsants. The anemia responds to folic ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant fever", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "fever"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Levalbuterol?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Levalbuterol"]], "act": "question"}]}
{"index": 1, "text": "Levalbuterol may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "glaucoma", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "inform"}]}
{"index": 2, "text": "The following serious adverse reactions are described below and elsewhere in the labeling: Paradoxical bronchospasm [see Warnings and Precautions (5.1) ] Cardiovascular effects [see Warnings and Precautions (5.4) ] Immediate hypersensitivity reactions [see Warnings and Precautions (5.6) ] Hypokalemia [see Warnings and Precautions (5.8) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant glaucoma", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Naloxone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Naloxone"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use Peridex\u2122?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Peridex\u2122"]], "act": "question"}]}
{"index": 0, "text": "what version of Peridex\u2122 is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "Peridex therapy should be initiated directly following a dental prophylaxis. Patients using Peridex should be reevaluated and given a thorough prophylaxis at intervals no longer than six months. Recommended use is twice daily oral rinsing for 30 seconds, morning and evening after toothbrushing. Usual dosage is 15ml (marked in cap) of undiluted Peridex. Patients should be instructed to not rinse with water or other mouthwashes, brush teeth or eat immediately after using Peridex. Peridex is not intended for ingestion and should be expectorated after rinsing.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Peridex therapy should be initiated directly following a dental prophylaxis. Patients using Peridex should be reevaluated and given a thorough prophylaxis at intervals no longer than six months. Recommended use is twice daily oral rinsing for 30 seconds, morning and evening after toothbrushing. Usual dosage is 15ml (marked in cap) of undiluted Peridex. Patients should be instructed to not rinse with water or other mouthwashes, brush teeth or eat immediately after using Peridex. Peridex is not intended for ingestion and should be expectorated after rinsing.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "can i take Brompheniramine  if I am tourettes?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Brompheniramine"], ["<condition>", "tourettes"]], "act": "question"}]}
{"index": 0, "text": "The most frequent adverse reactions to brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup 2 mg/30 mg/10 mg per 5 mL are: sedation; dryness of mouth, nose and throat; thickening of bronchial secretions; dizziness. Other adverse reactions may include: Dermatologic: Urticaria, drug rash, photosensitivity, pruritus. Cardiovascular System: Hypotension, hypertension, cardiac arrhythmias, palpitation. CNS: Disturbed coordination, tremor, irritability, insomnia, visual disturbances, weakness, nervousness, convulsions, headache, euphoria, and dysphoria. G.U. System: Urinary frequency, difficult urination. G.I. System: Epigastric discomfort, anorexia, nause", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much Sodium should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sodium"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of Sodium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Sodium is 4 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Labetalol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Labetalol"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Labetalol is 4 mg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Ammonium?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ammonium"]], "act": "question"}]}
{"index": 1, "text": "what version of Ammonium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Ammonium", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Sterile?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sterile"]], "act": "question"}]}
{"index": 1, "text": "what version of Sterile is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of Norvir?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Norvir"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of Norvir: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "vomiting", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "inform"}]}
{"index": 2, "text": "vomiting is a common side effect of Norvir. The following adverse reactions are discussed in greater detail in other sections of the labeling. Drug Interactions [see Warnings and Precautions (5.1)] Hepatotoxicity [see Warnings and Precautions (5.3)] Pancreatitis [see Warnings and Precautions (5.4)] Allergic Reactions/Hypersensitivity [see Warnings and Precautions (5.5)] When co-administering NORVIR with other protease inhibitors, see the full prescribing information for that protease inhibitor including adverse reactions. 6.1 Clinical Trial Experience Because clinical trials are conducted under widely varying conditions, adverse reactions rates observed in the clinical trials of a drug cannot be directly compared to rates in the clini", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "actually i meant itchy_skin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "itchy_skin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Sterile", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sterile"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "itchy_skin is a serious side effect of Sterile. Possible adverse effects arising from the irrigation of body cavities, tissues, or indwelling catheters and tubes are completely avoidable when proper procedures are followed. Displaced catheters or drainage tubes can lead to irrigation or infiltration of unintended structures or cavities. Excessive volume or pressure during irrigation of closed cavities may cause undue distention or disruption of tissues. Accidental contamination from careless technique may transmit infection. Should any adverse reaction occur, discontinue the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination, if deemed necessary.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Megestrol?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Megestrol"]], "act": "question"}]}
{"index": 1, "text": "what version of Megestrol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Breast cancer: 160 mg/day (40 mg q.i.d.). Endometrial carcinoma: 40 to 320 mg/day in divided doses. At least 2 months of continuous treatment is considered an adequate period for determining the efficacy of megestrol acetate.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Chlorthalidone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Chlorthalidone"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Therapy should be initiated with the lowest possible dose. This dose should be titrated according to individual patient response to gain maximal therapeutic benefit while maintaining lowest dosage possible. A single dose given in the morning with food is recommended; divided daily doses are unnecessary.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Desonide?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Desonide"]], "act": "question"}]}
{"index": 1, "text": "what version of Desonide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "DESONIDE,PETROLATUM", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Felbamate?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Felbamate"]], "act": "question"}]}
{"index": 0, "text": "what version of Felbamate is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Felbamate,citric acid monohydrate,carboxymethylcellulose sodium, unspecified form,FD&C Yellow No. 6,FD&C Red No. 40,glycerin,methylparaben,microcrystalline cellulose,polysorbate 80,propylparaben,sorbitol,sucralose,water,dimethicone", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Gemfibrozil", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Gemfibrozil"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "GEMFIBROZIL,CALCIUM STEARATE,SILICON DIOXIDE,HYPROMELLOSE 2910 (6 MPA.S),HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED,HYDROXYPROPYL CELLULOSE (TYPE H),CELLULOSE, MICROCRYSTALLINE,POLYETHYLENE GLYCOL 400,POLYSORBATE 80,STARCH, CORN,TITANIUM DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the side effects of Desonide?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Desonide"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of Desonide: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "diarrhea", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "diarrhea"]], "act": "inform"}]}
{"index": 1, "text": "diarrhea is a dangerous side effect of Desonide. In controlled clinical trials, the total incidence of adverse reactions associated with the use of desonide was approximately 8%. These were: stinging and burning approximately 3%, irritation, contact dermatitis, condition worsened, peeling of skin, itching, intense transient erythema, and dryness/scaliness, each less than 2%. The following additional local adverse reactions have been reported infrequently with other topical corticosteroids, and they may occur more frequently with the use of occlusive dressings, especially with higher potency corticosteroids. These reactions are listed in an approximate decreasing order of occurrence: folliculitis, acneiform eruptions, hypopigmentation, peri", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Phentolamine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Phentolamine"]], "act": "question"}]}
{"index": 1, "text": "what version of Phentolamine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "The reconstituted solution should be used upon preparation and should not be stored. 1. Prevention or control of hypertensive episodes in the patient with pheochromo-cytoma. For preoperative reduction of elevated blood pressure, 5 mg of phentolamine mesylate (1 mg for children) is injected intravenously or intramuscularly 1 or 2 hours before surgery, and repeated if necessary. During surgery, phentolamine mesylate (5 mg for adults, 1 mg for children) is administered intravenously as indicated, to help prevent or control paroxysms of hypertension, tachycardia, respiratory depression, convulsions, or other effects of epinephrine intoxication. (Postoperatively, norepinephrine may be given to co", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant 148", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "148"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Bleomycin?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Bleomycin"]], "act": "question"}]}
{"index": 1, "text": "what version of Bleomycin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "BLEOMYCIN SULFATE,SULFURIC ACID,SODIUM HYDROXIDE,BLEOMYCIN SULFATE,SULFURIC ACID,SODIUM HYDROXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Dextrose safe  if I am infection?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dextrose"], ["<condition>", "infection"]], "act": "question"}]}
{"index": 1, "text": "Hypersensitivity reactions, including anaphylaxis and chills. Reactions which may occur because of the injection or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "What is Depo?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Depo"]], "act": "question"}]}
{"index": 0, "text": "DEPO-Testosterone Injection is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone. 1. Primary hypogonadism (congenital or acquired )-testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome; or orchidectomy. 2. Hypogonadotropic hypogonadism (congenital or acquired )- gonadotropin or LHRH deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. Safety and efficacy of DEPO-Testosterone (testosterone cypionate) in men with \"age-related hypogonadism\" (also referred to as \"late-onset hypogonadism\") have not been established.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Avita?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Avita"]], "act": "question"}]}
{"index": 1, "text": "what version of Avita is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "TRETINOIN,BUTYLATED HYDROXYTOLUENE,ISOPROPYL MYRISTATE,NITROGEN,POLYOXYL 40 STEARATE,PROPYLENE GLYCOL,SORBIC ACID,STEARIC ACID,STEARYL ALCOHOL,XANTHAN GUM,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does chlorzoxazone cause suicidal?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "chlorzoxazone"], ["<symptom>", "suicidal"]], "act": "question"}]}
{"index": 0, "text": "suicidal is a dangerous side effect of chlorzoxazone. Chlorzoxazone-containing products are usually well tolerated. It is possible in rare instances that chlorzoxazone may have been associated with gastrointestinal bleeding. Drowsiness, dizziness, light- headedness, malaise, or overstimulation may be noted by an occasional patient. Rarely, allergic-type skin rashes, petechiae, or ecchymoses may develop during treatment. Angioneurotic edema or anaphylactic reactions are extremely rare. There is no evidence that the drug will cause renal damage. Rarely, a patient may note discoloration of the urine resulting from a phenolic metabolite of chlorzoxazone. This finding is of no known clinical significance.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use Lyza?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lyza"]], "act": "question"}]}
{"index": 0, "text": "what version of Lyza is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "To achieve maximum contraceptive effectiveness, norethindrone tablets must be taken exactly as directed. One tablet is taken every day, at the same time. Administration is continuous, with no interruption between pill packs. See Detailed Patient Labeling for detailed instruction.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Lisinopril safe  if I have TB?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lisinopril"], ["<condition>", "TB"]], "act": "question"}]}
{"index": 1, "text": "Lisinopril and Hydrochlorothiazide Tablets have been evaluated for safety in 930 patients including 100 patients treated for 50 weeks or more. In clinical trials with lisinopril and hydrochlorothiazide tablets no adverse experiences peculiar to this combination drug have been observed. Adverse experiences that have occurred have been limited to those that have been previously reported with lisinopril or hydrochlorothiazide. The most frequent clinical adverse experiences in controlled trials (including open label extensions) with any combination of lisinopril and hydrochlorothiazide were: dizziness (7.5%), headache (5.2%), cough (3.9%), fatigue (3.7%) and orthostatic effects (3.2%), all of wh", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant tourettes", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Lisinopril has been found to be generally well tolerated in controlled clinical trials involving 1969 patients with hypertension or heart failure. For the most part, adverse experiences were mild and transient. Hypertension In clinical trials in patients with hypertension treated with lisinopril, discontinuation of therapy due to clinical adverse experiences occurred in 5.7% of patients. The overall frequency of adverse experiences could not be related to total daily dosage within the recommended therapeutic dosage range. For adverse experiences occurring in greater than 1% of patients with hypertension treated with lisinopril or lisinopril plus hydrochlorothiazide in controlled clinical tri", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is tramadol?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "tramadol"]], "act": "question"}]}
{"index": 1, "text": "Tramadol hydrochloride tablets are indicated for the management of pain in adults that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses ( see WARNINGS ), reserve tramadol hydrochloride tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics]:  Have not been tolerated, or are not expected to be tolerated.  Have not provided adequate analgesia, or are not expected to provide adequate analgesia.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Clotrimazole?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Clotrimazole"]], "act": "question"}]}
{"index": 1, "text": "what version of Clotrimazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Clotrimazole is administered only as a lozenge that must be slowly dissolved in the mouth. The recommended dose is one troche five times a day for fourteen consecutive days. Only limited data are available on the safety and effectiveness of the clotrimazole troche after prolonged administration; therefore, therapy should be limited to short term use, if possible. For prophylaxis to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation, the recommended dose is one troche three times daily for the duration of chemother", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Clotrimazole is administered only as a lozenge that must be slowly dissolved in the mouth. The recommended dose is one troche five times a day for fourteen consecutive days. Only limited data are available on the safety and effectiveness of the clotrimazole troche after prolonged administration; therefore, therapy should be limited to short term use, if possible. For prophylaxis to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation, the recommended dose is one troche three times daily for the duration of chemother", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Mephyton?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Mephyton"]], "act": "question"}]}
{"index": 1, "text": "Mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors II,VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity. Mephyton tablets are indicated in: - anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives; - hypoprothrombinemia secondary to antibacterial therapy; - hypoprothrombinemia secondary to administration of salicylates; - hypoprothrombinemia secondary to obstructive jaundice or biliary fistulas but only if bile salts are administered concurrently, since otherwise the oral vitamin K will not be absorbed.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Is Sodium safe  if I have tourettes?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sodium"], ["<condition>", "tourettes"]], "act": "question"}]}
{"index": 0, "text": "Adverse reactions involve the possibility of phosphate intoxication. Phosphate intoxication results in a reduction of serum calcium and the symptoms are those of hypocalcemic tetany (see WARNINGS ).", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant low_blood_pressure", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use CEFACLOR?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CEFACLOR"]], "act": "question"}]}
{"index": 1, "text": "what version of CEFACLOR is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "Cefaclor is administered orally. Adults \u2013The usual adult dosage is 250 mg every 8 hours. For more severe infections (such as pneumonia) or those caused by less susceptible organisms, doses may be doubled. Pediatric patients \u2013The usual recommended daily dosage for pediatric patients is 20 mg/kg/day in divided doses every 8 hours. In more serious infections, otitis media, and infections caused by less susceptible organisms, 40 mg/kg/day are recommended, with a maximum dosage of 1 g/day. Cefaclor may be administered in the presence of impaired renal function. Under such a condition, the dosage usually is unchanged (see Precautions). In the treatment of \u03b2-hemolytic streptococcal infections, a th", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant PROMETHAZINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "PROMETHAZINE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Promethazine hydrochloride and phenylephrine hydrochloride syrup is contraindicated for children under 2 years of age ( see WARNINGS \u2013 Black Box Warning and Use In Pediatric Patients ). The recommended doses are given in the following table: Adults And Children 12 Years And Over 1 teaspoonful (5 mL) every 4 to 6 hours, not to exceed 6 teaspoonsful (30 mL) in 24 hours. Children 6 To Under 12 Years Of Age \u00bd to 1 teaspoonful (2.5 to 5 mL) every 4 to 6 hours, not to exceed 6 teaspoonsful (30 mL) in 24 hours. Children 2 To Under 6 Years Of Age \u00bc to \u00bd teaspoonful (1.25 to 2.5 mL) every 4 to 6 hours.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Ibuprofen contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ibuprofen"]], "act": "question"}]}
{"index": 1, "text": "what version of Ibuprofen is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "IBUPROFEN,CARNAUBA WAX,SILICON DIOXIDE,CROSCARMELLOSE SODIUM,HYPROMELLOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POLYDEXTROSE,POLYETHYLENE GLYCOL,TITANIUM DIOXIDE,POLYSORBATE 80,IBUPROFEN,CARNAUBA WAX,SILICON DIOXIDE,CROSCARMELLOSE SODIUM,HYPROMELLOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POLYDEXTROSE,POLYETHYLENE GLYCOL,TITANIUM DIOXIDE,POLYSORBATE 80,IBUPROFEN,CARNAUBA WAX,SILICON DIOXIDE,CROSCARMELLOSE SODIUM,HYPROMELLOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POLYDEXTROSE,POLYETHYLENE GLYCOL,TITANIUM DIOXIDE,POLYSORBATE 80", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Norco", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Norco"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "do I need to keep METOCLOPRAMIDE in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "METOCLOPRAMIDE"]], "act": "question"}]}
{"index": 0, "text": "what version of METOCLOPRAMIDE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug METOCLOPRAMIDE", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant donepezil", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "donepezil"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Is AZITHROMYCIN safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "AZITHROMYCIN"]], "act": "question"}]}
{"index": 0, "text": "AZITHROMYCIN may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "IBD", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "inform"}]}
{"index": 1, "text": "In clinical trials, most of the reported side effects were mild to moderate in severity and were reversible upon discontinuation of the drug. Potentially serious side effects of angioedema and cholestatic jaundice were reported rarely. Approximately 0.7% of the patients (adults and pediatric patients) from the 5-day multiple-dose clinical trials discontinued Azithromycin tablet therapy because of treatment -related side effects. In adults given 500 mg/day for 3 days, the discontinuation rate due to treatment-related side effects was 0.6%. In clinical trials in pediatric patients given 30 mg/kg, either as a single dose or over 3 days, discontinuation from the trials due to treatment-related s", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Ascorbic", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ascorbic"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant pregnant", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Transient mild soreness may occur at the site of intramuscular or subcutaneous injection. Too-rapid intravenous administration of the solution may cause temporary faintness or dizziness.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "do I need to keep Morphine in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Morphine"]], "act": "question"}]}
{"index": 0, "text": "what version of Morphine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Morphine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Cyanocobalamin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cyanocobalamin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Cyanocobalamin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is tiredness a common side effect of Epinephrine?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Epinephrine"], ["<symptom>", "tiredness"]], "act": "question"}]}
{"index": 0, "text": "tiredness is a common side effect of Epinephrine. Transient and minor: Anxiety, headache, fear, and palpitations often occur with therapeutic doses, especially in hyperthyroid and hypertensive individuals. Cardiac arrhythmias and excessive rise in blood pressure may occur with therapeutic doses or inadvertent overdosage. Local: Repeated local injections can result in necrosis at sites of injection from vascular constriction. Systemic: Cerebral hemorrhage; hemiplegia; subarachnoid hemorrhage; anginal pain in patients with angina pectoris; anxiety; restlessness; throbbing headache; tremor; weakness; dizziness; pallor; respiratory difficulty; palpitation; apprehensiveness; sweating; nausea; vomiting. Epinephrine-fastness can occur with prolong", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant vomiting", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant Ketoprofen", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ketoprofen"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is NYSTATIN?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NYSTATIN"]], "act": "question"}]}
{"index": 0, "text": "Nystatin Cream USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species. Nystatin Cream USP is not indicated for systemic, oral, intravaginal or ophthalmic use.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Modafinil", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Modafinil"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Modafinil tablets, USP are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). Limitations of Use In OSA, modafinil tablets, USP are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction. If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating and during treatment with modafinil tablets, USP for excessive sleepiness.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Glycopyrrolate contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Glycopyrrolate"]], "act": "question"}]}
{"index": 1, "text": "what version of Glycopyrrolate is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "GLYCOPYRROLATE,DIBASIC CALCIUM PHOSPHATE DIHYDRATE,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,POVIDONE, UNSPECIFIED,SODIUM STARCH GLYCOLATE TYPE A POTATO", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Famotidine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Famotidine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "FAMOTIDINE,ANHYDROUS CITRIC ACID,CELLULOSE, MICROCRYSTALLINE,SUCROSE,XANTHAN GUM,CARBOXYMETHYLCELLULOSE SODIUM,STARCH, CORN,SILICON DIOXIDE,SODIUM BENZOATE,METHYLPARABEN SODIUM", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does CITALOPRAM cause aggression?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CITALOPRAM"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 0, "text": "aggression is a serious side effect of CITALOPRAM. The premarketing development program for citalopram included citalopram exposures in patients and/or normal subjects from 3 different groups of studies: 429 normal subjects in clinical pharmacology/pharmacokinetic studies; 4,422 exposures from patients in controlled and uncontrolled clinical trials, corresponding to approximately 1,370 patient-exposure years. There were, in addition, over 19,000 exposures from mostly open-label, European postmarketing studies. The conditions and duration of treatment with citalopram varied greatly and included (in overlapping categories) open-label and double-blind studies, inpatient and outpatient studies, fixed-dose and dose-titration studies, and short-te", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant vomiting", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "vomiting is a mild side effect of CITALOPRAM. The premarketing development program for citalopram included citalopram exposures in patients and/or normal subjects from 3 different groups of studies: 429 normal subjects in clinical pharmacology/pharmacokinetic studies; 4422 exposures from patients in controlled and uncontrolled clinical trials, corresponding to approximately 1370 patient-exposure years. There were, in addition, over 19,000 exposures from mostly open-label, European postmarketing studies. The conditions and duration of treatment with citalopram varied greatly and included (in overlapping categories) open-label and double-blind studies, inpatient and outpatient studies, fixed-dose and dose-titration studies, and short-term", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does ATRACURIUM cause vomiting?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ATRACURIUM"], ["<symptom>", "vomiting"]], "act": "question"}]}
{"index": 0, "text": "vomiting is a mild side effect of ATRACURIUM. Observed in Controlled Clinical Studies: Atracurium was well tolerated and produced few adverse reactions during extensive clinical trials. Most adverse reactions were suggestive of histamine release. In studies including 875 patients, atracurium was discontinued in only one patient (who required treatment for bronchial secretions) and six other patients required treatment for adverse reactions attributable to atracurium (wheezing in one, hypotension in five). Of the five patients who required treatment for hypotension, three had a history of significant cardiovascular disease. The overall incidence rate for clinically important adverse reactions, therefore, was 7/875 or 0.8%. Table 1 includ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what do I do with CLONIDINE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CLONIDINE"]], "act": "question"}]}
{"index": 0, "text": "what version of CLONIDINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "Adults The dose of clonidine hydrochloride tablets must be adjusted according to the patient's individual blood pressure response. The following is a general guide to its administration.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Demeclocycline", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Demeclocycline"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in HYDROCORTISONE?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROCORTISONE"]], "act": "question"}]}
{"index": 1, "text": "what version of HYDROCORTISONE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "HYDROCORTISONE,SILICON DIOXIDE,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM LAURYL SULFATE,SODIUM STARCH GLYCOLATE TYPE A POTATO,HYDROCORTISONE,SILICON DIOXIDE,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM LAURYL SULFATE,SODIUM STARCH GLYCOLATE TYPE A POTATO,HYDROCORTISONE,SILICON DIOXIDE,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM LAURYL SULFATE,SODIUM STARCH GLYCOLATE TYPE A POTATO", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "HYDROCORTISONE,SILICON DIOXIDE,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM LAURYL SULFATE,SODIUM STARCH GLYCOLATE TYPE A POTATO,HYDROCORTISONE,SILICON DIOXIDE,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM LAURYL SULFATE,SODIUM STARCH GLYCOLATE TYPE A POTATO,HYDROCORTISONE,SILICON DIOXIDE,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM LAURYL SULFATE,SODIUM STARCH GLYCOLATE TYPE A POTATO", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Carisoprodol?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Carisoprodol"]], "act": "question"}]}
{"index": 1, "text": "Carisoprodol is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Carisoprodol tablets, USP should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [see Dosage and Administration (2)].", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Minocycline", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Minocycline"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Minocycline hydrochloride capsules, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae. Respiratory tract infections caused by Mycoplasma pneumoniae . Lymphogranuloma venereum caused by Chlamydia trachomatis . Psittacosis (Ornithosis) due to Chlamydia psittaci . Trachoma caused by Chlamydia trachomatis , although the infectious agent is not always eliminated, as judged by immunofluorescence. Inclusion conjunctivitis caused by Chlamydia trachomatis . Nongonococcal urethritis, endocervical, or rec", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Lidocaine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "question"}]}
{"index": 0, "text": "Lidocaine hydrochloride injection administered intravenously or intramuscularly, is specifically indicated in the acute management of ventricular arrhythmias such as those occurring in relation to acute myocardial infarction, or during cardiac manipulation, such as cardiac surgery.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Cetirizine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cetirizine"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Perennial Allergic Rhinitis: Cetirizine hydrochloride is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens such as dust mites, animal dander and molds in children 6 to 23 months of age. Symptoms treated effectively include sneezing, rhinorrhea, postnasal discharge, nasal pruritus, ocular pruritus, and tearing. Chronic Urticaria: Cetirizine hydrochloride is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in children 6 months to 5 years of age. It significantly reduces the occurrence, severity, and duration of hives and significantly reduces pruritus.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "what do I do with Taclonex?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Taclonex"]], "act": "question"}]}
{"index": 0, "text": "what version of Taclonex is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Apply an adequate layer of Taclonex  Ointment to the affected area(s) once daily for up to 4 weeks. Taclonex  Ointment should be rubbed in gently and completely. Patients should wash their hands after applying Taclonex  Ointment. Therapy should be discontinued when control is achieved. Patients 18 years and older should not use more than 100 g per week and patients 12 to 17 years should not use more than 60 g per week. Treatment of more than 30% body surface area is not recommended. Taclonex  Ointment should not be used with occlusive dressings unless directed by a physician. Avoid use on the face, groin, or axillae, or if skin atrophy is present at the treatment site. Taclonex  Ointment is ", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant AcetaZOLAMIDE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "AcetaZOLAMIDE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Glaucoma AcetaZOLAMIDE should be used as an adjunct to the usual therapy. The dosage employed in the treatment of chronic simple (open-angle) glaucoma ranges from 250 mg to 1 g of acetaZOLAMIDE per 24 hours, usually in divided doses for amounts over 250 mg. It has usually been found that a dosage in excess of 1 g per 24 hours does not produce an increased effect. In all cases, the dosage should be adjusted with careful individual attention both to symptomatology and ocular tension. Continuous supervision by a physician is advisable. In treatment of secondary glaucoma and in the preoperative treatment of some cases of acute congestive (closed-angle) glaucoma , the preferred dosage is 250 mg e", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the ingredients of Flecainide?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Flecainide"]], "act": "question"}]}
{"index": 0, "text": "what version of Flecainide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "FLECAINIDE ACETATE,CROSCARMELLOSE SODIUM,HYDROGENATED COTTONSEED OIL,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,STARCH, CORN,FLECAINIDE ACETATE,CROSCARMELLOSE SODIUM,HYDROGENATED COTTONSEED OIL,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,STARCH, CORN,FLECAINIDE ACETATE,CROSCARMELLOSE SODIUM,HYDROGENATED COTTONSEED OIL,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,STARCH, CORN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Cathflo", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cathflo"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Pantoprazole?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Pantoprazole"]], "act": "question"}]}
{"index": 1, "text": "what version of Pantoprazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "What is Sodium?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sodium"]], "act": "question"}]}
{"index": 0, "text": "Sodium Phosphates Injection, USP is indicated as a source of phosphate, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. The concomitant amount of sodium (4 mEq/mL) must be calculated into total electrolyte dose of such prepared solutions.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "do I need to keep Cyclobenzaprine in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cyclobenzaprine"]], "act": "question"}]}
{"index": 0, "text": "what version of Cyclobenzaprine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Cyclobenzaprine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "do I need to keep Umecta in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Umecta"]], "act": "question"}]}
{"index": 0, "text": "what version of Umecta is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Umecta", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant BENZTROPINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "BENZTROPINE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug BENZTROPINE", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for UNASYN?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "UNASYN"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 2, "text": "what version of UNASYN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for UNASYN is 3 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have anxiety with Ibuprofen?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ibuprofen"], ["<symptom>", "anxiety"]], "act": "question"}]}
{"index": 1, "text": "anxiety is a mild side effect of Ibuprofen. 6.1 Clinical Trials Experience The most frequently reported adverse events with Ibuprofen Lysine were as shown in Table 1. 6.2 Renal Function Compared to placebo, there was a small decrease in urinary output in the ibuprofen group on days 2-6 of life, with a compensatory increase in urine output on day 9. In other studies, adverse events classified as renal insufficiency including oliguria, elevated BUN, elevated creatinine, or renal failure were reported in ibuprofen treated infants. 6.3 Additional Adverse Events The adverse events reported in the multicenter study and of unknown association include tachycardia, cardiac failure, abdominal distension, gastroesophageal reflux, gastritis, ileu", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Tranexamic", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Tranexamic"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "anxiety is a common side effect of Tranexamic. Gastrointestinal disturbances (nausea, vomiting, diarrhea) may occur but disappear when the dosage is reduced. Allergic dermatitis, giddiness, and hypotension have been reported occasionally. Hypotension has been observed when intravenous injection is too rapid. To avoid this response, the solution should not be injected more rapidly than 1 mL per minute. Worldwide Postmarketing Reports: Thromboembolic events (e.g., deep vein thrombosis, pulmonary embolism, cerebral thrombosis, acute renal cortical necrosis, and central retinal artery and vein obstruction) have been rarely reported in patients receiving tranexamic acid for indications other than hemorrhage prevention in patients with hemophi", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much PROMETHAZINE should i take for a child?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PROMETHAZINE"], ["<age_group>", "child"]], "act": "question"}]}
{"index": 1, "text": "what version of PROMETHAZINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for PROMETHAZINE is 2 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Cytotec", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cytotec"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Losartan in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Losartan"]], "act": "question"}]}
{"index": 1, "text": "what version of Losartan is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Losartan", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Eletriptan?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Eletriptan"]], "act": "question"}]}
{"index": 1, "text": "what version of Eletriptan is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "ELETRIPTAN HYDROBROMIDE,SILICON DIOXIDE,CROSCARMELLOSE SODIUM,FD&C YELLOW NO. 6,HYPROMELLOSE 2910 (3 MPA.S),HYPROMELLOSE 2910 (6 MPA.S),LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,POLYDEXTROSE,POLYETHYLENE GLYCOL 8000,TITANIUM DIOXIDE,TRIACETIN,ELETRIPTAN HYDROBROMIDE,SILICON DIOXIDE,CROSCARMELLOSE SODIUM,FD&C YELLOW NO. 6,HYPROMELLOSE 2910 (3 MPA.S),HYPROMELLOSE 2910 (6 MPA.S),LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,POLYDEXTROSE,POLYETHYLENE GLYCOL 8000,TITANIUM DIOXIDE,TRIACETIN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is mood_swings a common side effect of Metronidazole?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metronidazole"], ["<symptom>", "mood_swings"]], "act": "question"}]}
{"index": 1, "text": "mood_swings is a common side effect of Metronidazole. The following reactions have been reported during treatment with metronidazole: Central Nervous System: The most serious adverse reactions reported in patients treated with metronidazole have been convulsive seizures, encephalopathy, aseptic meningitis, optic and peripheral neuropathy, the latter characterized mainly by numbness or paresthesia of an extremity. Since persistent peripheral neuropathy has been reported in some patients receiving prolonged administration of metronidazole, patients should be specifically warned about these reactions and should be told to stop the drug and report immediately to their physicians if any neurologic symptoms occur. In addition, patients have reported ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Amiodarone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Amiodarone"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "does Nimodipine contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nimodipine"]], "act": "question"}]}
{"index": 0, "text": "what version of Nimodipine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "NIMODIPINE,GLYCERIN,PEPPERMINT OIL,WATER,POLYETHYLENE GLYCOL 400,GELATIN, UNSPECIFIED,TITANIUM DIOXIDE,FERROSOFERRIC OXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Potassium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "POTASSIUM CHLORIDE,CELLULOSE, MICROCRYSTALLINE,CROSCARMELLOSE SODIUM,ETHYLCELLULOSE (45 MPA.S),TRIETHYL CITRATE,ALCOHOL,ISOPROPYL ALCOHOL,POTASSIUM CHLORIDE,CELLULOSE, MICROCRYSTALLINE,CROSCARMELLOSE SODIUM,ETHYLCELLULOSE (45 MPA.S),TRIETHYL CITRATE,ALCOHOL,ISOPROPYL ALCOHOL", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "is hallucinations a common side effect of femhrt?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "femhrt"], ["<symptom>", "hallucinations"]], "act": "question"}]}
{"index": 0, "text": "hallucinations is a serious side effect of femhrt. See BOXED WARNING , WARNINGS and PRECAUTIONS . Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The adverse reaction information from clinical trials does, however, provide a basis for identifying the adverse events that appear to be related to drug use and for approximating rates. Adverse events reported in controlled clinical studies of femhrt are shown in Table 6 below. Table 6. All Treatment-Emergent Adverse Events Reported at a Frequency of \u22655% of Patients with femhrt BODY SY", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have itchy_skin with PRAVASTATIN?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PRAVASTATIN"], ["<symptom>", "itchy_skin"]], "act": "question"}]}
{"index": 1, "text": "itchy_skin is a serious side effect of PRAVASTATIN. Pravastatin is generally well tolerated; adverse reactions have usually been mild and transient. In 4 month-long placebo-controlled trials, 1.7% of pravastatin-treated patients and 1.2% of placebo-treated patients were discontinued from treatment because of adverse experiences attributed to study drug therapy; this difference was not statistically significant. (See also PRECAUTIONS , Geriatric Use ).", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant desonide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "desonide"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "is nausea a common side effect of Ethambutol?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ethambutol"], ["<symptom>", "nausea"]], "act": "question"}]}
{"index": 0, "text": "nausea is a common side effect of Ethambutol. Ethambutol hydrochloride may produce decreases in visual acuity, including irreversible blindness, which appear to be due to optic neuritis. Optic neuropathy including optic neuritis or retrobulbar neuritis occurring in association with ethambutol therapy may be characterized by one or more of the following events: decreased visual acuity, scotoma, color blindness, and/or visual defect. These events have also been reported in the absence of a diagnosis of optic or retrobulbar neuritis. Patients should be advised to report promptly to their physician any change of visual acuity. The change in visual acuity may be unilateral or bilateral and hence each eye must be tested separately and both ey", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Rx in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Rx"]], "act": "question"}]}
{"index": 1, "text": "what version of Rx is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Rx", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Sertraline", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sertraline"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "storage instructions for drug Sertraline", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of 10%?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "10%"]], "act": "question"}]}
{"index": 1, "text": "what version of 10% is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "CALCIUM CHLORIDE,WATER,HYDROCHLORIC ACID,SODIUM HYDROXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant 3%", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "3%"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "HYDROCHLORIC ACID,SODIUM CHLORIDE,SODIUM HYDROXIDE,WATER,MEPIVACAINE HYDROCHLORIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Paricalcitol safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Paricalcitol"]], "act": "question"}]}
{"index": 1, "text": "Paricalcitol may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "low_blood_pressure", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "inform"}]}
{"index": 2, "text": "Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does ENALAPRIL contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ENALAPRIL"]], "act": "question"}]}
{"index": 0, "text": "what version of ENALAPRIL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "lactose monohydrate,starch, corn,zinc stearate,water,enalapril maleate,hydrochlorothiazide,enalapril maleate,hydrochlorothiazide,lactose monohydrate,starch, corn,zinc stearate,water", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant TIZANIDINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "TIZANIDINE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "tizanidine hydrochloride,anhydrous lactose,SILICON DIOXIDE,cellulose, microcrystalline,stearic acid", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use Doxycycline?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxycycline"]], "act": "question"}]}
{"index": 0, "text": "what version of Doxycycline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "THE USUAL DOSAGE AND FREQUENCY OF ADMINISTRATION OF DOXYCYCLINE DIFFERS FROM THAT OF THE OTHER TETRACYCLINES. EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE OF SIDE EFFECTS. Adults: The usual dose of oral doxycycline is 200 mg on the first day of treatment (administered 100 mg every 12 hours or 50 mg every 6 hours) followed by a maintenance dose of 100 mg/day. The maintenance dose may be administered as a single dose or as 50 mg every 12 hours. In the management of more severe infections (particularly chronic infections of the urinary tract), 100 mg every 12 hours is recommended. Pediatric Patients: For all pediatric patients weighing less than 45 kg with severe or lif", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Amlodipine safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amlodipine"]], "act": "question"}]}
{"index": 1, "text": "Amlodipine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "pregnant", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "inform"}]}
{"index": 2, "text": "The following serious adverse reactions are discussed in greater detail in other sections of the label: Rhabdomyolysis and myopathy [see Warnings and Precautions ( 5.1 ) ] Liver enzyme abnormalities [see Warnings and Precautions ( 5.2 ) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "how do I take Zileuton?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Zileuton"]], "act": "question"}]}
{"index": 0, "text": "what version of Zileuton is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "The recommended dosage of Zileuton Extended-Release Tablets for the treatment of patients with asthma is two 600 mg extended-release tablets twice daily, within one hour after morning and evening meals, for a total daily dose of 2400 mg. Tablets should not be chewed, cut or crushed. If a dose is missed, the patient should take the next dose at the scheduled time and not double the dose. Assess hepatic function enzymes prior to initiation of Zileuton Extended-Release Tablets and periodically during treatment [see Contraindications (4) , Warnings and Precautions (5) , and Use in Specific Populations (8.7) ].", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Clobetasol?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Clobetasol"]], "act": "question"}]}
{"index": 1, "text": "what version of Clobetasol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "CLOBETASOL PROPIONATE,PROPYLENE GLYCOL,SORBITAN SESQUIOLEATE,PETROLATUM", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant Metoclopramide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Metoclopramide"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "METOCLOPRAMIDE HYDROCHLORIDE,MICROCRYSTALLINE CELLULOSE,SILICON DIOXIDE,STARCH, CORN,STEARIC ACID", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Vitamin is the correct dose for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Vitamin"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 1, "text": "what version of Vitamin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Vitamin is 3 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Potassium?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "question"}]}
{"index": 1, "text": "what version of Potassium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Potassium Chloride in 5% Dextrose Injection, USP is for intravenous infusion. Potassium Chloride in 5% Dextrose Injection, USP should not be administered by intravenous push. Potassium Chloride in 5% Dextrose Injection, USP has an osmolarity of 293 mOsmol/L (calc). The choice of specific potassium chloride and dextrose dosage, volume, rate and duration of administration depends on the age, weight and clinical condition of the patient, concomitant therapy, and administration should be determined by a physician. For patients with electrolyte and glucose abnormalities and for pediatric patients, consult a physician experienced in intravenous fluid therapy. A gradual increase of flow rate should", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does BuPROPion cause vomiting?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BuPROPion"], ["<symptom>", "vomiting"]], "act": "question"}]}
{"index": 1, "text": "vomiting is a common side effect of BuPROPion. (See also WARNINGS and PRECAUTIONS.) The information included under the Incidence in Controlled Trials subsection of ADVERSE REACTIONS is based primarily on data from controlled clinical trials with bupropion hydrochloride extended-release tablets (SR). Information on additional adverse events associated with the sustained-release formulation of bupropion in smoking cessation trials, as well as the immediate-release formulation of bupropion, is included in a separate section (see Other Events Observed During the Clinical Development and Postmarketing Experience of Bupropion). Incidence in Controlled Trials With Bupropion: Adverse Events Associated With Discontinuation of Treatment Among Pati", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant insomnia", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "insomnia"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take Econazole  if I have infection?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Econazole"], ["<condition>", "infection"]], "act": "question"}]}
{"index": 0, "text": "During clinical trials, approximately 3% of patients treated with econazole nitrate 1% cream reported side effects thought possibly to be due to the drug, consisting mainly of burning, itching, stinging, and erythema. One case of pruritic rash has also been reported.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Triamcinolone?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Triamcinolone"]], "act": "question"}]}
{"index": 1, "text": "what version of Triamcinolone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Apply a thin film of the 0.1% Triamcinolone Acetonide Ointment, as appropriate, to the affected area two to three times daily.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use PROMETHAZINE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PROMETHAZINE"]], "act": "question"}]}
{"index": 0, "text": "what version of PROMETHAZINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Promethazine hydrochloride and phenylephrine hydrochloride syrup is contraindicated for children under 2 years of age ( see WARNINGS \u2013 Black Box Warning and Use In Pediatric Patients ). The recommended doses are given in the following table: Adults And Children 12 Years And Over 1 teaspoonful (5 mL) every 4 to 6 hours, not to exceed 6 teaspoonsful (30 mL) in 24 hours. Children 6 To Under 12 Years Of Age \u00bd to 1 teaspoonful (2.5 to 5 mL) every 4 to 6 hours, not to exceed 6 teaspoonsful (30 mL) in 24 hours. Children 2 To Under 6 Years Of Age \u00bc to \u00bd teaspoonful (1.25 to 2.5 mL) every 4 to 6 hours.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Flutamide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Flutamide"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "The recommended dosage is 2 capsules 3 times a day at 8 hour intervals for a total daily dose of 750 mg.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "do I need to keep Penicillin in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Penicillin"]], "act": "question"}]}
{"index": 0, "text": "what version of Penicillin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Penicillin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Methimazole contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methimazole"]], "act": "question"}]}
{"index": 1, "text": "what version of Methimazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "METHIMAZOLE,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,STARCH, CORN,TALC", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Flutamide?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Flutamide"]], "act": "question"}]}
{"index": 1, "text": "what version of Flutamide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "The recommended dosage is 2 capsules 3 times a day at 8 hour intervals for a total daily dose of 750 mg.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "What is Epinephrine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Epinephrine"]], "act": "question"}]}
{"index": 0, "text": "Epinephrine is used to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity reactions to drugs and other allergens, and to prolong the action of anesthetics. Its cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes, but it is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock. Epinephrine is used as a hemostatic agent. It is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angi", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "what is the dose for Epinephrine?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Epinephrine"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of Epinephrine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Epinephrine is 4 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant elderly", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant 30", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Epinephrine is 4 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 7, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use Clindamycin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Clindamycin"]], "act": "question"}]}
{"index": 0, "text": "what version of Clindamycin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Apply a thin film of clindamycin phosphate topical solution, clindamycin phosphate topical lotion, clindamycin phosphate topical gel, or use a clindamycin phosphate topical solution pledget for the application of clindamycin phosphate twice daily to affected area. More than one pledget may be used. Each pledget should be used only once and then be discarded. Lotion: Shake well immediately before using. Pledget: Remove pledget from foil just before use. Do not use if the seal is broken. Discard after single use. Keep all liquid dosage forms in containers tightly closed.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Dialyvite", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Dialyvite"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "do I need to keep Tranexamic in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tranexamic"]], "act": "question"}]}
{"index": 0, "text": "what version of Tranexamic is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Tranexamic", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant CYKLOKAPRON", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CYKLOKAPRON"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug CYKLOKAPRON", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Cevimeline?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cevimeline"]], "act": "question"}]}
{"index": 1, "text": "what version of Cevimeline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "The recommended dose of cevimeline hydrochloride is 30 mg taken three times a day. There is insufficient safety information to support doses greater than 30 mg tid. There is also insufficient evidence for additional efficacy of cevimeline hydrochloride at doses greater than 30 mg tid.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The recommended dose of cevimeline hydrochloride is 30 mg taken three times a day. There is insufficient safety information to support doses greater than 30 mg tid. There is also insufficient evidence for additional efficacy of cevimeline hydrochloride at doses greater than 30 mg tid.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I take Naproxen?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Naproxen"]], "act": "question"}]}
{"index": 0, "text": "what version of Naproxen is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Carefully consider the potential benefits and risks of Naproxen Suspension and other treatment options before deciding to use Naproxen Suspension. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS; Gastrointestinal Bleeding, Ulceration, and Perforation ) . After observing the response to initial therapy with Naproxen Suspension, the dose and frequency should be adjusted to suit an individual patient's needs. Different dose strengths and formulations (ie, tablets, suspension) of the drug are not necessarily bioequivalent. This difference should be taken into consideration when changing formulation. Although Naproxen Suspen", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use Azulfidine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Azulfidine"]], "act": "question"}]}
{"index": 0, "text": "what version of Azulfidine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "The dosage of AZULFIDINE EN-tabs Tablets should be adjusted to each individual's response and tolerance. Patients should be instructed to take AZULFIDINE EN-tabs in evenly divided doses, preferably after meals, and to swallow the tablets whole.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "The dosage of AZULFIDINE Tablets should be adjusted to each individual's response and tolerance.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Butorphanol is the correct dose for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Butorphanol"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 1, "text": "what version of Butorphanol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Butorphanol is 3 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is aggression a common side effect of Clindamycin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Clindamycin"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 0, "text": "aggression is a serious side effect of Clindamycin. In 18 clinical studies of various formulations of clindamycin phosphate using placebo vehicle and/or active comparator drugs as controls, patients experienced a number of treatment emergent adverse dermatologic events [see table below]. Number of Patients Reporting Events Treatment Emergent Adverse Event Solution n=553(%) Gel N=148(%) Suspension N=160(%) Burning 62(11) 15(10) 17(11) Itching 36(7) 15(10) 17(11) Burning/Stinging 60(11) not recorded (-) (-) Dryness 105(19) 34(23) 29(18) Erythema 86(16) 10(7) 22(14) Oiliness/Oily Skin 8(1) 26(18) 12 of 126 subjects (10) Peeling 61(11) (-) 11(7) Orally and parenterally administered clindamycin has been associated with severe colitis which may end", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant Armour", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Armour"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Should I take Fludeoxyglucose  for someone with tourettes?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fludeoxyglucose"], ["<condition>", "tourettes"]], "act": "question"}]}
{"index": 0, "text": "Hypersensitivity reactions with pruritus, edema and rash have been reported in the post-marketing setting. Have emergency resuscitation equipment and personnel immediately available.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant tourettes", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant To", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "To"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Is Vanatol safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Vanatol"]], "act": "question"}]}
{"index": 0, "text": "Vanatol may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 1, "text": "Frequently Observed: The most frequently reported adverse reactions are drowsiness, lightheadedness, dizziness, sedation, shortness of breath, nausea, vomiting, abdominal pain, and intoxicated feeling. Infrequently Observed: All adverse events tabulated below are classified as infrequent. Central Nervous System: headache, shaky feeling, tingling, agitation, fainting, fatigue, heavy eyelids, high energy, hot spells, numbness, sluggishness, seizure. Mental confusion, excitement or depression can also occur due to intolerance, particularly in elderly or debilitated patients, or due to overdosage of butalbital. Autonomic Nervous System: dry mouth, hyperhidrosis. Gastrointestinal: difficulty swal", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant liver_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Sulfasalazine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sulfasalazine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The most common adverse reactions associated with sulfasalazine in ulcerative colitis are anorexia, headache, nausea, vomiting, gastric distress, and apparently reversible oligospermia. These occur in about one-third of the patients. Less frequent adverse reactions are pruritus, urticaria, rash, fever, Heinz body anemia, hemolytic anemia and cyanosis, which may occur at a frequency of 1 in 30 patients or less. Experience suggests that with a daily dose of 4 g or more, or total serum sulfapyridine levels above 50 mcg/mL, the incidence of adverse reactions tends to increase. Similar adverse reactions are associated with sulfasalazine use in adult rheumatoid arthritis, although there was a grea", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "where should I keep Diethylpropion?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Diethylpropion"]], "act": "question"}]}
{"index": 0, "text": "what version of Diethylpropion is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Diethylpropion", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Dipyridamole", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Dipyridamole"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take PROMETHAZINE  for someone with low_blood_pressure?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PROMETHAZINE"], ["<condition>", "low_blood_pressure"]], "act": "question"}]}
{"index": 1, "text": "Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Wockhardt USA, LLC at 1-800-445-4290. For more information about Promethazine with Codeine Oral Solution, go to www.wockhardtusa.com or call Wockhardt USA, LLC at 1-800-346-6854.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Chlordiazepoxide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Chlordiazepoxide"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "is bleeding a common side effect of Fluocinonide?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluocinonide"], ["<symptom>", "bleeding"]], "act": "question"}]}
{"index": 0, "text": "bleeding is a dangerous side effect of Fluocinonide. The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Itching Irritation Dryness Folliculitis Hypertrichosis Acneiform Eruptions Hypopigmentation Perioral Dermatitis Allergic Contact Dermatitis Maceration of the Skin Secondary Infection Skin Atrophy Striae Miliaria", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant tiredness", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "tiredness"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Butalbital?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Butalbital"]], "act": "question"}]}
{"index": 0, "text": "Butalbital and acetaminophen tablets are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Allergenic", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Allergenic"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. Confirmation is determined by skin testing. Diagnostic use of allergenic extracts usually begins with direct skin testing. This product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "does Fluoridex cause stomach_ache?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluoridex"], ["<symptom>", "stomach_ache"]], "act": "question"}]}
{"index": 0, "text": "stomach_ache is a dangerous side effect of Fluoridex. Allergic reactions and other idiosyncrasies have rarely been reported.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Amiloride?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amiloride"]], "act": "question"}]}
{"index": 1, "text": "what version of Amiloride is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "AMILORIDE HYDROCHLORIDE ANHYDROUS,D&C YELLOW NO. 10,FD&C YELLOW NO. 6,CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SILICON DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant Amantadine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Amantadine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "AMANTADINE HYDROCHLORIDE,MICROCRYSTALLINE CELLULOSE,POVIDONE,SODIUM STARCH GLYCOLATE TYPE A CORN,MAGNESIUM STEARATE,FD&C YELLOW NO. 6,GELATIN,SODIUM LAURYL SULFATE,FD&C RED NO. 40,TITANIUM DIOXIDE,SHELLAC,PROPYLENE GLYCOL,POTASSIUM HYDROXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "where should I keep Diazepam?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Diazepam"]], "act": "question"}]}
{"index": 0, "text": "what version of Diazepam is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Diazepam", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use ZIAGEN?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ZIAGEN"]], "act": "question"}]}
{"index": 1, "text": "what version of ZIAGEN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "A Medication Guide and Warning Card that provide information about recognition of hypersensitivity reactions should be dispensed with each new prescription and refill. To facilitate reporting of hypersensitivity reactions and collection of information on each case, an Abacavir Hypersensitivity Registry has been established. Physicians should register patients by calling 1-800-270-0425. ZIAGEN may be taken with or without food.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Oxycodone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxycodone"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Important Dosage and Administration Instructions Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see Warnings ]. Initiate the dosing regimen for each patient individually, taking into account the patient's severity of pain, patient response, prior analgesic treatment experience, and risk factors for addiction, abuse, and misuse [see WARNINGS ]. Monitor patients closely for respiratory depression, especially within the first 24 to 72 hours of initiating therapy and following dosage increases with Oxycodone and Acetaminophen Tablets and adjust the dosage accordingly [see WARNINGS ]. Initial Dosage Initiating Treatment with Oxycodone", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "Should I take Sulfamethoxazole  if I am low_blood_pressure?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sulfamethoxazole"], ["<condition>", "low_blood_pressure"]], "act": "question"}]}
{"index": 0, "text": "The most common adverse effects are gastrointestinal disturbances (nausea, vomiting, anorexia) and allergic skin reactions (such as rash and urticaria). FATALITIES ASSOCIATED WITH THE ADMINISTRATION OF SULFONAMIDES, ALTHOUGH RARE, HAVE OCCURRED DUE TO SEVERE REACTIONS, INCLUDING STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, FULMINANT HEPATIC NECROSIS, AGRANULOCYTOSIS, APLASTIC ANEMIA AND OTHER BLOOD DYSCRASIAS (SEE WARNINGS SECTION). Hematologic: Agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia, neutropenia, hemolytic anemia, megaloblastic anemia, hypoprothrombinemia, methemoglobinemia, eosinophilia. Allergic Reactions: Stevens-Johnson syndrome, toxic epidermal necrolys", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant Potassium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "One of the most severe adverse effects is hyperkalemia (see CONTRAINDICATIONS , WARNINGS and OVERDOSAGE ). There have also been reports of upper and lower gastrointestinal conditions including obstruction, bleeding, ulceration, and perforation (see CONTRAINDICATIONS and WARNINGS ). The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. These symptoms are due to irritation of the gastrointestinal tract and are best managed by diluting the preparation further, taking the dose with meals or reducing the amount taken at one time.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is CALAN?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CALAN"]], "act": "question"}]}
{"index": 1, "text": "CALAN tablets are indicated for the treatment of the following:", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant BACTRIM\u2122", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "BACTRIM\u2122"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bactrim (sulfamethoxazole and trimethoprim) tablets and other antibacterial drugs, Bactrim (sulfamethoxazole and trimethoprim) tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Phentermine?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Phentermine"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 2, "text": "what version of Phentermine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Phentermine is 3 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for DILTIAZEM?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DILTIAZEM"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 2, "text": "what version of DILTIAZEM is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for DILTIAZEM is 3 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant Mefenamic", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Mefenamic"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "actually i meant adult", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "update"}]}
{"index": 6, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 7, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 7, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Benzonatate contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Benzonatate"]], "act": "question"}]}
{"index": 1, "text": "what version of Benzonatate is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Benzonatate,D&C YELLOW NO. 10,GELATIN, UNSPECIFIED,GLYCERIN,WATER,Benzonatate,D&C YELLOW NO. 10,GELATIN, UNSPECIFIED,GLYCERIN,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Cefuroxime?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cefuroxime"]], "act": "question"}]}
{"index": 0, "text": "Cefuroxime for Injection, USP is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: Lower Respiratory Tract Infections, including pneumonia, caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes , and Escherichia coli . Urinary Tract Infections caused by Escherichia coli and Klebsiella spp. Skin and Skin Structure Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes , E", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Tramadol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Tramadol"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Tramadol hydrochloride extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long term opioid treatment and for which alternative treatment options are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [ see WARNINGS ], reserve tramadol hydrochloride extended-release tablets or use in patients for whom alternative treatment options [e.g., non-opioid analgesics or immediate-release opioids], are ineffective, not tolerated, or would be otherwise inadequate to pro", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Venlafaxine?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Venlafaxine"]], "act": "question"}]}
{"index": 0, "text": "what version of Venlafaxine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "VENLAFAXINE HYDROCHLORIDE,MICROCRYSTALLINE CELLULOSE,LACTOSE MONOHYDRATE,STARCH, CORN,SODIUM STARCH GLYCOLATE TYPE A POTATO,FERRIC OXIDE RED,FERRIC OXIDE YELLOW,MAGNESIUM STEARATE,SILICON DIOXIDE,VENLAFAXINE HYDROCHLORIDE,MICROCRYSTALLINE CELLULOSE,LACTOSE MONOHYDRATE,STARCH, CORN,SODIUM STARCH GLYCOLATE TYPE A POTATO,FERRIC OXIDE RED,FERRIC OXIDE YELLOW,MAGNESIUM STEARATE,SILICON DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant lorazepam", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "lorazepam"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many NIPRIDE is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NIPRIDE"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 2, "text": "what version of NIPRIDE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for NIPRIDE is 3 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant 40", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how much ReadySharp should i take for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ReadySharp"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 0, "text": "what version of ReadySharp is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for ReadySharp is 3 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant adult", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for ReadySharp is 3 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use LINDANE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LINDANE"]], "act": "question"}]}
{"index": 0, "text": "what version of LINDANE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Most patients will require only 1 ounce of Lindane Shampoo. Based on the length and density of hair, some patients may require 2 ounces of Lindane Shampoo. Apply shampoo directly to dry hair without adding water. Work thoroughly into the hair and allow to remain in place for 4 minutes only. Special attention should be given to the fine hairs along the neck. After 4 minutes, add small quantities of water to hair until a good lather forms. Immediately rinse all lather away. Avoid unnecessary contact of lather with other body surfaces. Do not prescribe more than 2 ounces for larger adults. Do not retreat. (See boxed WARNINGS .) Patients should be provided specific information on use of product.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant IBU", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "IBU"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Carefully consider the potential benefits and risks of IBU tabletsand other treatment options before deciding to use IBU tablets. Usethe lowest effective dose for the shortest duration consistent withindividual patient treatment goals (see WARNINGS). After observing the response to initial therapy with IBU tablets, thedose and frequency should be adjusted to suit an individual patient\u2019sneeds.Do not exceed 3200 mg total daily dose. If gastrointestinal complaintsoccur, administer IBU tablets with meals or milk.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is vomiting a common side effect of TRAMADOL?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TRAMADOL"], ["<symptom>", "vomiting"]], "act": "question"}]}
{"index": 1, "text": "vomiting is a dangerous side effect of TRAMADOL. The following serious adverse reactions are described in greater detail, in other sections: Addiction, Abuse, and Misuse [see Warnings and Precautions (5.1)] Life-Threatening Respiratory Depression [see Warnings and Precautions (5.2)] Ultra-Rapid Metabolism of Tramadol and Other Risk Factors for Life-Threatening Respiratory Depression in Children [see Warnings and Precautions (5.3)] Neonatal Opioid Withdrawal Syndrome [see Warnings and Precautions (5.4)] Interactions with Benzodiazepines and Other CNS Depressants [see Warnings and Precautions (5.6)] Serotonin Syndrome [see Warnings and Precautions (5.7)] Seizures [see Warnings and Precautions (5.8)] Suicide [see Warnings and Precautions (5.9", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Clobetasol?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Clobetasol"]], "act": "question"}]}
{"index": 1, "text": "what version of Clobetasol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Apply a thin layer of clobetasol propionate cream or ointment to the affected skin areas twice daily and rub in gently and completely (see INDICATIONS AND USAGE ). Clobetasol propionate cream and ointment are super-high potency topical corticosteroids; therefore, treatment should be limited to 2 consecutive weeks and amounts greater than 50 g/week should not be used. As with other highly active corticosteroids, therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Clobetasol propionate cream and ointment should not be used with occlusive dressings.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take Desipramine  for someone with low_blood_pressure?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Desipramine"], ["<condition>", "low_blood_pressure"]], "act": "question"}]}
{"index": 0, "text": "Included in the following listing are a few adverse reactions that have not been reported with this specific drug. However, the pharmacologic similarities among the tricyclic antidepressant drugs require that each of the reactions be considered when desipramine hydrochloride is given.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in DIPYRIDAMOLE?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DIPYRIDAMOLE"]], "act": "question"}]}
{"index": 1, "text": "what version of DIPYRIDAMOLE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "DIPYRIDAMOLE,ACACIA,CARNAUBA WAX,STARCH, CORN,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,D&C YELLOW NO. 10,D&C RED NO. 30,ALUMINUM OXIDE,SODIUM BENZOATE,METHYLPARABEN,PROPYLPARABEN,POLYETHYLENE GLYCOLS,POVIDONE,SUCROSE,TALC,TITANIUM DIOXIDE,WHITE WAX", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Folic", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Folic"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "LACTOSE MONOHYDRATE,CELLULOSE, MICROCRYSTALLINE,SODIUM STARCH GLYCOLATE TYPE A POTATO,STEARIC ACID,FOLIC ACID", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take UroAv-B?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "UroAv-B"]], "act": "question"}]}
{"index": 1, "text": "what version of UroAv-B is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "Adults: One tablet orally 4 times per day followed by liberal fluid intake. Pediatric: Dosage must be individualized by physician for older children. Not recommended for use in children six years of age or younger.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Potassium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Potassium Chloride in 5% Dextrose Injection, USP is for intravenous infusion. Potassium Chloride in 5% Dextrose Injection, USP should not be administered by intravenous push. Potassium Chloride in 5% Dextrose Injection, USP has an osmolarity of 293 mOsmol/L (calc). The choice of specific potassium chloride and dextrose dosage, volume, rate and duration of administration depends on the age, weight and clinical condition of the patient, concomitant therapy, and administration should be determined by a physician. For patients with electrolyte and glucose abnormalities and for pediatric patients, consult a physician experienced in intravenous fluid therapy. A gradual increase of flow rate should", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "do I need to keep Chlorthalidone in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Chlorthalidone"]], "act": "question"}]}
{"index": 0, "text": "what version of Chlorthalidone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Chlorthalidone", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Haloperidol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Haloperidol"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with cytarabine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "cytarabine"]], "act": "question"}]}
{"index": 1, "text": "what version of cytarabine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "Cytarabine Injection is not active orally. The schedule and method of administration varies with the program of therapy to be used. Cytarabine Injection may be given by intravenous infusion or injection, subcutaneously, or intrathecally (preservative free preparation only). Thrombophlebitis has occurred at the site of drug injection or infusion in some patients, and rarely patients have noted pain and inflammation at subcutaneous injection sites. In most instances, however, the drug has been well tolerated. Patients can tolerate higher total doses when they receive the drug by rapid intravenous injection as compared with slow infusion. This phenomenon is related to the drug\u2019s rapid inactivat", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant DELESTROGEN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "DELESTROGEN"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Decitabine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Decitabine"]], "act": "question"}]}
{"index": 1, "text": "what version of Decitabine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "There are two regimens for decitabine for injection administration. With either regimen it is recommended that patients be treated for a minimum of 4 cycles; however, a complete or partial response may take longer than 4 cycles. Complete blood counts and platelet counts should be performed as needed to monitor response and toxicity, but at a minimum, prior to each cycle. Liver chemistries and serum creatinine should be obtained prior to initiation of treatment.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Fondaparinux?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fondaparinux"]], "act": "question"}]}
{"index": 1, "text": "Fondaparinux may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 2, "text": "The following serious adverse reactions are described elsewhere in the labeling:  Spinal or epidural hematomas [See Warnings and Precautions ( 5.1 ) ]  Hemorrhage [See Warnings and Precautions ( 5.2 )]  Renal impairment and bleeding risk [See Warnings and Precautions ( 5.3 ) ]  Body weight <50 Kg and bleeding risk [See Warnings and Precautions ( 5.4 ) ]  Thrombocytopenia [See Warnings and Precautions ( 5.5 ) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant 0.25%", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "0.25%"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of clarithromycin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "clarithromycin"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of clarithromycin: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "hallucinations", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "hallucinations"]], "act": "inform"}]}
{"index": 2, "text": "hallucinations is a mild side effect of clarithromycin. The most frequent and common adverse reactions related to clarithromycin therapy for both adult and pediatric populations are abdominal pain, diarrhea, nausea, vomiting and dysgeusia. These adverse reactions are consistent with the known safety profile of macrolide antibiotics. There was no significant difference in the incidence of these gastrointestinal adverse reactions during clinical trials between the patient population with or without preexisting mycobacterial infections. Adverse Reactions Observed During Clinical Trials of Clarithromycin The following adverse reactions were observed in clinical trials with clarithromycin at a rate greater than or equal to 1%: Gastrointestinal Disorde", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "actually i meant vomiting", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant ALBUTEROL", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ALBUTEROL"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Should I take LISINOPRIL?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LISINOPRIL"]], "act": "question"}]}
{"index": 0, "text": "LISINOPRIL may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "anxiety", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "inform"}]}
{"index": 1, "text": "Lisinopril and Hydrochlorothiazide Tablets has been evaluated for safety in 930 patients, including 100 patients treated for 50 weeks or more. In clinical trials with Lisinopril and Hydrochlorothiazide Tablets no adverse experiences peculiar to this combination drug have been observed. Adverse experiences that have occurred have been limited to those that have been previously reported with lisinopril or hydrochlorothiazide. The most frequent clinical adverse experiences in controlled trials (including open label extensions) with any combination of lisinopril and hydrochlorothiazide were: dizziness (7.5 percent), headache (5.2 percent), cough (3.9 percent), fatigue (3.7 percent) and orthostat", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant HYDROQUINONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROQUINONE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "The following adverse reactions have been reported: dryness and fissuring of paranasal and infraorbital areas, erythema, and stinging. Occasional hypersensitivity (localized contact dermatitis) may develop. If this occurs, the medication should be discontinued and the physician notified immediately.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "what is the dose for ALLOPURINOL?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ALLOPURINOL"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 1, "text": "what version of ALLOPURINOL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "90", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for ALLOPURINOL is 1 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant Metopirone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Metopirone"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "where should I keep DIHYDROERGOTAMINE?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DIHYDROERGOTAMINE"]], "act": "question"}]}
{"index": 0, "text": "what version of DIHYDROERGOTAMINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug DIHYDROERGOTAMINE", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Bensal", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Bensal"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Bensal", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Metoprolol for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metoprolol"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of Metoprolol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Metoprolol is 4 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Adapalene?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Adapalene"]], "act": "question"}]}
{"index": 1, "text": "Adapalene may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "glaucoma", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "inform"}]}
{"index": 2, "text": "Some adverse effects such as erythema, scaling, dryness, pruritus, and burning will occur in 10-40% of patients. Pruritus or burning immediately after application also occurs in approximately 20% of patients. The following additional adverse experiences were reported in approximately 1% or less of patients: skin irritation, burning/stinging, erythema, sunburn, and acne flares. These are most commonly seen during the first month of therapy and decrease in frequency and severity thereafter. All adverse effects with use of adapalene gel during clinical trials were reversible upon discontinuation of therapy.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Phentolamine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Phentolamine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Ipratropium?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ipratropium"]], "act": "question"}]}
{"index": 1, "text": "what version of Ipratropium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "The recommended dose of ipratropium bromide and albuterol sulfate inhalation solution is one 3 mL vial administered 4 times per day via nebulization with up to 2 additional 3 mL doses allowed per day, if needed. Safety and efficacy of additional doses or increased frequency of administration of ipratropium bromide and albuterol sulfate inhalation solution beyond these guidelines has not been studied and the safety and efficacy of extra doses of albuterol sulfate or ipratropium bromide in addition to the recommended doses of ipratropium bromide and albuterol sulfate inhalation solution have not been studied. The use of ipratropium bromide and albuterol sulfate inhalation solution can be conti", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much HYDROCORTISONE should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROCORTISONE"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of HYDROCORTISONE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for HYDROCORTISONE is 4 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for HYDROCORTISONE is 4 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take Aminophylline  if I am glaucoma?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Aminophylline"], ["<condition>", "glaucoma"]], "act": "question"}]}
{"index": 0, "text": "Adverse reactions associated with theophylline are generally mild when peak serum theophylline concentrations are <20 mcg/mL and mainly consist of transient caffeine-like adverse effects such as nausea, vomiting, headache, and insomnia. When peak serum theophylline concentrations exceed 20 mcg/mL, however, theophylline produces a wide range of adverse reactions including persistent vomiting, cardiac arrhythmias, and intractable seizures which can be lethal (see OVERDOSAGE ). Other adverse reactions that have been reported at serum theophylline concentrations <20 mcg/mL include diarrhea, irritability, restlessness, fine skeletal muscle tremors, and transient diuresis. In patients with hypoxia", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant low_blood_pressure", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant Rocuronium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Rocuronium"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Lisinopril?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lisinopril"]], "act": "question"}]}
{"index": 1, "text": "what version of Lisinopril is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Lisinopril", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant Ofloxacin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ofloxacin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "What is Thiamine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Thiamine"]], "act": "question"}]}
{"index": 0, "text": "Thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety. Thiamine hydrochloride injection should be used where rapid restoration of thiamine is necessary, as in Wernicke's encephalopathy, infantile beriberi with acute collapse, cardiovascular disease due to thiamine deficiency, or neuritis of pregnancy if vomiting is severe. It is also indicated when giving IV dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure. Thiamine hydrochloride injection is also indicated in patients w", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Flecainide?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Flecainide"]], "act": "question"}]}
{"index": 0, "text": "In patients without structural heart disease, flecainide acetate tablets, USP are indicated for the prevention of \u2014 paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms \u2014 paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms Flecainide acetate tablets, USP are also indicated for the prevention of \u2014 documented ventricular arrhythmias, such as sustained ventricular tachycardia ( sustained VT), that in the judgment of the physician are life-threatening. Use of flecainide acetate ta", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant FELODIPINEEXTENDED-RELEASE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "FELODIPINEEXTENDED-RELEASE"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Felodipine extended-release tablets are indicated for the treatment of hypertension. Felodipine extended-release tablets may be used alone or concomitantly with other antihypertensive agents.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "does Antabuse contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Antabuse"]], "act": "question"}]}
{"index": 0, "text": "what version of Antabuse is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "DISULFIRAM,SILICON DIOXIDE,ANHYDROUS LACTOSE,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,SODIUM STARCH GLYCOLATE TYPE A POTATO,STEARIC ACID,DISULFIRAM,SILICON DIOXIDE,ANHYDROUS LACTOSE,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,SODIUM STARCH GLYCOLATE TYPE A POTATO,STEARIC ACID", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant bisoprolol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "bisoprolol"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Dextroamphetamine cause aggression?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dextroamphetamine"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 0, "text": "aggression is a mild side effect of Dextroamphetamine. Cardiovascular \u2013 Palpitations, tachycardia, elevation of blood pressure, sudden death, myocardial infarction. There have been isolated reports of cardiomyopathy associated with chronic amphetamine use. Central Nervous System \u2013 Psychotic episodes at recommended doses, overstimulation, restlessness, irritability, euphoria, dyskinesia, dysphoria, depression, tremor, tics, aggression, anger, logorrhea, dermatillomania. Eye Disorders \u2013 Vision blurred, mydriasis. Gastrointestinal \u2013 Dryness of the mouth, unpleasant taste, diarrhea, constipation, other gastrointestinal disturbances. Anorexia and weight loss may occur as undesirable effects. Allergic \u2013 Urticaria, rash, hypersensitivity reactions incl", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for LEVOTHYROXINE for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LEVOTHYROXINE"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 1, "text": "what version of LEVOTHYROXINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for LEVOTHYROXINE is 3 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant 90", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for LEVOTHYROXINE is 3 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "how much Celecoxib should i take for a child?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Celecoxib"], ["<age_group>", "child"]], "act": "question"}]}
{"index": 0, "text": "what version of Celecoxib is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Celecoxib is 2 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant baby", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The dosage for Celecoxib is 1 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "where should I keep Avalide?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Avalide"]], "act": "question"}]}
{"index": 0, "text": "what version of Avalide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Avalide", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Methylphenidate", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Methylphenidate"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "storage instructions for drug Methylphenidate", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Oxaprozin in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxaprozin"]], "act": "question"}]}
{"index": 1, "text": "what version of Oxaprozin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Oxaprozin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant CHLOROTHIAZIDE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CHLOROTHIAZIDE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the ingredients of Ciclopirox?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ciclopirox"]], "act": "question"}]}
{"index": 0, "text": "what version of Ciclopirox is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "CICLOPIROX,ETHYL ACETATE,ISOPROPYL ALCOHOL,MALEIC ACID", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant SYMJEPI", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "SYMJEPI"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take HALOBETASOL?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HALOBETASOL"]], "act": "question"}]}
{"index": 1, "text": "HALOBETASOL may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "tourettes", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "inform"}]}
{"index": 2, "text": "In controlled clinical trials, the most frequent adverse events reported for Halobetasol Propionate Cream included stinging, burning or itching in 4.4% of the patients. Less frequently reported adverse reactions were: dry skin, erythema, skin atrophy, leukoderma, vesicles and rash. The following additional local adverse reactions are reported infrequently with topical corticosteroids, and they may occur more frequently with high potency corticosteroids, such as Halobetasol Propionate Cream. These reactions are listed in an approximate decreasing order of occurrence: folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondar", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant Lorazepam", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lorazepam"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant low_blood_pressure", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Most adverse reactions to benzodiazepines, including CNS effects and respiratory depression, are dose dependent, with more severe effects occurring with high doses. In a sample of about 3500 patients treated for anxiety, the most frequent adverse reaction to lorazepam was sedation (15.9%), followed by dizziness (6.9%), weakness (4.2%), and unsteadiness (3.4%). The incidence of sedation and unsteadiness increased with age. Other adverse reactions to benzodiazepines, including lorazepam are fatigue, drowsiness, amnesia, memory impairment, confusion, disorientation, depression, unmasking of depression, disinhibition, euphoria, suicidal ideation/attempt, ataxia, asthenia, extrapyramidal symptoms", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Carbidopa?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Carbidopa"]], "act": "question"}]}
{"index": 1, "text": "Carbidopa Tablets are indicated for use with carbidopa-levodopa or with levodopa in the treatment of the symptoms of idiopathic Parkinson\u2019s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication. Carbidopa is for use with carbidopa-levodopa in patients for whom the dosage of carbidopa-levodopa provides less than adequate daily dosage (usually 70 mg daily) of carbidopa. Carbidopa is for use with levodopa in the occasional patient whose dosage requirement of carbidopa and levodopa necessitates separate titration of each entity. Carbidopa is used with car", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Cerezyme", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cerezyme"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Cerezyme (imiglucerase for injection) is indicated for long-term enzyme replacement therapy for pediatric and adult patients with a confirmed diagnosis of Type 1 Gaucher disease that results in one or more of the following conditions: a. anemia b. thrombocytopenia c. bone disease d. hepatomegaly or splenomegaly", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "Is PROPOXYPHENE safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PROPOXYPHENE"]], "act": "question"}]}
{"index": 0, "text": "PROPOXYPHENE may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "low_blood_pressure", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "inform"}]}
{"index": 1, "text": "During clinical trials, the most frequently reported adverse reactions were dizziness, sedation, nausea, and vomiting. Other adverse reactions include constipation, abdominal pain, skin rashes, lightheadedness, headache, weakness, euphoria, dysphoria, hallucinations, and minor visual disturbances. The most frequently reported postmarketing adverse events have included completed suicide, accidental and intentional overdose, drug dependence, cardiac arrest, coma, drug ineffective, drug toxicity, nausea, respiratory arrest, cardio-respiratory arrest, death, vomiting, dizziness, convulsion, confusional state, and diarrhea. Additional adverse experiences reported through postmarketing surveillanc", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant metronidazole", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "metronidazole"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what are the ingredients of Methylergonovine?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methylergonovine"]], "act": "question"}]}
{"index": 0, "text": "what version of Methylergonovine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Methylergonovine Maleate,Maleic Acid,Sodium Chloride,Water", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Premarin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Premarin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how do I use Cevimeline?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cevimeline"]], "act": "question"}]}
{"index": 0, "text": "what version of Cevimeline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "The recommended dose of cevimeline hydrochloride is 30 mg taken three times a day. There is insufficient safety information to support doses greater than 30 mg tid. There is also insufficient evidence for additional efficacy of cevimeline hydrochloride at doses greater than 30 mg tid.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is HYDROCHLOROTHIAZIDE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROCHLOROTHIAZIDE"]], "act": "question"}]}
{"index": 0, "text": "Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I take Nafcillin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nafcillin"]], "act": "question"}]}
{"index": 0, "text": "what version of Nafcillin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Nafcillin for Injection is available for intramuscular and intravenous use. The usual I.V. dosage for adults is 500 mg every 4 hours. For severe infections, 1 gram every 4 hours is recommended. Administer slowly over at least 30 to 60 minutes to minimize the risk of vein irritation and extravasation. RECOMMENDED DOSAGE FOR NAFCILLIN FOR INJECTION, USP Drug Adults Infants and Children <40 kg (88 lbs) Other Recommendations Nafcillin 500 mg IM every 4 to 6 hours. IV every 4 hours 25 mg/kg IM twice daily Neonates 10 mg/kg IM twice daily Nafcillin 1 gram IM or IV every 4 hours (severe infections) Bacteriologic studies to determine the causative organisms and their susceptibility to nafcillin shou", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Prazosin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Prazosin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take 306?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "306"]], "act": "question"}]}
{"index": 1, "text": "what version of 306 is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "Carefully consider the potential benefits and risks of ibuprofen tablets and other treatment options before deciding to use ibuprofen tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). After observing the response to initial therapy with ibuprofen tablets, the dose and frequency should be adjusted to suit an individual patient\u2019s needs. Do not exceed 3200 mg total daily dose. If gastrointestinal complaints occur, administer ibuprofen tablets with meals or milk. Rheumatoid arthritis and osteoarthritis, including flare-ups of chronic disease Suggested Dosage: 1200 mg-3200 mg daily (300 mg qid; 400 mg, 600 mg or 80", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Doxycycline", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxycycline"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "THE USUAL DOSAGE AND FREQUENCY OF ADMINISTRATION OF DOXYCYCLINE DIFFERS FROM THAT OF THE OTHER TETRACYCLINES. EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE OF SIDE EFFECTS. Adults: The usual dose of oral doxycycline is 200 mg on the first day of treatment (administered 100 mg every 12 hours or 50 mg every 6 hours) followed by a maintenance dose of 100 mg/day. The maintenance dose may be administered as a single dose or as 50 mg every 12 hours. In the management of more severe infections (particularly chronic infections of the urinary tract), 100 mg every 12 hours is recommended. Pediatric Patients: For all pediatric patients weighing less than 45 kg with severe or lif", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Doxazosin in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxazosin"]], "act": "question"}]}
{"index": 1, "text": "what version of Doxazosin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Doxazosin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "What is Tramadol?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tramadol"]], "act": "question"}]}
{"index": 0, "text": "Tramadol hydrochloride extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long term opioid treatment and for which alternative treatment options are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [ see WARNINGS ], reserve tramadol hydrochloride extended-release tablets or use in patients for whom alternative treatment options [e.g., non-opioid analgesics or immediate-release opioids], are ineffective, not tolerated, or would be otherwise inadequate to pro", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Revesta", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Revesta"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Revesta is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels, Vitamin D deficiency or are in need of Vitamin D supplementation and other nutritional supplementation.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "do I need to keep Indomethacin in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Indomethacin"]], "act": "question"}]}
{"index": 0, "text": "what version of Indomethacin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Indomethacin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is To?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "To"]], "act": "question"}]}
{"index": 1, "text": "Clindamycin Injection, USP is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin Injection, USP is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of antibiotic-associated pseudomembranous colitis, as described in the BOXED WARNING , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). Bac", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Tretinoin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Tretinoin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Tretinoin is indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Pazeo?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Pazeo"]], "act": "question"}]}
{"index": 1, "text": "PAZEO is indicated for the treatment of ocular itching associated with allergic conjunctivitis.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Modafinil", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Modafinil"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Modafinil tablets, USP are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). Limitations of Use In OSA, modafinil tablets, USP are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction. If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating and during treatment with modafinil tablets, USP for excessive sleepiness.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "where should I keep Bactrim?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Bactrim"]], "act": "question"}]}
{"index": 0, "text": "what version of Bactrim is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Bactrim", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant NIACOR", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "NIACOR"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Sulfacetamide?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sulfacetamide"]], "act": "question"}]}
{"index": 1, "text": "Sulfacetamide Sodium and Prednisolone Sodium Phosphate Ophthalmic Solution is indicated for corticosteroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. Ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns or penetr", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is AMITRIPTYLINE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "AMITRIPTYLINE"]], "act": "question"}]}
{"index": 1, "text": "For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than are other depressive states.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of FLUDROCORTISONE?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "FLUDROCORTISONE"]], "act": "question"}]}
{"index": 1, "text": "what version of FLUDROCORTISONE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "ANHYDROUS LACTOSE,STARCH, CORN,CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE,D&C YELLOW NO. 10,ALUMINUM OXIDE,MAGNESIUM STEARATE,SODIUM STARCH GLYCOLATE TYPE A POTATO,TALC,FLUDROCORTISONE ACETATE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Prazosin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Prazosin"]], "act": "question"}]}
{"index": 1, "text": "what version of Prazosin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "The dose of prazosin hydrochloride capsules should be adjusted according to the patient's individual blood pressure response. The following is a guide to its administration:", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is NALTREXONE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NALTREXONE"]], "act": "question"}]}
{"index": 1, "text": "Naltrexone hydrochloride tablets are indicated: In the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids. Naltrexone hydrochloride tablets have not been shown to provide any therapeutic benefit except as part of an appropriate plan of management for the addictions.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant NORTRIPTYLINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "NORTRIPTYLINE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Nortriptyline hydrochloride capsules are indicated for the relief of symptoms of depression. Endogenous depressions are more likely to be alleviated than are other depressive states.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is DROPERIDOL?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DROPERIDOL"]], "act": "question"}]}
{"index": 1, "text": "Droperidol injection is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "how do I use Loxapine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Loxapine"]], "act": "question"}]}
{"index": 0, "text": "what version of Loxapine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "Loxapine Capsules, USP are administered, usually in divided doses, two to four times a day. Daily dosage (in terms of base equivalents) should be adjusted to the individual patient's needs as assessed by the severity of symptoms and previous history of response to antipsychotic drugs.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Moexipril?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Moexipril"]], "act": "question"}]}
{"index": 1, "text": "what version of Moexipril is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "MOEXIPRIL HYDROCHLORIDE,HYDROCHLOROTHIAZIDE,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,POVIDONE K29/32,SODIUM BICARBONATE,POLYETHYLENE GLYCOL 3350,POLYVINYL ALCOHOL,TALC,TITANIUM DIOXIDE,FD&C YELLOW NO. 5,FD&C YELLOW NO. 6,MOEXIPRIL HYDROCHLORIDE,HYDROCHLOROTHIAZIDE,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,POVIDONE K29/32,SODIUM BICARBONATE,POLYETHYLENE GLYCOLS,POLYVINYL ALCOHOL,TALC,TITANIUM DIOXIDE,MOEXIPRIL HYDROCHLORIDE,HYDROCHLOROTHIAZIDE,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,POVIDONE K29/32,SODIUM BICARBONATE,POLYETHYLENE GLYCOL 3350,POLYVINYL ALCOHOL,TALC,TITANIUM DIOXIDE,FD&C RED NO. 40,FD&C YELLOW NO. 5,FD&C YELLOW NO. 6", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant Magnesium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Magnesium"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Hydrocortisone?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrocortisone"]], "act": "question"}]}
{"index": 1, "text": "what version of Hydrocortisone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Apply to affected area 3 to 4 times daily in accordance with physician\u2019s directions.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Losartan", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Losartan"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I take Nitroglycerin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nitroglycerin"]], "act": "question"}]}
{"index": 0, "text": "what version of Nitroglycerin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "One tablet should be dissolved under the tongue or in the buccal pouch at the first sign of an acute anginal attack. The dose may be repeated approximately every 5 minutes until relief is obtained. If the pain persists after a total of 3 tablets in a 15-minute period, or if the pain is different than is typically experienced, prompt medical attention is recommended. Nitroglycerin may be used prophylactically 5 to 10 minutes prior to engaging in activities that might precipitate an acute attack. During administration the patient should rest, preferably in the sitting position. No dosage adjustment is required in patients with renal failure.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant CITALOPRAM", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CITALOPRAM"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Probenecid  if I am liver_problems?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Probenecid"], ["<condition>", "liver_problems"]], "act": "question"}]}
{"index": 1, "text": "The following adverse reactions have been observed and within each category are listed in order of decreasing severity.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "what is in Ammonium?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ammonium"]], "act": "question"}]}
{"index": 0, "text": "what version of Ammonium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "AMMONIUM LACTATE,CETYL ALCOHOL,GLYCERIN,GLYCERYL MONOSTEARATE,LAURETH-4,LIGHT MINERAL OIL,MAGNESIUM ALUMINUM SILICATE,METHYLCELLULOSE (400 MPA.S),METHYLPARABEN,PEG-100 STEARATE,POLYOXYL 40 STEARATE,PROPYLENE GLYCOL,PROPYLPARABEN,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant HYOSYNE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HYOSYNE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "HYOSCYAMINE SULFATE,ALCOHOL,ANHYDROUS CITRIC ACID,FD&C RED NO. 40,FD&C YELLOW NO. 6,GLYCERIN,SODIUM BENZOATE,SODIUM CITRATE,SORBITOL,SUCROSE,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Hyophen?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hyophen"]], "act": "question"}]}
{"index": 0, "text": "Hyophen \u2122 tablets are indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Oxycodone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxycodone"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "OXYCODONE HCl EXTENDED-RELEASE TABLETS are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate in:  Adults; and  Opioid-tolerant pediatric patients 11 years of age and older who are already receiving and tolerate a minimum daily opioid dose of at least 20 mg oxycodone orally or its equivalent. Limitations of Use  Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see Warnings and Precautions (5.1)], reserve OXYCODONE HCl EXTENDED-RELE", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Amifostine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amifostine"]], "act": "question"}]}
{"index": 1, "text": "what version of Amifostine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "For Reduction of Cumulative Renal Toxicity with Chemotherapy: The recommended starting dose of Amifostine for injection is 910 mg/m 2 administered once daily as a 15-minute i.v. infusion, starting 30 minutes prior to chemotherapy. The 15-minute infusion is better tolerated than more extended infusions. Further reductions in infusion times for chemotherapy regimens have not been systematically investigated. Patients should be adequately hydrated prior to Amifostine for injection infusion and kept in a supine position during the infusion. Blood pressure should be monitored every 5 minutes during the infusion, and thereafter as clinically indicated. The infusion of Amifostine for injection shou", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant SYMJEPI", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "SYMJEPI"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "This product delivers 0.3 mg epinephrine injection (0.3 mL) and is intended for patients who weigh 30 kg or more (approximately 66 pounds or more). Inject SYMJEPI intramuscularly or subcutaneously into the anterolateral aspect of the thigh with the needle facing downwards. It can be injected through clothing if necessary. Instruct caregivers of young children who are prescribed SYMJEPI and who may be uncooperative and kick or move during an injection to hold the leg firmly in place and limit movement prior to and during an injection [ see Warnings and Precautions ( 5.2 ) ]. Each SYMJEPI contains a single dose of epinephrine for single-use injection. Since the doses of Epinephrine delivered f", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of GEMFIBROZIL?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "GEMFIBROZIL"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of GEMFIBROZIL: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "aggression", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "aggression"]], "act": "inform"}]}
{"index": 2, "text": "aggression is a serious side effect of GEMFIBROZIL. In the double-blind controlled phase of the primary prevention component of the Helsinki Heart Study, 2046 patients received gemfibrozil tablets for up to five years. In that study, the following adverse reactions were statistically more frequent in subjects in the gemfibrozil tablets group: Gemfibrozil Tablet (N = 2046) Placebo (N = 2035) Frequency in percent of subjects Gastrointestinal reactions 34.2 23.8 Dyspepsia 19.6 11.9 Abdominal pain 9.8 5.6 Acute appendicitis (histologically confirmed in most cases where data were available) 1.2 0.6 Atrial fibrillation 0.7 0.1 Adverse events reported by more than 1% subjects, but without a significant difference between groups: Diarrhea 7.2 6.5 Fat", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "actually i meant stomach_ache", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "stomach_ache"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "stomach_ache is a common side effect of GEMFIBROZIL. In the double-blind controlled phase of the primary prevention component of the Helsinki Heart Study, 2046 patients received gemfibrozil tablets for up to five years. In that study, the following adverse reactions were statistically more frequent in subjects in the gemfibrozil tablets group: Gemfibrozil Tablet (N = 2046) Placebo (N = 2035) Frequency in percent of subjects Gastrointestinal reactions 34.2 23.8 Dyspepsia 19.6 11.9 Abdominal pain 9.8 5.6 Acute appendicitis (histologically confirmed in most cases where data were available) 1.2 0.6 Atrial fibrillation 0.7 0.1 Adverse events reported by more than 1% subjects, but without a significant difference between groups: Diarrhea 7.2 6.5 Fat", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is anxiety a common side effect of CYCLOBENZAPRINE?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CYCLOBENZAPRINE"], ["<symptom>", "anxiety"]], "act": "question"}]}
{"index": 1, "text": "anxiety is a dangerous side effect of CYCLOBENZAPRINE. Incidence of most common adverse reactions in the 2 double-blind \u2021 , placebo-controlled 5 mg studies (incidence of > 3% on cyclobenzaprine hydrochloride tablets 5 mg): Cyclobenzaprine Hydrochloride Tablets 5 mg N=464 Cyclobenzaprine Hydrochloride Tablets 10 mg N=249 Placebo N=469 Drowsiness 29% 38% 10% Dry Mouth 21% 32% 7% Fatigue 6% 6% 3% Headache 5% 5% 8% Adverse reactions which were reported in 1% to 3% of the patients were: abdominal pain, acid regurgitation, constipation, diarrhea, dizziness, nausea, irritability, mental acuity decreased, nervousness, upper respiratory infection, and pharyngitis. The following list of adverse reactions is based on the experience in 473 patients treated ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant K-TAB", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "K-TAB"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "anxiety"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "What is BENZTROPINE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BENZTROPINE"]], "act": "question"}]}
{"index": 0, "text": "Benztropine mesylate tablets, USP are indicated for use as an adjunct in the therapy of all forms of parkinsonism. Useful also in the control of extrapyramidal disorders (except tardive dyskinesia - see PRECAUTIONS ) due to neuroleptic drugs (e.g., phenothiazines).", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Orphenadrine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Orphenadrine"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Orphenadrine citrate extended-release tablets, USP are indicated as an adjunct to rest, physical therapy and other measures for the relief of discomfort associated with acute painful musculo skeletal conditions.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Hydrocodone?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrocodone"]], "act": "question"}]}
{"index": 1, "text": "what version of Hydrocodone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "CROSCARMELLOSE SODIUM,CROSPOVIDONE (15 MPA.S AT 5%),MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POVIDONES,STARCH, CORN,STEARIC ACID,HYDROCODONE BITARTRATE,ACETAMINOPHEN,CROSCARMELLOSE SODIUM,CROSPOVIDONE (15 MPA.S AT 5%),MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POVIDONES,STARCH, CORN,STEARIC ACID,D&C YELLOW NO. 10,HYDROCODONE BITARTRATE,ACETAMINOPHEN,CROSCARMELLOSE SODIUM,CROSPOVIDONE (15 MPA.S AT 5%),MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POVIDONES,STARCH, CORN,STEARIC ACID,HYDROCODONE BITARTRATE,ACETAMINOPHEN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Flurazepam", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Flurazepam"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Revesta?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Revesta"]], "act": "question"}]}
{"index": 0, "text": "what version of Revesta is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "CHOLECALCIFEROL,FOLIC ACID,WATER,SOYBEAN OIL,YELLOW WAX,LECITHIN, SOYBEAN,FD&C BLUE NO. 1,GLYCERIN,TITANIUM DIOXIDE,GELATIN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Naltrexone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Naltrexone"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Naltrexone Hydrochloride,silicon dioxide,croscarmellose sodium,hypromellose, unspecified,hydroxypropyl cellulose (1200000 MW),anhydrous lactose,magnesium stearate,microcrystalline cellulose,polyethylene glycol, unspecified,titanium dioxide,ferric oxide yellow", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "where should I keep Potassium?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "question"}]}
{"index": 1, "text": "what version of Potassium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Potassium", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant HALOPERIDOL", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HALOPERIDOL"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Quinapril?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Quinapril"]], "act": "question"}]}
{"index": 1, "text": "what version of Quinapril is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "As individual monotherapy, quinapril is an effective treatment of hypertension in once-daily doses of 10 mg to 80 mg and hydrochlorothiazide is effective in doses of 12.5 mg to 50 mg. In clinical trials of quinapril/hydrochlorothiazide combination therapy using quinapril doses of 2.5 mg to 40 mg and hydrochlorothiazide doses of 6.25 mg to 25 mg, the antihypertensive effects increased with increasing dose of either component. The side effects (see WARNINGS ) of quinapril are generally rare and apparently independent of dose; those of hydrochlorothiazide are a mixture of dose-dependent phenomena (primarily hypokalemia) and dose-independent phenomena (e.g., pancreatitis), the former much more c", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "As individual monotherapy, quinapril is an effective treatment of hypertension in once-daily doses of 10 mg to 80 mg and hydrochlorothiazide is effective in doses of 12.5 mg to 50 mg. In clinical trials of quinapril/hydrochlorothiazide combination therapy using quinapril doses of 2.5 mg to 40 mg and hydrochlorothiazide doses of 6.25 mg to 25 mg, the antihypertensive effects increased with increasing dose of either component. The side effects (see WARNINGS ) of quinapril are generally rare and apparently independent of dose; those of hydrochlorothiazide are a mixture of dose-dependent phenomena (primarily hypokalemia) and dose-independent phenomena (e.g., pancreatitis), the former much more c", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take 1.5%?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "1.5%"]], "act": "question"}]}
{"index": 1, "text": "1.5% may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "low_blood_pressure", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "inform"}]}
{"index": 2, "text": "Adverse reactions may result from intravascular absorption of glycine. Large intravenous doses of glycine are known to cause salivation, nausea and lightheadedness. Other consequences of absorption of urologic irrigating solutions include fluid and electrolyte disturbances such as acidosis, electrolyte loss, marked diuresis, urinary retention, edema, dryness of mouth, thirst, dehydration, coma from hyponatremia, secondary hyponatremia due to fluid overload, and hyperammonemia with resultant coma and/or encephalopathy; cardiovascular disorders such as hypotension, tachycardia, angina-like pains; pulmonary disorders such as pulmonary congestion; and other general reactions such as blurred visi", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Lyza in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lyza"]], "act": "question"}]}
{"index": 1, "text": "what version of Lyza is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Lyza", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant LIOTHYRONINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "LIOTHYRONINE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use TussiCaps?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TussiCaps"]], "act": "question"}]}
{"index": 1, "text": "what version of TussiCaps is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "Adults and Children 12 Years and Older One (1) full-strength TussiCaps  extended-release capsule (hydrocodone polistirex equivalent to 10 mg of hydrocodone bitartrate and chlorpheniramine polistirex equivalent to 8 mg of chlorpheniramine maleate) every 12 hours; do not exceed 2 capsules in 24 hours . Children 6 to 11 Years of Age One (1) half-strength TussiCaps  extended-release capsule (hydrocodone polistirex equivalent to 5 mg of hydrocodone bitartrate and chlorpheniramine polistirex equivalent to 4 mg of chlorpheniramine maleate) every 12 hours; do not exceed 2 capsules in 24 hours . This medicine is contraindicated in children under 6 years of age ( see CONTRAINDICATIONS ).", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "Is NYSTATIN safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NYSTATIN"]], "act": "question"}]}
{"index": 0, "text": "NYSTATIN may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "infection", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "inform"}]}
{"index": 1, "text": "The frequency of adverse events reported in patients using Nystatin Cream USP is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application (see PRECAUTIONS-General ).", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Daunorubicin?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Daunorubicin"]], "act": "question"}]}
{"index": 1, "text": "what version of Daunorubicin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "DAUNORUBICIN HYDROCHLORIDE,MANNITOL", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have nausea with CLARITHROMYCIN?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CLARITHROMYCIN"], ["<symptom>", "nausea"]], "act": "question"}]}
{"index": 1, "text": "nausea is a mild side effect of CLARITHROMYCIN. The majority of side effects observed in clinical trials were of a mild and transient nature. Fewer than 3% of adult patients without mycobacterial infections and fewer than 2% of pediatric patients without mycobacterial infections discontinued therapy because of drug-related side effects. The most frequently reported events in adults taking clarithromycin tablet were diarrhea (3%), nausea (3%), abnormal taste (3%), dyspepsia (2%), abdominal pain/discomfort (2%), and headache (2%). In pediatric patients, the most frequently reported events were diarrhea (6%), vomiting (6%), abdominal pain (3%), rash (3%), and headache (2%). Most of these events were described as mild or moderate in severity.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "can i take CLONIDINE?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CLONIDINE"]], "act": "question"}]}
{"index": 0, "text": "CLONIDINE may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "infection", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "inform"}]}
{"index": 1, "text": "Most adverse effects are mild and tend to diminish with continued therapy. The most frequent (which appear to be dose-related) are dry mouth, occurring in about 40 of 100 patients; drowsiness, about 33 in 100; dizziness, about 16 in 100; constipation and sedation, each about 10 in 100. The following less frequent adverse experiences have also been reported in patients receiving clonidine hydrochloride tablets, but in many cases patients were receiving concomitant medication and a causal relationship has not been established. Body as a Whole: Fatigue, fever, headache, pallor, weakness, and withdrawal syndrome. Also reported were a weakly positive Coombs\u2019 test and increased sensitivity to alco", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "what are the side effects of Voriconazole?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Voriconazole"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of Voriconazole: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "suicidal", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "suicidal"]], "act": "inform"}]}
{"index": 1, "text": "suicidal is a serious side effect of Voriconazole. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant stomach_ache", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "stomach_ache"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant DIHYDROERGOTAMINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "DIHYDROERGOTAMINE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "stomach_ache is a serious side effect of DIHYDROERGOTAMINE. Serious cardiac events, including some that have been fatal, have occurred following use of dihydroergotamine mesylate injection, but are extremely rare. Events reported have included coronary artery vasospasm, transient myocardial ischemia, myocardial infarction, ventricular tachycardia, and ventricular fibrillation. (See CONTRAINDICATIONS , WARNINGS , and PRECAUTIONS .). Fibrotic complications have been reported in association with long term use of injectable dihydroergotamine mesylate ( See WARNINGS: Fibrotic Complications ). Post-introduction Reports The following events derived from postmarketing experience have been occasionally reported in patients receiving dihydroergotamine mesylate", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Selenium?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Selenium"]], "act": "question"}]}
{"index": 1, "text": "what version of Selenium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "See application instructions on rear panel of this bottle. For treatment of dandruff and seborrheic dermatitis: For the usual case, two applications each week for two weeks will afford control. After this, the suspension may be used at less frequent intervals - weekly, every two weeks, or even every 3 or 4 weeks in some cases. The preparation should not be applied more frequently than required to maintain control. For treatment of tinea versicolor: Apply to affected areas and lather with a small amount of water. Allow product to remain on skin for 10 minutes, then rinse the body thoroughly. Repeat this procedure once a day for seven days.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "See application instructions on rear panel of this bottle. For treatment of dandruff and seborrheic dermatitis: For the usual case, two applications each week for two weeks will afford control. After this, the suspension may be used at less frequent intervals - weekly, every two weeks, or even every 3 or 4 weeks in some cases. The preparation should not be applied more frequently than required to maintain control. For treatment of tinea versicolor: Apply to affected areas and lather with a small amount of water. Allow product to remain on skin for 10 minutes, then rinse the body thoroughly. Repeat this procedure once a day for seven days.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Minipress?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Minipress"]], "act": "question"}]}
{"index": 1, "text": "MINIPRESS is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on g", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Cleocin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cleocin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "CLEOCIN PEDIATRIC (clindamycin palmitate HCl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the BOXED WARNING , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). Anaerobes: Serious respiratory tract in", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "does Doxycycline contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxycycline"]], "act": "question"}]}
{"index": 0, "text": "what version of Doxycycline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Doxycycline,Microcrystalline Cellulose,Sodium Starch Glycolate Type A Potato,Magnesium Stearate,Silicon Dioxide,Titanium Dioxide,Gelatin, Unspecified,Shellac,Propylene Glycol,Ferric Oxide Yellow,Ferrosoferric Oxide,Doxycycline,Microcrystalline Cellulose,Sodium Starch Glycolate Type A Potato,Magnesium Stearate,Silicon Dioxide,Titanium Dioxide,Gelatin, Unspecified,Ferric Oxide Red,Ferrosoferric Oxide,Ferric Oxide Yellow,Shellac,Propylene Glycol,Doxycycline,Microcrystalline Cellulose,Sodium Starch Glycolate Type A Potato,Magnesium Stearate,Silicon Dioxide,Titanium Dioxide,Gelatin, Unspecified,Ferric Oxide Red,Ferrosoferric Oxide,Ferric Oxide Yellow,Shellac,Propylene Glycol", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "SILICON DIOXIDE,FD&C YELLOW NO. 6,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM STARCH GLYCOLATE TYPE A POTATO,TITANIUM DIOXIDE,HYPROMELLOSE 2910 (3 MPA.S),HYPROMELLOSE 2910 (6 MPA.S),D&C YELLOW NO. 10,POLYETHYLENE GLYCOL 400,POLYSORBATE 80,DOXYCYCLINE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is ATORVASTATIN safe  for someone with liver_problems?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ATORVASTATIN"], ["<condition>", "liver_problems"]], "act": "question"}]}
{"index": 1, "text": "The following serious adverse reactions are discussed in greater detail in other sections of the label: Rhabdomyolysis and myopathy [see Warnings and Precautions (5.1) ] Liver enzyme abnormalities [see Warnings and Precautions (5.2) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is gabapentin safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "gabapentin"]], "act": "question"}]}
{"index": 1, "text": "gabapentin may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "low_blood_pressure", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "inform"}]}
{"index": 2, "text": "The following serious adverse reactions are discussed in greater detail in other sections: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity [see Warnings and Precautions (5.1)] Anaphylaxis and Angioedema [see Warnings and Precautions (5.2)] Somnolence/Sedation and Dizziness [see Warnings and Precautions (5.4)] Withdrawal Precipitated Seizure, Status Epilepticus [see Warnings and Precautions (5.5)] Suicidal Behavior and Ideation [see Warnings and Precautions (5.6)] Neuropsychiatric Adverse Reactions (Pediatric Patients 3-12 Years of Age) [see Warnings and Precautions (5.7)] Sudden and Unexplained Death in Patients with Epilepsy [see Warnings and Precau", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant CLONIDINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CLONIDINE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is depression a common side effect of Calcium?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Calcium"], ["<symptom>", "depression"]], "act": "question"}]}
{"index": 1, "text": "depression is a common side effect of Calcium. The following serious adverse reactions are also described elsewhere in the labeling: Arrhythmias with Concomitant Cardiac Glycoside Use \ufeff[see Warnings and Precautions ( \ufeff5.1 \ufeff)] End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates \ufeff[see Warnings and Precautions ( \ufeff5.2 \ufeff)] Tissue Necrosis and Calcinosis \ufeff[see Warnings and Precautions ( \ufeff5.5 \ufeff)] Hypotension, Bradycardia, and Cardiac Arrhythmias \ufeff[see Warnings and Precautions ( \ufeff5.5 \ufeff)] Aluminum toxicity \ufeff[see Warnings and precautions ( \ufeff5.5 \ufeff)] The following adverse reactions associated with the use of calcium gluconate were identified in the literature. Because these reactions are reported voluntarily from a population of u", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in ProFeno?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ProFeno"]], "act": "question"}]}
{"index": 1, "text": "what version of ProFeno is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "FENOPROFEN CALCIUM,SILICON DIOXIDE,CROSCARMELLOSE SODIUM,HYPROMELLOSE, UNSPECIFIED,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,POLYETHYLENE GLYCOL, UNSPECIFIED,POLYSORBATE 80,STARCH, CORN,SODIUM LAURYL SULFATE,TITANIUM DIOXIDE,FD&C YELLOW NO. 6", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "does Tretinoin cause itchy_skin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tretinoin"], ["<symptom>", "itchy_skin"]], "act": "question"}]}
{"index": 0, "text": "itchy_skin is a mild side effect of Tretinoin. The skin of certain sensitive individuals may become excessively red, edematous, blistered, or crusted. If these effects occur, the medication should either be discontinued until the integrity of the skin is restored, or the medication should be adjusted to a level the patient can tolerate. True contact allergy to topical tretinoin is rarely encountered. Temporary hyper- or hypopigmentation has been reported with repeated application of tretinoin. Some individuals have been reported to have heightened susceptibility to sunlight while under treatment with tretinoin. To date, all adverse effects of tretinoin have been reversible upon discontinuance of therapy (see Dosage and Administration ).", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Vaseretic?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Vaseretic"]], "act": "question"}]}
{"index": 0, "text": "what version of Vaseretic is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Enalapril Maleate,Hydrochlorothiazide,ferric oxide red,LACTOSE, UNSPECIFIED FORM,magnesium stearate,sodium bicarbonate,starch, corn", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Tranexamic", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Tranexamic"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "TRANEXAMIC ACID,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Amantadine?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amantadine"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 2, "text": "what version of Amantadine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Amantadine is 4 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "can i take MENEST  if I am pregnant?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "MENEST"], ["<condition>", "pregnant"]], "act": "question"}]}
{"index": 0, "text": "See Boxed Warnings , WARNINGS and PRECAUTIONS . The following additional adverse reactions have been reported with estrogens and/or progestin therapy.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant low_blood_pressure", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant BACITRACIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "BACITRACIN"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "where should I keep Labetalol?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Labetalol"]], "act": "question"}]}
{"index": 0, "text": "what version of Labetalol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Labetalol", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Trelegy", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Trelegy"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Trelegy", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for GABAPENTIN?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "GABAPENTIN"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 2, "text": "what version of GABAPENTIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for GABAPENTIN is 3 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Is Spironolactone safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Spironolactone"]], "act": "question"}]}
{"index": 0, "text": "Spironolactone may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "IBD", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "inform"}]}
{"index": 1, "text": "The following adverse reactions have been reported and, within each category (body system), are listed in order of decreasing severity.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant HydrOXYzine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HydrOXYzine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Skin and Appendages: Oral hydroxyzine hydrochloride is associated with fixed drug eruptions in postmarketing reports. Side effects reported with the administration of hydroxyzine hydrochloride are usually mild and transitory in nature. To report SUSPECTED ADVERSE REACTIONS, contact Hi-Tech Pharmacal Co., Inc. at 1-800-262-9010 or FDA at 1-800- FDA-1088 or www.fda.gov/medwatch.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have aggression with Dextroamphetamine?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dextroamphetamine"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 1, "text": "aggression is a mild side effect of Dextroamphetamine. Cardiovascular \u2013 Palpitations, tachycardia, elevation of blood pressure, sudden death, myocardial infarction. There have been isolated reports of cardiomyopathy associated with chronic amphetamine use. Central Nervous System \u2013 Psychotic episodes at recommended doses, overstimulation, restlessness, irritability, euphoria, dyskinesia, dysphoria, depression, tremor, tics, aggression, anger, logorrhea, dermatillomania. Eye Disorders \u2013 Vision blurred, mydriasis. Gastrointestinal \u2013 Dryness of the mouth, unpleasant taste, diarrhea, constipation, other gastrointestinal disturbances. Anorexia and weight loss may occur as undesirable effects. Allergic \u2013 Urticaria, rash, hypersensitivity reactions incl", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Depo", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Depo"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "do I need to keep Doxorubicin in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxorubicin"]], "act": "question"}]}
{"index": 0, "text": "what version of Doxorubicin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Doxorubicin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant gabapentin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "gabapentin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Trandolapril contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Trandolapril"]], "act": "question"}]}
{"index": 0, "text": "what version of Trandolapril is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "TRANDOLAPRIL,STARCH, CORN,CROSCARMELLOSE SODIUM,HYPROMELLOSE,LACTOSE MONOHYDRATE,POVIDONE,SODIUM STEARYL FUMARATE,FERRIC OXIDE RED", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant THEOPHYLLINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "THEOPHYLLINE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is it normal to have mood_swings with Gemfibrozil?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Gemfibrozil"], ["<symptom>", "mood_swings"]], "act": "question"}]}
{"index": 0, "text": "mood_swings is a dangerous side effect of Gemfibrozil. In the double-blind controlled phase of the primary prevention component of the Helsinki Heart Study, 2046 patients received gemfibrozil for up to five years. In that study, the following adverse reactions were statistically more frequent in subjects in the gemfibrozil group: GEMFIBROZIL ( N = 2046 ) PLACEBO ( N = 2035 ) Frequency in percent of subjects Gastrointestinal reactions 34.2 23.8 Dyspepsia 19.6 11.9 Abdominal pain 9.8 5.6 Acute appendicitis 1.2 0.6 (histologically confirmed in most cases where data were available) Atrial fibrillation 0.7 0.1 Adverse events reported by more than 1% of subjects, but without a significant difference between groups: Diarrhea 7.2 6.5 Fatigue 3.8 3.5 Nau", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "What is 4%?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "4%"]], "act": "question"}]}
{"index": 0, "text": "4% Lidocaine Hydrochloride Injection, USP is indicated for the production of topical anesthesia of the mucous membranes of the respiratory tract or the genito-urinary tract. It may be injected trans-tracheally to anesthetize the larynx and trachea, and it may be administered by retrobulbar injection to provide anesthesia for ophthalmic surgery.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Celexa", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Celexa"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Celexa (citalopram HBr) is indicated for the treatment of depression. The efficacy of Celexa in the treatment of depression was established in 4-6 week, controlled trials of outpatients whose diagnosis corresponded most closely to the DSM-III and DSM-III-R category of major depressive disorder (see CLINICAL PHARMACOLOGY ). A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypers", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Potassium?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "question"}]}
{"index": 1, "text": "what version of Potassium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "POTASSIUM CHLORIDE,DEXTROSE MONOHYDRATE,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "how do I store TOLAK?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TOLAK"]], "act": "question"}]}
{"index": 0, "text": "what version of TOLAK is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug TOLAK", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "storage instructions for drug TOLAK", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store GANCICLOVIR?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "GANCICLOVIR"]], "act": "question"}]}
{"index": 1, "text": "what version of GANCICLOVIR is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug GANCICLOVIR", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant Terbutaline", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Terbutaline"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Terbutaline", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Hydrochlorothiazide cause diarrhea?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrochlorothiazide"], ["<symptom>", "diarrhea"]], "act": "question"}]}
{"index": 0, "text": "diarrhea is a common side effect of Hydrochlorothiazide. The adverse reactions associated with hydrochlorothiazide have been shown to be dose related. In controlled clinical trials, the adverse events reported with doses of 12.5 mg hydrochlorothiazide once daily were comparable to placebo. The following adverse reactions have been reported for doses of hydrochlorothiazide 25 mg and greater and, within each category, are listed in the order of decreasing severity. Body as a whole: Weakness. Cardiovascular: Hypotension including orthostatic hypotension (may be aggravated by alcohol, barbiturates, narcotics or antihypertensive drugs). Digestive: Pancreatitis, jaundice (intrahepatic cholestatic jaundice), diarrhea, vomiting, sialadenitis, cramping, co", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "Is VIDEX safe  if I have TB?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "VIDEX"], ["<condition>", "TB"]], "act": "question"}]}
{"index": 0, "text": "The following serious adverse reactions are described below and elsewhere in the labeling:  Pancreatitis [ see Boxed Warning , Warnings and Precautions (5.1) ]  Lactic acidosis/severe hepatomegaly with steatosis [ see Boxed Warning , Warnings and Precautions (5.2) ]  Hepatic toxicity [ see Warnings and Precautions (5.3) ]  Non-cirrhotic portal hypertension [ see Warnings and Precautions (5.4) ]  Peripheral neuropathy [ see Warnings and Precautions (5.5) ]  Retinal changes and optic neuritis [ see Warnings and Precautions (5.6) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant low_blood_pressure", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "The following serious adverse reactions are described below and elsewhere in the labeling:  Pancreatitis [ see Boxed Warning , Warnings and Precautions (5.1) ]  Lactic acidosis/severe hepatomegaly with steatosis [ see Boxed Warning , Warnings and Precautions (5.2) ]  Hepatic toxicity [ see Warnings and Precautions (5.3) ]  Non-cirrhotic portal hypertension [ see Warnings and Precautions (5.4) ]  Peripheral neuropathy [ see Warnings and Precautions (5.5) ]  Retinal changes and optic neuritis [ see Warnings and Precautions (5.6) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in QUETIAPINE?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "QUETIAPINE"]], "act": "question"}]}
{"index": 1, "text": "what version of QUETIAPINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "POVIDONE, UNSPECIFIED,DIBASIC CALCIUM PHOSPHATE DIHYDRATE,MICROCRYSTALLINE CELLULOSE,SODIUM STARCH GLYCOLATE TYPE A POTATO,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,HYPROMELLOSE 2910 (6 MPA.S),POLYETHYLENE GLYCOL, UNSPECIFIED,TITANIUM DIOXIDE,FERRIC OXIDE RED,FERRIC OXIDE YELLOW,QUETIAPINE FUMARATE,POVIDONE, UNSPECIFIED,DIBASIC CALCIUM PHOSPHATE DIHYDRATE,MICROCRYSTALLINE CELLULOSE,SODIUM STARCH GLYCOLATE TYPE A POTATO,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,HYPROMELLOSE 2910 (5 MPA.S),POLYETHYLENE GLYCOL, UNSPECIFIED,TITANIUM DIOXIDE,QUETIAPINE FUMARATE,POVIDONE, UNSPECIFIED,DIBASIC CALCIUM PHOSPHATE DIHYDRATE,MICROCRYSTALLINE CELLULOSE,SODIUM STARCH GLYCOLATE TYPE A POTATO,LACTOSE MONOHYDRATE,", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "POVIDONE, UNSPECIFIED,DIBASIC CALCIUM PHOSPHATE DIHYDRATE,MICROCRYSTALLINE CELLULOSE,SODIUM STARCH GLYCOLATE TYPE A POTATO,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,HYPROMELLOSE 2910 (6 MPA.S),POLYETHYLENE GLYCOL, UNSPECIFIED,TITANIUM DIOXIDE,FERRIC OXIDE RED,FERRIC OXIDE YELLOW,QUETIAPINE FUMARATE,POVIDONE, UNSPECIFIED,DIBASIC CALCIUM PHOSPHATE DIHYDRATE,MICROCRYSTALLINE CELLULOSE,SODIUM STARCH GLYCOLATE TYPE A POTATO,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,HYPROMELLOSE 2910 (5 MPA.S),POLYETHYLENE GLYCOL, UNSPECIFIED,TITANIUM DIOXIDE,QUETIAPINE FUMARATE,POVIDONE, UNSPECIFIED,DIBASIC CALCIUM PHOSPHATE DIHYDRATE,MICROCRYSTALLINE CELLULOSE,SODIUM STARCH GLYCOLATE TYPE A POTATO,LACTOSE MONOHYDRATE,", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "What is COMPLERA?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "COMPLERA"]], "act": "question"}]}
{"index": 0, "text": "COMPLERA\u2122, a combination of two nucleoside analog HIV-1 reverse transcriptase inhibitors (NRTIs) (emtricitabine and tenofovir disoproxil fumarate) and one non-nucleoside reverse transcriptase inhibitor (NNRTI) (rilpivirine), is indicated for use as a complete regimen for the treatment of HIV-1 infection in patients 12 years of age and older with no antiretroviral treatment history and with HIV-1 RNA less than or equal to 100,000 copies/mL at the start of therapy, and in certain virologically-suppressed (HIV-1 RNA <50 copies/mL) patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see below). The following points s", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Metoclopramide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Metoclopramide"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "The use of metoclopramide tablets, USP is recommended for adults only. Therapy should not exceed 12 weeks in duration.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what do I do with Penicillin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Penicillin"]], "act": "question"}]}
{"index": 0, "text": "what version of Penicillin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Penicillin G potassium may be given intravenously or intramuscularly. The usual dose recommendations are as follows:", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "The dosage of penicillin V should be determined according to the sensitivity of the causative microorganisms and the severity of infection, and adjusted to the clinical response of the patient. The usual dosage recommendations for adults and children 12 years and over are as follows:", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Fluocinonide?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluocinonide"]], "act": "question"}]}
{"index": 1, "text": "Fluocinonide Cream USP, 0.05%, Fluocinonide Cream USP, 0.05% (Emulsified Base), Fluocinonide Gel USP, 0.05% and Fluocinonide Ointment USP, 0.05% are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much Flecainide should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Flecainide"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 2, "text": "what version of Flecainide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Flecainide is 4 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant Latanoprost", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Latanoprost"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 7, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is ABELCET?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ABELCET"]], "act": "question"}]}
{"index": 0, "text": "ABELCET  is indicated for the treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy. This is based on open-label treatment of patients judged by their physicians to be intolerant to or failing conventional amphotericin B therapy (See DESCRIPTION OF CLINICAL STUDIES). DESCRIPTION OF CLINICAL STUDIES Fungal Infections Data from 473 patients were pooled from three open-label studies in which ABELCET  was provided for the treatment of patients with invasive fungal infections who were judged by their physicians to be refractory to or intolerant of conventional amphotericin B, or who had preexisting nephrotoxicity. Results of", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant MENEST", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "MENEST"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Menest is indicated in the: Treatment of moderate to severe vasomotor symptoms associated with the menopause. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. Female hypogonadism. Female castration. Primary ovarian failure. Breast cancer (for palliation only) in appropriately selected women and men with metastatic disease. Prostatic carcinoma - palliative therapy of advanced disease.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for VITAMIN?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "VITAMIN"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 2, "text": "what version of VITAMIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for VITAMIN is 3 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant elderly", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "actually i meant Losartan", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Losartan"]], "act": "update"}]}
{"index": 6, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 7, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 7, "text": "The dosage for Losartan is 4 mg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "how much FAMCICLOVIR should i take for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "FAMCICLOVIR"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 0, "text": "what version of FAMCICLOVIR is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for FAMCICLOVIR is 1 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant Medrol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Medrol"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I store Calcium?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Calcium"]], "act": "question"}]}
{"index": 0, "text": "what version of Calcium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Calcium", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Diclofenac", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Diclofenac"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "storage instructions for drug Diclofenac", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Amrix contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amrix"]], "act": "question"}]}
{"index": 1, "text": "what version of Amrix is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "CYCLOBENZAPRINE HYDROCHLORIDE,DIETHYL PHTHALATE,ETHYLCELLULOSES,GELATIN,SUCROSE,TITANIUM DIOXIDE,D&C YELLOW NO. 10,FD&C GREEN NO. 3,FD&C RED NO. 40,STARCH, CORN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant Oxycodone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxycodone"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "OXYCODONE HYDROCHLORIDE,HYDROXYPROPYL CELLULOSE, UNSPECIFIED,HYPROMELLOSE, UNSPECIFIED,POLYETHYLENE GLYCOL, UNSPECIFIED,MAGNESIUM STEARATE,BUTYLATED HYDROXYTOLUENE,POLYETHYLENE GLYCOL 400,TITANIUM DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the side effects of Docetaxel?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Docetaxel"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of Docetaxel: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "suicidal", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "suicidal"]], "act": "inform"}]}
{"index": 1, "text": "suicidal is a dangerous side effect of Docetaxel. The most serious adverse reactions from docetaxel are: Toxic Deaths [ see Boxed Warning , Warnings and Precautions (5.1) ] Hepatotoxicity [ see Boxed Warning , Warnings and Precautions (5.2) ] Neutropenia [ see Boxed Warning , Warnings and Precautions (5.3) ] Hypersensitivity [ see Boxed Warning , Warnings and Precautions (5.4) ] Fluid Retention [ see Boxed Warning , Warnings and Precautions (5.5) ] The most common adverse reactions across all docetaxel indications are infections, neutropenia, anemia, febrile neutropenia, hypersensitivity, thrombocytopenia, neuropathy, dysgeusia, dyspnea, constipation, anorexia, nail disorders, fluid retention, asthenia, pain, nausea, diarrhea, vomiting, muc", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant diarrhea", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "diarrhea"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Buspirone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Buspirone"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what is in Bleomycin?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Bleomycin"]], "act": "question"}]}
{"index": 0, "text": "what version of Bleomycin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "BLEOMYCIN SULFATE,SULFURIC ACID,SODIUM HYDROXIDE,BLEOMYCIN SULFATE,SULFURIC ACID,SODIUM HYDROXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many ALLOPURINOL is the correct dose for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ALLOPURINOL"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 1, "text": "what version of ALLOPURINOL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for ALLOPURINOL is 1 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant PAMELOR", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "PAMELOR"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Promethazine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Promethazine"]], "act": "question"}]}
{"index": 1, "text": "Promethazine HCl Injection is indicated for the following conditions: Amelioration of allergic reactions to blood or plasma. In anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled. For other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. For sedation and relief of apprehension and to produce light sleep from which the patient can be easily aroused. Active treatment of motion sickness. Prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. As an adjunct to analgesics for the control of postoperative pain. Preoperative, post", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Lorazepam", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lorazepam"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Lorazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The effectiveness of lorazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use Diclofenac?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Diclofenac"]], "act": "question"}]}
{"index": 0, "text": "what version of Diclofenac is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Carefully consider the potential benefits and risks of diclofenac sodium and misoprostol delayed-release tablets and other treatment options before deciding to use diclofenac sodium and misoprostol delayed-release tablets. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions (5) ]. After observing the response to initial therapy with diclofenac sodium and misoprostol delayed-release tablets, the dose and frequency should be adjusted to suit an individual patient\u2019s needs. For the relief of rheumatoid arthritis and osteoarthritis, the dosage is given below. Diclofenac sodium and misoprostol delayed-release ta", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Metformin for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metformin"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 1, "text": "what version of Metformin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Metformin is 1 mg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with RESCRIPTOR?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "RESCRIPTOR"]], "act": "question"}]}
{"index": 1, "text": "what version of RESCRIPTOR is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "The recommended dosage for RESCRIPTOR tablets is 400 mg (four 100-mg or two 200-mg tablets) 3 times daily. RESCRIPTOR should be used in combination with other antiretroviral therapy. The complete prescribing information for other antiretroviral agents should be consulted for information on dosage and administration. The 100-mg RESCRIPTOR tablets may be dispersed in water prior to consumption. To prepare a dispersion, add four 100-mg RESCRIPTOR tablets to at least 3 ounces of water, allow to stand for a few minutes, and then stir until a uniform dispersion occurs (see CLINICAL PHARMACOLOGY : Pharmacokinetics: Absorption and Bioavailability ). The dispersion should be consumed promptly. The gl", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Should I take AcetaZOLAMIDE  if I have heart_problems?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "AcetaZOLAMIDE"], ["<condition>", "heart_problems"]], "act": "question"}]}
{"index": 0, "text": "Adverse reactions, occurring most often early in therapy, include paresthesias, particularly a tingling feeling in the extremities, hearing dysfunction or tinnitus, loss of appetite, taste alteration and gastrointestinal disturbances such as nausea, vomiting and diarrhea, polyuria, and occasional instances of drowsiness and confusion. Metabolic acidosis and electrolyte imbalance may occur. Transient myopia has been reported. This condition invariably subsides upon diminution or discontinuance of the medication. Other occasional adverse reactions include urticaria, melena, hematuria, glycosuria, hepatic insufficiency, flaccid paralysis, photosensitivity and convulsions. Also see PRECAUTIONS: ", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "where should I keep Loperamide?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Loperamide"]], "act": "question"}]}
{"index": 0, "text": "what version of Loperamide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Loperamide", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "can i take Truvada  if I have pregnant?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Truvada"], ["<condition>", "pregnant"]], "act": "question"}]}
{"index": 0, "text": "The following adverse reactions are discussed in other sections of the labeling: Severe Acute Exacerbations of Hepatitis B [see BOXED WARNING, WARNINGS AND PRECAUTIONS (5.1)]. New Onset or Worsening Renal Impairment [see WARNINGS AND PRECAUTIONS (5.2)]. Lactic Acidosis/Severe Hepatomegaly with Steatosis [see WARNINGS AND PRECAUTIONS (5.3)]. Bone Effects of Tenofovir DF [see WARNINGS AND PRECAUTIONS (5.5)]. Immune Reconstitution Syndrome [see WARNINGS AND PRECAUTIONS (5.6)]. 6.1 Adverse Reactions from Clinical Trials Experience in HIV-1 Infected Subjects Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cann", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant SUMYCIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "SUMYCIN"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is it normal to have hallucinations with PERPHENAZINE?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PERPHENAZINE"], ["<symptom>", "hallucinations"]], "act": "question"}]}
{"index": 0, "text": "hallucinations is a serious side effect of PERPHENAZINE. Not all of the following adverse reactions have been reported with this specific drug; however, pharmacological similarities among various phenothiazine derivatives require that each be considered. With the piperazine group (of which perphenazine is an example), the extrapyramidal symptoms are more common, and others (e.g., sedative effects, jaundice, and blood dyscrasias) are less frequently seen. CNS Effects Extrapyramidal Reactions opisthotonus, trismus, torticollis, retrocollis, aching and numbness of the limbs, motor restlessness, oculogyric crisis, hyperreflexia, dystonia, including protrusion, discoloration, aching and rounding of the tongue, tonic spasm of the masticatory muscles, ti", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant bleeding", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "bleeding"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "bleeding is a common side effect of PERPHENAZINE. Not all of the following adverse reactions have been reported with this specific drug; however, pharmacological similarities among various phenothiazine derivatives require that each be considered. With the piperazine group (of which perphenazine is an example), the extrapyramidal symptoms are more common, and others (e.g., sedative effects, jaundice, and blood dyscrasias) are less frequently seen. CNS Effects Extrapyramidal Reactions opisthotonus, trismus, torticollis, retrocollis, aching and numbness of the limbs, motor restlessness, oculogyric crisis, hyperreflexia, dystonia, including protrusion, discoloration, aching and rounding of the tongue, tonic spasm of the masticatory muscles, ti", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "do I need to keep Potassium in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "question"}]}
{"index": 0, "text": "what version of Potassium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Potassium", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Olopatadine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Olopatadine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Olopatadine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Ondansetron?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ondansetron"]], "act": "question"}]}
{"index": 1, "text": "Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin \u226550 mg/m 2 . Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. Prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. Prevention of postoperative nausea and/or vomiting. As with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients where nausea and/or vomitin", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Oxaprozin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxaprozin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Oxaprozin tablets are indicated: For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis For relief of the signs and symptoms of juvenile rheumatoid arthritis", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is stomach_ache a common side effect of Nabumetone?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nabumetone"], ["<symptom>", "stomach_ache"]], "act": "question"}]}
{"index": 0, "text": "stomach_ache is a mild side effect of Nabumetone. Adverse reaction information was derived from blinded-controlled and open-labelled clinical trials and from worldwide marketing experience. In the description below, rates of the more common events (greater than 1%) and many of the less common events (less than 1%) represent results of US clinical studies. Of the 1,677 patients who received nabumetone during US clinical trials, 1,524 were treated for at least 1 month, 1,327 for at least 3 months, 929 for at least a year, and 750 for at least 2 years. More than 300 patients have been treated for 5 years or longer. The most frequently reported adverse reactions were related to the gastrointestinal tract and included diarrhea, dyspepsia, and ab", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant Ammonium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ammonium"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "stomach_ache is a dangerous side effect of Ammonium. The most frequent adverse experiences in patients with xerosis are transient stinging (1 in 30 patients), burning (1 in 30 patients), erythema (1 in 50 patients) and peeling (1 in 60 patients). Other adverse reactions which occur less frequently are irritation, eczema, petechiae, dryness, and hyperpigmentation. Due to the more severe initial skin conditions associated with ichthyosis, there was a higher incidence of transient stinging, burning and erythema (each occurring in 1 in 10 patients).", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much ISOSORBIDE should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ISOSORBIDE"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 2, "text": "what version of ISOSORBIDE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for ISOSORBIDE is 4 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant child", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for ISOSORBIDE is 2 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 7, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Adapalene  for someone with glaucoma?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Adapalene"], ["<condition>", "glaucoma"]], "act": "question"}]}
{"index": 1, "text": "Some adverse effects such as erythema, scaling, dryness, pruritus, and burning will occur in 10-40% of patients. Pruritus or burning immediately after application also occurs in approximately 20% of patients. The following additional adverse experiences were reported in approximately 1% or less of patients: skin irritation, burning/stinging, erythema, sunburn, and acne flares. These are most commonly seen during the first month of therapy and decrease in frequency and severity thereafter. All adverse effects with use of adapalene gel during clinical trials were reversible upon discontinuation of therapy.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant infection", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Tussionex?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tussionex"]], "act": "question"}]}
{"index": 1, "text": "Tussionex may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "pregnant", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "inform"}]}
{"index": 2, "text": "Gastrointestinal Disorders Nausea and vomiting may occur; they are more frequent in ambulatory than in recumbent patients. Prolonged administration of TUSSIONEX Pennkinetic Extended-Release Suspension may produce constipation. General Disorders and Administration Site Conditions Death Nervous System Disorders Sedation, drowsiness, mental clouding, lethargy, impairment of mental and physical performance, anxiety, fear, dysphoria, euphoria, dizziness, psychic dependence, mood changes. Renal and Urinary Disorders Ureteral spasm, spasm of vesical sphincters, and urinary retention have been reported with opiates. Respiratory, Thoracic and Mediastinal Disorders Dryness of the pharynx, occasional t", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant Metformin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Metformin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant pregnant", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take Glycopyrrolate?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Glycopyrrolate"]], "act": "question"}]}
{"index": 0, "text": "Glycopyrrolate may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "pregnant", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "inform"}]}
{"index": 1, "text": "Anticholinergics produce certain effects, most of which are extensions of their fundamental pharmacological actions. Adverse reactions to anticholinergics in general may include xerostomia; decreased sweating; urinary hesitancy and retention; blurred vision; tachycardia; palpitations; dilatation of the pupil; cycloplegia; increased ocular tension; loss of taste; headaches; nervousness; mental confusion; drowsiness; weakness; dizziness; insomnia; nausea; vomiting; constipation; bloated feeling; impotence; suppression of lactation; severe allergic reaction or drug idiosyncrasies including anaphylaxis, urticaria and other dermal manifestations. Glycopyrrolate is chemically a quaternary ammonium", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "What is Bicillin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Bicillin"]], "act": "question"}]}
{"index": 0, "text": "To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bicillin C-R and other antibacterial drugs, Bicillin C-R should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. This drug is indicated in the treatment of moderately severe infections due to penicillin-G-susceptible microorganisms that are susceptible to serum levels common to this particul", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many Sotalol is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sotalol"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 1, "text": "what version of Sotalol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "90", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Sotalol is 2 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant 70", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Sotalol is 2 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "what are the side effects of 236?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "236"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of 236: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "tiredness", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "tiredness"]], "act": "inform"}]}
{"index": 1, "text": "tiredness is a common side effect of 236. In U.S. and foreign controlled studies, the frequency of serious adverse reactions reported was very low. Of 702 patients, 11.8% reported adverse reactions and in only 1.5% was glipizide discontinued.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant bleeding", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "bleeding"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Penicillin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Penicillin"]], "act": "question"}]}
{"index": 1, "text": "Therapy: Penicillin G Potassium for Injection, USP is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin G. Therapy with penicillin G Potassium for Injection, USP may be indicated before results of such tests are known when there is reason to believe the infection may involve any of the organisms listed below, however, once these results become available, appropriate therapy should be continued. Clinical Indicatio", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is it normal to have insomnia with CYCLOBENZAPRINE?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CYCLOBENZAPRINE"], ["<symptom>", "insomnia"]], "act": "question"}]}
{"index": 0, "text": "insomnia is a serious side effect of CYCLOBENZAPRINE. Incidence of most common adverse reactions in the 2 double-blind \u2021 , placebo-controlled 5 mg studies (incidence of > 3% on cyclobenzaprine hydrochloride tablets 5 mg): Cyclobenzaprine Hydrochloride Tablets 5 mg N=464 Cyclobenzaprine Hydrochloride Tablets 10 mg N=249 Placebo N=469 Drowsiness 29% 38% 10% Dry Mouth 21% 32% 7% Fatigue 6% 6% 3% Headache 5% 5% 8% Adverse reactions which were reported in 1% to 3% of the patients were: abdominal pain, acid regurgitation, constipation, diarrhea, dizziness, nausea, irritability, mental acuity decreased, nervousness, upper respiratory infection, and pharyngitis. The following list of adverse reactions is based on the experience in 473 patients treated ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant ribavirin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ribavirin"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant insomnia", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "insomnia"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Enalapril is the correct dose for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Enalapril"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 1, "text": "what version of Enalapril is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Enalapril is 1 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Bumetanide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Bumetanide"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Bumetanide is 1 mg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "Is Promethazine safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Promethazine"]], "act": "question"}]}
{"index": 0, "text": "Promethazine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "liver_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "inform"}]}
{"index": 1, "text": "Respiratory Depression Promethazine hydrochloride injection is contraindicated in pediatric patients less than 2 years of age, because of the potential for fatal respiratory depression. Promethazine hydrochloride injection should be used with caution in pediatric patients 2 years of age and older (see WARNINGS - Respiratory Depression ). Severe Tissue Injury, Including Gangrene Promethazine hydrochloride injection can cause severe chemical irritation and damage to tissues regardless of the route of administration. Irritation and damage can result from perivascular extravasation, unintentional intra-arterial injection and intraneuronal or perineuronal infiltration. Adverse reactions include b", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "how many TRIMETHOBENZAMIDE is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TRIMETHOBENZAMIDE"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 1, "text": "what version of TRIMETHOBENZAMIDE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for TRIMETHOBENZAMIDE is 3 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant adult", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant 70", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 7, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take Tizanidine?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tizanidine"]], "act": "question"}]}
{"index": 0, "text": "Tizanidine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "low_blood_pressure", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "inform"}]}
{"index": 1, "text": "In multiple-dose, placebo-controlled clinical studies, 264 patients were treated with tizanidine and 261 with placebo. Adverse events, including severe adverse events, were more frequently reported with tizanidine than with placebo.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "what are the side effects of Doxycycline?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxycycline"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of Doxycycline: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "diarrhea", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "diarrhea"]], "act": "inform"}]}
{"index": 1, "text": "diarrhea is a common side effect of Doxycycline. Due to oral doxycycline's virtually complete absorption, side effects to the lower bowel, particularly diarrhea, have been infrequent. The following adverse reactions have been observed in patients receiving tetracyclines. Gastrointestinal: Anorexia, nausea, vomiting, diarrhea, glossitis, dysphagia, enterocolitis, and inflammatory lesions (with monilial overgrowth) in the anogenital region, and pancreatitis. Hepatotoxicity has been reported. These reactions have been caused by both the oral and parenteral administration of tetracyclines. Rare instances of esophagitis and esophageal ulcerations have been reported in patients receiving capsule and tablet forms of drugs in the tetracycline clas", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant To", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "To"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Dihydroergotamine safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dihydroergotamine"]], "act": "question"}]}
{"index": 1, "text": "Dihydroergotamine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "liver_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "inform"}]}
{"index": 2, "text": "During clinical studies and the foreign postmarketing experience with Dihydroergotamine Mesylate, USP Nasal Spray there have been no fatalities due to cardiac events. Serious cardiac events, including some that have been fatal, have occurred following use of the parenteral form of dihydroergotamine mesylate (D.H.E. 45  Injection), but are extremely rare. Events reported have included coronary artery vasospasm, transient myocardial ischemia, myocardial infarction, ventricular tachycardia, and ventricular fibrillation. (See CONTRAINDICATIONS , WARNINGS , and PRECAUTIONS ). Fibrotic complications have been reported in association with long term use of injectable dihydroergotamine mesylate (see ", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant Levothyroxine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Levothyroxine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant liver_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Adverse reactions associated with levothyroxine therapy are primarily those of hyperthyroidism due to therapeutic overdosage (see PRECAUTIONS and OVERDOSAGE ). They include the following: General: fatigue, increased appetite, weight loss, heat intolerance, fever, excessive sweating; Central nervous system: headache, hyperactivity, nervousness, anxiety, irritability, emotional lability, insomnia; Musculoskeletal: tremors, muscle weakness; Cardiovascular: palpitations, tachycardia, arrhythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction, cardiac arrest; Respiratory: dyspnea; Gastrointestinal: diarrhea, vomiting, abdominal cramps and elevation in liver func", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much Levofloxacin should i take for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Levofloxacin"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of Levofloxacin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Levofloxacin is 4 mg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Proventil", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Proventil"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Proventil is 4 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take TIZANIDINE?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TIZANIDINE"]], "act": "question"}]}
{"index": 0, "text": "TIZANIDINE may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "tourettes", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "inform"}]}
{"index": 1, "text": "In multiple dose, placebo-controlled clinical studies, 264 patients were treated with tizanidine and 261 with placebo. Adverse events, including severe adverse events, were more frequently reported with tizanidine than with placebo. Common Adverse Events Leading to Discontinuation Forty-five of 264 (17%) patients receiving tizanidine and 13 of 261 (5%) of patients receiving placebo in three multiple dose, placebo-controlled clinical studies, discontinued treatment for adverse events. When patients withdrew from the study, they frequently had more than one reason for discontinuing. The adverse events most frequently leading to withdrawal of tizanidine treated patients in the controlled clinic", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant pregnant", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "do I need to keep Hyoscyamine in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hyoscyamine"]], "act": "question"}]}
{"index": 0, "text": "what version of Hyoscyamine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Hyoscyamine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep 0.25% in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "0.25%"]], "act": "question"}]}
{"index": 1, "text": "what version of 0.25% is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug 0.25%", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take Mephyton  if I am low_blood_pressure?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Mephyton"], ["<condition>", "low_blood_pressure"]], "act": "question"}]}
{"index": 0, "text": "Severe hypersensitivity reactions, including anaphylactoid reactions and deaths, have been reported following parenteral administration. The majority of these reported events occurred following intravenous administration. Transient \"flushing sensations\" and \"peculiar\" sensations of taste have been observed with parenteral phytonadione, as well as rare instances of dizziness, rapid and weak pulse, profuse sweating, brief hypotension, dyspnea, and cyanosis. Hyperbilirubinemia has been observed in the newborn following administration of parenteral phytonadione. This has occurred rarely and primarily with doses above those recommended. To report SUSPECTED ADVERSE REACTIONS, contact Valeant Pharm", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant oxycodone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "oxycodone"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Dapsone?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dapsone"]], "act": "question"}]}
{"index": 1, "text": "Dapsone may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "infection", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "inform"}]}
{"index": 2, "text": "In addition to the warnings listed above, the following syndromes and serious reactions have been reported in patients on Dapsone. Hematologic Effects: Dose-related hemolysis is the most common adverse effect and is seen in patients with or without G6PD deficiency. Almost all patients demonstrate the inter-related changes of a loss of 1 to 2g of hemoglobin, an increase in the reticulocytes (2 to 12%), a shortened red cell life span and a rise in methemoglobin. G6PD deficient patients have greater responses. Nervous System Effects: Peripheral neuropathy is a definite but unusual complication of Dapsone therapy in non-leprosy patients. Motor loss is predominant. If muscle weakness appears, Dap", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant heart_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Rosadan", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Rosadan"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Sulfamethoxazole?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sulfamethoxazole"]], "act": "question"}]}
{"index": 0, "text": "what version of Sulfamethoxazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "SULFAMETHOXAZOLE,TRIMETHOPRIM,ALCOHOL,CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM,ANHYDROUS CITRIC ACID,SILICON DIOXIDE,FD&C RED NO. 40,GLYCERIN,METHYLPARABEN,MICROCRYSTALLINE CELLULOSE,POLYSORBATE 80,WATER,SACCHARIN SODIUM,SODIUM BENZOATE,SORBITOL", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Sulfamethoxazole,Trimethoprim,Docusate sodium,sodium benzoate,SODIUM STARCH GLYCOLATE TYPE A POTATO,magnesium stearate,STARCH, CORN,Sulfamethoxazole,Trimethoprim,Docusate sodium,sodium benzoate,SODIUM STARCH GLYCOLATE TYPE A POTATO,magnesium stearate,STARCH, CORN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Lidocaine  for someone with pregnant?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"], ["<condition>", "pregnant"]], "act": "question"}]}
{"index": 1, "text": "Localized Reactions: During or immediately after treatment with lidocaine and prilocaine cream on intact skin, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation. Rare cases of discrete purpuric or petechial reactions at the application site have been reported. Rare cases of hyperpigmentation following the use of lidocaine and prilocaine cream have been reported. The relationship to lidocaine and prilocaine cream or the underlying procedure has not been established. In clinical studies on intact skin involving over 1,300 lidocaine and prilocaine cream-treated subjects, one or more such local reactions were noted in 56% of patients, and w", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Phentermine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Phentermine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "The following adverse reactions are described, or described in greater detail, in other sections: Primary pulmonary hypertension [see Warnings and Precautions (5.2)] Valvular heart disease [see Warnings and Precautions (5.3)] Effect on the ability to engage in potentially hazardous tasks [see Warnings and Precautions (5.5)] Withdrawal effects following prolonged high dosage administration [see Drug Abuse and Dependence (9.3)] The following adverse reactions to phentermine have been identified: Cardiovascular: Primary pulmonary hypertension and/or regurgitant cardiac valvular disease, palpitation, tachycardia, elevation of blood pressure, ischemic events. Central Nervous System: Overstimulati", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Erythromycin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Erythromycin"]], "act": "question"}]}
{"index": 1, "text": "Erythromycin is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below: Upper respiratory tract infections of mild to moderate degree caused by Streptococcus pyogenes, Streptococcus pneumoniae, or Haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of H. influenzae are not susceptible to the erythromycin concentrations ordinarily achieved) (see appropriate sulfonamide labeling for prescribing information). Lower respiratory tract infections of mild to moderate severity caused by Streptococcus pneumoniae or Streptococcus pyogenes. Listeriosis caused by Listeria monocyto", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Phenazopyridine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Phenazopyridine"]], "act": "question"}]}
{"index": 0, "text": "Phenazopyridine HCl is indicated for the symptomatic relief of pain, burning, urgency frequency, and other discomforts arising from irritation of the mucosa of the lower urinary tract caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters. The use of phenazopyridine for relief of symptoms should not delay definitive diagnosis and treatment of causative conditions. The drug should be used for symptomatic relief of pain and not as a substitute for specific surgery or antimicrobial therapy. Phenazopyridine is compatible with antimicrobial therapy and can help relieve pain and discomfort during the interval before antimicrobial therapy controls the inf", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant ganciclovir", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ganciclovir"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Ganciclovir Ophthalmic Gel 0.15% is indicated for the treatment of acute herpetic keratitis (dendritic ulcers).", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Lidocaine?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "question"}]}
{"index": 1, "text": "what version of Lidocaine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "LIDOCAINE,PRILOCAINE,WATER,POLYOXYL 40 HYDROGENATED CASTOR OIL,SODIUM HYDROXIDE,CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "LIDOCAINE,PRILOCAINE,WATER,POLYOXYL 40 HYDROGENATED CASTOR OIL,SODIUM HYDROXIDE,CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is METHYLPREDNISOLONE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "METHYLPREDNISOLONE"]], "act": "question"}]}
{"index": 1, "text": "Methylprednisolone Tablets are indicated in the following conditions: 1.Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer 2.Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode orexacerbation) in: Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance the", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is the dose for Butalbital, for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Butalbital,"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 0, "text": "what version of Butalbital, is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Butalbital, is 4 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant 10", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Didanosine?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Didanosine"]], "act": "question"}]}
{"index": 1, "text": "Didanosine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "IBD", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "inform"}]}
{"index": 2, "text": "The following adverse reactions are discussed in greater detail in other sections: Pancreatitis [see Boxed Warning , Warnings and Precautions (5.1) ] Lactic acidosis/severe hepatomegaly with steatosis [see Boxed Warning , Warnings and Precautions (5.2) ] Hepatic toxicity [see Warnings and Precautions (5.3) ] Non-cirrhotic portal hypertension [see Warnings and Precautions (5.4) ] Peripheral neuropathy [see Warnings and Precautions (5.5) ] Retinal changes and optic neuritis [see Warnings and Precautions (5.6) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant Isoniazid", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Isoniazid"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant IBD", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much Zonisamide should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Zonisamide"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 1, "text": "what version of Zonisamide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "10", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Zonisamide is 2 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant 90", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant HESPAN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HESPAN"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of TRICOR?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TRICOR"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of TRICOR: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "insomnia", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "insomnia"]], "act": "inform"}]}
{"index": 2, "text": "insomnia is a dangerous side effect of TRICOR.  Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is SOTALOL safe  if I am low_blood_pressure?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SOTALOL"], ["<condition>", "low_blood_pressure"]], "act": "question"}]}
{"index": 1, "text": "During premarketing trials, 3186 patients with cardiac arrhythmias (1363 with sustained ventricular tachycardia) received oral sotalol, of whom 2451 received the drug for at least two weeks. The most important adverse effects are torsade de pointes and other serious new ventricular arrhythmias (see WARNINGS ), occurring at rates of almost 4% and 1%, respectively, in the VT/VF population. Overall, discontinuation because of unacceptable side-effects was necessary in 17% of all patients in clinical trials, and in 13% of patients treated for at least two weeks. The most common adverse reactions leading to discontinuation of sotalol are as follows: fatigue 4%, bradycardia (less than 50 bpm) 3%, ", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Flurbiprofen", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Flurbiprofen"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Transient burning and stinging upon instillation and other minor symptoms of ocular irritation have been reported with the use of Flurbiprofen Sodium Ophthalmic Solution. Other adverse reactions reported with the use of Flurbiprofen Sodium Ophthalmic Solution include: fibrosis, hyphema, miosis, mydriasis, and ocular hyperemia. Increased bleeding tendency of ocular tissues in conjunction with ocular surgery has also been reported (see Warnings ). To report SUSPECTED ADVERSE REACTIONS, contact Bausch + Lomb, a division of Valeant Pharmaceuticals North America LLC, at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "can i take Timolol  if I am anxiety?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Timolol"], ["<condition>", "anxiety"]], "act": "question"}]}
{"index": 0, "text": "In clinical trials, transient blurred vision upon instillation of the drop was reported in approximately one in three patients (lasting from 30 seconds to 5 minutes). Less than 1% of patients discontinued from the studies due to blurred vision. The frequency of patients reporting burning and stinging upon instillation was comparable between Timolol Maleate Ophthalmic Gel Forming Solution and Timolol Maleate Ophthalmic Solution (approximately one in eight patients). Adverse experiences reported in 1-5% of patients were: Ocular: Pain, conjunctivitis, discharge (e.g., crusting), foreign body sensation, itching and tearing; Systemic: Headache, dizziness, and upper respiratory infections. The fol", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant IBD", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant Vitamin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Vitamin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Mild transient diarrhea, polycythemia vera, peripheral vascular thrombosis, itching transitory exanthema, feeling of swelling of entire body, anaphylactic shock and death. Sensitivity to the ingredients listed may occur (see WARNINGS ). Use should be discontinued upon observance of any untoward reaction. Pain upon intramuscular injection may be noted.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Pentamidine cause fever?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Pentamidine"], ["<symptom>", "fever"]], "act": "question"}]}
{"index": 0, "text": "fever is a common side effect of Pentamidine. CAUTION : Fatalities due to severe hypotension, hypoglycemia, acute pancreatitis and cardiac arrhythmias have been reported in patients treated with pentamidine isethionate, both by the IM and IV routes. Nephrotoxic events (increased creatinine, impaired renal function, azotemia, and renal failure) are common with the parenteral administration of pentamidine isethionate. The administration of the drug should, therefore, be limited to the patients in whom Pneumocystis carinii has been demonstrated. The most frequently reported spontaneous adverse events (1 to 30%) reported in clinical trials, regardless of their relation to pentamidine isethionate therapy were as follows (n=424): Cardiovascul", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant Glycopyrrolate", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Glycopyrrolate"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Omeprazole  if I am infection?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Omeprazole"], ["<condition>", "infection"]], "act": "question"}]}
{"index": 1, "text": "The following serious adverse reactions are described below and elsewhere in labeling:  Acute Interstitial Nephritis [see Warnings and Precautions ( 5.2 )]  Clostridium difficile-Associated Diarrhea [see Warnings and Precautions ( 5.4) ]  Bone Fracture [see Warnings and Precautions ( 5.5 )]  Cutaneous and Systemic Lupus Erythematosus [see Warnings and Precautions ( 5.6 )]  Cyanocobalamin (Vitamin B-12) Deficiency [see Warnings and Precautions ( 5.8 )]  Hypomagnesemia [see Warnings and Precautions ( 5.9 )]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant liver_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Zileuton", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Zileuton"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for LEVOPHED for a child?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LEVOPHED"], ["<age_group>", "child"]], "act": "question"}]}
{"index": 1, "text": "what version of LEVOPHED is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for LEVOPHED is 2 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for LEVOPHED is 2 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "Is OXALIPLATIN safe  if I am tourettes?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "OXALIPLATIN"], ["<condition>", "tourettes"]], "act": "question"}]}
{"index": 0, "text": "The following serious adverse reactions are discussed in greater detail in other sections of the label: Anaphylaxis and Allergic reactions [see Boxed Warning , Warnings and Precautions (5.1) .] Neuropathy [s ee Warnings and Precautions (5.2) .] Severe Neutropenia [see Warnings and Precautions (5.3) .] Pulmonary Toxicities [see Warnings and Precautions (5.4) .] Hepatotoxicity [see Warnings and Precautions (5.5) .] Cardiovascular Toxicities [see Warnings and Precautions (5.6) .] Rhabdomyolysis [see Warnings and Precautions (5.7) .]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant Clindamycin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Clindamycin"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant tourettes", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "In 18 clinical studies of various formulations of clindamycin phosphate using placebo vehicle and/or active comparator drugs as controls, patients experienced a number of treatment emergent adverse dermatologic events [see table below]. Number of Patients Reporting Events Treatment Emergent Adverse Event Solution n=553(%) Gel N=148(%) Suspension N=160(%) Burning 62(11) 15(10) 17(11) Itching 36(7) 15(10) 17(11) Burning/Stinging 60(11) not recorded (-) (-) Dryness 105(19) 34(23) 29(18) Erythema 86(16) 10(7) 22(14) Oiliness/Oily Skin 8(1) 26(18) 12 of 126 subjects (10) Peeling 61(11) (-) 11(7) Orally and parenterally administered clindamycin has been associated with severe colitis which may end", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "what are the ingredients of Levofloxacin?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Levofloxacin"]], "act": "question"}]}
{"index": 0, "text": "what version of Levofloxacin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "LEVOFLOXACIN,BENZALKONIUM CHLORIDE,SODIUM CHLORIDE,WATER,SODIUM HYDROXIDE,HYDROCHLORIC ACID", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "SILICON DIOXIDE,STARCH, CORN,CROSPOVIDONE,HYPROMELLOSES,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POLYETHYLENE GLYCOLS,TITANIUM DIOXIDE,LEVOFLOXACIN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does amlodipine contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "amlodipine"]], "act": "question"}]}
{"index": 0, "text": "what version of amlodipine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "AMLODIPINE BESYLATE,CELLULOSE, MICROCRYSTALLINE,MAGNESIUM STEARATE,SODIUM STARCH GLYCOLATE TYPE A POTATO,ANHYDROUS DIBASIC CALCIUM PHOSPHATE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Haloperidol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Haloperidol"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "HALOPERIDOL LACTATE,PROPYLENE GLYCOL,METHYLPARABEN,PROPYLPARABEN,LACTIC ACID,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take fosphenytoin  if I am anxiety?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "fosphenytoin"], ["<condition>", "anxiety"]], "act": "question"}]}
{"index": 1, "text": "The more important adverse clinical events caused by the IV use of fosphenytoin sodium injection or phenytoin are cardiovascular collapse and/or central nervous system depression. Hypotension can occur when either drug is administered rapidly by the IV route. The rate of administration is very important; for fosphenytoin sodium injection, it should not exceed 150 mg PE/min. The adverse clinical events most commonly observed with the use of fosphenytoin sodium injection in clinical trials were nystagmus, dizziness, pruritus, paresthesia, headache, somnolence, and ataxia. With two exceptions, these events are commonly associated with the administration of IV phenytoin. Paresthesia and pruritus", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Sodium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sodium"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "The most important adverse reactions to sodium nitroprusside are the avoidable ones of excessive hypotension and cyanide toxicity, described above under WARNINGS . The adverse reactions described in this section develop less rapidly and, as it happens, less commonly. Methemoglobinemia: As described in CLINICAL PHARMACOLOGY above, sodium nitroprusside infusions can cause sequestration of hemoglobin as methemoglobin. The back conversion process is normally rapid, and clinically significant methemoglobinemia (>10%) is seen only rarely in patients receiving sodium nitroprusside. Even patients congenitally incapable of back converting methemoglobin should demonstrate 10% methemoglobinemia only af", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Cevimeline?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cevimeline"]], "act": "question"}]}
{"index": 1, "text": "what version of Cevimeline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "The recommended dose of cevimeline hydrochloride is 30 mg taken three times a day. There is insufficient safety information to support doses greater than 30 mg tid. There is also insufficient evidence for additional efficacy of cevimeline hydrochloride at doses greater than 30 mg tid.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Glycopyrrolate", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Glycopyrrolate"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep GUANIDINE in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "GUANIDINE"]], "act": "question"}]}
{"index": 1, "text": "what version of GUANIDINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug GUANIDINE", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant Potassium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Potassium", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much Hydroxyzine should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydroxyzine"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 2, "text": "what version of Hydroxyzine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Hydroxyzine is 1 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what do I do with Cholestyramine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cholestyramine"]], "act": "question"}]}
{"index": 0, "text": "what version of Cholestyramine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "The recommended starting adult dose for cholestyramine for oral suspension USP light powder is one pouch or one level scoopful once or twice a day. The recommended maintenance dose for cholestyramine for oral suspension USP light powder is 2 to 4 pouches or scoopfuls daily (8 to 16 grams anhydrous cholestyramine resin) divided into two doses. Four grams of anhydrous cholestyramine resin is contained in each measured dose of cholestyramine for oral suspension USP light powder as follows: Cholestyramine for oral suspension USP light powder 5.5 grams It is recommended that increases in dose be gradual with periodic assessment of lipid/lipoprotein levels at intervals of not less than 4 weeks. Th", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Mirtazapine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Mirtazapine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "where should I keep Amrix?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amrix"]], "act": "question"}]}
{"index": 1, "text": "what version of Amrix is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Amrix", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much acetaminophen should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "acetaminophen"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 2, "text": "what version of acetaminophen is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for acetaminophen is 4 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant Cyproheptadine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cyproheptadine"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 7, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Flecainide?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Flecainide"]], "act": "question"}]}
{"index": 1, "text": "what version of Flecainide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "FLECAINIDE ACETATE,CROSCARMELLOSE SODIUM,HYDROGENATED COTTONSEED OIL,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,STARCH, CORN,FLECAINIDE ACETATE,CROSCARMELLOSE SODIUM,HYDROGENATED COTTONSEED OIL,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,STARCH, CORN,FLECAINIDE ACETATE,CROSCARMELLOSE SODIUM,HYDROGENATED COTTONSEED OIL,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,STARCH, CORN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Sumatriptan", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sumatriptan"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "SUMATRIPTAN SUCCINATE,croscarmellose sodium,ANHYDROUS LACTOSE,LACTOSE MONOHYDRATE,magnesium stearate,mannitol,MICROCRYSTALLINE CELLULOSE,talc,titanium dioxide,triacetin,SUMATRIPTAN SUCCINATE,croscarmellose sodium,ANHYDROUS LACTOSE,LACTOSE MONOHYDRATE,magnesium stearate,mannitol,MICROCRYSTALLINE CELLULOSE,talc,titanium dioxide,triacetin", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Methylprednisolone safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methylprednisolone"]], "act": "question"}]}
{"index": 1, "text": "Methylprednisolone may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 2, "text": "The following adverse reactions have been reported with methylprednisolone sodium succinate or other corticosteroids: Allergic reactions: Allergic or hypersensitivity reactions, anaphylactoid reaction, anaphylaxis, angioedema. Blood and lymphatic system disorders: Leukocytosis. Cardiovascular: Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction (see WARNINGS ), pulmonary edema, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis. Dermatologic: Acne, allergic dermatitis, burnin", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep DIAZEPAM in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DIAZEPAM"]], "act": "question"}]}
{"index": 1, "text": "what version of DIAZEPAM is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug DIAZEPAM", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have diarrhea with Ketalar?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ketalar"], ["<symptom>", "diarrhea"]], "act": "question"}]}
{"index": 1, "text": "diarrhea is a dangerous side effect of Ketalar. \ufeffCardiovascular: \ufeffBlood pressure and pulse rate are frequently elevated following administration of Ketalar alone. However, hypotension and bradycardia have been observed. Arrhythmia has also occurred. \ufeffRespiration: \ufeffAlthough respiration is frequently stimulated, severe depression of respiration or apnea may occur following rapid intravenous administration of high doses of Ketalar. Laryngospasms and other forms of airway obstruction have occurred during Ketalar anesthesia. \ufeffEye: \ufeffDiplopia and nystagmus have been noted following Ketalar administration. It also may cause a slight elevation in intraocular pressure measurement. \ufeffPsychological: \ufeff(See Special Note.) \ufeffNeurological: \ufeffIn some patient", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant vomiting", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Evamist", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Evamist"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does atenolol contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "atenolol"]], "act": "question"}]}
{"index": 0, "text": "what version of atenolol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "POVIDONE,ATENOLOL,CELLULOSE, MICROCRYSTALLINE,ANHYDROUS CITRIC ACID,SILICON DIOXIDE,CROSCARMELLOSE SODIUM,MAGNESIUM STEARATE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Guanfacine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Guanfacine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take ADENOCARD  if I am pregnant?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ADENOCARD"], ["<condition>", "pregnant"]], "act": "question"}]}
{"index": 1, "text": "The following reactions were reported with intravenous Adenocard (adenosine injection) used in controlled U.S. clinical trials. The placebo group had less than 1% rate of all of these reactions.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant PACERONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "PACERONE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Adverse reactions have been very common in virtually all series of patients treated with amiodarone hydrochloride for ventricular arrhythmias with relatively large doses of drug (400 mg/day and above), occurring in about three-fourths of all patients and causing discontinuation in 7% to 18%. The most serious reactions are pulmonary toxicity, exacerbation of arrhythmia, and rare serious liver injury (see WARNINGS ), but other adverse effects constitute important problems. They are often reversible with dose reduction or cessation of amiodarone hydrochloride treatment. Most of the adverse effects appear to become more frequent with continued treatment beyond six months, although rates appear t", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "do I need to keep Naproxen in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Naproxen"]], "act": "question"}]}
{"index": 0, "text": "what version of Naproxen is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Naproxen", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Intelence", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Intelence"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Intelence", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Clobetasol safe  for someone with heart_problems?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Clobetasol"], ["<condition>", "heart_problems"]], "act": "question"}]}
{"index": 1, "text": "In a controlled clinical trial with clobetasol propionate gel, the only reported adverse reaction that was considered to be drug related was a report of burning sensation (1.8% of treated patients). In controlled clinical trials, the most frequent adverse reactions reported for clobetasol propionate cream were burning and stinging sensation in 1% of treated patients. Less frequent adverse reactions were itching, skin atrophy, and cracking and fissuring of the skin. In controlled clinical trials, the most frequent adverse events reported for clobetasol propionate ointment were burning sensation, irritation, and itching in 0.5% of treated patients. Less frequent adverse reactions were stinging", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Niacin?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Niacin"]], "act": "question"}]}
{"index": 1, "text": "what version of Niacin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "NIACIN,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (TYPE E),LECITHIN, SOYBEAN,POLYETHYLENE GLYCOL 1000,POLYVINYL ALCOHOL, UNSPECIFIED,SODIUM STEARYL FUMARATE,TALC,TITANIUM DIOXIDE,FERRIC OXIDE RED,FERRIC OXIDE YELLOW,NIACIN,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (TYPE E),LECITHIN, SOYBEAN,POLYETHYLENE GLYCOL 1000,POLYVINYL ALCOHOL, UNSPECIFIED,SODIUM STEARYL FUMARATE,TALC,TITANIUM DIOXIDE,FERRIC OXIDE RED,FERRIC OXIDE YELLOW", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "NIACIN,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (TYPE E),LECITHIN, SOYBEAN,POLYETHYLENE GLYCOL 1000,POLYVINYL ALCOHOL, UNSPECIFIED,SODIUM STEARYL FUMARATE,TALC,TITANIUM DIOXIDE,FERRIC OXIDE RED,FERRIC OXIDE YELLOW,NIACIN,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (TYPE E),LECITHIN, SOYBEAN,POLYETHYLENE GLYCOL 1000,POLYVINYL ALCOHOL, UNSPECIFIED,SODIUM STEARYL FUMARATE,TALC,TITANIUM DIOXIDE,FERRIC OXIDE RED,FERRIC OXIDE YELLOW", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what do I do with Levetiracetam?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Levetiracetam"]], "act": "question"}]}
{"index": 0, "text": "what version of Levetiracetam is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "2.1 Important Administration Instructions Levetiracetam is given orally with or without food. The Levetiracetam dosing regimen depends on the indication, age group, dosage form (tablets or oral solution), and renal function. Prescribe the oral solution for pediatric patients with body weight \u2264 20 kg. Prescribe the oral solution or tablets for pediatric patients with body weight above 20 kg. When using the oral solution in pediatric patients, dosing is weight-based (mg per kg) using a calibrated measuring device (not a household teaspoon or tablespoon). 2.2 Dosing for Partial Onset Seizures Adults 16 Years and Older Initiate treatment with a daily dose of 1000 mg/day, given as twice-daily dos", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant GALZIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "GALZIN"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how do I use Corvert?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Corvert"]], "act": "question"}]}
{"index": 0, "text": "what version of Corvert is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "The recommended dose based on controlled trials (see CLINICAL STUDIES ) is outlined in the Table below. Ibutilide infusion should be stopped as soon as the presenting arrhythmia is terminated or in the event of sustained or nonsustained ventricular tachycardia, or marked prolongation of QT or QTc. Recommended Dose of CORVERT Injection Patient Weight Initial Infusion (over 10 minutes) Second Infusion 60 kg (132 lb) or more One vial (1 mg ibutilide fumarate) If the arrhythmia does not terminate within 10 minutes after the end of the initial infusion, a second 10-minute infusion of equal strength may be administered 10 minutes after completion of the first infusion. Less than 60 kg (132 lb) 0.1", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Selenium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Selenium"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Risperidone?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Risperidone"]], "act": "question"}]}
{"index": 1, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant ULTRAMICROSIZE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ULTRAMICROSIZE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Ultramicrosize Griseofulvin Tablets, USP are indicated for the treatment of the following ringworm infections; tinea corporis (ringworm of the body), tinea pedis (athlete's foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber's itch), tinea capitis (ringworm of the scalp), and tinea unguium (onychomycosis, ringworm of the nails), when caused by one or more of the following genera of fungi: Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitalis, Trichophyton verrucosum, Trichophyton megnini, Trichophyton gallinae, Trichophyton crateriform, Trichophyton sulphureum, Trichophyton schoenleini, Microsporum audouini, Microsporum ", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Carbidopa safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Carbidopa"]], "act": "question"}]}
{"index": 1, "text": "Carbidopa may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 2, "text": "Carbidopa has not been demonstrated to have any overt pharmacodynamic actions in the recommended doses. The only adverse reactions that have been observed have been with concomitant use of carbidopa with other drugs such as levodopa, and with carbidopa-levodopa combination products. When Carbidopa is administered concomitantly with levodopa or carbidopa-levodopa combination products, the most common adverse reactions have included dyskinesias such as choreiform, dystonic, and other involuntary movements, and nausea. Other adverse reactions reported with Carbidopa when administered concomitantly with levodopa alone or carbidopa-levodopa combination products were psychotic episodes including d", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant Demadex", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Demadex"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Tetracycline cause bruising?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tetracycline"], ["<symptom>", "bruising"]], "act": "question"}]}
{"index": 1, "text": "bruising is a dangerous side effect of Tetracycline. Gastrointestinal: anorexia, nausea, epigastric distress, vomiting, diarrhea, glossitis, black hairy tongue, dysphagia, enterocolitis, and inflammatory lesions (with Candida overgrowth) in the anogenital region. Esophagitis and esophageal ulceration have been reported in patients receiving particularly the capsule and also the tablet forms of tetracyclines. Most of the patients were reported to have taken medication immediately before going to bed (see DOSAGE AND ADMINISTRATION ). Teeth: permanent discoloration of teeth may be caused during tooth development. Enamel hypoplasia has been reported (see WARNINGS ). Skin: maculopapular and erythrematous rashes. Exfoliative dermatitis has been repo", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant fever", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "fever"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Levocetirizine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Levocetirizine"]], "act": "question"}]}
{"index": 1, "text": "1.1 Seasonal Allergic Rhinitis Levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. 1.2 Perennial Allergic Rhinitis Levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children 6 months of age and older. 1.3 Chronic Idiopathic Urticaria Levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does CHLOROTHIAZIDE cause bruising?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CHLOROTHIAZIDE"], ["<symptom>", "bruising"]], "act": "question"}]}
{"index": 1, "text": "bruising is a dangerous side effect of CHLOROTHIAZIDE. The following adverse reactions have been reported and, within each category, are listed in order of decreasing severity. Body as a whole: Weakness. Cardiovascular: Hypotension including orthostatic hypotension (may be aggravated by alcohol, barbiturates, narcotics or antihypertensive drugs). Digestive: Pancreatitis, jaundice (intrahepatic cholestatic jaundice), diarrhea, vomiting, sialadenitis, cramping, constipation, gastric irritation, nausea, anorexia. Hematologic: Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia. Hypersensitivity: Anaphylactic reactions, necrotizing angiitis (vasculitis and cutaneous vasculitis), respiratory distress including pneumonitis", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Lacrisert", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lacrisert"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant mood_swings", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "mood_swings"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Atropine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Atropine"]], "act": "question"}]}
{"index": 1, "text": "what version of Atropine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "Atropine Sulfate Injection, USP may be administered subcutaneously, ntramuscularly or intravenously. The average adult dose is 0.5 mg (5 mL of a 0.1 mg/mL solution), range 0.4 to 0.6 mg (4 to 6 mL). As an antisialogogue it is usually injected intramuscularly prior to induction of anesthesia. This produces only minimal blocking of vagal activity. In children, the dosage ranges from 0.1 mg in the newborn to 0.6 mg (6 mL of a 0.1 mg/mL solution) in a child age 12 years, injected subcutaneously 30 minutes before surgery. During surgery, the drug is given intravenously when reduction in pulse rate and cessation of cardiac action are due to increased vagal activity; however, if the anesthetic is c", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Atropine Sulfate Injection, USP may be administered subcutaneously, ntramuscularly or intravenously. The average adult dose is 0.5 mg (5 mL of a 0.1 mg/mL solution), range 0.4 to 0.6 mg (4 to 6 mL). As an antisialogogue it is usually injected intramuscularly prior to induction of anesthesia. This produces only minimal blocking of vagal activity. In children, the dosage ranges from 0.1 mg in the newborn to 0.6 mg (6 mL of a 0.1 mg/mL solution) in a child age 12 years, injected subcutaneously 30 minutes before surgery. During surgery, the drug is given intravenously when reduction in pulse rate and cessation of cardiac action are due to increased vagal activity; however, if the anesthetic is c", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is mood_swings a common side effect of Nortriptyline?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nortriptyline"], ["<symptom>", "mood_swings"]], "act": "question"}]}
{"index": 0, "text": "mood_swings is a mild side effect of Nortriptyline. Note - Included in the following list are a few adverse reactions that have not been reported with this specific drug. However, the pharmacologic similarities among the tricyclic antidepressant drugs require that each of the reactions be considered when nortriptyline is administered. Cardiovascular - Hypotension, hypertension, tachycardia, palpitation, myocardial infarction, arrhythmias, heart block, stroke. Psychiatric - Confusional states (especially in the elderly) with hallucinations, disorientation, delusions; anxiety, restlessness, agitation; insomnia, panic, nightmares; hypomania; exacerbation of psychosis. Neurologic - Numbness, tingling, paresthesias of extremities; incoordination, ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant tiredness", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "tiredness"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Minocycline?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Minocycline"]], "act": "question"}]}
{"index": 1, "text": "Minocycline hydrochloride capsules, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae. Respiratory tract infections caused by Mycoplasma pneumoniae . Lymphogranuloma venereum caused by Chlamydia trachomatis . Psittacosis (Ornithosis) due to Chlamydia psittaci . Trachoma caused by Chlamydia trachomatis , although the infectious agent is not always eliminated, as judged by immunofluorescence. Inclusion conjunctivitis caused by Chlamydia trachomatis . Nongonococcal urethritis, endocervical, or rec", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Neomycin?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Neomycin"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 2, "text": "what version of Neomycin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Neomycin is 4 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is BENZONATATE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BENZONATATE"]], "act": "question"}]}
{"index": 1, "text": "Benzonatate capsules are indicated for the symptomatic relief of cough.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant epifoam", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "epifoam"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Methimazole?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methimazole"]], "act": "question"}]}
{"index": 1, "text": "what version of Methimazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Methimazole", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Methimazole", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of NAFTIN?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NAFTIN"]], "act": "question"}]}
{"index": 1, "text": "what version of NAFTIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "WATER,ALCOHOL,EDETATE DISODIUM,CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED),POLYSORBATE 80,DIISOPROPANOLAMINE,NAFTIFINE HYDROCHLORIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Triamterene contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Triamterene"]], "act": "question"}]}
{"index": 1, "text": "what version of Triamterene is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,SODIUM STARCH GLYCOLATE TYPE A POTATO,D&C YELLOW NO. 10,FD&C BLUE NO. 1,TRIAMTERENE,HYDROCHLOROTHIAZIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Ofloxacin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ofloxacin"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "OFLOXACIN,BENZALKONIUM CHLORIDE,HYDROCHLORIC ACID,SODIUM CHLORIDE,SODIUM HYDROXIDE,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "Is Levalbuterol safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Levalbuterol"]], "act": "question"}]}
{"index": 0, "text": "Levalbuterol may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 1, "text": "The following serious adverse reactions are described below and elsewhere in the labeling: Paradoxical bronchospasm [see Warnings and Precautions (5.1) ] Cardiovascular effects [see Warnings and Precautions (5.4) ] Immediate hypersensitivity reactions [see Warnings and Precautions (5.6) ] Hypokalemia [see Warnings and Precautions (5.8) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant infection", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "The following serious adverse reactions are described below and elsewhere in the labeling:  Paradoxical bronchospasm [see Warnings and Precautions ( 5.1 ) ]  Cardiovascular effects [see Warnings and Precautions ( 5.4 ) ]  Immediate hypersensitivity reactions [see Warnings and Precautions ( 5.6 ) ]  Hypokalemia [see Warnings and Precautions ( 5.8 ) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "where should I keep Zithromax?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Zithromax"]], "act": "question"}]}
{"index": 0, "text": "what version of Zithromax is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Zithromax", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take NAPROXEN?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NAPROXEN"]], "act": "question"}]}
{"index": 1, "text": "what version of NAPROXEN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Carefully consider the potential benefits and risks of naproxen sodium tablets and other treatment options before deciding to use naproxen sodium tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). After observing the response to initial therapy with naproxen sodium tablets, the dose and frequency should be adjusted to suit an individual patient's needs. Different dose strengths and formulations (i.e., tablets, suspension) of the drug are not necessarily bioequivalent. This difference should be taken into consideration when changing formulation. Although naproxen tablets, naproxen suspension, naproxen delayed-re", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the ingredients of Foltabs?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Foltabs"]], "act": "question"}]}
{"index": 0, "text": "what version of Foltabs is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "PYRIDOXINE HYDROCHLORIDE,FOLIC ACID,CYANOCOBALAMIN,DIBASIC CALCIUM PHOSPHATE DIHYDRATE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant Lidocaine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "LIDOCAINE,PRILOCAINE,WATER,POLYOXYL 40 HYDROGENATED CASTOR OIL,SODIUM HYDROXIDE,CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Nitroglycerin?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nitroglycerin"]], "act": "question"}]}
{"index": 1, "text": "what version of Nitroglycerin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Nitroglycerin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Diethylpropion", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Diethylpropion"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Tetrabenazine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tetrabenazine"]], "act": "question"}]}
{"index": 1, "text": "Tetrabenazine tablets are indicated for the treatment of chorea associated with Huntington\u2019s disease.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Estropipate", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Estropipate"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Estropipate tablets are indicated in the: Treatment of moderate to severe vasomotor symptoms associated with the menopause. Treatment of moderate to severe symptoms of vulval and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. Treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure. Prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and for whom non-estrogen medications are not considere", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "where should I keep VinCRIStine?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "VinCRIStine"]], "act": "question"}]}
{"index": 0, "text": "what version of VinCRIStine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug VinCRIStine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "Should I take Lorazepam  if I have anxiety?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lorazepam"], ["<condition>", "anxiety"]], "act": "question"}]}
{"index": 0, "text": "Most adverse reactions to benzodiazepines, including CNS effects and respiratory depression, are dose dependent, with more severe effects occurring with high doses. In a sample of about 3500 patients treated for anxiety, the most frequent adverse reaction to lorazepam was sedation (15.9%), followed by dizziness (6.9%), weakness (4.2%), and unsteadiness (3.4%). The incidence of sedation and unsteadiness increased with age. Other adverse reactions to benzodiazepines, including lorazepam are fatigue, drowsiness, amnesia, memory impairment, confusion, disorientation, depression, unmasking of depression, disinhibition, euphoria, suicidal ideation/attempt, ataxia, asthenia, extrapyramidal symptoms", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant TB", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant ADCETRIS", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ADCETRIS"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many Sodium is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sodium"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of Sodium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Sodium is 4 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant 50", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Sodium is 4 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "can i take Acetazolamide?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Acetazolamide"]], "act": "question"}]}
{"index": 0, "text": "Acetazolamide may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 1, "text": "Adverse reactions, occurring most often early in therapy, include paresthesias, particularly a \"tingling\" feeling in the extremities, hearing dysfunction or tinnitus, loss of appetite, taste alteration and gastrointestinal disturbances such as nausea, vomiting and diarrhea; polyuria, and occasional instances of drowsiness and confusion. Metabolic acidosis and electrolyte imbalance may occur. Transient myopia has been reported. This condition invariably subsides upon diminution or discontinuance of the medication. Other occasional adverse reactions include urticaria, melena, hematuria, glycosuria, hepatic insufficiency, flaccid paralysis, photosensitivity and convulsions. Also see PRECAUTIONS", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant pregnant", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Acetaminophen contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Acetaminophen"]], "act": "question"}]}
{"index": 0, "text": "what version of Acetaminophen is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "ALCOHOL,FD&C RED NO. 40,FD&C YELLOW NO. 6,GLYCERIN,PROPYLENE GLYCOL,WATER,SACCHARIN SODIUM,SUCROSE,ACETAMINOPHEN,CODEINE PHOSPHATE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Lisinopril", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lisinopril"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "HYDROCHLOROTHIAZIDE,LISINOPRIL,ANHYDROUS DIBASIC CALCIUM PHOSPHATE,SILICON DIOXIDE,STARCH, CORN,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,MANNITOL,SODIUM STARCH GLYCOLATE TYPE A POTATO,FERRIC OXIDE YELLOW", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for buprenorphine for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "buprenorphine"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 1, "text": "what version of buprenorphine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for buprenorphine is 3 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store AZITHROMYCIN?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "AZITHROMYCIN"]], "act": "question"}]}
{"index": 1, "text": "what version of AZITHROMYCIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug AZITHROMYCIN", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant BusPIRone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "BusPIRone"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "storage instructions for drug BusPIRone", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "how many SORBITOL-MANNITOL is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SORBITOL-MANNITOL"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of SORBITOL-MANNITOL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for SORBITOL-MANNITOL is 4 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "how many IBU is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "IBU"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of IBU is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for IBU is 4 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant ISOSORBIDE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ISOSORBIDE"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have stomach_ache with TRIAMCINOLONE?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TRIAMCINOLONE"], ["<symptom>", "stomach_ache"]], "act": "question"}]}
{"index": 1, "text": "stomach_ache is a mild side effect of TRIAMCINOLONE. The following local adverse reactions may occur with corticosteroid-containing dental pastes: burning, itching, irritation, dryness, blistering or peeling not present prior to therapy, perioral dermatitis, allergic contact dermatitis, maceration of the oral mucosa, secondary infection, and atrophy of the oral mucosa. Also, see PRECAUTIONS for potential effects of systemic absorption.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is fever a common side effect of 3%?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "3%"], ["<symptom>", "fever"]], "act": "question"}]}
{"index": 1, "text": "fever is a mild side effect of 3%. Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. Too rapid infusion of hypertonic solutions may cause local pain and venous irritation. Rate of administration should be adjusted according to tolerance. Use of the largest peripheral vein and a well-placed small bore needle is recommended. (See DOSAGE AND ADMINISTRATION .) The physician should also be alert to the possibility of adverse reactions to drug additives. Prescribing information for drug additives to be administered in this manner should ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant itchy_skin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "itchy_skin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Demadex", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Demadex"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what do I do with Methylprednisolone?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methylprednisolone"]], "act": "question"}]}
{"index": 0, "text": "what version of Methylprednisolone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "NOTE: After mixing as directed, methylprednisolone contains benzyl alcohol (see DESCRIPTION , WARNINGS and PRECAUTIONS , Pediatric Use ). Because of possible physical incompatibilities, methylprednisolone should not be diluted or mixed with other solutions. Use only Bacteriostatic Water for Injection with Benzyl Alcohol when reconstituting methylprednisolone sodium succinate for injection, USP (see DESCRIPTION ). Use within 48 hours after mixing. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. This preparation may be administered by intravenous injection, by intravenous infusion, o", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Tramadol?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tramadol"]], "act": "question"}]}
{"index": 1, "text": "what version of Tramadol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Adults (17 years of age and over) For patients with moderate to moderately severe chronic pain not requiring rapid onset of analgesic effect, the tolerability of tramadol hydrochloride tablets can be improved by initiating therapy with the following titration regimen: The total daily dose may be increased by 50 mg as tolerated every 3 days to reach 200 mg/day (50 mg q.i.d.). After titration, tramadol hydrochloride tablets 50 mg to 100 mg can be administered as needed for pain relief every four to six hours, not to exceed 400 mg per day. For the subset of patients for whom rapid onset of analgesic effect is required and for whom the benefits outweigh the risk of discontinuation due to adverse", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Bethanechol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Bethanechol"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Dosage must be individualized, depending on the type and severity of the condition to be treated. Preferably give the drug when the stomach is empty. If taken soon after eating, nausea and vomiting may occur. The usual adult oral dose ranges from 10 to 50 mg three or four times a day. The minimum effective dose is determined by giving 5 to 10 mg initially, and repeating the same amount at hourly intervals until satisfactory response occurs, or until a maximum of 50 mg has been given. The effects of the drug sometimes appear within 30 minutes, and are usually maximal within 60 to 90 minutes. The drug effects persist for about one hour. If necessary, the effects of the drug can be abolished pr", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Mesalamine?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Mesalamine"]], "act": "question"}]}
{"index": 1, "text": "Mesalamine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 2, "text": "In combined domestic and foreign clinical trials, more than 2100 patients with ulcerative colitis or Crohn's disease received Mesalamine therapy. Generally, Mesalamine therapy was well tolerated. The most common events (ie, greater than or equal to 1%) were diarrhea (3.4%), headache (2.0%), nausea (1.8%), abdominal pain (1.7%), dyspepsia (1.6%), vomiting (1.5%), and rash (1.0%). In two domestic placebo-controlled trials involving over 600 ulcerative colitis patients, adverse events were fewer in Mesalamine-treated patients than in the placebo group (Mesalamine 14% vs placebo 18%) and were not dose-related. Events occurring at 1% or more are shown in the table below. Of these, only nausea and", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant Azulfidine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Azulfidine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The most common adverse reactions associated with sulfasalazine in ulcerative colitis are anorexia, headache, nausea, vomiting, gastric distress, and apparently reversible oligospermia. These occur in about one-third of the patients. Less frequent adverse reactions are pruritus, urticaria, rash, fever, Heinz body anemia, hemolytic anemia and cyanosis, which may occur at a frequency of 1 in 30 patients or less. Experience suggests that with a daily dose of 4 g or more, or total serum sulfapyridine levels above 50 \u00b5g/mL, the incidence of adverse reactions tends to increase. Similar adverse reactions are associated with sulfasalazine use in adult rheumatoid arthritis, although there was a great", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "how do I take NDC?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NDC"]], "act": "question"}]}
{"index": 0, "text": "what version of NDC is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Application of one SITAVIG 50 mg buccal tablet as a single dose to the upper gum (canine fossa) region (2.1) . SITAVIG should be applied within one hour after the onset of prodromal symptoms and before the appearance of any signs of herpes labailis. Do not crush, chew, suck or swallow tablets ( 2.2 )", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Application of one SITAVIG 50 mg buccal tablet as a single dose to the upper gum (canine fossa) region (2.1) . SITAVIG should be applied within one hour after the onset of prodromal symptoms and before the appearance of any signs of herpes labailis. Do not crush, chew, suck or swallow tablets ( 2.2 )", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many BROMFED is the correct dose for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BROMFED"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 0, "text": "what version of BROMFED is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for BROMFED is 3 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use 4%?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "4%"]], "act": "question"}]}
{"index": 1, "text": "what version of 4% is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "When 4% Lidocaine Hydrochloride Injection, USP is used concomitantly with other products containing lidocaine, the total dose contributed by all formulations must be kept in mind. The dosage varies and depends upon the area to be anesthetized, vascularity of the tissues, individual tolerance and the technique of anesthesia. The lowest dosage needed to provide effective anesthesia should be administered. Dosages should be reduced for children and for elderly and debilitated patients. Although the incidence of adverse effects with 4% Lidocaine Hydrochloride Injection, USP is quite low, caution should be exercised, particularly when employing large volumes and concentrations of lidocaine since ", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Losartan cause depression?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Losartan"], ["<symptom>", "depression"]], "act": "question"}]}
{"index": 1, "text": "depression is a serious side effect of Losartan. Hypertension Losartan potassium tablets have been evaluated for safety in more than 3300 adult patients treated for essential hypertension and 4058 patients/subjects overall. Over 1200 patients were treated for over 6 months and more than 800 for over one year. In general, treatment with losartan potassium tablets were well-tolerated. The overall incidence of adverse experiences reported with losartan potassium tablets were similar to placebo. In controlled clinical trials, discontinuation of therapy due to clinical adverse experiences was required in 2.3 percent of patients treated with losartan potassium tablets and 3.7 percent of patients given placebo. The following table of adverse even", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Cartia", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cartia"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant itchy_skin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "itchy_skin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take dicyclomine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "dicyclomine"]], "act": "question"}]}
{"index": 1, "text": "what version of dicyclomine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Dosage must be adjusted to individual patient needs.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Triamterene?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Triamterene"]], "act": "question"}]}
{"index": 1, "text": "Triamterene may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 2, "text": "Side effects observed in association with the use of triamterene and hydrochlorothiazide tablets, other combination products containing triamterene/hydrochlorothiazide, and products containing triamterene or hydrochlorothiazide include the following: Gastrointestinal: jaundice (intrahepatic cholestatic jaundice), pancreatitis, nausea, appetite disturbance, taste alteration, vomiting, diarrhea, constipation, anorexia, gastric irritation, cramping. Central Nervous System: drowsiness and fatigue, insomnia, headache, dizziness, dry mouth, depression, anxiety, vertigo, restlessness, paresthesias. Cardiovascular: tachycardia, shortness of breath and chest pain, orthostatic hypotension (may be aggr", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant low_blood_pressure", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant BETAMETHASONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "BETAMETHASONE"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what is the dose for XANAX?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "XANAX"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 1, "text": "what version of XANAX is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for XANAX is 1 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant 10", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant adult", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for XANAX is 3 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "What is Metformin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metformin"]], "act": "question"}]}
{"index": 0, "text": "Metformin hydrochloride tablets USP is indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take PRAVASTATIN?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PRAVASTATIN"]], "act": "question"}]}
{"index": 0, "text": "PRAVASTATIN may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "liver_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "inform"}]}
{"index": 1, "text": "Pravastatin is generally well tolerated; adverse reactions have usually been mild and transient. In 4 month-long placebo-controlled trials, 1.7% of pravastatin-treated patients and 1.2% of placebo-treated patients were discontinued from treatment because of adverse experiences attributed to study drug therapy; this difference was not statistically significant. (See also PRECAUTIONS , Geriatric Use ).", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "how many Lidocaine is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 1, "text": "what version of Lidocaine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "10", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Lidocaine is 1 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant 90", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant HALOBETASOL", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HALOBETASOL"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for HALOBETASOL is 1 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 7, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much Diltiazem should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Diltiazem"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 1, "text": "what version of Diltiazem is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Diltiazem is 3 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Calcipotriene?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Calcipotriene"]], "act": "question"}]}
{"index": 1, "text": "Calcipotriene Ointment, 0.005%, is indicated for the treatment of plaque psoriasis in adults. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Sodium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sodium"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Sodium Phosphates Injection, USP is indicated as a source of phosphate, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. The concomitant amount of sodium (4 mEq/mL) must be calculated into total electrolyte dose of such prepared solutions.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is insomnia a common side effect of Ipratropium?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ipratropium"], ["<symptom>", "insomnia"]], "act": "question"}]}
{"index": 1, "text": "insomnia is a common side effect of Ipratropium. Adverse reaction information concerning Ipratropium Bromide and Albuterol Sulfate Inhalation Solution was derived from the 12-week controlled clinical trial. ADVERSE EVENTS OCCURRING IN \u2265 1% OF \u2265 1 TREATMENT GROUP(S) AND WHERE THE COMBINATION TREATMENT SHOWED THE HIGHEST PERCENTAGE Summary of Heart Protection Study Results Body System COSTART Term Albuterol n (%) Ipratropium n (%) Ipratropium Bromide and Albuterol Sulfate Inhalation Solution n (%) NUMBER OF PATIENTS 761 754 765 N (%) Patients with AE 327 (43.0) 329 (43.6) 367 (48.0) BODY AS A WHOLE Pain 8 (1.1) 4 (0.5) 10 (1.3) Pain chest 11 (1.4) 14 (1.9) 20 (2.6) DIGESTIVE Diarrhea 5 (0.7) 9 (1.2) 14 (1.8) Dyspepsia 7 (0.9) 8 (1.1) 10 (1.3", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant tiredness", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "tiredness"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "tiredness is a serious side effect of Ipratropium. Adverse reaction information concerning ipratropium bromide and albuterol sulfate inhalation solution was derived from the 12 week controlled clinical trial. ADVERSE EVENTS OCCURRING IN \u2265 1% OF \u2265 1 TREATMENT GROUP(S) AND WHERE THE COMBINATION TREATMENT SHOWED THE HIGHEST PERCENTAGE Body System Albuterol Ipratropium Ipratropium Bromide and Albuterol Sulfate Inhalation Solution COSTART Term n (%) n (%) n (%) NUMBER OF PATIENTS 761 754 765 N (%) Patients with AE 327 (43) 329 (43.6) 367 (48) BODY AS A WHOLE Pain 8 (1.1) 4 (0.5) 10 (1.3) Pain chest 11 (1.4) 14 (1.9) 20 (2.6) DIGESTIVE Diarrhea 5 (0.7) 9 (1.2) 14 (1.8) Dyspepsia 7 (0.9) 8 (1.1) 10 (1.3) Nausea 7 (0.9) 6 (0.8) 11 (1.4) MUSCULO-SKEL", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Guanfacine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Guanfacine"]], "act": "question"}]}
{"index": 1, "text": "Guanfacine tablets are indicated in the management of hypertension. Guanfacine tablets may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Besivance?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Besivance"]], "act": "question"}]}
{"index": 1, "text": "what version of Besivance is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "BESIFLOXACIN,BENZALKONIUM CHLORIDE,POLYCARBOPHIL,MANNITOL,POLOXAMER 407,SODIUM CHLORIDE,EDETATE DISODIUM,SODIUM HYDROXIDE,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Ceftriaxone?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ceftriaxone"]], "act": "question"}]}
{"index": 1, "text": "what version of Ceftriaxone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "Ceftriaxone for injection may be administered intravenously or intramuscularly. Do not use diluents containing calcium, such as Ringer's solution or Hartmann's solution, to reconstitute ceftriaxone for injection vials or to further dilute a reconstituted vial for IV administration because a precipitate can form. Precipitation of ceftriaxone-calcium can also occur when ceftriaxone for injection is mixed with calcium-containing solutions in the same IV administration line. Ceftriaxone for injection must not be administered simultaneously with calcium-containing IV solutions, including continuous calcium-containing infusions such as parenteral nutrition via a Y-site. However, in patients other ", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "Should I take Loxapine?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Loxapine"]], "act": "question"}]}
{"index": 0, "text": "Loxapine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "pregnant", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "inform"}]}
{"index": 1, "text": "CNS Effects: Manifestations of adverse effects on the central nervous system, other than extrapyramidal effects, have been seen infrequently. Drowsiness, usually mild, may occur at the beginning of therapy or when dosage is increased. It usually subsides with continued loxapine therapy. The incidence of sedation has been less than that of certain aliphatic phenothiazines and slightly more than the piperazine phenothiazines. Dizziness, faintness, staggering gait, shuffling gait, muscle twitching, weakness, insomnia, agitation, tension, seizures, akinesia, slurred speech, numbness, and confusional states have been reported. Neuroleptic malignant syndrome (NMS) has been reported (see WARNINGS )", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant heart_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Brompheniramine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Brompheniramine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The most frequent adverse reactions to Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide Syrup are: sedation; dryness of mouth, nose and throat; thickening of bronchial secretions; dizziness. Other adverse reactions may include: Dermatologic: Urticaria, drug rash, photosensitivity, pruritus. Cardiovascular System: Hypotension, hypertension, cardiac arrhythmias, palpitation. CNS: Disturbed coordination, tremor, irritability, insomnia, visual disturbances, weakness, nervousness, convulsions, headache, euphoria, and dysphoria. G.U. System: Urinary frequency, difficult urination. G.I. System: Epigastric discomfort, anorexia, nausea, vomiting, diarrhea, con", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Gabapentin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Gabapentin"]], "act": "question"}]}
{"index": 0, "text": "Gabapentin capsules, USP are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Nifediac", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Nifediac"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Nifediac  CC extended-release tablets are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "what is the dose for Hydroxychloroquine for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydroxychloroquine"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 0, "text": "what version of Hydroxychloroquine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Hydroxychloroquine is 3 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant 90", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The dosage for Hydroxychloroquine is 3 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Dutasteride?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dutasteride"]], "act": "question"}]}
{"index": 1, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many ADAPALENE is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ADAPALENE"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 2, "text": "what version of ADAPALENE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for ADAPALENE is 1 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for ADAPALENE is 1 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "how do I take Oxandrolone?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxandrolone"]], "act": "question"}]}
{"index": 0, "text": "what version of Oxandrolone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Therapy with anabolic steroids is adjunctive to and not a replacement for conventional therapy. The duration of therapy with Oxandrolone Tablets will depend on the response of the patient and the possible appearance of adverse reactions. Therapy should be intermittent.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant CYSTARAN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CYSTARAN"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Extended in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Extended"]], "act": "question"}]}
{"index": 1, "text": "what version of Extended is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Extended", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is it normal to have anxiety with GEMFIBROZIL?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "GEMFIBROZIL"], ["<symptom>", "anxiety"]], "act": "question"}]}
{"index": 0, "text": "anxiety is a dangerous side effect of GEMFIBROZIL. In the double-blind controlled phase of the primary prevention component of the Helsinki Heart Study, 2046 patients received gemfibrozil for up to five years. In that study, the following adverse reactions were statistically more frequent in subjects in the gemfibrozil group: GEMFIBROZIL (N=2046) PLACEBO (N=2035) Frequency in percent of subjects Gastrointestinal reactions 34.2 23.8 Dyspepsia 19.6 11.9 Abdominal pain 9.8 5.6 Acute appendicitis (histologically confirmed in most cases where data were available) 1.2 0.6 Atrial fibrillation 0.7 0.1 Adverse events reported by more than 1% of subjects, but without a significant difference between groups: Diarrhea 7.2 6.5 Fatigue 3.8 3.5 Nausea/Vomi", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant tiredness", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "tiredness"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "tiredness is a mild side effect of GEMFIBROZIL. In the double-blind controlled phase of the primary prevention component of the Helsinki Heart Study, 2046 patients received gemfibrozil tablets for up to five years. In that study, the following adverse reactions were statistically more frequent in subjects in the gemfibrozil tablets group: Gemfibrozil Tablet (N = 2046) Placebo (N = 2035) Frequency in percent of subjects Gastrointestinal reactions 34.2 23.8 Dyspepsia 19.6 11.9 Abdominal pain 9.8 5.6 Acute appendicitis (histologically confirmed in most cases where data were available) 1.2 0.6 Atrial fibrillation 0.7 0.1 Adverse events reported by more than 1% subjects, but without a significant difference between groups: Diarrhea 7.2 6.5 Fat", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many NAPROXEN is the correct dose for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NAPROXEN"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of NAPROXEN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for NAPROXEN is 4 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant child", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for NAPROXEN is 2 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is hallucinations a common side effect of 50%?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "50%"], ["<symptom>", "hallucinations"]], "act": "question"}]}
{"index": 1, "text": "hallucinations is a serious side effect of 50%. Hyperosmolar syndrome, resulting from excessively rapid administration of concentrated dextrose may cause mental confusion and/or loss of consciousness. Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant fever", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "fever"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Primidone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Primidone"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "do I need to keep PROMETHAZINE in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PROMETHAZINE"]], "act": "question"}]}
{"index": 0, "text": "what version of PROMETHAZINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug PROMETHAZINE", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Cyclopentolate", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cyclopentolate"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Heparin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Heparin"]], "act": "question"}]}
{"index": 1, "text": "Heparin Sodium Injection is indicated for: Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; Low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease (see DOSAGE AND ADMINISTRATION ); Prophylaxis and treatment of pulmonary embolism; Atrial fibrillation with embolization; Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); Prevention of clotting in arterial and cardiac surgery; Prophylaxis and treatment of peripheral arterial embolism. Hepa", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much Diphenoxylate should i take for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Diphenoxylate"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 1, "text": "what version of Diphenoxylate is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "90", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Diphenoxylate is 3 mg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "what do I do with Ropivacaine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ropivacaine"]], "act": "question"}]}
{"index": 0, "text": "what version of Ropivacaine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "The rapid injection of a large volume of local anesthetic solution should be avoided and fractional (incremental) doses should always be used. The smallest dose and concentration required to produce the desired result should be administered. There have been adverse event reports of chondrolysis in patients receiving intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures. Ropivacaine hydrochloride injection is not approved for this use (see WARNINGS and DOSAGE AND ADMINISTRATION ). The dose of any local anesthetic administered varies with the anesthetic procedure, the area to be anesthetized, the vascularity of the tissues, the number of neuronal s", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much Chloroprocaine should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Chloroprocaine"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 2, "text": "what version of Chloroprocaine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Chloroprocaine is 3 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use 3%?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "3%"]], "act": "question"}]}
{"index": 1, "text": "what version of 3% is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "As with all local anesthetics, the dose varies and depends upon the area to be anesthetized, the vascularity of the tissues, individual tolerance and the technique of anesthesia. The lowest dose needed to provide effective anesthesia should be administered. For specific techniques and procedures refer to standard dental manuals and textbooks. For infiltration and block injections in the upper or lower jaw, the average dose of 1 cartridge will usually suffice. Each cartridge contains 1.7 mL (34 mg of 2% or 51 mg of 3%). 5.3 cartridges (180 mg of the 2% solution or 270 mg of the 3% solution) are usually adequate to effect anesthesia of the entire oral cavity. Whenever a larger dose seems to be", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant 6930120P", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "6930120P"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "When Lidocaine Hydrochloride Jelly USP, 2% is used concomitantly with other products containing lidocaine, the total dose contributed by all formulations must be kept in mind. The dosage varies and depends upon the area to be anesthetized, vascularity of the tissues, individual tolerance, and the technique of anesthesia. The lowest dosage needed to provide effective anesthesia should be administered. Dosages should be reduced for children and for elderly and debilitated patients. Although the incidence of adverse effects with Lidocaine Hydrochloride Jelly USP, 2% is quite low, caution should be exercised, particularly when employing large amounts, since the incidence of adverse effects is di", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of Lidocaine?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of Lidocaine: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "fever", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "fever"]], "act": "inform"}]}
{"index": 2, "text": "fever is a common side effect of Lidocaine. Adverse experiences following the administration of lidocaine are similar in nature to those observed with other amide local anesthetic agents. Adverse experiences may result from high plasma levels caused by excessive dosage or may result from a hypersensitivity, idiosyncrasy or diminished tolerance on the part of the patient. Serious adverse experiences are generally systemic in nature. The following types are those most commonly reported. The adverse experiences under Central Nervous System and Cardiovascular System are listed, in general, in a progression from mild to severe. Central Nervous System: CNS reactions are excitatory and/or depressant and may be characterized by light-headedne", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "actually i meant insomnia", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "insomnia"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is HESPAN safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HESPAN"]], "act": "question"}]}
{"index": 1, "text": "HESPAN may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "TB", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "inform"}]}
{"index": 2, "text": "The serious adverse events reported in clinical trials are increased mortality and renal replacement therapy renal in critically ill patients. Most common adverse reactions are hypersensitivity, coagulopathy, hemodilution, circulatory overload and metabolic acidosis.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "What is Levobunolol?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Levobunolol"]], "act": "question"}]}
{"index": 0, "text": "Levobunolol Hydrochloride Ophthalmic Solution has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertension.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "What is Latanoprost?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Latanoprost"]], "act": "question"}]}
{"index": 0, "text": "Latanoprost Sterile Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have fever with NYSTATIN?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NYSTATIN"], ["<symptom>", "fever"]], "act": "question"}]}
{"index": 1, "text": "fever is a dangerous side effect of NYSTATIN. Nystatin is well tolerated even with prolonged therapy. Oral irritation and sensitization have been reported. (See PRECAUTIONS: General ). Gastrointestinal : Diarrhea (including one case of bloody diarrhea), nausea, vomiting, gastrointestinal upset/disturbances. Dermatologic : Rash, including urticaria has been reported rarely. Stevens-Johnson syndrome has been reported very rarely. Other : Tachycardia, broncho-spasm, facial swelling, and non-specific myalgia have also been rarely reported.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Pentasa", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Pentasa"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take Vanilla  if I am heart_problems?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Vanilla"], ["<condition>", "heart_problems"]], "act": "question"}]}
{"index": 0, "text": "Adverse reactions accompanying the use of barium sulfate formulations are infrequent and usually mild, though severe reactions (approximately 1 in 500,000) and fatalities (approximately 1 in 2,000,000) have occurred. Procedural complications are rare, but may include aspiration pneumonitis, barium sulfate impaction, granuloma formation, intravasation, embolization and peritonitis following intestinal perforation, vasovagal and syncopal episodes, and fatalities. EKG changes have been shown to occur following or during barium sulfate suspension enemas. It is of the utmost importance to be completely prepared to treat any such occurrence. Due to the increased likelihood of allergic reactions in", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant Flecainide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Flecainide"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant pregnant", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Erythromycin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Erythromycin"]], "act": "question"}]}
{"index": 1, "text": "Erythromycin is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below: Upper respiratory tract infections of mild to moderate degree caused by Streptococcus pyogenes, Streptococcus pneumoniae, or Haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of H. influenzae are not susceptible to the erythromycin concentrations ordinarily achieved) (see appropriate sulfonamide labeling for prescribing information). Lower respiratory tract infections of mild to moderate severity caused by Streptococcus pneumoniae or Streptococcus pyogenes. Listeriosis caused by Listeria monocyto", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Is ISOSORBIDE safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ISOSORBIDE"]], "act": "question"}]}
{"index": 0, "text": "ISOSORBIDE may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "IBD", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "inform"}]}
{"index": 1, "text": "Adverse reactions to isosorbide dinitrate are generally dose-related, and almost all of these reactions are the result of isosorbide dinitrate's activity as a vasodilator. Headache, which may be severe, is the most commonly reported side effect. Headache may be recurrent with each daily dose, especially at higher doses. Transient episodes of lightheadedness, occasionally related to blood pressure changes, may also occur. Hypotension occurs infrequently, but in some patients it may be severe enough to warrant discontinuation of therapy. Syncope, crescendo angina, and rebound hypertension have been reported but are uncommon. Extremely rarely, ordinary doses of organic nitrates have caused meth", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant TB", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for amoxicillin?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "amoxicillin"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 2, "text": "what version of amoxicillin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for amoxicillin is 1 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Metronidazole?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metronidazole"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 2, "text": "what version of Metronidazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Metronidazole is 1 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what do I do with Amantadine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amantadine"]], "act": "question"}]}
{"index": 0, "text": "what version of Amantadine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "The dose of amantadine hydrochloride capsules may need reduction in patients with congestive heart failure, peripheral edema, orthostatic hypotension, or impaired renal function (see Dosage for Impaired Renal Function ).", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Sulfacetamide in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sulfacetamide"]], "act": "question"}]}
{"index": 1, "text": "what version of Sulfacetamide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Sulfacetamide", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant Hydrocortisone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrocortisone"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Hydrocortisone", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Ciclopirox?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ciclopirox"]], "act": "question"}]}
{"index": 1, "text": "what version of Ciclopirox is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "CICLOPIROX,ETHYL ACETATE,ISOPROPYL ALCOHOL,MALEIC ACID", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant Balsalazide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Balsalazide"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "SILICON DIOXIDE,MAGNESIUM STEARATE,TITANIUM DIOXIDE,PROPYLENE GLYCOL,AMMONIA,SHELLAC,FERRIC OXIDE RED,BALSALAZIDE DISODIUM", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much SODIUM should i take for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SODIUM"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 0, "text": "what version of SODIUM is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for SODIUM is 1 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant HYDROQUINONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROQUINONE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant adult", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store SULINDAC?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SULINDAC"]], "act": "question"}]}
{"index": 1, "text": "what version of SULINDAC is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug SULINDAC", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is SILVER?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SILVER"]], "act": "question"}]}
{"index": 1, "text": "Silver Sulfadiazine Cream 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of ADCETRIS?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ADCETRIS"]], "act": "question"}]}
{"index": 1, "text": "what version of ADCETRIS is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "Brentuximab Vedotin,Trehalose Dihydrate,Trisodium Citrate Dihydrate,Citric Acid Monohydrate,Polysorbate 80", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Sulfamethoxazole", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sulfamethoxazole"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "SULFAMETHOXAZOLE,TRIMETHOPRIM,ALCOHOL,CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM,ANHYDROUS CITRIC ACID,SILICON DIOXIDE,FD&C RED NO. 40,GLYCERIN,METHYLPARABEN,MICROCRYSTALLINE CELLULOSE,POLYSORBATE 80,WATER,SACCHARIN SODIUM,SODIUM BENZOATE,SORBITOL", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Midazolam safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Midazolam"]], "act": "question"}]}
{"index": 1, "text": "Midazolam may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "TB", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "inform"}]}
{"index": 2, "text": "See WARNINGS concerning serious cardiorespiratory events and possible paradoxical reactions. Fluctuations in vital signs were the most frequently seen findings following parenteral administration of midazolam in adults and included decreased tidal volume and/or respiratory rate decrease (23.3% of patients following intravenous and 10.8% of patients following intramuscular administration) and apnea (15.4% of patients following intravenous administration), as well as variations in blood pressure and pulse rate. The majority of serious adverse effects, particularly those associated with oxygenation and ventilation, have been reported when midazolam is administered with other medications capable", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant glaucoma", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Caffeine?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Caffeine"]], "act": "question"}]}
{"index": 1, "text": "what version of Caffeine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "CAFFEINE CITRATE,CITRIC ACID MONOHYDRATE,TRISODIUM CITRATE DIHYDRATE,WATER,CAFFEINE CITRATE,CITRIC ACID MONOHYDRATE,TRISODIUM CITRATE DIHYDRATE,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant LEVETIRACETAM", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "LEVETIRACETAM"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Levetiracetam,acesulfame potassium,glycyrrhizin, ammoniated,citric acid monohydrate,glycerin,maltitol,methylparaben,propylparaben,water,trisodium citrate dihydrate", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "how many Colistimethate is the correct dose for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Colistimethate"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 0, "text": "what version of Colistimethate is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "90", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Colistimethate is 4 grams per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant 80", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what do I do with amlodipine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "amlodipine"]], "act": "question"}]}
{"index": 0, "text": "what version of amlodipine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "2.1 Adults The usual initial antihypertensive oral dose of amlodipine besylate tablets are 5 mg once daily, and the maximum dose is 10 mg once daily. Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily and this dose may be used when adding amlodipine besylate tablets to other antihypertensive therapy. Adjust dosage according to blood pressure goals. In general, wait 7 to 14 days between titration steps. Titrate more rapidly, however, if clinically warranted, provided the patient is assessed frequently. Angina: The recommended dose for chronic stable or vasospastic angina is 5\u201310 mg, with the lower dose suggested in the elderly and i", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "2.1 Adults The usual initial antihypertensive oral dose of amlodipine besylate tablets are 5 mg once daily, and the maximum dose is 10 mg once daily. Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily and this dose may be used when adding amlodipine besylate tablets to other antihypertensive therapy. Adjust dosage according to blood pressure goals. In general, wait 7 to 14 days between titration steps. Titrate more rapidly, however, if clinically warranted, provided the patient is assessed frequently. Angina: The recommended dose for chronic stable or vasospastic angina is 5\u201310 mg, with the lower dose suggested in the elderly and i", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Tramadol?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tramadol"]], "act": "question"}]}
{"index": 1, "text": "what version of Tramadol is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Adults (17 years of age and over) For patients with moderate to moderately severe chronic pain not requiring rapid onset of analgesic effect, the tolerability of tramadol hydrochloride tablets can be improved by initiating therapy with the following titration regimen: The total daily dose may be increased by 50 mg as tolerated every 3 days to reach 200 mg/day (50 mg q.i.d.). After titration, tramadol hydrochloride tablets 50 mg to 100 mg can be administered as needed for pain relief every four to six hours, not to exceed 400 mg per day. For the subset of patients for whom rapid onset of analgesic effect is required and for whom the benefits outweigh the risk of discontinuation due to adverse", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Matulane", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Matulane"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much Nitroglycerin should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nitroglycerin"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 2, "text": "what version of Nitroglycerin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Nitroglycerin is 2 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have suicidal with Carbidopa?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Carbidopa"], ["<symptom>", "suicidal"]], "act": "question"}]}
{"index": 1, "text": "suicidal is a mild side effect of Carbidopa. The most common adverse reactions reported with carbidopa and levodopa therapy have included dyskinesias, such as choreiform, dystonic, and other involuntary movements and nausea. The following other adverse reactions have been reported with carbidopa and levodopa: Body as a Whole: chest pain, asthenia. Cardiovascular: cardiac irregularities, hypotension, orthostatic effects including orthostatic hypotension, hypertension, syncope, phlebitis, palpitation. Gastrointestinal: dark saliva, gastrointestinal bleeding, development of duodenal ulcer, anorexia, vomiting, diarrhea, constipation, dyspepsia, dry mouth, taste alterations. Hematologic: agranulocytosis, hemolytic and nonhemolytic anemia, t", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Tretinoin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Tretinoin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant aggression", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "aggression"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Adapalene?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Adapalene"]], "act": "question"}]}
{"index": 1, "text": "what version of Adapalene is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Adapalene gel 0.1% should be applied once a day to affected areas after washing in the evening before retiring. A thin film of the gel should be applied, avoiding eyes, lips, and mucous membranes. During the early weeks of therapy, an apparent exacerbation of acne may occur. This is due to the action of the medication on previously unseen lesions and should not be considered a reason to discontinue therapy. Therapeutic results should be noticed after eight to twelve weeks of treatment.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Oxybutynin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxybutynin"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Syrup Adults: The usual dose is one teaspoon (5 mg/5 mL) of syrup two to three times a day. The maximum recommended dose is one teaspoon (5 mg/5 mL) of syrup four times a day. A lower starting dose of 2.5 mg two or three times a day is recommended for the frail elderly. Pediatric patients over 5 years of age: The usual dose is one teaspoon (5 mg/5 mL) of syrup two times a day. The maximum recommended dose is one teaspoon (5 mg/5mL) of syrup three times a day.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Phenoxybenzamine?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Phenoxybenzamine"]], "act": "question"}]}
{"index": 1, "text": "what version of Phenoxybenzamine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Phenoxybenzamine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant LOVASTATIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "LOVASTATIN"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "storage instructions for drug LOVASTATIN", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Isosorbide safe  for someone with anxiety?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Isosorbide"], ["<condition>", "anxiety"]], "act": "question"}]}
{"index": 1, "text": "Adverse reactions to isosorbide dinitrate are generally dose-related, and almost all of these reactions are the result of isosorbide dinitrate's activity as a vasodilator. Headache, which may be severe, is the most commonly reported side effect. Headache may be recurrent with each daily dose, especially at higher doses. Transient episodes of lightheadedness, occasionally related to blood pressure changes, may also occur. Hypotension occurs infrequently, but in some patients it may be severe enough to warrant discontinuation of therapy. Syncope, crescendo angina, and rebound hypertension have been reported but are uncommon. Extremely rarely, ordinary doses of organic nitrates have caused meth", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much Ranitidine should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ranitidine"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of Ranitidine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Ranitidine is 4 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant baby", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Ranitidine is 1 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have diarrhea with Nitroglycerin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nitroglycerin"], ["<symptom>", "diarrhea"]], "act": "question"}]}
{"index": 1, "text": "diarrhea is a mild side effect of Nitroglycerin. Headache that may be severe and persistent may occur immediately after use. Vertigo, dizziness, weakness, palpitation, and other manifestations of postural hypotension may develop occasionally, particularly in erect, immobile patients. Marked sensitivity to the hypotensive effects of nitrates (manifested by nausea, vomiting, weakness, diaphoresis, pallor, and collapse) may occur at therapeutic doses. Syncope due to nitrate vasodilatation has been reported. Flushing, drug rash, and exfoliative dermatitis have been reported in patients receiving nitrate therapy.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Colgate", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Colgate"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "where should I keep Calcium?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Calcium"]], "act": "question"}]}
{"index": 1, "text": "what version of Calcium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Calcium", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Cefazolin cause blurred_vision?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cefazolin"], ["<symptom>", "blurred_vision"]], "act": "question"}]}
{"index": 0, "text": "blurred_vision is a mild side effect of Cefazolin. The following reactions have been reported:", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant Acetic", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Acetic"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what do I do with Rifampin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Rifampin"]], "act": "question"}]}
{"index": 0, "text": "what version of Rifampin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "Rifampin can be administered by IV infusion (see INDICATIONS AND USAGE ). See CLINICAL PHARMACOLOGY for dosing information in patients with renal failure. Tuberculosis Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, IV Pediatric Patients: 10-20 mg/kg, not to exceed 600 mg/day, IV Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide (e.g., RIFATER  ) is recommended in the initial phase of short-course therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Rifampin can be administered by IV infusion (see INDICATIONS AND USAGE ). See CLINICAL PHARMACOLOGY for dosing information in patients with renal failure. Tuberculosis Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, IV Pediatric Patients: 10-20 mg/kg, not to exceed 600 mg/day, IV Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide (e.g., RIFATER  ) is recommended in the initial phase of short-course therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Nitroglycerin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nitroglycerin"]], "act": "question"}]}
{"index": 1, "text": "what version of Nitroglycerin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "One tablet should be dissolved under the tongue or in the buccal pouch at the first sign of an acute anginal attack. The dose may be repeated approximately every 5 minutes until relief is obtained. If the pain persists after a total of 3 tablets in a 15-minute period, or if the pain is different than is typically experienced, prompt medical attention is recommended. Nitroglycerin may be used prophylactically 5 to 10 minutes prior to engaging in activities that might precipitate an acute attack. During administration the patient should rest, preferably in the sitting position. No dosage adjustment is required in patients with renal failure.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Phenazopyridine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Phenazopyridine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Adults: 200 mg 3 times daily after meals. When used concomitantly with an antibacterial agent for the treatment of a urinary tract infection, the administration of phenazopyridine should not exceed 2 days. If symptoms persist, the patient should be re-evaluated.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Sulfacetamide cause itchy_skin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sulfacetamide"], ["<symptom>", "itchy_skin"]], "act": "question"}]}
{"index": 1, "text": "itchy_skin is a common side effect of Sulfacetamide. Adverse reactions have occurred with corticosteroid/anti-infective combination drugs which can be attributed to the corticosteroid component, the anti-infective component, or the combination. Exact incidence figures are not available since no denominator of treated patients is available. Reactions occurring most often from the presence of the anti-infective ingredient are allergic sensitizations. Fatalities have occurred, although rarely, due to severe reactions to sulfonamides including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia, and other blood dyscrasias (see WARNINGS ). Sulfacetamide sodium may cause local irritation", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Primidone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Primidone"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant vomiting", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "vomiting is a mild side effect of Primidone. The most frequently occurring early side effects are ataxia and vertigo. These tend to disappear with continued therapy, or with reduction of initial dosage. Occasionally, the following have been reported: nausea, anorexia, vomiting, fatigue, hyperirritability, emotional disturbances, sexual impotency, diplopia, nystagmus, drowsiness, and morbilliform skin eruptions. Granulocytopenia, agranulocytosis, and red-cell hypoplasia and aplasia, have been reported rarely. These and, occasionally, other persistent or severe side effects may necessitate withdrawal of the drug. Megaloblastic anemia may occur as a rare idiosyncrasy to primidone and to other anticonvulsants. The anemia responds to folic ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "what is the dose for CYCLOBENZAPRINE?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CYCLOBENZAPRINE"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 1, "text": "what version of CYCLOBENZAPRINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for CYCLOBENZAPRINE is 2 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant elderly", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for CYCLOBENZAPRINE is 4 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 7, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is it normal to have stomach_ache with ROSUVASTATIN?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ROSUVASTATIN"], ["<symptom>", "stomach_ache"]], "act": "question"}]}
{"index": 0, "text": "stomach_ache is a serious side effect of ROSUVASTATIN. The following serious adverse reactions are discussed in greater detail in other sections of the label: Rhabdomyolysis with myoglobinuria and acute renal failure and myopathy (including myositis) [see Warnings and Precautions ( 5.1 )] Liver enzyme abnormalities [see Warnings and Precautions ( 5.2 )]", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant clindamycin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "clindamycin"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is DOXYCYCLINE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DOXYCYCLINE"]], "act": "question"}]}
{"index": 1, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is the dose for Theophylline for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Theophylline"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 0, "text": "what version of Theophylline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Theophylline is 1 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant 10", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "10"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Adapalene", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Adapalene"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Adapalene is 1 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "what are the side effects of To?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "To"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of To: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "fever", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "fever"]], "act": "inform"}]}
{"index": 1, "text": "fever is a dangerous side effect of To. The following reactions have been reported with the use of clindamycin.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Procentra", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Procentra"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant fever", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "fever"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "What is Hyoscyamine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hyoscyamine"]], "act": "question"}]}
{"index": 0, "text": "Hyoscyamine Sulfate Tablets, USP are effective as adjunctive therapy in the treatment of peptic ulcer. They can also be used to control gastric secretions, visceral spasm and hypermotility in spastic colitis, spastic bladder, cystitis, pylorospasm and associated abdominal cramps. May be used in functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries, diverticulitis and acute enterocolitis. For use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and functional gastrointestinal disorders. Also used as adjunctive therapy in the treatment of neurogenic bladder and neurogenic bowel disturbances (", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is NAPROXEN?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NAPROXEN"]], "act": "question"}]}
{"index": 0, "text": "Carefully consider the potential benefits and risks of naproxen delayed-release tablets and other treatment options before deciding to use naproxen delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Naproxen delayed-release tablets are indicated: For the relief of the signs and symptoms of rheumatoid arthritis For the relief of the signs and symptoms of osteoarthritis For the relief of the signs and symptoms of ankylosing spondylitis For the relief of the signs and symptoms of juvenile arthritis Naproxen as naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain t", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Theophylline", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Theophylline"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Granisetron?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Granisetron"]], "act": "question"}]}
{"index": 1, "text": "what version of Granisetron is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "Emetogenic Chemotherapy The recommended adult dosage of oral granisetron hydrochloride is 2 mg once daily or 1 mg twice daily. In the 2 mg once-daily regimen, two 1 mg tablets are given up to 1 hour before chemotherapy. In the 1 mg twice-daily regimen, the first 1 mg tablet is given up to 1 hour before chemotherapy, and the second tablet, 12 hours after the first. Either regimen is administered only on the day(s) chemotherapy is given. Continued treatment, while not on chemotherapy, has not been found to be useful. Use in the Elderly, Renal Failure Patients or Hepatically Impaired Patients No dosage adjustment is recommended (see CLINICAL PHARMACOLOGY: Pharmacokinetics ) . Pediatric Use Safe", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Dextroamphetamine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Dextroamphetamine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Amphetamines should be administered at the lowest effective dosage and dosage should be individually adjusted. Late evening doses should be avoided because of the resulting insomnia. Narcolepsy Usual dose is 5 to 60 mg per day in divided doses, depending on the individual patient response. Narcolepsy seldom occurs in children under 12 years of age; however, when it does, dextroamphetamine sulfate tablets may be used. The suggested initial dose for patients aged 6 to 12 is 5 mg daily; daily dose may be raised in increments of 5 mg at weekly intervals until an optimal response is obtained. In patients 12 years of age and older, start with 10 mg daily; daily dosage may be raised in increments o", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Ondansetron cause itchy_skin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ondansetron"], ["<symptom>", "itchy_skin"]], "act": "question"}]}
{"index": 1, "text": "itchy_skin is a mild side effect of Ondansetron. The following have been reported as adverse events in clinical trials of patients treated with ondansetron, the active ingredient of ondansetron orally disintegrating tablets. A causal relationship to therapy with ondansetron has been unclear in many cases. Chemotherapy-Induced Nausea and Vomiting The adverse events in Table 5 have been reported in \u22655% of adult patients receiving a single 24 mg ondansetron tablet in 2 trials. These patients were receiving concurrent highly emetogenic cisplatin-based chemotherapy regimens (cisplatin dose \u226550 mg/m 2 ). Table 5. Principal Adverse Events in U.S. Trials: Single Day Therapy With 24 mg Ondansetron Tablets (Highly Emetogenic Chemotherapy) Event Onda", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant hallucinations", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "hallucinations"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Midazolam in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Midazolam"]], "act": "question"}]}
{"index": 1, "text": "what version of Midazolam is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Midazolam", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store 0.45%?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "0.45%"]], "act": "question"}]}
{"index": 1, "text": "what version of 0.45% is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug 0.45%", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug 0.45%", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is fever a common side effect of TriLyte?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TriLyte"], ["<symptom>", "fever"]], "act": "question"}]}
{"index": 1, "text": "fever is a dangerous side effect of TriLyte. Nausea, abdominal fullness and bloating are the most common adverse reactions (occurring in up to 50% of patients) to administration of TRILYTE with flavor packs. Abdominal cramps, vomiting and anal irritation occur less frequently. These adverse reactions are transient and subside rapidly. Isolated cases of urticaria, rhinorrhea, dermatitis, and (rarely) anaphylactic reaction have been reported which may represent allergic reactions. Published literature contains isolated reports of serious adverse reactions following the administration of PEG-ELS products in patients over 60 years of age. These adverse events include upper GI bleeding from Mallory-Weiss Tear, esophageal perforation, asysto", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "where should I keep Exelderm?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Exelderm"]], "act": "question"}]}
{"index": 1, "text": "what version of Exelderm is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Exelderm", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant acyclovir", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "acyclovir"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "storage instructions for drug acyclovir", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Fluphenazine cause stomach_ache?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluphenazine"], ["<symptom>", "stomach_ache"]], "act": "question"}]}
{"index": 1, "text": "stomach_ache is a serious side effect of Fluphenazine. Central Nervous System The side effects most frequently reported with phenothiazine compounds are extrapyramidal symptoms including pseudoparkinsonism, dystonia, dyskinesia, akathisia, oculogyric crises, opisthotonos, and hyperreflexia. Muscle rigidity sometimes accompanied by hyperthermia has been reported following use of fluphenazine decanoate. Most often these extrapyramidal symptoms are reversible; however, they may be persistent (see below). The frequency of such reactions is related in part to chemical structure: one can expect a higher incidence with fluphenazine decanoate than with less potent piperazine derivatives or with straight-chain phenothiazines such as chlorpromazine. With ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant SODIUM", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "SODIUM"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant depression", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "depression"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "do I need to keep Revesta in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Revesta"]], "act": "question"}]}
{"index": 0, "text": "what version of Revesta is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Revesta", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have stomach_ache with Taclonex?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Taclonex"], ["<symptom>", "stomach_ache"]], "act": "question"}]}
{"index": 1, "text": "stomach_ache is a serious side effect of Taclonex. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant SOOLANTRA", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "SOOLANTRA"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "stomach_ache is a common side effect of SOOLANTRA. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. During clinical trials, 2047 subjects with inflammatory lesions of rosacea received SOOLANTRA cream once daily. A total of 1555 subjects were treated once daily for more than 12 weeks, and 519 for approximately one year. Adverse reactions, reported in \u2264 1% of subjects treated with SOOLANTRA cream for at least 3 months in vehicle-controlled clinical trials, included skin burning sensation and skin irritation. In postmarketing use wit", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Citalopram is the correct dose for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Citalopram"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 1, "text": "what version of Citalopram is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Citalopram is 3 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Demadex?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Demadex"]], "act": "question"}]}
{"index": 1, "text": "what version of Demadex is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "General DEMADEX tablets may be given at any time in relation to a meal, as convenient. Special dosage adjustment in the elderly is not necessary. Congestive Heart Failure The usual initial dose of DEMADEX is 10 mg or 20 mg of once-daily oral DEMADEX. If the diuretic response is inadequate, the dose should be titrated upward by approximately doubling until the desired diuretic response is obtained. Single doses higher than 200 mg have not been adequately studied. Chronic Renal Failure The usual initial dose of DEMADEX is 20 mg of once-daily oral DEMADEX. If the diuretic response is inadequate, the dose should be titrated upward by approximately doubling until the desired diuretic response is ", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Cefprozil", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cefprozil"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what is the dose for HYDROXYZINE?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROXYZINE"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 1, "text": "what version of HYDROXYZINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for HYDROXYZINE is 1 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Phenazopyridine is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Phenazopyridine"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 2, "text": "what version of Phenazopyridine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Phenazopyridine is 3 mg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "actually i meant Ringers", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ringers"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 7, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Diclofenac cause stomach_ache?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Diclofenac"], ["<symptom>", "stomach_ache"]], "act": "question"}]}
{"index": 1, "text": "stomach_ache is a serious side effect of Diclofenac. The following adverse reactions are discussed in greater detail in other sections of the labeling:  Cardiovascular Thrombotic Events (see WARNINGS )  GI Bleeding, Ulceration and Perforation (see WARNINGS )  Hepatotoxicity (see WARNINGS )  Hypertension (see WARNINGS )  Heart Failure and Edema (see WARNINGS )  Renal Toxicity and Hyperkalemia (see WARNINGS )  Anaphylactic Reactions (see WARNINGS )  Serious Skin Reactions (see WARNINGS )  Hematologic Toxicity (see WARNINGS )", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I take metformin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "metformin"]], "act": "question"}]}
{"index": 0, "text": "what version of metformin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "There is no fixed dosage regimen for the management of hyperglycemia in patients with type 2 diabetes with metformin hydrochloride extended-release tablets or any other pharmacologic agent. Dosage of metformin hydrochloride extended-release tablets must be individualized on the basis of both effectiveness and tolerance, while not exceeding the maximum recommended daily doses. The maximum recommended daily dose of metformin hydrochloride extended-release tablets in adults is 2000 mg. Metformin hydrochloride extended-release tablets should generally be given once daily with the evening meal. Metformin hydrochloride extended-release tablets should be started at a low dose, with gradual dose esc", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with BENZTROPINE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BENZTROPINE"]], "act": "question"}]}
{"index": 1, "text": "what version of BENZTROPINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Benztropine mesylate tablets should be used when patients are able to take oral medication. Because of cumulative action, therapy should be initiated with a low dose which is increased gradually at five or six-day intervals to the smallest amount necessary for optimal relief. Increases should be made in increments of 0.5 mg. to a maximum of 6 mg. or until optimal results are obtained without excessive adverse reactions.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Butisol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Butisol"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I store Phenytoin?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Phenytoin"]], "act": "question"}]}
{"index": 0, "text": "what version of Phenytoin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Phenytoin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "storage instructions for drug Phenytoin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Tetracycline?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tetracycline"]], "act": "question"}]}
{"index": 1, "text": "what version of Tetracycline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "Adults: Usual daily dose, 1 gram as 500 mg twice a day or 250 mg four times a day. Higher doses such as 500 mg four times a day may be required for severe infections or for those infections which do not respond to the smaller doses. For pediatric patients above eight years of age: Usual daily dose, 10 mg/lb to 20 mg/lb (25mg/kg to 50 mg/kg) body weight divided in four equal doses. Administration of adequate amounts of fluid with the capsule formulation of tetracycline is recommended to wash down the drug and reduce the risk of esophageal irritation and ulceration (see ADVERSE REACTIONS ). Absorption of tetracycline is impaired by antacids containing aluminum, calcium or magnesium and prepara", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant LOVASTATIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "LOVASTATIN"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The patient should be placed on a standard cholesterol-lowering diet before receiving lovastatin and should continue on this diet during treatment with lovastatin (see NCEP Treatment Guidelines for details on dietary therapy). Lovastatin should be given with meals. Adult Patients: The usual recommended starting dose is 20 mg once a day given with the evening meal. The recommended dosing range is 10-80 mg/day in single or two divided doses; the maximum recommended dose is 80 mg/day. Doses should be individualized according to the recommended goal of therapy (see NCEP Guidelines and CLINICAL PHARMACOLOGY ). Patients requiring reductions in LDL-C of 20% or more to achieve their goal (see INDICA", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Should I take Sertraline?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sertraline"]], "act": "question"}]}
{"index": 0, "text": "Sertraline may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "heart_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "heart_problems"]], "act": "inform"}]}
{"index": 1, "text": "During its premarketing assessment, multiple doses of sertraline hydrochloride were administered to over 4000 adult subjects as of February 18, 2000. The conditions and duration of exposure to sertraline hydrochloride varied greatly, and included (in overlapping categories) clinical pharmacology studies, open and double-blind studies, uncontrolled and controlled studies, inpatient and outpatient studies, fixed-dose and titration studies, and studies for multiple indications, including major depressive disorder, OCD, panic disorder, PTSD, PMDD and social anxiety disorder. Untoward events associated with this exposure were recorded by clinical investigators using terminology of their own choos", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "What is Azulfidine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Azulfidine"]], "act": "question"}]}
{"index": 0, "text": "AZULFIDINE EN-tabs Tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; b) for the prolongation of the remission period between acute attacks of ulcerative colitis; c) in the treatment of patients with rheumatoid arthritis who have responded inadequately to salicylates or other nonsteroidal anti-inflammatory drugs (e.g., an insufficient therapeutic response to, or intolerance of, an adequate trial of full doses of one or more nonsteroidal anti-inflammatory drugs); and d) in the treatment of pediatric patients with polyarticular-course 1 juvenile rheumatoid arthritis who have responded inadequately to salicy", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Cyanocobalamin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cyanocobalamin"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Cyanocobalamin is indicated for Vitamin B 12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacterial overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency It may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see Drug/Laboratory Test Interactions ), use of a gluten-free diet in nont", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Hydrocodone?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrocodone"]], "act": "question"}]}
{"index": 1, "text": "what version of Hydrocodone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "CROSCARMELLOSE SODIUM,CROSPOVIDONE (15 MPA.S AT 5%),MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POVIDONES,STARCH, CORN,STEARIC ACID,HYDROCODONE BITARTRATE,ACETAMINOPHEN,CROSCARMELLOSE SODIUM,CROSPOVIDONE (15 MPA.S AT 5%),MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POVIDONES,STARCH, CORN,STEARIC ACID,D&C YELLOW NO. 10,HYDROCODONE BITARTRATE,ACETAMINOPHEN,CROSCARMELLOSE SODIUM,CROSPOVIDONE (15 MPA.S AT 5%),MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POVIDONES,STARCH, CORN,STEARIC ACID,HYDROCODONE BITARTRATE,ACETAMINOPHEN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Clotrimazole?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Clotrimazole"]], "act": "question"}]}
{"index": 1, "text": "Clotrimazole is indicated for the local treatment of oropharyngeal candidiasis. The diagnosis should be confirmed by a KOH smear and/or culture prior to treatment. Clotrimazole is also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. There are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence. (See DOSAGE AND ADMINISTR", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Unituxin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Unituxin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Unituxin (dinutuximab) is indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2) and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy [see Clinical Studies (14) ].", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Cefuroxime?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cefuroxime"]], "act": "question"}]}
{"index": 1, "text": "what version of Cefuroxime is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "CEFUROXIME", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many AMINOCAPROIC is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "AMINOCAPROIC"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of AMINOCAPROIC is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for AMINOCAPROIC is 4 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Indomethacin?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Indomethacin"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "child", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "inform"}]}
{"index": 2, "text": "what version of Indomethacin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "40", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "40"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Indomethacin is 2 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "Is LIDOCAINE safe  if I have TB?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LIDOCAINE"], ["<condition>", "TB"]], "act": "question"}]}
{"index": 0, "text": "Adverse experiences following the administration of lidocaine are similar in nature to those observed with other amide local anesthetic agents. These adverse experiences are, in general, dose-related and may result from high plasma levels caused by excessive dosage or rapid absorption, or may result from a hypersensitivity, idiosyncrasy or diminished tolerance on the part of the patient. Serious adverse experiences are generally systemic in nature. The following types are those most commonly reported: There have been rare reports of endotracheal tube occlusion associated with the presence of dried jelly residue in the inner lumen of the tube. See also WARNINGS and DOSAGE AND ADMINISTRATION .", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant Flunisolide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Flunisolide"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant low_blood_pressure", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I take Fluocinonide?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluocinonide"]], "act": "question"}]}
{"index": 0, "text": "what version of Fluocinonide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Fluocinonide Ointment USP, 0.05% is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of the occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Sirolimus", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sirolimus"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Sirolimus tablets are to be administered orally once daily, consistently with or without food [see Dosage and Administration ( 2.5 ), Clinical Pharmacology (12.3) ]. Tablets should not be crushed, chewed or split. Patients unable to take the tablets should be prescribed the solution and instructed in its use.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the ingredients of Amiodarone?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amiodarone"]], "act": "question"}]}
{"index": 0, "text": "what version of Amiodarone is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "AMIODARONE HYDROCHLORIDE,BENZYL ALCOHOL,POLYSORBATE 80,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "do I need to keep BENZTROPINE in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BENZTROPINE"]], "act": "question"}]}
{"index": 0, "text": "what version of BENZTROPINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug BENZTROPINE", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Fluconazole", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluconazole"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Fluconazole", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Bactrim?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Bactrim"]], "act": "question"}]}
{"index": 1, "text": "what version of Bactrim is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "BACTRIM is contraindicated in pediatric patients less than 2 months of age.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "where should I keep LMD?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LMD"]], "act": "question"}]}
{"index": 1, "text": "what version of LMD is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug LMD", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is anxiety a common side effect of Diclofenac?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Diclofenac"], ["<symptom>", "anxiety"]], "act": "question"}]}
{"index": 1, "text": "anxiety is a mild side effect of Diclofenac. The following adverse reactions are discussed in greater detail in other sections of the labeling:  Cardiovascular Thrombotic Events (see WARNINGS )  GI Bleeding, Ulceration and Perforation (see WARNINGS )  Hepatotoxicity (see WARNINGS )  Hypertension (see WARNINGS )  Heart Failure and Edema (see WARNINGS )  Renal Toxicity and Hyperkalemia (see WARNINGS )  Anaphylactic Reactions (see WARNINGS )  Serious Skin Reactions (see WARNINGS )  Hematologic Toxicity (see WARNINGS )", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Antizol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Antizol"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "anxiety is a dangerous side effect of Antizol. The most frequent adverse events reported as drug-related or unknown relationship to study drug in the 78 patients and 63 normal volunteers who received Antizol  (fomepizole) Injection were headache (14%), nausea (11%), and dizziness, increased drowsiness, and bad taste/metallic taste (6% each). All other adverse events in this population were reported in approximately 3% or fewer of those receiving Antizol  and were as follows: Body as a Whole: Abdominal pain, fever, multiorgan system failure, pain during Antizol  injection, inflammation at injection site, lumbalgia/backache, hangover Cardiovascular: Sinus bradycardia/bradycardia, phlebosclerosis, tachycardia, phlebitis, shock, hypotension ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "can i take Metoprolol?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metoprolol"]], "act": "question"}]}
{"index": 1, "text": "Metoprolol may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "TB", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "inform"}]}
{"index": 2, "text": "Hypertension and Angina These adverse reactions were reported for treatment with oral metoprolol tartrate. Most adverse effects have been mild and transient. Central Nervous System Tiredness and dizziness have occurred in about 10 of 100 patients. Depression has been reported in about 5 of 100 patients. Mental confusion and short-term memory loss have been reported. Headache, nightmares, and insomnia have also been reported. Cardiovascular Shortness of breath and bradycardia have occurred in approximately 3 of 100 patients. Cold extremities; arterial insufficiency, usually of the Raynaud type; palpitations; congestive heart failure; peripheral edema; and hypotension have been reported in abo", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant glaucoma", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant DOXYCYCLINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "DOXYCYCLINE"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Due to oral doxycycline's virtually complete absorption, side effects of the lower bowel, particularly diarrhea, have been infrequent. The following adverse reactions have been observed in patients receiving tetracyclines: Gastrointestinal: anorexia, nausea, vomiting, diarrhea, glossitis, dysphagia, enterocolitis, inflammatory lesions (with monilial overgrowth) in the anogenital region, and pancreatitis. Hepatotoxicity has been reported rarely. These reactions have been caused by both the oral and parenteral administration of tetracyclines. Superficial discoloration of the adult permanent dentition, reversible upon drug discontinuation and professional dental cleaning has been reported. Perm", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many Sildenafil is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sildenafil"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 1, "text": "what version of Sildenafil is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Sildenafil is 1 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Amantadine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amantadine"]], "act": "question"}]}
{"index": 0, "text": "Amantadine hydrochloride capsules, USP are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine hydrochloride capsules, USP are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Spironolactone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Spironolactone"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Spironolactone, an ingredient of spironolactone and hydrochlorothiazide tablets, has been shown to be a tumorigen in chronic toxicity studies in rats (see Precautions section). Spironolactone and hydrochlorothiazide tablets should be used only in those conditions described below. Unnecessary use of this drug should be avoided.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does DOXYCYCLINE cause blurred_vision?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DOXYCYCLINE"], ["<symptom>", "blurred_vision"]], "act": "question"}]}
{"index": 1, "text": "blurred_vision is a serious side effect of DOXYCYCLINE. Due to oral doxycycline's virtually complete absorption, side effects of the lower bowel, particularly diarrhea, have been infrequent. The following adverse reactions have been observed in patients receiving tetracyclines: Gastrointestinal: anorexia, nausea, vomiting, diarrhea, glossitis, dysphagia, enterocolitis, inflammatory lesions (with monilial overgrowth) in the anogenital region, and pancreatitis. Hepatotoxicity has been reported rarely. These reactions have been caused by both the oral and parenteral administration of tetracyclines. Superficial discoloration of the adult permanent dentition, reversible upon drug discontinuation and professional dental cleaning has been reported. Perm", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant bleeding", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "bleeding"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how do I take GlyBURIDE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "GlyBURIDE"]], "act": "question"}]}
{"index": 0, "text": "what version of GlyBURIDE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Patients should be retitrated when transferred from glyburide (micronized) tablets or other oral hypoglycemic agents (see PRECAUTIONS). There is no fixed dosage regimen for the management of diabetes mellitus with glyburide tablets or any other hypoglycemic agent. In addition to the usual monitoring of urinary glucose, the patient\u2019s blood glucose must also be monitored periodically to determine the minimum effective dose for the patient; to detect primary failure, i.e. , inadequate lowering of blood glucose at the maximum recommended dose of medication; and to detect secondary failure, i.e. , loss of adequate blood glucose lowering response after an initial period of effectiveness. Glycosyla", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant ANCOBON", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ANCOBON"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The usual dosage of ANCOBON is 50 to 150 mg/kg/day administered in divided doses at 6-hour intervals. Nausea or vomiting may be reduced or avoided if the capsules are given a few at a time over a 15-minute period. If the BUN or the serum creatinine is elevated, or if there are other signs of renal impairment, the initial dose should be at the lower level (see WARNINGS ). ANCOBON should be used in combination with amphotericin B for the treatment of systemic candidiasis and cryptococcosis because of the emergence of resistance to ANCOBON (see MICROBIOLOGY ).", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Amrix?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amrix"]], "act": "question"}]}
{"index": 1, "text": "what version of Amrix is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "CYCLOBENZAPRINE HYDROCHLORIDE,DIETHYL PHTHALATE,ETHYLCELLULOSES,GELATIN,SUCROSE,TITANIUM DIOXIDE,D&C YELLOW NO. 10,FD&C GREEN NO. 3,FD&C RED NO. 40,STARCH, CORN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant Eletriptan", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Eletriptan"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "ELETRIPTAN HYDROBROMIDE,MICROCRYSTALLINE CELLULOSE,LACTOSE, UNSPECIFIED FORM,CROSCARMELLOSE SODIUM,MAGNESIUM STEARATE,TITANIUM DIOXIDE,HYPROMELLOSE, UNSPECIFIED,TRIACETIN,FD&C YELLOW NO. 6,ALUMINUM OXIDE,ELETRIPTAN HYDROBROMIDE,MICROCRYSTALLINE CELLULOSE,LACTOSE, UNSPECIFIED FORM,CROSCARMELLOSE SODIUM,MAGNESIUM STEARATE,TITANIUM DIOXIDE,HYPROMELLOSE, UNSPECIFIED,TRIACETIN,FD&C YELLOW NO. 6,ALUMINUM OXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the ingredients of Midodrine?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Midodrine"]], "act": "question"}]}
{"index": 0, "text": "what version of Midodrine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "midodrine hydrochloride,silicon dioxide,starch, corn,magnesium stearate,microcrystalline cellulose,talc,midodrine hydrochloride,silicon dioxide,starch, corn,magnesium stearate,microcrystalline cellulose,FD&C Red No. 40,talc,midodrine hydrochloride,silicon dioxide,starch, corn,magnesium stearate,microcrystalline cellulose,FD&C Red No. 40,FD&C Blue No. 1,talc", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant NALOXONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "NALOXONE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "does BETHANECHOL cause stomach_ache?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BETHANECHOL"], ["<symptom>", "stomach_ache"]], "act": "question"}]}
{"index": 0, "text": "stomach_ache is a mild side effect of BETHANECHOL. Adverse reactions are rare following oral administration of bethanechol, but are more common following subcutaneous injection. Adverse reactions are more likely to occur when dosage is increased. The following adverse reactions have been observed: Body as a Whole: malaise; Digestive: abdominal cramps or discomfort, colicky pain, nausea and belching, diarrhea, borborygmi, salivation; Renal: urinary urgency; Nervous System: headache; Cardiovascular: a fall in blood pressure with reflex tachycardia, vasomotor response; Skin: flushing producing a feeling of warmth, sensation of heat about the face, sweating; \" Respiratory :\" bronchial constriction, asthmatic attacks; Special Senses: lacrimation,", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant blurred_vision", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "blurred_vision"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Methocarbamol?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methocarbamol"]], "act": "question"}]}
{"index": 0, "text": "Methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant SULFASALAZINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "SULFASALAZINE"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Sulfasalazine tablets are indicated: 1. in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and 2. for the prolongation of the remission period between acute attacks of ulcerative colitis.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is CALAN safe  if I am low_blood_pressure?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CALAN"], ["<condition>", "low_blood_pressure"]], "act": "question"}]}
{"index": 1, "text": "Serious adverse reactions are uncommon when CALAN therapy is initiated with upward dose titration within the recommended single and total daily dose. See WARNINGS for discussion of heart failure, hypotension, elevated liver enzymes, AV block, and rapid ventricular response. Reversible (upon discontinuation of verapamil) non-obstructive, paralytic ileus has been infrequently reported in association with the use of verapamil. The following reactions to orally administered verapamil occurred at rates greater than 1.0% or occurred at lower rates but appeared clearly drug-related in clinical trials in 4,954 patients: Constipation 7.3% Dyspnea 1.4% Dizziness 3.3% Bradycardia (HR <50/min) 1.4% Naus", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Busulfan", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Busulfan"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant glaucoma", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "glaucoma"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Proparacaine?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Proparacaine"]], "act": "question"}]}
{"index": 1, "text": "what version of Proparacaine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "PROPARACAINE HYDROCHLORIDE,BENZALKONIUM CHLORIDE,GLYCERIN,HYDROCHLORIC ACID,WATER,SODIUM HYDROXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Carac?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Carac"]], "act": "question"}]}
{"index": 0, "text": "Carac is indicated for the topical treatment of multiple actinic or solar keratoses of the face and anterior scalp.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much NEOMYCIN should i take?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NEOMYCIN"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "baby", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "inform"}]}
{"index": 1, "text": "what version of NEOMYCIN is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for NEOMYCIN is 1 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant LOVASTATIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "LOVASTATIN"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "does Methylergonovine contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methylergonovine"]], "act": "question"}]}
{"index": 0, "text": "what version of Methylergonovine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Methylergonovine Maleate,Maleic Acid,Sodium Chloride,Water", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Methylergonovine Maleate,Maleic Acid,Sodium Chloride,Water", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Sorine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sorine"]], "act": "question"}]}
{"index": 1, "text": "what version of Sorine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "As with other antiarrhythmic agents, Sorine  (Sotalol Hydrochloride) Tablets should be initiated and doses increased in a hospital with facilities for cardiac rhythm monitoring and assessment (see INDICATIONS AND USAGE ). Sorine  (Sotalol Hydrochloride) Tablets should be administered only after appropriate clinical assessment (see INDICATIONS AND USAGE ), and the dosage of Sorine  (Sotalol Hydrochloride) Tablets must be individualized for each patient on the basis of therapeutic response and tolerance. Proarrhythmic events can occur not only at initiation of therapy, but also with each upward dosage adjustment.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Citalopram", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Citalopram"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Citalopram oral solution should be administered once daily, in the morning or evening, with or without food. Initial Treatment Citalopram oral solution should be administered at an initial dose of 20 mg once daily, with an increase to a maximum dose of 40 mg/day at an interval of no less than one week. Doses above 40 mg/day are not recommended due to the risk of QT prolongation. Additionally, the only study pertinent to dose response for effectiveness did not demonstrate an advantage for the 60 mg/day dose over the 40 mg/day dose. Special Populations 20 mg/day is the maximum recommended dose for patients who are greater than 60 years of age, patients with hepatic impairment, and for CYP2C19 ", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Is Ionosol safe  if I have glaucoma?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ionosol"], ["<condition>", "glaucoma"]], "act": "question"}]}
{"index": 0, "text": "Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant CYSTARAN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "CYSTARAN"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is aggression a common side effect of Aktipak?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Aktipak"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 1, "text": "aggression is a common side effect of Aktipak. During clinical trials, 550 acne patients were studied. Of these patients, 236 were treated with Aktipak \ufeffTM . The most frequently reported adverse event considered at least possibly related was dry skin (7.6%) as compared to Vehicle (3.9%). Application site reactions (stinging, burning sensation, tingling, erythema) were reported in 2.5% of patients versus 1.3% of Vehicle patients. Blepharitis, pruritus and photosensitivity reactions were reported in <2% of patients who used the dual pouch product. Treatment Group Summaries Number of Patients (%) COSTART Term Aktipak \ufeffTM N = 236 Aktipak \ufeffTM Vehicle N = 153 Benzamycin Topical Gel N = 121 Benzamycin Topical Gel Vehicle N = 40 DRY SKIN 18 (7.6", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant HESPAN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HESPAN"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep CAPTOPRIL in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CAPTOPRIL"]], "act": "question"}]}
{"index": 1, "text": "what version of CAPTOPRIL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug CAPTOPRIL", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Salicylic?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Salicylic"]], "act": "question"}]}
{"index": 1, "text": "what version of Salicylic is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Wet hair and apply Salicylic Acid Shampoo, 6% to the scalp. Work into a lather then rinse. Repeat the treatment as needed until the condition clears. Once clearing is apparent, the occasional use of Salicylic Acid Shampoo, 6% will usually maintain the remission.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Wet hair and apply Salicylic Acid Shampoo, 6% to the scalp. Work into a lather then rinse. Repeat the treatment as needed until the condition clears. Once clearing is apparent, the occasional use of Salicylic Acid Shampoo, 6% will usually maintain the remission.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with HYDROCORTISONE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROCORTISONE"]], "act": "question"}]}
{"index": 1, "text": "what version of HYDROCORTISONE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "The initial dosage of hydrocortisone tablets may vary from 20 mg to 240 mg of hydrocortisone per day depending on the specific disease entity being treated. In situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time there is a lack of satisfactory clinical response, hydrocortisone should be discontinued and the patient transferred to other appropriate therapy. IT SHOULD BE EMPHASIZED THAT DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE INDIVIDUALIZED ON THE BASIS OF THE DISEASE UNDER TREATMENT AND", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The initial dosage of hydrocortisone tablets may vary from 20 mg to 240 mg of hydrocortisone per day depending on the specific disease entity being treated. In situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time there is a lack of satisfactory clinical response, hydrocortisone should be discontinued and the patient transferred to other appropriate therapy. IT SHOULD BE EMPHASIZED THAT DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE INDIVIDUALIZED ON THE BASIS OF THE DISEASE UNDER TREATMENT AND", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "What is Pentazocine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Pentazocine"]], "act": "question"}]}
{"index": 0, "text": "Pentazocine and Naloxone Tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses, reserve Pentazocine and Naloxone Tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] Have not been tolerated, or are not expected to be tolerated, Have not provided adequate analgesia, or are not expected to provide adequate analgesia", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does VITAMIN cause aggression?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "VITAMIN"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 1, "text": "aggression is a dangerous side effect of VITAMIN. Hypervitaminosis D is characterized by effects on the following organ system: Renal: Impairment of renal function with polyuria, nocturia, polydipsia, hypercalciuria, reversible azotemia, hypertension, nephrocalcinosis, generalized vascular calcification, or irreversible renal insufficiency which may result in death. CNS: Mental retardation. Soft Tissues: Widespread calcification of the soft tissues, including the heart, blood vessels, renal tubules, and lungs. Skeletal: Bone demineralization (osteoporosis) in adults occurs concomitantly. Decline in the average rate of linear growth and increased mineralization of bones in infants and children (dwarfism), vague aches, stiffness, and weakness", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Lorazepam", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Lorazepam"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant mood_swings", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "mood_swings"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Atorvastatin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Atorvastatin"]], "act": "question"}]}
{"index": 1, "text": "Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. In patients with CHD or multiple risk factors for CHD, atorvastatin calcium tablets can be started simultaneously with diet.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much Amantadine should i take for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amantadine"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of Amantadine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Amantadine is 4 mg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take 20%?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "20%"]], "act": "question"}]}
{"index": 1, "text": "20% may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "infection", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "infection"]], "act": "inform"}]}
{"index": 2, "text": "Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. Extensive use of mannitol over the last several decades has produced recorded adverse events, in a variety of clinical settings, that are isolated or idiosyncratic in nature. None of these adverse reactions have occurred with any great frequency nor with any security in attributing them to mannitol. The inability to clearly exclude the drug related nature of such events in these isolated reports prompts the necessity to list the reactions that have", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "can i take Solu-Medrol  for someone with low_blood_pressure?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Solu-Medrol"], ["<condition>", "low_blood_pressure"]], "act": "question"}]}
{"index": 0, "text": "The following adverse reactions have been reported with SOLU-MEDROL or other corticosteroids: Allergic reactions : Allergic or hypersensitivity reactions, anaphylactoid reaction, anaphylaxis, angioedema. Blood and lymphatic system disorders : Leukocytosis. Cardiovascular : Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction (see WARNINGS ), pulmonary edema, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis. Dermatologic : Acne, allergic dermatitis, burning or tingling (espec", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant pregnant", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant PROCAINAMIDE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "PROCAINAMIDE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for ALLOPURINOL for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ALLOPURINOL"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of ALLOPURINOL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for ALLOPURINOL is 4 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for ALLOPURINOL is 4 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "is it normal to have insomnia with CYCLOBENZAPRINE?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CYCLOBENZAPRINE"], ["<symptom>", "insomnia"]], "act": "question"}]}
{"index": 0, "text": "insomnia is a serious side effect of CYCLOBENZAPRINE. Incidence of most common adverse reactions in the 2 double-blind \u2021 , placebo-controlled 5 mg studies (incidence of > 3% on cyclobenzaprine hydrochloride tablets 5 mg): Cyclobenzaprine Hydrochloride Tablets 5 mg N=464 Cyclobenzaprine Hydrochloride Tablets 10 mg N=249 Placebo N=469 Drowsiness 29% 38% 10% Dry Mouth 21% 32% 7% Fatigue 6% 6% 3% Headache 5% 5% 8% Adverse reactions which were reported in 1% to 3% of the patients were: abdominal pain, acid regurgitation, constipation, diarrhea, dizziness, nausea, irritability, mental acuity decreased, nervousness, upper respiratory infection, and pharyngitis. The following list of adverse reactions is based on the experience in 473 patients treated ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant depression", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "depression"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have bruising with LIDOCAINE?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LIDOCAINE"], ["<symptom>", "bruising"]], "act": "question"}]}
{"index": 1, "text": "bruising is a mild side effect of LIDOCAINE. Adverse experiences following the administration of lidocaine are similar in nature to those observed with other amide local anesthetic agents. Adverse experiences may result from high plasma levels caused by excessive dosage or may result from a hypersensitivity, idiosyncrasy or diminished tolerance on the part of the patient. Serious adverse experiences are generally systemic in nature. The following types are those most commonly reported. The adverse experiences under Central Nervous System and Cardiovascular System are listed, in general, in a progression from mild to severe. Central Nervous System: CNS reactions are excitatory and/or depressant and may be characterized by light-headedne", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant bleeding", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "bleeding"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "bleeding is a mild side effect of LIDOCAINE. Adverse experiences following the administration of lidocaine are similar in nature to those observed with other amide local anesthetic agents. These adverse experiences are, in general, dose-related and may result from high plasma levels caused by excessive dosage or rapid absorption, or may result from a hypersensitivity, idiosyncrasy or diminished tolerance on the part of the patient. Serious adverse experiences are generally systemic in nature. The following types are those most commonly reported: There have been rare reports of endotracheal tube occlusion associated with the presence of dried jelly residue in the inner lumen of the tube. See also WARNINGS and DOSAGE AND ADMINISTRATION .", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Nexterone?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nexterone"]], "act": "question"}]}
{"index": 0, "text": "NEXTERONE is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy. NEXTERONE also can be used to treat patients with VT/VF for whom oral amiodarone is indicated, but who are unable to take oral medication. During or after treatment with NEXTERONE, patients may be transferred to oral amiodarone therapy [see Dosage and Administration (2) ]. Use NEXTERONE for acute treatment until the patient's ventricular arrhythmias are stabilized. Most patients will require this therapy for 48 to 96 hours, but NEXTERONE may be safely administered for longer ", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant LEVALBUTEROL", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "LEVALBUTEROL"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Levalbuterol inhalation solution (concentrate) is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Ibandronate?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ibandronate"]], "act": "question"}]}
{"index": 1, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Folic is the correct dose for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Folic"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of Folic is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Folic is 4 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant adult", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Folic is 3 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is 279 safe  if I am tourettes?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "279"], ["<condition>", "tourettes"]], "act": "question"}]}
{"index": 1, "text": "Skin and Appendages: Oral hydroxyzine hydrochloride is associated with Acute Generalized Exanthematous Pustulosis (AGEP) and fixed drug eruptions in post marketing reports. Side effects reported with the administration of hydroxyzine hydrochloride are usually mild and transitory in nature. Anticholinergic : Dry mouth. Central Nervous System : Drowsiness is usually transitory and may disappear in a few days of continued therapy or upon reduction of dose. Involuntary motor activity including rare instances of tremor and convulsions have been reported, usually with doses considerably higher than those recommended. Clinically significant respiratory depression has not been reported at recommende", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Ipratropium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ipratropium"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Adverse reaction information concerning Ipratropium Bromide Inhalation Solution is derived from 12-week active-controlled clinical trials. Additional information is derived from foreign post-marketing experience and the published literature. All adverse events, regardless of drug relationship, reported by three percent or more patients in the 12-week controlled clinical trials appear in the table. Additional adverse reactions reported in less than three percent of the patients treated with ipratropium bromide include tachycardia, palpitations, eye pain, urinary retention, urinary tract infection and urticaria. Cases of precipitation or worsening of narrow-angle glaucoma, mydriasis, and acute", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "can i take Urecholine  if I have pregnant?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Urecholine"], ["<condition>", "pregnant"]], "act": "question"}]}
{"index": 0, "text": "Adverse reactions are rare following oral administration of bethanechol chloride, but are more common following subcutaneous injection. Adverse reactions are more likely to occur when dosage is increased. The following adverse reactions have been observed: Body as a Whole: malaise Digestive: abdominal cramps or discomfort, colicky pain, nausea and belching, diarrhea, borborygmi, salivation Renal: urinary urgency Nervous System: headache Cardiovascular: a fall in blood pressure with reflex tachycardia, vasomotor response Skin: flushing producing a feeling of warmth, sensation of heat about the face, sweating Respiratory: bronchial constriction, asthmatic attacks Special Senses: lacrimation, m", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Lorazepam?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lorazepam"]], "act": "question"}]}
{"index": 0, "text": "what version of Lorazepam is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "LORAZEPAM,LACTOSE,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,POLACRILIN POTASSIUM", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant PredniSONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "PredniSONE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Lanthanum?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lanthanum"]], "act": "question"}]}
{"index": 1, "text": "what version of Lanthanum is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Divide the total daily dose of LANTHANUM CARBONATE and take with or immediately after meals. The recommended initial total daily dose of LANTHANUM CARBONATE is 1500 mg. Titrate the dose every 2-3 weeks until an acceptable serum phosphate level is reached. Monitor serum phosphate levels as needed during dose titration and on a regular basis thereafter. In clinical studies of ESRD patients, LANTHANUM CARBONATE doses up to 4500 mg were evaluated. Most patients required a total daily dose between 1500 mg and 3000 mg to reduce plasma phosphate levels to less than 6.0 mg/dL. Doses were generally titrated in increments of 750 mg/day. Chew or crush LANTHANUM CARBONATE completely before swallowing. D", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Detrol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Detrol"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The initial recommended dose of DETROL Tablets is 2 mg twice daily. The dose may be lowered to 1 mg twice daily based on individual response and tolerability. For patients with significantly reduced hepatic or renal function or who are currently taking drugs that are potent inhibitors of CYP3A4, the recommended dose of DETROL is 1 mg twice daily (see PRECAUTIONS, General , PRECAUTIONS, Reduced Hepatic and Renal Function , and PRECAUTIONS, Drug Interactions ).", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Atropine in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Atropine"]], "act": "question"}]}
{"index": 1, "text": "what version of Atropine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Atropine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant DOPamine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "DOPamine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "does Ampicillin contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ampicillin"]], "act": "question"}]}
{"index": 0, "text": "what version of Ampicillin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "AMPICILLIN SODIUM,AMPICILLIN SODIUM,AMPICILLIN SODIUM,AMPICILLIN SODIUM", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Doxycycline?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxycycline"]], "act": "question"}]}
{"index": 0, "text": "what version of Doxycycline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Doxycycline,Microcrystalline Cellulose,Sodium Starch Glycolate Type A Potato,Magnesium Stearate,Silicon Dioxide,Titanium Dioxide,Gelatin, Unspecified,Shellac,Propylene Glycol,Ferric Oxide Yellow,Ferrosoferric Oxide,Doxycycline,Microcrystalline Cellulose,Sodium Starch Glycolate Type A Potato,Magnesium Stearate,Silicon Dioxide,Titanium Dioxide,Gelatin, Unspecified,Ferric Oxide Red,Ferrosoferric Oxide,Ferric Oxide Yellow,Shellac,Propylene Glycol,Doxycycline,Microcrystalline Cellulose,Sodium Starch Glycolate Type A Potato,Magnesium Stearate,Silicon Dioxide,Titanium Dioxide,Gelatin, Unspecified,Ferric Oxide Red,Ferrosoferric Oxide,Ferric Oxide Yellow,Shellac,Propylene Glycol", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant AMOXICILLIN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "AMOXICILLIN"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,CITRIC ACID MONOHYDRATE,GELATIN,TITANIUM DIOXIDE,FERRIC OXIDE RED,FERRIC OXIDE YELLOW,AMOXICILLIN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Keveyis?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Keveyis"]], "act": "question"}]}
{"index": 0, "text": "KEVEYIS is indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Should I take TEMOZOLOMIDE  if I have low_blood_pressure?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "TEMOZOLOMIDE"], ["<condition>", "low_blood_pressure"]], "act": "question"}]}
{"index": 0, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant Triamcinolone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Triamcinolone"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant pregnant", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "Should I take Metformin?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metformin"]], "act": "question"}]}
{"index": 0, "text": "Metformin may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "anxiety", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "inform"}]}
{"index": 1, "text": "In a U.S. double-blind clinical study of metformin hydrochloride tablets in patients with type 2 diabetes, a total of 141 patients received metformin hydrochloride tablets therapy (up to 2550 mg per day) and 145 patients received placebo. Adverse reactions reported in greater than 5% of the metformin hydrochloride tablets patients, and that were more common in metformin hydrochloride tablets- than placebo-treated patients, are listed in Table 7 . Table 7: Most Common Adverse Reactions (>5 Percent) in a Placebo-Controlled Clinical Study of Metformin Hydrochloride Tablets Monotherapy* Adverse Reaction Metformin Hydrochloride Tablets Monotherapy (n = 141) Placebo (n = 145) % of Patients * React", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "what are the side effects of Fludeoxyglucose?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fludeoxyglucose"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of Fludeoxyglucose: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "diarrhea", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "diarrhea"]], "act": "inform"}]}
{"index": 1, "text": "diarrhea is a common side effect of Fludeoxyglucose. Hypersensitivity reactions with pruritus, edema and rash have been reported in the post-marketing setting. Have emergency resuscitation equipment and personnel immediately available.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant 20%", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "20%"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant stomach_ache", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "stomach_ache"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Amiodarone?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Amiodarone"]], "act": "question"}]}
{"index": 1, "text": "Because of its life-threatening side effects and the substantial management difficulties associated with its use (see \" WARNINGS \" below), amiodarone is indicated only for the treatment of the following documented, life-threatening recurrent ventricular arrhythmias when these have not responded to documented adequate doses of other available antiarrhythmics or when alternative agents could not be tolerated. Recurrent ventricular fibrillation. Recurrent hemodynamically unstable ventricular tachycardia. As is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of amiodarone HCl tablets favorably affects survival. Amiodarone should be used only by ", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Azithromycin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Azithromycin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Azithromycin Tablets, USP are indicated for the treatment of patients with mild to moderate infections (pneumonia: see WARNINGS ) caused by susceptible strains of the designated microorganisms in the specific conditions listed below. As recommended dosages, durations of therapy and applicable patient populations vary among these infections, please see DOSAGE AND ADMINISTRATION for specific dosing recommendations.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Sevoflurane,?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sevoflurane,"]], "act": "question"}]}
{"index": 1, "text": "what version of Sevoflurane, is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "SEVOFLURANE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "where should I keep NITRO-BID?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NITRO-BID"]], "act": "question"}]}
{"index": 0, "text": "what version of NITRO-BID is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug NITRO-BID", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Oxycodone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxycodone"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Oxycodone", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is insomnia a common side effect of PROPAFENONE?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PROPAFENONE"], ["<symptom>", "insomnia"]], "act": "question"}]}
{"index": 1, "text": "insomnia is a common side effect of PROPAFENONE. Adverse reactions associated with propafenone HCl occur most frequently in the gastrointestinal, cardiovascular, and central nervous systems. About 20% of patients treated with propafenone HCl have discontinued treatment because of adverse reactions. Adverse reactions reported for > 1.5% of 474 SVT patients who received propafenone in U.S. clinical trials are presented in the following table by incidence and percent discontinuation, reported to the nearest percent. Adverse Reactions Reported for > 1.5% of SVT Patients Incidence (N=480) % of Pts. who Discontinued Unusual Taste 14% 1.3% Nausea and/or Vomiting 11% 2.9% Dizziness 9% 1.7% Constipation 8% 0.2% Headache 6% 0.8% Fatigue 6% 1.5% Blur", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Citalopram", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Citalopram"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "insomnia is a common side effect of Citalopram. The premarketing development program for citalopram included citalopram exposures in patients and/or normal subjects from 3 different groups of studies: 429 normal subjects in clinical pharmacology/pharmacokinetic studies; 4422 exposures from patients in controlled and uncontrolled clinical trials, corresponding to approximately 1370 patient-exposure years. There were, in addition, over 19,000 exposures from mostly open-label, European postmarketing studies. The conditions and duration of treatment with citalopram varied greatly and included (in overlapping categories) open-label and double-blind studies, inpatient and outpatient studies, fixed-dose and dose-titration studies, and short-term", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the side effects of LISINOPRIL?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LISINOPRIL"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of LISINOPRIL: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "stomach_ache", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "stomach_ache"]], "act": "inform"}]}
{"index": 1, "text": "stomach_ache is a mild side effect of LISINOPRIL. Lisinopril and Hydrochlorothiazide Tablets has been evaluated for safety in 930 patients, including 100 patients treated for 50 weeks or more. In clinical trials with Lisinopril and Hydrochlorothiazide Tablets no adverse experiences peculiar to this combination drug have been observed. Adverse experiences that have occurred have been limited to those that have been previously reported with lisinopril or hydrochlorothiazide. The most frequent clinical adverse experiences in controlled trials (including open label extensions) with any combination of lisinopril and hydrochlorothiazide were: dizziness (7.5 percent), headache (5.2 percent), cough (3.9 percent), fatigue (3.7 percent) and orthostat", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant vomiting", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Cholestyramine contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cholestyramine"]], "act": "question"}]}
{"index": 1, "text": "what version of Cholestyramine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "CHOLESTYRAMINE,ANHYDROUS CITRIC ACID,ASPARTAME,D&C YELLOW NO. 10,FD&C YELLOW NO. 6,MANNITOL,ORANGE,PROPYLENE GLYCOL ALGINATE,SILICON DIOXIDE,VANILLA,XANTHAN GUM", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant doxycycline", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "doxycycline"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "DOXYCYCLINE HYCLATE,FD&C BLUE NO. 1,GELATIN, UNSPECIFIED,MAGNESIUM STEARATE,POWDERED CELLULOSE,SODIUM LAURYL SULFATE,TITANIUM DIOXIDE,FERROSOFERRIC OXIDE,POTASSIUM HYDROXIDE,PROPYLENE GLYCOL,SHELLAC,AMMONIA,DOXYCYCLINE HYCLATE,FD&C BLUE NO. 1,GELATIN, UNSPECIFIED,MAGNESIUM STEARATE,POWDERED CELLULOSE,SODIUM LAURYL SULFATE,TITANIUM DIOXIDE,FERROSOFERRIC OXIDE,POTASSIUM HYDROXIDE,PROPYLENE GLYCOL,SHELLAC,AMMONIA,DOXYCYCLINE HYCLATE,SILICON DIOXIDE,CROSCARMELLOSE SODIUM,FD&C BLUE NO. 2,FD&C YELLOW NO. 6,TRIACETIN,HYPROMELLOSE, UNSPECIFIED,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,POLYDEXTROSE,POLYETHYLENE GLYCOL, UNSPECIFIED,SODIUM LAURYL SULFATE,TITANIUM DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Ibuprofen in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ibuprofen"]], "act": "question"}]}
{"index": 1, "text": "what version of Ibuprofen is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Ibuprofen", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "can i take METOPROLOL  if I have heart_problems?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "METOPROLOL"], ["<condition>", "heart_problems"]], "act": "question"}]}
{"index": 0, "text": "The following adverse reactions are described elsewhere in labeling: Worsening angina or myocardial infarction. [see Warnings and Precautions (5) ] Worsening heart failure. [see Warnings and Precautions (5) ] Worsening AV block. [see Contraindications (4) ]", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant Ketoprofen", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ketoprofen"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "What is Prepidil?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Prepidil"]], "act": "question"}]}
{"index": 0, "text": "PREPIDIL Gel is indicated for ripening an unfavorable cervix in pregnant women at or near term with a medical or obstetrical need for labor induction.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant REYATAZ", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "REYATAZ"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "REYATAZ (atazanavir) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients 3 months and older weighing at least 5 kg. Limitations of Use:  REYATAZ is not recommended for use in pediatric patients below the age of 3 months due to the risk of kernicterus.  Use of REYATAZ/ritonavir in treatment-experienced patients should be guided by the number of baseline primary protease inhibitor resistance substitutions [see MICROBIOLOGY (12.4)].", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "how many MELOXICAM is the correct dose for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "MELOXICAM"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 0, "text": "what version of MELOXICAM is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "90", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "90"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for MELOXICAM is 1 grams per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant 80", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant child", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for APLISOL for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "APLISOL"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of APLISOL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "80", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for APLISOL is 4 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "What is PENTOXIFYLLINE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PENTOXIFYLLINE"]], "act": "question"}]}
{"index": 0, "text": "Pentoxifylline extended-release tablets are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. Pentoxifylline can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "do I need to keep Acetaminophen in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Acetaminophen"]], "act": "question"}]}
{"index": 0, "text": "what version of Acetaminophen is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Acetaminophen", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Ceftriaxone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Ceftriaxone"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is dicyclomine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "dicyclomine"]], "act": "question"}]}
{"index": 1, "text": "Dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant benzonatate", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "benzonatate"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Benzonatate USP is indicated for the symptomatic relief of cough.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "how do I use Indomethacin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Indomethacin"]], "act": "question"}]}
{"index": 0, "text": "what version of Indomethacin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "Carefully consider the potential benefits and risks of indomethacin extended-release capsules and other treatment options before deciding to use indomethacin extended-release capsules. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Indomethacin extended-release capsules 75 mg are available for oral use. Indomethacin extended-release capsules can be administered once a day and can be substituted for indomethacin 25 mg capsules t.i.d. However, there will be significant differences between the two dosage regimens in indomethacin blood levels, especially after 12 hours (see CLINICAL PHARMACOLOGY ). In addition, indometh", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Gabapentin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Gabapentin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Gabapentin is given orally with or without food. If gabapentin dose is reduced, discontinued, or substituted with an alternative medication, this should be done gradually over a minimum of 1 week (a longer period may be needed at the discretion of the prescriber). Postherpetic Neuralgia In adults with postherpetic neuralgia, gabapentin therapy may be initiated as a single 300-mg dose on Day 1, 600 mg/day on Day 2 (divided BID), and 900 mg/day on Day 3 (divided TID). The dose can subsequently be titrated up as needed for pain relief to a daily dose of 1800 mg (divided TID). In clinical studies, efficacy was demonstrated over a range of doses from 1800 mg/day to 3600 mg/day with comparable eff", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is ESZOPICLONE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ESZOPICLONE"]], "act": "question"}]}
{"index": 1, "text": "Eszopiclone tablets are indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. The clinical trials performed in support of efficacy were up to 6 months in duration. The final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only).", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant TestosteroneCypionate", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "TestosteroneCypionate"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Testosterone cypionate injection is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone. 1. Primary hypogonadism (congenital or acquired)-testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome; or orchidectomy. 2. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or LHRH deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. Safety and efficacy of testosterone cypionate in men with age-related hypogonadism (also referred to as late-onset hypogonadism) have not been established.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the side effects of Hydroxyzine?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydroxyzine"]], "act": "question"}]}
{"index": 0, "text": "these are some common side effects of Hydroxyzine: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "anxiety", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "anxiety"]], "act": "inform"}]}
{"index": 1, "text": "anxiety is a common side effect of Hydroxyzine. Therapeutic doses of hydroxyzine seldom produce impairment of mental alertness. However, drowsiness may occur; if so, it is usually transitory and may disappear in a few days of continued therapy or upon reduction of the dose. Dryness of the mouth may be encountered at higher doses. Extensive clinical use has substantiated the absence of toxic effects on the liver or bone marrow when administered in the recommended doses for over four years of uninterrupted therapy. The absence of adverse effects has been further demonstrated in experimental studies in which excessively high doses were administered. Involuntary motor activity, including rare instances of tremor and convulsions, has been repo", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant suicidal", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "suicidal"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "suicidal is a serious side effect of Hydroxyzine. Therapeutic doses of hydroxyzine seldom produce impairment of mental alertness. However, drowsiness may occur; if so, it is usually transitory and may disappear in a few days of continued therapy or upon reduction of the dose. Dryness of the mouth may be encountered at higher doses. Extensive clinical use has substantiated the absence of toxic effects on the liver or bone marrow when administered in the recommended doses for over four years of uninterrupted therapy. The absence of adverse effects has been further demonstrated in experimental studies in which excessively high doses were administered. Involuntary motor activity, including rare instances of tremor and convulsions, has been repo", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take To?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "To"]], "act": "question"}]}
{"index": 1, "text": "what version of To is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "If diarrhea occurs during therapy, this antibiotic should be discontinued. (See BOXED WARNING ). Clindamycin phosphate IM administration should be used undiluted. Clindamycin phosphate IV administration should be diluted (see Dilution for IV use and IV infusion rates below). Adults Parenteral (IM or IV Administration): Serious infections due to aerobic gram-positive cocci and the more susceptible anaerobes (NOT generally including Bacteroides fragilis , Peptococcus species and Clostridium species other than Clostridium perfringens ): 600 to 1,200 mg/day in 2, 3 or 4 equal doses More severe infections, particularly those due to proven or suspected Bacteroides fragilis , Peptococcus species, o", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant INTRAVENOUS", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "INTRAVENOUS"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what is the dose for 5%?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "5%"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 1, "text": "what version of 5% is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "20", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "20"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for 5% is 4 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Optiray?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Optiray"]], "act": "question"}]}
{"index": 1, "text": "Optiray is indicated for:", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is stomach_ache a common side effect of Indomethacin?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Indomethacin"], ["<symptom>", "stomach_ache"]], "act": "question"}]}
{"index": 1, "text": "stomach_ache is a serious side effect of Indomethacin. The adverse reactions for indomethacin capsules listed in the following table have been arranged into two groups: (1) incidence greater than 1% and (2) incidence less than 1%. The incidence for group (1) was obtained from 33 double-blind controlled clinical trials reported in the literature (1,092 patients). The incidence for group (2) was based on reports in clinical trials, in the literature, and on voluntary reports since marketing. The probability of a causal relationship exists between indomethacin and these adverse reactions, some of which have been reported only rarely. In controlled clinical trials, the incidence of adverse reactions to indomethacin extended-release capsules and equa", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant aggression", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "aggression"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant METOCLOPRAMIDE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "METOCLOPRAMIDE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how do I take Lidocaine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "question"}]}
{"index": 0, "text": "what version of Lidocaine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant Bethanechol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Bethanechol"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Dosage must be individualized, depending on the type and severity of the condition to be treated. Preferably give the drug when the stomach is empty. If taken soon after eating, nausea and vomiting may occur. The usual adult oral dose ranges from 10 to 50 mg three or four times a day. The minimum effective dose is determined by giving 5 to 10 mg initially, and repeating the same amount at hourly intervals until satisfactory response occurs, or until a maximum of 50 mg has been given. The effects of the drug sometimes appear within 30 minutes, and are usually maximal within 60 to 90 minutes. The drug effects persist for about one hour. If necessary, the effects of the drug can be abolished pr", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I take Cephalexin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cephalexin"]], "act": "question"}]}
{"index": 0, "text": "what version of Cephalexin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Cephalexin is administered orally. Adults: The adult dosage ranges from 1 to 4 g daily in divided doses. The usual adult dose is 250 mg every 6 hours. For the following infections, a dosage of 500 mg may be administered every 12 hours: streptococcal pharyngitis, skin and skin structure infections, and uncomplicated cystitis in patients over 15 years of age. Cystitis therapy should be continued for 7 to 14 days. For more severe infections or those caused by less susceptible organisms, larger doses may be needed. If daily doses of Cephalexin greater than 4 g are required, parenteral cephalosporins, in appropriate doses, should be considered. Pediatric Patients: The usual recommended daily dosa", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Glipizide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Glipizide"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "What is Hydrocortisone?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrocortisone"]], "act": "question"}]}
{"index": 0, "text": "Topcial corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Buprenorphine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Buprenorphine"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Buprenorphine and Naloxone Sublingual Tablets are indicated for the maintenance treatment of opioid dependence and should be used as part of a complete treatment plan to include counseling and psychosocial support. Under the Drug Addiction Treatment Act (DATA) codified at 21 U.S.C. 823(g), prescription use of this product in the treatment of opioid dependence is limited to physicians who meet certain qualifying requirements, and who have notified the Secretary of Health and Human Services (HHS) of their intent to prescribe this product for the treatment of opioid dependence and have been assigned a unique identification number that must be included on every prescription.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is PROMETHAZINE?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PROMETHAZINE"]], "act": "question"}]}
{"index": 0, "text": "Promethazine hydrochloride tablets are useful for: Perennial and seasonal allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasma. Dermographism. Anaphylactic reactions, as adjunctive therapy to epinephrine and other standard measures, after the acute manifestations have been controlled. Preoperative, postoperative, or obstetric sedation. Prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. Therapy adjunctive to meperidine or other analgesics for control of postoperativ", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Is Fludeoxyglucose safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fludeoxyglucose"]], "act": "question"}]}
{"index": 0, "text": "Fludeoxyglucose may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "low_blood_pressure", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "low_blood_pressure"]], "act": "inform"}]}
{"index": 1, "text": "Hypersensitivity reactions with pruritus, edema and rash have been reported in the post-marketing setting. Have emergency resuscitation equipment and personnel immediately available.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "What is Citalopram?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Citalopram"]], "act": "question"}]}
{"index": 0, "text": "Citalopram tablets USP are indicated for the treatment of depression. The efficacy of citalopram in the treatment of depression was established in 4-6 week, controlled trials of outpatients whose diagnosis corresponded most closely to the DSM-lII and DSM-llI-R category of major depressive disorder (see CLINICAL PHARMACOLOGY ). A major depressive episode (DSM-lV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hy", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant OXYCODONE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "OXYCODONE"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Oxycodone and Acetaminophen Tablets are indicated for the relief of moderate to moderately severe pain.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "is it normal to have itchy_skin with BENZTROPINE?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BENZTROPINE"], ["<symptom>", "itchy_skin"]], "act": "question"}]}
{"index": 0, "text": "itchy_skin is a mild side effect of BENZTROPINE. The adverse reactions below, most of which are anticholinergic in nature, have been reported and within each category are listed in order of decreasing severity. Cardiovascular Tachycardia. Digestive Paralytic ileus, constipation, vomiting, nausea, dry mouth. If dry mouth is so severe that there is difficulty in swallowing or speaking, or loss of appetite and weight, reduce dosage, or discontinue the drug temporarily. Slight reduction in dosage may control nausea and still give sufficient relief of symptoms. Vomiting may be controlled by temporary discontinuation, followed by resumption at a lower dosage. Nervous System Toxic psychosis, including confusion, disorientation, memory impairment,", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Ofloxacin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ofloxacin"]], "act": "question"}]}
{"index": 1, "text": "what version of Ofloxacin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "The recommended dosage regimen for the treatment of bacterial conjunctivitis is: Days 1 and 2 Instill one to two drops every two to four hours in the affected eye(s). Days 3 through 7 Instill one to two drops four times daily. The recommended dosage regimen for the treatment of bacterial corneal ulcer is: Days 1 and 2 Instill one to two drops into the affected eye every 30 minutes, while awake. Awaken at approximately four and six hours after retiring and instill one to two drops. Days 3 through 7 to 9 Instill one to two drops hourly, while awake. Days 7 to 9 throughtreatment completion Instill one to two drops, four times daily.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Amitriptyline", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Amitriptyline"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store CYTOMEL?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CYTOMEL"]], "act": "question"}]}
{"index": 1, "text": "what version of CYTOMEL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug CYTOMEL", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Metoprolol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Metoprolol"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "storage instructions for drug Metoprolol", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Nystatin?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nystatin"]], "act": "question"}]}
{"index": 0, "text": "what version of Nystatin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "ALCOHOL,CITRIC ACID MONOHYDRATE,D&C YELLOW NO. 10,FD&C RED NO. 40,GLYCERIN,METHYLPARABEN,POTASSIUM PHOSPHATE, DIBASIC,PROPYLENE GLYCOL,PROPYLPARABEN,WATER,SUCROSE,MAGNESIUM ALUMINUM SILICATE,NYSTATIN,ALCOHOL,CITRIC ACID MONOHYDRATE,D&C YELLOW NO. 10,FD&C RED NO. 40,GLYCERIN,METHYLPARABEN,POTASSIUM PHOSPHATE, DIBASIC,PROPYLENE GLYCOL,PROPYLPARABEN,WATER,SUCROSE,MAGNESIUM ALUMINUM SILICATE,NYSTATIN", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant POTASSIUM", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "POTASSIUM"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use CYTOMEL?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CYTOMEL"]], "act": "question"}]}
{"index": 1, "text": "what version of CYTOMEL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "The dosage of thyroid hormones is determined by the indication and must in every case be individualized according to patient response and laboratory findings. Cytomel (liothyronine sodium) Tablets are intended for oral administration; once-a-day dosage is recommended. Although liothyronine sodium has a rapid cutoff, its metabolic effects persist for a few days following discontinuance.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Urecholine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Urecholine"]], "act": "question"}]}
{"index": 1, "text": "what version of Urecholine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "Dosage must be individualized, depending on the type and severity of the condition to be treated. Preferably give the drug when the stomach is empty. If taken soon after eating, nausea and vomiting may occur. The usual adult oral dose ranges from 10 to 50 mg three or four times a day. The minimum effective dose is determined by giving 5 to 10 mg initially and repeating the same amount at hourly intervals until satisfactory response occurs, or until a maximum of 50 mg has been given. The effects of the drug sometimes appear within 30 minutes and are usually maximal within 60 to 90 minutes. The drug effects persist for about one hour. If necessary, the effects of the drug can be abolished prom", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what is in Sodium?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sodium"]], "act": "question"}]}
{"index": 0, "text": "what version of Sodium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "SODIUM NITROPRUSSIDE,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant DOXYCYCLINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "DOXYCYCLINE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "DOXYCYCLINE HYCLATE,STARCH, CORN,CROSCARMELLOSE SODIUM,DOCUSATE SODIUM,MAGNESIUM STEARATE,CELLULOSE, MICROCRYSTALLINE,ALCOHOL,HYPROMELLOSE 2910 (10000 MPA.S),POLYETHYLENE GLYCOL 400,TITANIUM DIOXIDE,FD&C BLUE NO. 2,FD&C YELLOW NO. 6,SILICON DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "how do I take DIHYDROERGOTAMINE?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DIHYDROERGOTAMINE"]], "act": "question"}]}
{"index": 0, "text": "what version of DIHYDROERGOTAMINE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Dihydroergotamine mesylate injection should be administered in a dose of 1 mL intravenously, intramuscularly or subcutaneously. The dose can be repeated, as needed, at 1 hour intervals to a total dose of 3 mL for intramuscular or subcutaneous delivery or 2 mL for intravenous delivery in a 24 hour period. The total weekly dosage should not exceed 6 mL. Dihydroergotamine mesylate injection, should not be used for chronic daily administration.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Clindamycin?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Clindamycin"]], "act": "question"}]}
{"index": 1, "text": "what version of Clindamycin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Clindamycin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant FLUOCINONIDE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "FLUOCINONIDE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what do I do with Furosemide?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Furosemide"]], "act": "question"}]}
{"index": 1, "text": "what version of Furosemide is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "Adults Parenteral therapy with Furosemide Injection, USP should be used only in patients unable to take oral medication or in emergency situations and should be replaced with oral therapy as soon as practical. Edema The usual initial dose of furosemide is 20 to 40 mg given as a single dose injected intramuscularly or intravenously. The intravenous dose should be given slowly (1 to 2 minutes). Ordinarily a prompt diuresis ensues. If needed, another dose may be administered in the same manner 2 hours later or the dose may be increased. The dose may be raised by 20 mg and given not sooner than 2 hours after the previous dose until the desired diuretic effect has been obtained. This individually", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "What is Xylocaine?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Xylocaine"]], "act": "question"}]}
{"index": 0, "text": "4% Xylocaine (lidocaine HCl) Topical Solution is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant NAPROXEN", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "NAPROXEN"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Carefully consider the potential benefits and risks of naproxen delayed-release tablets and other treatment options before deciding to use naproxen delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Naproxen delayed-release tablets are indicated: For the relief of the signs and symptoms of rheumatoid arthritis For the relief of the signs and symptoms of osteoarthritis For the relief of the signs and symptoms of ankylosing spondylitis For the relief of the signs and symptoms of juvenile arthritis Naproxen as naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain t", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is it normal to have diarrhea with Alclometasone?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Alclometasone"], ["<symptom>", "diarrhea"]], "act": "question"}]}
{"index": 1, "text": "diarrhea is a dangerous side effect of Alclometasone. The following local adverse reactions have been reported with alclometasone dipropionate ointment in approximately 1% of patients: itching, burning, and erythema. The following additional local adverse reactions have been reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in approximate decreasing order of occurrence: folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, and miliaria.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant tiredness", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "tiredness"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Keveyis", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Keveyis"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Phenazopyridine?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Phenazopyridine"]], "act": "question"}]}
{"index": 1, "text": "what version of Phenazopyridine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "CELLULOSE, MICROCRYSTALLINE,SODIUM STARCH GLYCOLATE TYPE A CORN,MAGNESIUM STEARATE,PHENAZOPYRIDINE HYDROCHLORIDE,CELLULOSE, MICROCRYSTALLINE,SODIUM STARCH GLYCOLATE TYPE A CORN,MAGNESIUM STEARATE,PHENAZOPYRIDINE HYDROCHLORIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Azacitidine cause insomnia?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Azacitidine"], ["<symptom>", "insomnia"]], "act": "question"}]}
{"index": 1, "text": "insomnia is a serious side effect of Azacitidine. The following adverse reactions are described in other labeling sections:  Anemia, Neutropenia and Thrombocytopenia [see Warnings and Precautions ( 5.1 )]  Hepatotoxicity in Patients with Severe Pre-existing Hepatic Impairment [see Warnings and Precautions ( 5.2 ) ]  Renal Toxicity [see Warnings and Precautions ( 5.3 ) ]  Tumor Lysis Syndrome [see Warnings and Precautions ( 5.4 ) ]  Embryo-Fetal Risk [see Warnings and Precautions ( 5.5 ) ] Most Commonly Occurring Adverse Reactions (SC or IV Route) : nausea, anemia, thrombocytopenia, vomiting, pyrexia, leukopenia, diarrhea, injection site erythema, constipation, neutropenia, ecchymosis. The most common adverse reactions by IV route also inclu", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant Diazepam", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Diazepam"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Oxaprozin cause aggression?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxaprozin"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 0, "text": "aggression is a common side effect of Oxaprozin. The following adverse reactions are discussed in greater detail in other sections of the labeling: Cardiovascular Thrombotic Events [see Warnings and Precautions (5.1) ] GI Bleeding, Ulceration and Perforation [see Warnings and Precautions (5.2) ] Hepatotoxicity [see Warnings and Precautions (5.3 )] Hypertension [see Warnings and Precautions (5.4) ] Heart Failure and Edema [see Warnings and Precautions (5.5) ] Renal Toxicity and Hyperkalemia [see Warnings and Precautions ( 5.6 ) ] Anaphylactic Reactions [see Warnings and Precautions (5.7) ] Serious Skin Reactions [see Warnings and Precautions (5.9) ] Hematologic Toxicity [see Warnings and Precautions (5.11) ]", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant Flunisolide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Flunisolide"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "does Neomycin contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Neomycin"]], "act": "question"}]}
{"index": 1, "text": "what version of Neomycin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "NEOMYCIN SULFATE,POLYMYXIN B SULFATE,BACITRACIN ZINC,HYDROCORTISONE,MINERAL OIL,PETROLATUM", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant Naproxen", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Naproxen"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "Naproxen,SUCROSE,MAGNESIUM ALUMINUM SILICATE,SORBITOL,SODIUM CHLORIDE,METHYLPARABEN,FUMARIC ACID,FD&C YELLOW NO. 6,WATER", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is it normal to have bleeding with Metronidazole?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Metronidazole"], ["<symptom>", "bleeding"]], "act": "question"}]}
{"index": 0, "text": "bleeding is a serious side effect of Metronidazole. The following reactions have been reported during treatment with metronidazole: Central Nervous System: The most serious adverse reactions reported in patients treated with metronidazole have been convulsive seizures, encephalopathy, aseptic meningitis, optic and peripheral neuropathy, the latter characterized mainly by numbness or paresthesia of an extremity. Since persistent peripheral neuropathy has been reported in some patients receiving prolonged administration of metronidazole, patients should be specifically warned about these reactions and should be told to stop the drug and report immediately to their physicians if any neurologic symptoms occur. In addition, patients have reported ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Infant?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Infant"]], "act": "question"}]}
{"index": 1, "text": "what version of Infant is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "Sodium Bicarbonate Injection, USP is administered by the intravenous route. In cardiac arrest , a rapid intravenous dose of one to two 50 mL vials (44.6 to 100 mEq) may be given initially and continued at a rate of 50 mL (44.6 to 50 mEq) every 5 to 10 minutes if necessary (as indicated by arterial pH and blood gas monitoring) to reverse the acidosis. Caution should be observed in emergencies where very rapid infusion of large quantities of bicarbonate is indicated. Bicarbonate solutions are hypertonic and may produce an undesirable rise in plasma sodium concentration in the process of correcting the metabolic acidosis. In cardiac arrest, however, the risks from acidosis exceed those of hyper", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Omeprazole?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Omeprazole"]], "act": "question"}]}
{"index": 1, "text": "what version of Omeprazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant Hydrocodone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Hydrocodone"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "Dosage should be adjusted according to the severity of the pain and response of the patient. However, it should be kept in mind that tolerance to hydrocodone can develop with continued use and that the incidence of untoward effects is dose-related. The usual adult dosage for Hydrocodone Bitartrate and Acetaminophen Tablets USP is: Product Strength Usual Adult Dosage AS NEEDED FOR PAIN The total daily dosage should not exceed Lorcet  5 mg/325 mg One or two tablets every four to six hours 12 tablets Lorcet  PLUS 7.5 mg/325 mg One tablet every four to six hours 6 tablets Lorcet  HD 10 mg/325 mg One tablet every four to six hours 6 tablets", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many Promethazine is the correct dose for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Promethazine"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 0, "text": "what version of Promethazine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "50", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "50"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Promethazine is 1 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I store SOTALOL?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "SOTALOL"]], "act": "question"}]}
{"index": 0, "text": "what version of SOTALOL is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug SOTALOL", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is 2%?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "2%"]], "act": "question"}]}
{"index": 1, "text": "Lidocaine HCl injection is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much Meloxicam should i take for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Meloxicam"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 1, "text": "what version of Meloxicam is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Meloxicam is 1 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant elderly", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for Meloxicam is 4 mcg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "what do I do with Ferralet?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ferralet"]], "act": "question"}]}
{"index": 0, "text": "what version of Ferralet is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "One tablet daily or as directed by a physician.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant COMPLERA", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "COMPLERA"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The recommended dose of COMPLERA in patients 12 years of age and older and weighing at least 35 kg is one tablet taken orally once daily with food [See Use in Specific Populations (8.4) and Clinical Pharmacology (12.3) ].", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Indomethacin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Indomethacin"]], "act": "question"}]}
{"index": 1, "text": "Carefully consider the potential benefits and risks of indomethacin extended-release capsules, USP and other treatment options before deciding to use indomethacin extended-release capsules, USP . Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Indomethacin extended-release capsules, USP have been found effective in active stages of the following: 1. Moderate to severe rheumatoid arthritis including acute flares of chronic disease. 2. Moderate to severe ankylosing spondylitis. 3. Moderate to severe osteoarthritis. 4. Acute painful shoulder (bursitis and/or tendinitis). Indomethacin extended-release capsules, USP are n", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant Levocetirizine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Levocetirizine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "1.1 Seasonal Allergic Rhinitis Levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. 1.2 Perennial Allergic Rhinitis Levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children 6 months of age and older. 1.3 Chronic Idiopathic Urticaria Levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Doxepin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxepin"]], "act": "question"}]}
{"index": 1, "text": "what version of Doxepin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "For most patients with illness of mild to moderate severity, a starting daily dose of 75 mg is recommended. Dosage may subsequently be increased or decreased at appropriate intervals and according to individual response. The usual optimum dose range is 75 mg/day to 150 mg/day. In more severely ill patients higher doses may be required with subsequent gradual increase to 300 mg/day if necessary. Additional therapeutic effect is rarely to be obtained by exceeding a dose of 300 mg/day. In patients with very mild symptomatology or emotional symptoms accompanying organic disease, lower doses may suffice. Some of these patients have been controlled on doses as low as 25 to 50 mg/day. The total dai", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Tramadol?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Tramadol"]], "act": "question"}]}
{"index": 1, "text": "Tramadol hydrochloride extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long term opioid treatment and for which alternative treatment options are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [ see WARNINGS ], reserve tramadol hydrochloride extended-release tablets or use in patients for whom alternative treatment options [e.g., non-opioid analgesics or immediate-release opioids], are ineffective, not tolerated, or would be otherwise inadequate to pro", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I store Dantrium?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Dantrium"]], "act": "question"}]}
{"index": 0, "text": "what version of Dantrium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Dantrium", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Azithromycin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Azithromycin"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "storage instructions for drug Azithromycin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take AcetaZOLAMIDE  if I am pregnant?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "AcetaZOLAMIDE"], ["<condition>", "pregnant"]], "act": "question"}]}
{"index": 0, "text": "Adverse reactions, occurring most often early in therapy, include paresthesias, particularly a tingling feeling in the extremities, hearing dysfunction or tinnitus, loss of appetite, taste alteration and gastrointestinal disturbances such as nausea, vomiting and diarrhea, polyuria, and occasional instances of drowsiness and confusion. Metabolic acidosis and electrolyte imbalance may occur. Transient myopia has been reported. This condition invariably subsides upon diminution or discontinuance of the medication. Other occasional adverse reactions include urticaria, melena, hematuria, glycosuria, hepatic insufficiency, flaccid paralysis, photosensitivity and convulsions. Also see PRECAUTIONS: ", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant Trospium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Trospium"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant TB", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is aggression a common side effect of Ibuprofen?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ibuprofen"], ["<symptom>", "aggression"]], "act": "question"}]}
{"index": 1, "text": "aggression is a common side effect of Ibuprofen. The most frequent type of adverse reaction occurring with Ibuprofen tablets is gastrointestinal. In controlled clinical trials the percentage of patients reporting one or more gastrointestinal complaints ranged from 4% to 16%. In controlled studies when Ibuprofen tablets were compared to aspirin and indomethacin in equally effective doses, the overall incidence of gastrointestinal complaints was about half that seen in either the aspirin or indomethacin-treated patients. Adverse reactions observed during controlled clinical trials at an incidence greater than 1% are listed in the table. Those reactions listed in Column one encompass observations in approximately 3,000 patients. More than 500", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in Emcyt?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Emcyt"]], "act": "question"}]}
{"index": 1, "text": "what version of Emcyt is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "ESTRAMUSTINE PHOSPHATE SODIUM,MAGNESIUM STEARATE,SILICON DIOXIDE,SODIUM LAURYL SULFATE,TALC,TITANIUM DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Potassium safe  for someone with pregnant?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"], ["<condition>", "pregnant"]], "act": "question"}]}
{"index": 1, "text": "Abdominal discomfort, diarrhea, vomiting, and nausea are the most common adverse reactions to oral potassium supplements. These adverse reactions occur most frequently when the preparation is not taken with food, is not properly diluted, or not completely dissolved. Hyperkalemia occurs infrequently in patients with normal renal function who receive oral potassium supplements. The following are symptoms of hyperkalemia: mental confusion, unexplained anxiety, cardiac arrhythmias, numbness or tingling in lips, feet, or hands, difficult breathing or shortness of breath, weakness or heaviness of legs, and unusual fatigue or weakness. (See Contraindications, Warnings, and Overdosage).", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant liver_problems", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Dantrium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Dantrium"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Should I take Alclometasone?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Alclometasone"]], "act": "question"}]}
{"index": 1, "text": "Alclometasone may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "TB", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "TB"]], "act": "inform"}]}
{"index": 2, "text": "The following local adverse reactions have been reported with alclometasone dipropionate ointment in approximately 1% of patients: itching, burning, and erythema. The following additional local adverse reactions have been reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in approximate decreasing order of occurrence: folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, and miliaria.", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "what is the dose for FROVA?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "FROVA"]], "act": "question"}]}
{"index": 0, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "adult", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "adult"]], "act": "inform"}]}
{"index": 1, "text": "what version of FROVA is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "30", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "30"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for FROVA is 3 grams per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Temazepam", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Temazepam"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "The dosage for Temazepam is 3 grams per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 7, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good evening", "goals": {"greeting": "good evening"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Busulfan?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Busulfan"]], "act": "question"}]}
{"index": 1, "text": "what version of Busulfan is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant MINOCYCLINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "MINOCYCLINE"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "where should I keep Theophylline?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Theophylline"]], "act": "question"}]}
{"index": 0, "text": "what version of Theophylline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Theophylline", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "where should I keep metformin?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "metformin"]], "act": "question"}]}
{"index": 1, "text": "what version of metformin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug metformin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant Pyridium", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Pyridium"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "how do I store Niacin?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Niacin"]], "act": "question"}]}
{"index": 0, "text": "what version of Niacin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Niacin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant HYDROCHLOROTHIAZIDE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "HYDROCHLOROTHIAZIDE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Should I take ERYTHROMYCIN?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ERYTHROMYCIN"]], "act": "question"}]}
{"index": 0, "text": "ERYTHROMYCIN may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "liver_problems", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "liver_problems"]], "act": "inform"}]}
{"index": 1, "text": "The most frequent side effects of oral erythromycin preparations are gastrointestinal and are dose-related. They include nausea, vomiting, abdominal pain, diarrhea and anorexia. Symptoms of hepatitis, hepatic dysfunction and/or abnormal liver function test results may occur. (See WARNINGS section.) Onset of pseudomembranous colitis symptoms may occur during or after antibacterial treatment. (See WARNINGS section.) Erythromycin has been associated with QT prolongation and ventricular arrhythmias, including ventricular tachycardia and torsades de pointes. (See WARNINGS .) Allergic reactions ranging from urticaria to anaphylaxis have occurred. Skin reactions ranging from mild eruptions to eryth", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant pregnant", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Fluocinonide", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluocinonide"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Calcium safe  if I am liver_problems?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Calcium"], ["<condition>", "liver_problems"]], "act": "question"}]}
{"index": 1, "text": "The following serious adverse reactions are also described elsewhere in the labeling: Arrhythmias with Concomitant Cardiac Glycoside Use \ufeff[see Warnings and Precautions ( \ufeff5.1 \ufeff)] End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates \ufeff[see Warnings and Precautions ( \ufeff5.2 \ufeff)] Tissue Necrosis and Calcinosis \ufeff[see Warnings and Precautions ( \ufeff5.5 \ufeff)] Hypotension, Bradycardia, and Cardiac Arrhythmias \ufeff[see Warnings and Precautions ( \ufeff5.5 \ufeff)] Aluminum toxicity \ufeff[see Warnings and precautions ( \ufeff5.5 \ufeff)] The following adverse reactions associated with the use of calcium gluconate were identified in the literature. Because these reactions are reported voluntarily from a population of u", "dialog_acts": [{"act": "information_retrieval+should_question"}]}

{"index": 0, "text": "is diarrhea a common side effect of CETIRIZINE?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CETIRIZINE"], ["<symptom>", "diarrhea"]], "act": "question"}]}
{"index": 0, "text": "diarrhea is a mild side effect of CETIRIZINE. Pediatric studies were conducted with cetirizine hydrochloride. More than 1300 pediatric patients aged 6 to 11 years with more than 900 treated with cetirizine hydrochloride at doses of 1.25 to 10 mg per day were included in controlled and uncontrolled clinical trials conducted in the United States. The duration of treatment ranged from 2 to 12 weeks. Placebo-controlled trials up to 4 weeks duration included 168 pediatric patients aged 2 to 5 years who received cetirizine, the majority of whom received single daily doses of 5 mg. A placebo-controlled trial 18 months in duration included 399 patients aged 12 to 24 months treated with cetirizine (0.25 mg/kg bid), and another placebo-controlled", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "actually i meant Griseofulvin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Griseofulvin"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant depression", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "depression"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "depression is a common side effect of Griseofulvin. There have been post-marketing reports of severe skin and hepatic adverse events associated with griseofulvin use (see WARNINGS section). When adverse reactions occur, they are most commonly of the hypersensitivity type, such as skin rashes, urticaria, and rarely, angioneurotic edema, and erythema multiforme. These may necessitate withdrawal of therapy and appropriate countermeasures. Peripheral neuropathy and paresthesias of the hands and feet have been reported and may be related to treatment duration. Most patients treated with griseofulvin for less than six months experienced improvement or resolution of their neuropathy upon withdrawal of the griseofulvin. Other side effects reported oc", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I store Nifedipine?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nifedipine"]], "act": "question"}]}
{"index": 1, "text": "what version of Nifedipine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Nifedipine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant gabapentin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "gabapentin"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "do I need to keep DILTIAZEM in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "DILTIAZEM"]], "act": "question"}]}
{"index": 0, "text": "what version of DILTIAZEM is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug DILTIAZEM", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant North", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "North"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "what are the ingredients of Eprosartan?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Eprosartan"]], "act": "question"}]}
{"index": 0, "text": "what version of Eprosartan is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "EPROSARTAN MESYLATE,AMMONIA,FERROSOFERRIC OXIDE,SILICON DIOXIDE,CROSPOVIDONE, UNSPECIFIED,HYDROXYPROPYL CELLULOSE, UNSPECIFIED,HYPROMELLOSE, UNSPECIFIED,LACTOSE MONOHYDRATE,MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE,POLYETHYLENE GLYCOL, UNSPECIFIED,POLYSORBATE 80,POVIDONE, UNSPECIFIED,STARCH, CORN,PROPYLENE GLYCOL,SHELLAC,TITANIUM DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I store NUCYNTA?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NUCYNTA"]], "act": "question"}]}
{"index": 0, "text": "what version of NUCYNTA is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug NUCYNTA", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "does Once contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Once"]], "act": "question"}]}
{"index": 0, "text": "what version of Once is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "METHYLPHENIDATE HYDROCHLORIDE,SUCROSE,STARCH, CORN,ETHYLCELLULOSE, UNSPECIFIED,OLEIC ACID,MEDIUM-CHAIN TRIGLYCERIDES,TITANIUM DIOXIDE,GELATIN, UNSPECIFIED,SHELLAC,PROPYLENE GLYCOL,HYPROMELLOSE, UNSPECIFIED,POLYETHYLENE GLYCOL, UNSPECIFIED,FERROSOFERRIC OXIDE,FD&C BLUE NO. 2,FERRIC OXIDE YELLOW,SODIUM HYDROXIDE,POVIDONE, UNSPECIFIED,METHYLPHENIDATE HYDROCHLORIDE,SUCROSE,STARCH, CORN,ETHYLCELLULOSE, UNSPECIFIED,OLEIC ACID,MEDIUM-CHAIN TRIGLYCERIDES,TITANIUM DIOXIDE,GELATIN, UNSPECIFIED,SHELLAC,PROPYLENE GLYCOL,HYPROMELLOSE, UNSPECIFIED,POLYETHYLENE GLYCOL, UNSPECIFIED,FERROSOFERRIC OXIDE,FD&C BLUE NO. 2,SODIUM HYDROXIDE,POVIDONE, UNSPECIFIED,METHYLPHENIDATE HYDROCHLORIDE,SUCROSE,STARCH, CORN,E", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "METHYLPHENIDATE HYDROCHLORIDE,SUCROSE,STARCH, CORN,ETHYLCELLULOSE, UNSPECIFIED,OLEIC ACID,MEDIUM-CHAIN TRIGLYCERIDES,TITANIUM DIOXIDE,GELATIN, UNSPECIFIED,SHELLAC,PROPYLENE GLYCOL,HYPROMELLOSE, UNSPECIFIED,POLYETHYLENE GLYCOL, UNSPECIFIED,FERROSOFERRIC OXIDE,FD&C BLUE NO. 2,FERRIC OXIDE YELLOW,SODIUM HYDROXIDE,POVIDONE, UNSPECIFIED,METHYLPHENIDATE HYDROCHLORIDE,SUCROSE,STARCH, CORN,ETHYLCELLULOSE, UNSPECIFIED,OLEIC ACID,MEDIUM-CHAIN TRIGLYCERIDES,TITANIUM DIOXIDE,GELATIN, UNSPECIFIED,SHELLAC,PROPYLENE GLYCOL,HYPROMELLOSE, UNSPECIFIED,POLYETHYLENE GLYCOL, UNSPECIFIED,FERROSOFERRIC OXIDE,FD&C BLUE NO. 2,SODIUM HYDROXIDE,POVIDONE, UNSPECIFIED,METHYLPHENIDATE HYDROCHLORIDE,SUCROSE,STARCH, CORN,E", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 4, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what do I do with phendimetrazine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "phendimetrazine"]], "act": "question"}]}
{"index": 0, "text": "what version of phendimetrazine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Usual Adult Dosage: 1 tablet (35 mg) twice a day or three times a day one hour before meals. Dosage should be individualized to obtain an adequate response with the lowest effective dosage. In some cases, 1/2 tablet (17.5 mg) per dose may be adequate. Dosage should not exceed 2 tablets three times a day.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how many Rocuronium is the correct dose for a child?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Rocuronium"], ["<age_group>", "child"]], "act": "question"}]}
{"index": 0, "text": "what version of Rocuronium is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for Rocuronium is 2 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "The dosage for Rocuronium is 2 mcg per 4 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "can i take LEVOPHED  if I have low_blood_pressure?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LEVOPHED"], ["<condition>", "low_blood_pressure"]], "act": "question"}]}
{"index": 0, "text": "The following reactions can occur: Body As A Whole: Ischemic injury due to potent vasoconstrictor action and tissue hypoxia. Cardiovascular System: Bradycardia, probably as a reflex result of a rise in blood pressure, arrhythmias. Nervous System: Anxiety, transient headache. Respiratory System: Respiratory difficulty. Skin and Appendages: Extravasation necrosis at injection site. Prolonged administration of any potent vasopressor may result in plasma volume depletion which should be continuously corrected by appropriate fluid and electrolyte replacement therapy. If plasma volumes are not corrected, hypotension may recur when LEVOPHED is discontinued, or blood pressure may be maintained at th", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 1, "text": "actually i meant Cabergoline", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cabergoline"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "actually i meant tourettes", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "The safety of cabergoline tablets have been evaluated in more than 900 patients with hyperprolactinemic disorders. Most adverse events were mild or moderate in severity. In a 4-week, double-blind, placebo-controlled study, treatment consisted of placebo or cabergoline at fixed doses of 0.125, 0.5, 0.75, or 1.0 mg twice weekly. Doses were halved during the first week. Since a possible dose-related effect was observed for nausea only, the four cabergoline treatment groups have been combined. The incidence of the most common adverse events during the placebo-controlled study is presented in the following table. Incidence of Reported Adverse Events During the 4-week, Double-Blind, Placebo-Contro", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 4, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Prazosin?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Prazosin"]], "act": "question"}]}
{"index": 1, "text": "Prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. F", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Silver?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Silver"]], "act": "question"}]}
{"index": 0, "text": "Silver sulfadiazine cream, USP 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant FLURANDRENOLIDE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "FLURANDRENOLIDE"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "Flurandrenolide ointment is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 3, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "Should I take Azithromycin?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Azithromycin"]], "act": "question"}]}
{"index": 0, "text": "Azithromycin may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "pregnant", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "pregnant"]], "act": "inform"}]}
{"index": 1, "text": "In clinical trials, most of the reported side effects were mild to moderate in severity and were reversible upon discontinuation of the drug. Potentially serious side effects of angioedema and cholestatic jaundice were reported rarely. Approximately 0.7% of the patients (adults and pediatric patients) from the 5-day multiple-dose clinical trials discontinued azithromycin therapy because of treatment-related side effects. In adults given 500 mg/day for 3 days, the discontinuation rate due to treatment-related side effects was 0.6%. In clinical trials in pediatric patients given 30 mg/kg, either as a single dose or over 3 days, discontinuation from the trials due to treatment-related side effe", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 2, "text": "actually i meant Cortef", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cortef"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "anxiety"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "is it normal to have fever with Methylprednisolone?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Methylprednisolone"], ["<symptom>", "fever"]], "act": "question"}]}
{"index": 0, "text": "fever is a mild side effect of Methylprednisolone. The following adverse reactions have been reported with methylprednisolone sodium succinate or other corticosteroids: Allergic reactions: Allergic or hypersensitivity reactions, anaphylactoid reaction, anaphylaxis, angioedema. Blood and lymphatic system disorders: Leukocytosis. Cardiovascular: Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction (see WARNINGS ), pulmonary edema, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis. Dermatologic: Acne, allergic dermatitis, burnin", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "What is Captopril?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Captopril"]], "act": "question"}]}
{"index": 1, "text": "Hypertension: Captopril tablets US?are indicated for the Teatment of hypertension. tn using captopril, conslderallon should be gtven to the risk of neutropenia!agranutocytosls (seeWARNINGS). Captoprll maybe used as Initial therapy for patientswilh normal renal function, In whomthe rlskls relatively low. In patients with impaired renal function, particularly those wfth collagen vascular olSeas6, captopril should be reseNed for,hypertenslves who have either develoPed unacceptable side effecls on otherdrugs, orhave failed to responq satislactorily 10drug cOmbinations. Captopril is effective alone and in combination with other antihypertensive agents, ~peclally thiazide-type diuretics. The blood", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 2, "text": "actually i meant GUANIDINE", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "GUANIDINE"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "Guanidine is indicated for the reduction of the symptoms of muscle weakness and easy fatigability associated with the myasthenic syndrome of Eaton-Lambert. It is not indicated for treating myasthenia gravis. The Eaton-Lambert syndrome is ordinarily differentiated from myasthenia gravis by the usual association of the syndrome with small cell carcinoma of the lung, but myography may be necessary to make the diagnosis.", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how much ALPRAZOLAM should i take for a baby?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ALPRAZOLAM"], ["<age_group>", "baby"]], "act": "question"}]}
{"index": 1, "text": "what version of ALPRAZOLAM is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for ALPRAZOLAM is 1 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant child", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "child"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The dosage for ALPRAZOLAM is 2 mg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of Sildenafil?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Sildenafil"]], "act": "question"}]}
{"index": 1, "text": "what version of Sildenafil is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "SILDENAFIL CITRATE,CELLULOSE, MICROCRYSTALLINE,CROSCARMELLOSE SODIUM,SILICON DIOXIDE,MAGNESIUM STEARATE,Hydroxypropyl Cellulose (Type H),HYPROMELLOSE 2910 (15000 MPA.S),POLYETHYLENE GLYCOL 8000,TITANIUM DIOXIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "do I need to keep CEFACLOR in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CEFACLOR"]], "act": "question"}]}
{"index": 0, "text": "what version of CEFACLOR is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug CEFACLOR", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Calcipotriene", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Calcipotriene"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 4, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 4, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I use Cardizem?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Cardizem"]], "act": "question"}]}
{"index": 1, "text": "what version of Cardizem is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Patients controlled on diltiazem alone or in combination with other medications may be switched to CARDIZEM CD capsules at the nearest equivalent total daily dose. Higher doses of CARDIZEM CD may be needed in some patients. Monitor patients closely. Subsequent titration to higher or lower doses may be necessary. There is limited general clinical experience with doses above 360 mg, but doses to 540 mg have been studied in clinical trials. The incidence of side effects increases as the dose increases with first-degree AV block, dizziness, and sinus bradycardia bearing the strongest relationship to dose. Hypertension: Adjust dosage to individual patient needs. When used as monotherapy, reasonab", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Loestrin", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Loestrin"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "The tablet dispenser has been designed to make oral contraceptive dosing as easy and as convenient as possible. The tablets are arranged in either three or four rows of seven tablets each, with the days of the week appearing on the tablet dispenser above the first row of tablets. Note: Each tablet dispenser has been preprinted with the days of the week, starting with Sunday, to facilitate a Sunday-Start regimen. Six different days of the week stickers have been provided with the Detailed Patient & Brief Summary Patient Package Insert in order to accommodate a Day-1 Start regimen. If the patient is using the Day-1 Start regimen, she should place the self-adhesive days of the week sticker that", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Diclofenac in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Diclofenac"]], "act": "question"}]}
{"index": 1, "text": "what version of Diclofenac is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Diclofenac", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep LMD in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "LMD"]], "act": "question"}]}
{"index": 1, "text": "what version of LMD is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug LMD", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "What is Oxycodone?", "goals": {"question": "what_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxycodone"]], "act": "question"}]}
{"index": 0, "text": "OXYCODONE HCl EXTENDED-RELEASE TABLETS are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate in:  Adults; and  Opioid-tolerant pediatric patients 11 years of age and older who are already receiving and tolerate a minimum daily opioid dose of at least 20 mg oxycodone orally or its equivalent. Limitations of Use  Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see Warnings and Precautions (5.1)], reserve OXYCODONE HCl EXTENDED-RELE", "dialog_acts": [{"act": "information_retrieval+what_question"}]}
{"index": 1, "text": "actually i meant Oxycodone", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Oxycodone"]], "act": "update"}]}
{"index": 1, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 2, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 2, "text": "OXYCODONE HCl EXTENDED-RELEASE TABLETS are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate in:  Adults; and  Opioid-tolerant pediatric patients 11 years of age and older who are already receiving and tolerate a minimum daily opioid dose of at least 20 mg oxycodone orally or its equivalent. Limitations of Use  Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see Warnings and Precautions (5.1)], reserve OXYCODONE HCl EXTENDED-RELE", "dialog_acts": [{"act": "information_retrieval+what_question"}]}

{"index": 0, "text": "do I need to keep Azulfidine in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Azulfidine"]], "act": "question"}]}
{"index": 0, "text": "what version of Azulfidine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Azulfidine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is blurred_vision a common side effect of Pantoprazole?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Pantoprazole"], ["<symptom>", "blurred_vision"]], "act": "question"}]}
{"index": 0, "text": "blurred_vision is a dangerous side effect of Pantoprazole. The following serious adverse reactions are described below and elsewhere in labeling:  Acute Interstitial Nephritis [see Warnings and Precautions (5.2)]  Clostridium difficile-Associated Diarrhea [see Warnings and Precautions (5.3)]  Bone Fracture [see Warnings and Precautions (5.4)]  Cutaneous and Systemic Lupus Erythematosus [see Warnings and Precautions (5.5)]  Cyanocobalamin (Vitamin B-12) Deficiency [see Warnings and Precautions (5.6 )]  Hypomagnesemia [see Warnings and Precautions (5.7)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to ra", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 1, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 1, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how much BuPROPion should i take for a adult?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "BuPROPion"], ["<age_group>", "adult"]], "act": "question"}]}
{"index": 0, "text": "what version of BuPROPion is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 2, "text": "The dosage for BuPROPion is 3 mcg per weekly", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 3, "text": "actually i meant 80", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<strength>", "80"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant baby", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<age_group>", "baby"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Bicillin for a child?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Bicillin"], ["<age_group>", "child"]], "act": "question"}]}
{"index": 1, "text": "what version of Bicillin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Bicillin is 2 mg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is in HALOG?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "HALOG"]], "act": "question"}]}
{"index": 1, "text": "what version of HALOG is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "HALCINONIDE,POLYETHYLENE GLYCOL 300,POLYETHYLENE GLYCOL 400,POLYETHYLENE GLYCOL 1450,POLYETHYLENE GLYCOL 6000,BUTYLATED HYDROXYTOLUENE,MINERAL OIL", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hi", "goals": {"greeting": "hi"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how many Fluconazole is the correct dose?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluconazole"]], "act": "question"}]}
{"index": 1, "text": "for which age group?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "elderly", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<age_group>", "elderly"]], "act": "inform"}]}
{"index": 2, "text": "what version of Fluconazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 3, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 4, "text": "70", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "70"]], "act": "inform"}]}
{"index": 4, "text": "The dosage for Fluconazole is 4 mcg per 6 hours", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}

{"index": 0, "text": "do I need to keep Ammonia in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ammonia"]], "act": "question"}]}
{"index": 0, "text": "what version of Ammonia is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Ammonia", "dialog_acts": [{"act": "information_retrieval+store_question"}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the ingredients of NUCYNTA?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "NUCYNTA"]], "act": "question"}]}
{"index": 1, "text": "what version of NUCYNTA is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 2, "text": "TAPENTADOL HYDROCHLORIDE,MICROCRYSTALLINE CELLULOSE,lactose monohydrate,croscarmellose sodium,POVIDONE, UNSPECIFIED,magnesium stearate,POLYVINYL ALCOHOL, UNSPECIFIED,titanium dioxide,POLYETHYLENE GLYCOL, UNSPECIFIED,talc,aluminum oxide", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "is it normal to have tiredness with 50%?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "50%"], ["<symptom>", "tiredness"]], "act": "question"}]}
{"index": 0, "text": "tiredness is a dangerous side effect of 50%. Hyperosmolar syndrome, resulting from excessively rapid administration of concentrated dextrose may cause mental confusion and/or loss of consciousness. Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}

{"index": 0, "text": "what do I do with Promethazine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Promethazine"]], "act": "question"}]}
{"index": 0, "text": "what version of Promethazine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Promethazine and phenylephrine hydrochloride oral solution is contraindicated for children under 2 years of age ( see WARNINGS \u2013 Black Box Warning and Use In Pediatric Patients ). The recommended doses are given in the following table: Adults And Children 12 Years And Over 1 teaspoonful (5 mL) every 4 to 6 hours, not to exceed 6 teaspoonsful (30 mL) in 24 hours. Children 6 To Under 12 Years Of Age \u00bd to 1 teaspoonful (2.5 to 5 mL) every 4 to 6 hours, not to exceed 6 teaspoonsful (30 mL) in 24 hours. Children 2 To Under 6 Years Of Age \u00bc to \u00bd teaspoonful (1.25 to 2.5 mL) every 4 to 6 hours.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant ESTRADIOL", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "ESTRADIOL"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "When estrogen is prescribed for a postmenopausal woman with a uterus, progestin should also be initiated to reduce the risk of endometrial cancer. A woman without a uterus does not need progestin. Use of estrogen, alone or in combination with a progestin, should be with the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Patients should be reevaluated periodically as clinically appropriate (e.g., 3-month to 6-month intervals) to determine if treatment is still necessary (See BOXED WARNINGS and WARNINGS ). For women who have a uterus, adequate diagnostic measures, such as endometrial sampling, when indicated, should be un", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good morning", "goals": {"greeting": "good morning"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "do I need to keep Rx in the dark?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Rx"]], "act": "question"}]}
{"index": 1, "text": "what version of Rx is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug Rx", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "actually i meant Betoptic", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Betoptic"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "where should I keep Antabuse?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Antabuse"]], "act": "question"}]}
{"index": 0, "text": "what version of Antabuse is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Antabuse", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant intravenous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Cyclobenzaprine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Cyclobenzaprine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "storage instructions for drug Cyclobenzaprine", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what is the dose for Timoptic-XE for a elderly?", "goals": {"question": "dose_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Timoptic-XE"], ["<age_group>", "elderly"]], "act": "question"}]}
{"index": 1, "text": "what version of Timoptic-XE is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 2, "text": "what is the strength of the drug?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 3, "text": "60", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<strength>", "60"]], "act": "inform"}]}
{"index": 3, "text": "The dosage for Timoptic-XE is 4 mg per daily", "dialog_acts": [{"act": "information_retrieval+dose_question"}]}
{"index": 4, "text": "actually i meant Sterile", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Sterile"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 5, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 6, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 6, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 7, "text": "ok thanks", "goals": {"bye": "ok thanks"}, "db_result": null, "dialog_acts": []}
{"index": 7, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I take Olanzapine?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Olanzapine"]], "act": "question"}]}
{"index": 0, "text": "what version of Olanzapine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "subcutaneous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "inform"}]}
{"index": 1, "text": " Tag is not standard, found but no info or does not exist!", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Nalbuphine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Nalbuphine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "is diarrhea a common side effect of CEFACLOR?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "CEFACLOR"], ["<symptom>", "diarrhea"]], "act": "question"}]}
{"index": 1, "text": "diarrhea is a common side effect of CEFACLOR. Adverse effects considered to be related to therapy with cefaclor are listed below: Hypersensitivity reactions have been reported in about 1.5% of patients and include morbilliform eruptions (1 in 100). Pruritus, urticaria, and positive Coombs\u2019 tests each occur in less than 1 in 200 patients. Cases of serum-sickness-like reactions have been reported with the use of cefaclor. These are characterized by findings of erythema multiforme, rashes, and other skin manifestations accompanied by arthritis/arthralgia, with or without fever, and differ from classic serum sickness in that there is infrequently associated lymphadenopathy and proteinuria, no circulating immune complexes, and no evidence to", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 2, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "anxiety"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 3, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "do I need to keep Ribavirin in the fridge?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Ribavirin"]], "act": "question"}]}
{"index": 0, "text": "what version of Ribavirin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "storage instructions for drug Ribavirin", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 2, "text": "actually i meant Pyridostigmine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Pyridostigmine"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "what are the ingredients of Hyoscyamine?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Hyoscyamine"]], "act": "question"}]}
{"index": 0, "text": "what version of Hyoscyamine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "HYOSCYAMINE SULFATE,SILICON DIOXIDE,HYDROXYPROPYL CELLULOSE (1200000 MW),MAGNESIUM STEARATE,MICROCRYSTALLINE CELLULOSE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "how do I use Nitrofurantoin?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Nitrofurantoin"]], "act": "question"}]}
{"index": 0, "text": "what version of Nitrofurantoin is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "Nitrofurantoin should be given with food to improve drug absorption and, in some patients, tolerance. Adults 50 to 100 mg four times a day -- the lower dosage level is recommended for uncomplicated urinary tract infections. Pediatric Patients 5 to 7 mg/kg of body weight per 24 hours, given in four divided doses (contraindicated under one month of age). The following table is based on an average weight in each range receiving 5 to 6 mg/kg of body weight per 24 hours, given in four divided doses. It can be used to calculate an average dose of nitrofurantoin oral suspension (25 mg/5 mL) for pediatric patients. Table 3: Pediatric Dosing Table Pediatric Doses (milliliters) and Weight in Kilograms", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Methenamine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Methenamine"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "One tablet (1 g) twice daily for adults and children over 12 years of age. One-half tablet or one tablet (0.5 or 1 g) twice daily for children 6 to 12 years of age. The antibacterial activity of Methenamine Hippurate Tablets is greater in acid urine. Therefore, restriction of alkalinizing foods and medications is desirable. If necessary, as indicated by urinary pH and clinical response, supplemental acidification of the urine may be instituted. The efficacy of therapy should be monitored by repeated urine cultures.", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 5, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 5, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take ALLERGENIC?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "ALLERGENIC"]], "act": "question"}]}
{"index": 1, "text": "what version of ALLERGENIC is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "Prior to administering skin tests, the skin should be cleaned with alcohol and allowed to dry completely. The tests should be placed on the volar surface of the forearm and four rows may be placed on the back. INTRADERMAL TEST The intradermal test is performed by administering 0.1 mL of extract into the skin. The injection should be given as superficially as possible creating a distinct bleb approximately 5 mm in diameter. The tests should be examined after 15 - 20 minutes and read as negative or positive. Test sites that show a wheal and flare response should be measured and reported in mm of edema and erythema or scored as 1+ to 4+ based on a mm reference scale. Induration after 24 - 48 ho", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant subcutaneous", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "subcutaneous"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Thermazene", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Thermazene"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Omeprazole contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Omeprazole"]], "act": "question"}]}
{"index": 0, "text": "what version of Omeprazole is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "OMEPRAZOLE,CROSPOVIDONE (15 MPA.S AT 5%),HYPROMELLOSE, UNSPECIFIED,magnesium stearate,mannitol,meglumine,methacrylic acid - ethyl acrylate copolymer (1:1) type A,shellac,poloxamer 407,POVIDONE, UNSPECIFIED,triethyl citrate,D&C Red No. 28,FD&C Blue No. 1,FD&C Red No. 40,FD&C Yellow No. 6,ferric oxide yellow,GELATIN, UNSPECIFIED,silicon dioxide,sodium lauryl sulfate,titanium dioxide,butyl alcohol,propylene glycol", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 2, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "Is Guanfacine safe?", "goals": {"question": "should_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Guanfacine"]], "act": "question"}]}
{"index": 1, "text": "Guanfacine may not be recommended for people with <contraindications>, do you have any of these?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "tourettes", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<condition>", "tourettes"]], "act": "inform"}]}
{"index": 2, "text": "Adverse reactions noted with guanfacine are similar to those of other drugs of the central \u03b1 2 adrenoreceptor agonist class: dry mouth, sedation (somnolence), weakness (asthenia), dizziness, constipation, and impotence. While the reactions are common, most are mild and tend to disappear on continued dosing. Skin rash with exfoliation has been reported in a few cases; although clear cause and effect relationships to guanfacine could not be established, should a rash occur, guanfacine should be discontinued and the patient monitored appropriately. In the dose-response monotherapy study described under CLINICAL PHARMACOLOGY , the frequency of the most commonly observed adverse reactions showed ", "dialog_acts": [{"act": "information_retrieval+should_question"}]}
{"index": 3, "text": "actually i meant Levalbuterol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Levalbuterol"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant IBD", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<condition>", "IBD"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}
{"index": 6, "text": "thank you", "goals": {"bye": "thank you"}, "db_result": null, "dialog_acts": []}
{"index": 6, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "does Lidocaine contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Lidocaine"]], "act": "question"}]}
{"index": 0, "text": "what version of Lidocaine is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 1, "text": "LIDOCAINE,PRILOCAINE,WATER,POLYOXYL 40 HYDROGENATED CASTOR OIL,SODIUM HYDROXIDE,CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hi there", "goals": {"greeting": "hi there"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "where should I keep PAMELOR?", "goals": {"question": "store_question"}, "dialog_acts": [{"slots": [["<drug_name>", "PAMELOR"]], "act": "question"}]}
{"index": 1, "text": "what version of PAMELOR is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "storage instructions for drug PAMELOR", "dialog_acts": [{"act": "information_retrieval+store_question"}]}
{"index": 3, "text": "thanks", "goals": {"bye": "thanks"}, "db_result": null, "dialog_acts": []}
{"index": 3, "text": "no problem", "dialog_acts": [{"act": "bye", "slot": []}]}

{"index": 0, "text": "good afternoon", "goals": {"greeting": "good afternoon"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "how do I take Doxycycline?", "goals": {"question": "usage_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Doxycycline"]], "act": "question"}]}
{"index": 1, "text": "what version of Doxycycline is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "oral", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "inform"}]}
{"index": 2, "text": "THE USUAL DOSAGE AND FREQUENCY OF ADMINISTRATION OF DOXYCYCLINE DIFFERS FROM THAT OF THE OTHER TETRACYCLINES. EXCEEDING THE RECOMMENDED DOSAGE MAY RESULT IN AN INCREASED INCIDENCE OF SIDE EFFECTS. Adults: The usual dose of oral doxycycline is 200 mg on the first day of treatment (administered 100 mg every 12 hours or 50 mg every 6 hours) followed by a maintenance dose of 100 mg/day. The maintenance dose may be administered as a single dose or as 50 mg every 12 hours. In the management of more severe infections (particularly chronic infections of the urinary tract), 100 mg every 12 hours is recommended. Pediatric Patients: For all pediatric patients weighing less than 45 kg with severe or lif", "dialog_acts": [{"act": "information_retrieval+usage_question"}]}
{"index": 3, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Fluoxetine", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Fluoxetine"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

{"index": 0, "text": "does Desoxyn contain <ingredient>?", "goals": {"question": "ingredient_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Desoxyn"]], "act": "question"}]}
{"index": 0, "text": "what version of Desoxyn is that, for example: oral, intravenous or subcutaneous?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 1, "text": "intravenous", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<delivery>", "intravenous"]], "act": "inform"}]}
{"index": 1, "text": "STARCH, CORN,LACTOSE, UNSPECIFIED FORM,AMINOBENZOATE SODIUM,STEARIC ACID,TALC,METHAMPHETAMINE HYDROCHLORIDE,STARCH, CORN,LACTOSE, UNSPECIFIED FORM,AMINOBENZOATE SODIUM,STEARIC ACID,TALC,METHAMPHETAMINE HYDROCHLORIDE", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}
{"index": 2, "text": "actually i meant oral", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<delivery>", "oral"]], "act": "update"}]}
{"index": 2, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 3, "text": "actually i meant Acetic", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Acetic"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 4, "text": "ACETIC ACID", "dialog_acts": [{"act": "information_retrieval+ingredient_question"}]}

{"index": 0, "text": "hello", "goals": {"greeting": "hello"}, "db_result": null, "dialog_acts": []}
{"index": 0, "text": "hello, what can I help you with today?", "dialog_acts": [{"act": "welcomemsg", "slot": []}]}
{"index": 1, "text": "what are the side effects of Potassium?", "goals": {"question": "side_effect_question"}, "dialog_acts": [{"slots": [["<drug_name>", "Potassium"]], "act": "question"}]}
{"index": 1, "text": "these are some common side effects of Potassium: <side_effects>, are you seeing any other symptoms?", "dialog_acts": [{"act": "request_information+<units>"}]}
{"index": 2, "text": "vomiting", "goals": {"act": "inform"}, "dialog_acts": [{"slots": [["<symptom>", "vomiting"]], "act": "inform"}]}
{"index": 2, "text": "vomiting is a serious side effect of Potassium. The following adverse reactions associated with the use of Potassium Chloride in 5% Dextrose Injection, USP were identified in clinical trials or postmarketing reports. Because these reactions were reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency, reliably, or to establish a causal relationship to drug exposure. Hypersensitivity reactions : including anaphylaxis and chills. General disorders and administration site conditions : Infusion site rash, Infusion site pain. Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis ", "dialog_acts": [{"act": "information_retrieval+side_effect_question"}]}
{"index": 3, "text": "actually i meant anxiety", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<symptom>", "anxiety"]], "act": "update"}]}
{"index": 3, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 4, "text": "actually i meant Danazol", "goals": {"act": "update"}, "dialog_acts": [{"slots": [["<drug_name>", "Danazol"]], "act": "update"}]}
{"index": 4, "text": "ok, is there anything else to update?", "dialog_acts": [{"act": "check_update"}]}
{"index": 5, "text": "no", "goals": {}, "dialog_acts": []}
{"index": 5, "text": "sorry, there is no information for that.", "dialog_acts": [{"act": "no_information"}]}

